WO2015198859A1 - Condensed heterocyclic compound - Google Patents

Condensed heterocyclic compound Download PDF

Info

Publication number
WO2015198859A1
WO2015198859A1 PCT/JP2015/066673 JP2015066673W WO2015198859A1 WO 2015198859 A1 WO2015198859 A1 WO 2015198859A1 JP 2015066673 W JP2015066673 W JP 2015066673W WO 2015198859 A1 WO2015198859 A1 WO 2015198859A1
Authority
WO
WIPO (PCT)
Prior art keywords
compound
group
formula
compounds
reaction
Prior art date
Application number
PCT/JP2015/066673
Other languages
French (fr)
Japanese (ja)
Inventor
貴將 田邊
亮太 前畑
綾香 長谷部
慎哉 西村
Original Assignee
住友化学株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 住友化学株式会社 filed Critical 住友化学株式会社
Publication of WO2015198859A1 publication Critical patent/WO2015198859A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/64Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with three nitrogen atoms as the only ring hetero atoms
    • A01N43/647Triazoles; Hydrogenated triazoles
    • A01N43/6531,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/74Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,3
    • A01N43/761,3-Oxazoles; Hydrogenated 1,3-oxazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Definitions

  • the present invention relates to certain condensed heterocyclic compounds and their use for pest control.
  • An object of the present invention is to provide a compound having an excellent control effect against pests and a method for controlling pests using the compound.
  • the condensed heterocyclic compound represented by the following formula (1) has an excellent control effect against pests.
  • R 1 is a hydrogen atom, a C1-C3 alkyl group optionally having one or more halogen atoms, a halogen atom, a C1-C3 alkoxy group, a C2-C4 alkoxycarbonyl group, S (O) m R 2 , NR 3 R 4 represents a nitro group or a cyano group, R 2 represents a C1-C3 alkyl group, R 3 and R 4 each independently represents a hydrogen atom or a C1-C3 alkyl group, R 5 represents a C1-C3 perfluoroalkyl group or S (O) p —R 6 , R 6 represents a C1-C3 perfluoroalkyl group, n represents 0, 1 or 2, m represents 0, 1 or 2; p represents 0, 1 or 2.
  • a condensed heterocyclic compound represented by the following (hereinafter referred to as the present compound).
  • [2] The compound according to [1], wherein A is NCH 3 .
  • [3] The compound according to [1], wherein A is an oxygen atom.
  • R 1 is a hydrogen atom, a C1-C3 alkyl group optionally having one or more halogen atoms, a halogen atom, a C1-C3 alkoxy group, or S (O) m R 2 [1] ]
  • R 1 is a hydrogen atom, a C1-C3 alkyl group optionally having one or more halogen atoms, a halogen atom, a C1-C3 alkoxy group, or S (O) m R 2 [1] ]
  • S (O) m R 2 [1]
  • the compound of the present invention is useful as an active ingredient of a pest control agent because it has an excellent control activity against pests.
  • halogen atom means a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
  • examples of the “C1-C3 alkyl group” include a methyl group, an ethyl group, a propyl group, and an isopropyl group.
  • the “C1-C3 alkyl group optionally having one or more halogen atoms” refers to a C1-C3 alkyl group in which at least one hydrogen atom may be substituted with a halogen atom.
  • Represents a C3 alkyl group for example, fluoromethyl group, chloromethyl group, bromomethyl group, iodomethyl group, difluoromethyl group, dichloromethyl group, trifluoromethyl group, chlorodifluoromethyl group, bromodifluoromethyl group, trichloromethyl group, 2- Examples include fluoroethyl group, 2-chloroethyl group, 2-bromoethyl group, 2,2-difluoroethyl group, 2,2,2-trifluoroethyl group, pentafluoroethyl group, heptafluoropropyl group and heptafluoroisopropyl group. .
  • the “C1-C3 perfluoroalkyl group” represents a C1-C3 alkyl group in which all hydrogen atoms are substituted with fluorine atoms, specifically, a trifluoromethyl group, a pentafluoroethyl group, a heptafluoropropyl group, A heptafluoroisopropyl group is mentioned.
  • examples of the “C1-C3 alkoxy group” include a methoxy group, an ethoxy group, a propyloxy group, and an isopropyloxy group.
  • examples of the “C1-C3 alkylamino group” include a methylamino group, an ethylamino group, a propylamino group, and an isopropylamino group.
  • the “di (C1-C3 alkyl) amino group” includes N, N-dimethylamino group, N, N-diethylamino group, N, N-dipropylamino group, N, N-diisopropylamino group, N-methyl-N-ethylamino group, N-methyl-N-propylamino group, N-methyl-N-isopropylamino group, N-ethyl-N-propylamino group, and N-ethyl-N-isopropylamino group Is mentioned.
  • C2-C4 alkoxycarbonyl group represents a group in which a C1-C3 alkoxy group and a carbonyl group are bonded, and represents a methoxycarbonyl group, an ethoxycarbonyl group, a propoxycarbonyl group, or an isopropoxycarbonyl group.
  • S (O) m R 2 represents a C1-C3 alkylsulfanyl group in which m is 0, an alkylsulfinyl group in which m is 1 and an alkylsulfonyl group in which m is 2.
  • the C1-C3 alkylsulfanyl group represents a methylsulfanyl group, an ethylsulfanyl group, a propylsulfanyl group, and an isopropylsulfanyl group.
  • the C1-C3 alkylsulfinyl group represents a methylsulfinyl group, an ethylsulfinyl group, a propylsulfinyl group, and an isopropylsulfinyl group.
  • the C1-C3 alkylsulfonyl group represents a methylsulfonyl group, an ethylsulfonyl group, a propylsulfonyl group, and an isopropylsulfonyl group.
  • A is NCH 3
  • R 1 is a hydrogen atom, a C1-C3 alkyl group optionally having one or more halogen atoms, a halogen atom, an amino group, or S (O) m R
  • A is NCH 3
  • R 1 is a hydrogen atom, a C1-C3 alkyl group, a halogen atom, an amino group, or S (O) m R 2
  • R 5 is CF 3 or S (O ) P CF 3 and n is 0, 1 or 2
  • A is NCH 3
  • R 1 is a hydrogen atom, a chlorine atom, a methyl group, an amino group, a methylsulfanyl group, a methylsulfinyl group, or a methylsulfony
  • A is an oxygen atom
  • R 1 is a hydrogen atom, a C1-C3 alkyl group optionally having one or more halogen atoms, a halogen atom, an amino group, or S (O) m R A compound in which R 5 is a C1-C3 perfluoroalkyl group or S (O) p R 6 , and n is 0, 1 or 2;
  • A is an oxygen atom
  • R 1 is a hydrogen atom, a C1-C3 alkyl group, a halogen atom, an amino group, or S (O) m R 2
  • R 5 is CF 3 or S (O ) P CF 3 and n is 0, 1 or 2
  • A is an oxygen atom
  • R 1 is a hydrogen atom, a chlorine atom, a methyl group, an amino group, a methylsulfanyl group, a methylsulfinyl group, or a methylsulf
  • a compound which is in the formula (1) compounds wherein A is NCH 3 , R 1 is a methylsulfanyl group, a methylsulfinyl group or a methylsulfonyl group, and R 5 is a C1-C3 perfluoroalkyl group; In the formula (1), compounds wherein A is NCH 3 , R 1 is a methylsulfanyl group or a methylsulfonyl group, and R 5 is a C1-C3 perfluoroalkyl group; In the formula (1), compounds wherein A is NCH 3 , R 1 is NR 3 R 4 and R 5 is a C1-C3 perfluoroalkyl group; In the formula (1), A is NCH 3, R 1 is an amino group, C1-C3 alkylamino group, di is (C1-C3 alkyl) amino group or a nitro group, R 5 is C1-C3 perfluoroalkyl A compound which is a group; In
  • compounds wherein A is NCH 3 , R 1 is a C1-C3 alkyl group optionally having one or more halogen atoms, and R 5 is S (O) p CF
  • a compound which is in the formula (1) a compound wherein A is an oxygen atom, R 1 is a methylsulfanyl group, a methylsulfinyl group or a methylsulfonyl group, and R 5 is a C1-C3 perfluoroalkyl group;
  • A is an oxygen atom, R 1 is an amino group, a C1-C3 alkylamino group, a di (C1-C3 alkyl) amino group or a nitro group, and R 5 is a C1-C3 perfluoro
  • the compound of the present invention and the production intermediate compound can be produced, for example, by any of the production methods 1 to 11 described below.
  • the reaction is performed in the presence of a solvent.
  • a solvent used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile, alcohols such as methanol and ethanol, acetic acid, water, and mixtures thereof.
  • the oxidizing agent used in the reaction include sodium periodate, m-chloroperbenzoic acid, and hydrogen peroxide.
  • a base or a catalyst may be added as necessary.
  • the base used for the reaction include sodium carbonate.
  • Examples of the catalyst used for the reaction include tungstic acid and sodium tungstate.
  • an oxidizing agent is usually used in a proportion of 1 to 1.2 mol.
  • the base is generally used at a ratio of 0.01 to 1 mol per 1 mol of the compound (1a) of the present invention.
  • the catalyst is generally used in a proportion of 0.01 to 0.5 mol per 1 mol of the compound (1a) of the present invention.
  • the reaction temperature is usually in the range of ⁇ 20 to 80 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • the reaction mixture is extracted with an organic solvent, and the organic layer is washed with an aqueous solution of a reducing agent (for example, sodium sulfite and sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary.
  • a reducing agent for example, sodium sulfite and sodium thiosulfate
  • a base for example, sodium bicarbonate
  • the compound (1b) of the present invention can be isolated by drying and concentrating the washed organic layer.
  • the isolated compound (1b) of the present invention can be further purified by chromatography, recrystallization and the like.
  • the reaction is usually performed in the presence of a solvent.
  • a solvent used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile, alcohols such as methanol and ethanol, acetic acid, water, and mixtures thereof.
  • the oxidizing agent used in the reaction include m-chloroperbenzoic acid and hydrogen peroxide.
  • a base or a catalyst may be added as necessary.
  • the base used for the reaction include sodium carbonate.
  • the catalyst used in the reaction include sodium tungstate.
  • the oxidizing agent is usually used at a ratio of 1 to 4 moles with respect to 1 mole of the compound (1b) of the present invention.
  • the oxidizing agent is used in a ratio of 1 to 2 moles relative to 1 mole of the compound (1b) of the present invention.
  • the base is generally used at a ratio of 0.01 to 1 mol per 1 mol of the compound (1b) of the present invention.
  • the catalyst is generally used in a proportion of 0.01 to 0.5 mol with respect to 1 mol of the compound (1b) of the present invention.
  • the reaction temperature is usually in the range of ⁇ 20 to 120 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • the reaction mixture is extracted with an organic solvent, and the organic layer is washed with an aqueous solution of a reducing agent (for example, sodium sulfite and sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary.
  • a reducing agent for example, sodium sulfite and sodium thiosulfate
  • a base for example, sodium bicarbonate
  • the compound (1c) of the present invention can be isolated by drying and concentrating the organic layer.
  • the compound (1c) of the present invention can be further purified by chromatography, recrystallization and the like.
  • this invention compound (1c) can be manufactured by a one-step reaction (one pot) by making this invention compound (1a) and an oxidizing agent react.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile, alcohols such as methanol and ethanol, acetic acid, water, and mixtures thereof.
  • the oxidizing agent used in the reaction include m-chloroperbenzoic acid and hydrogen peroxide. When hydrogen peroxide is used as the oxidizing agent for the reaction, it is carried out in the presence of a base or a catalyst as necessary.
  • Examples of the base used for the reaction include sodium carbonate.
  • Examples of the catalyst used for the reaction include tungstic acid and sodium tungstate.
  • an oxidizing agent is usually used at a ratio of 2 to 5 moles.
  • the base is generally used at a ratio of 0.01 to 1 mol per 1 mol of the compound (1a) of the present invention.
  • the catalyst is generally used in a proportion of 0.01 to 0.5 mol per 1 mol of the compound (1a) of the present invention.
  • the reaction temperature of the reaction is usually in the range of 0 to 120 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • the reaction mixture is extracted with an organic solvent, and the organic layer is washed with an aqueous solution of a reducing agent (for example, sodium sulfite and sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary.
  • a reducing agent for example, sodium sulfite and sodium thiosulfate
  • a base for example, sodium bicarbonate
  • the compound (1c) of the present invention can be isolated by drying and concentrating the organic layer.
  • the isolated compound (1c) of the present invention can be further purified by chromatography, recrystallization and the like.
  • the compound of the present invention comprises a compound represented by formula (M1) (hereinafter referred to as compound (M1)) and a compound represented by formula (M2) (hereinafter referred to as compound (M2)) as a base. It can manufacture by making it react in presence. [Wherein, X represents a halogen atom, and other symbols have the same meaning as in formula (1). ]
  • Compound (M2) is known or can be produced according to a known method.
  • the present compound (1a) to the present compound (1c) can be produced according to this reaction. The reaction is usually performed in the presence of a solvent.
  • solvent used in the reaction examples include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether, and halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene.
  • ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether
  • halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene.
  • Aromatic hydrocarbons such as toluene, benzene, xylene, esters such as ethyl acetate and butyl acetate, acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolid
  • Non-protic polar solvents such as non- and dimethyl sulfoxide, nitrogen-containing aromatic compounds such as pyridine and quinoline, and mixtures thereof.
  • Examples of the base used in the reaction include alkali metal or alkaline earth metal hydrides such as sodium hydride, potassium hydride and calcium hydride, alkali metal carbonates such as sodium carbonate and potassium carbonate, or triethylamine and diisopropylene. And organic bases such as propylethylamine, pyridine and 4-dimethylaminopyridine.
  • the compound (M1) is usually used in a proportion of 1 to 2 mol
  • the base is usually used in a proportion of 1 to 5 mol.
  • the reaction temperature of the reaction is usually in the range of 0 to 120 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the reaction mixture After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered.
  • the compound of the present invention can be isolated by collecting by The isolated compound of the present invention can be further purified by recrystallization, chromatography or the like.
  • Manufacturing method 4 Compound (M1a) can be produced, for example, according to the following scheme. [Wherein the symbols have the same meaning as described above. ]
  • a compound represented by formula (M7) (hereinafter referred to as compound (M7)) is represented by a compound represented by formula (M6) (hereinafter referred to as compound (M6)), and two Xs represent the same halogen atom. ) And a chlorinating agent.
  • the compound (M6) include 3,6-difluoro-pyridine-2-carboxylic acid and 3,6-dichloro-pyridine-2-carboxylic acid, both of which are commercially available compounds.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include aromatic hydrocarbons such as toluene and xylene, aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, and mixtures thereof.
  • Examples of the chlorinating agent used in the reaction include thionyl chloride, oxalyl dichloride, phosphorus oxychloride and the like.
  • a chlorinating agent is usually used at a ratio of 1 to 15 mol with respect to 1 mol of the compound (M6).
  • the reaction temperature is usually in the range of 0 to 150 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours. After completion of the reaction, the compound (M7) can be isolated by removing the solvent.
  • a compound represented by formula (M9) (hereinafter referred to as compound (M9)) is obtained by reacting compound (M7) with a compound represented by formula (M8) (hereinafter referred to as compound (M8)).
  • compound (M8) a compound represented by formula (M8)
  • M8 N 1 -methyl-4-trifluoromethyl-benzene-1,2-diamine in which R 5 is CF 3 and A is NCH 3 is described in WO2010 / 125985 It can be manufactured by the method.
  • compound (M8) a compound (M8a) in which R 5 is CF 2 CF 3 , CF 2 CF 2 CF 3 , CF (CF 3 ) 2 , or SR 6 and A is NCH 3 (hereinafter referred to as compound (M8a )) Can be produced by the method described in Production Example 8.
  • Compound (M8b) in which R 5 is S (O) R 6 or S (O) 2 R 6 and A is NCH 3 in Compound (M8) (hereinafter referred to as Compound (M8b)) is described in Production Method 9. It can be manufactured by the method.
  • compound (M8) 2-amino-4-trifluoromethyl-phenol in which R 5 is CF 3 and A is an oxygen atom can be produced by the method described in US Pat. No. 5,780,483.
  • R 5 is R 5 is CF 2 CF 3 , CF 2 CF 2 CF 3 , CF (CF 3 ) 2 , SR 6 , S (O) R 6 , or S (O) 2 R 6
  • the compound (M8c) in which A is an oxygen atom (hereinafter referred to as the compound (M8c)) can be produced by the method described in Production Method 10. The reaction is usually performed in the presence of a solvent.
  • solvent used in the reaction examples include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether, and 1,4-dioxane, aliphatic hydrocarbons such as hexane, heptane, and octane, and aromatics such as toluene and xylene.
  • ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether, and 1,4-dioxane
  • aliphatic hydrocarbons such as hexane, heptane, and octane
  • aromatics such as toluene and xylene.
  • Aprotic polarities such as aromatic hydrocarbons, halogenated hydrocarbons such as chlorobenzene, esters such as ethyl acetate and butyl acetate, nitriles such as acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone and dimethyl sulfoxide Examples include solvents and mixtures thereof.
  • a base may be added as necessary.
  • the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, tertiary amines such as triethylamine and N, N-diisopropylethylamine, and nitrogen-containing aromatic compounds such as pyridine and 4-dimethylaminopyridine.
  • the compound (M7) is usually used in a proportion of 1 to 3 mol
  • the base is usually used in a proportion of 1 to 10 mol.
  • the reaction temperature is usually in the range of ⁇ 20 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound (M9) can be isolated by post-treatment such as addition of water to the reaction mixture, extraction with an organic solvent, and drying and concentration of the organic layer. The isolated compound (M9) can be further purified by chromatography, recrystallization and the like.
  • Compound (M9) can also be produced in a one-step reaction (one pot) by reacting compound (M6) and compound (M8) in the presence of a condensing agent.
  • the reaction is performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran, and tert-butyl methyl ether, and halogenations such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, and chlorobenzene.
  • Hydrocarbons aromatic hydrocarbons such as toluene, benzene and xylene, esters such as ethyl acetate and butyl acetate, acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazo Examples thereof include aprotic polar solvents such as lizinone and dimethyl sulfoxide, nitrogen-containing aromatic compounds such as pyridine and quinoline, and mixtures thereof.
  • Examples of the condensing agent used in the reaction include carbodiimides such as 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (hereinafter referred to as EDCI) and 1,3-dicyclohexylcarbodiimide.
  • EDCI 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride
  • EDCI 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride
  • HOBt 1-hydroxybenzotriazole
  • the ratio of the compound (M6) is usually 1 to 2 moles
  • the condensing agent is usually 1 to 5 moles
  • the catalyst is usually 0.01 to 1 mole.
  • the reaction temperature of the reaction is usually in the range of 0 to 120 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered.
  • the compound (M9) can be isolated by collecting by The isolated compound (M9) can be further purified by recrystallization, chromatography or the like.
  • a compound represented by formula (M10) (hereinafter referred to as compound (M10).
  • Two Xs represent the same halogen atom) can be produced by intramolecular condensation of compound (M9).
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether, and halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene.
  • Hydrogen aromatic hydrocarbons such as toluene, benzene and xylene, esters such as ethyl acetate and butyl acetate, nitriles such as acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl- Examples include aprotic polar solvents such as 2-imidazolidinone and dimethyl sulfoxide, nitrogen-containing aromatic compounds such as pyridine and quinoline, and mixtures thereof.
  • a condensing agent, an acid, a base, or a chlorinating agent may be added as necessary.
  • Examples of the condensing agent used in the reaction include acetic anhydride, trifluoroacetic anhydride, 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride, triphenylphosphine and base, and carbon tetrachloride or carbon tetrabromide. And mixtures of triphenylphosphine and azodiesters (eg diethyl azodicarboxylate).
  • Examples of the acid used for the reaction include sulfonic acids such as paratoluenesulfonic acid, carboxylic acids such as acetic acid, and polyphosphoric acid.
  • Examples of the base used in the reaction include pyridine, picoline, 2,6-lutidine, 1,8-diazabicyclo [5.4.0] -7-undecene, 1,5-diazabicyclo [4.3.0] -5.
  • -Nitrogen-containing heterocyclic compounds such as nonene, tertiary amines such as triethylamine and N, N-diisopropylethylamine, and alkali metal carbonates such as tripotassium phosphate, potassium carbonate and sodium hydride.
  • Examples of the chlorinating agent used in the reaction include phosphorus oxychloride.
  • the ratio of the condensing agent is usually 1 to 5 mol, and when an acid is used, the acid is usually 0.1 mol to 5 mol.
  • the base is usually used in a proportion of 1 to 5 mol
  • the chlorinating agent is usually used in a proportion of 1 to 5 mol.
  • the reaction temperature of the reaction is usually in the range of 0 to 200 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the reaction mixture After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered.
  • the compound (M10) can be isolated by collecting by The isolated compound (M10) can be further purified by recrystallization, chromatography or the like.
  • Compound (M1a) can be produced by reacting compound (M10) with ethyl mercaptan in the presence of a base.
  • the reaction is performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether, 1,4-dioxane, aromatic hydrocarbons such as toluene and xylene, acetonitrile, N, N-dimethylformamide. , N-methylpyrrolidone, aprotic polar solvents such as dimethyl sulfoxide, water, and mixtures thereof.
  • Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, and alkali metal hydrides such as sodium hydride.
  • ethyl mercaptan is usually used in a proportion of 1 to 10 mol
  • base is usually used in a proportion of 1 to 10 mol.
  • ethyl mercaptan is used in a proportion of 1.0 to 1.1 mol
  • a base is used in a proportion of 1 to 2 mol with respect to 1 mol of compound (M11).
  • the reaction temperature of the reaction is usually in the range of ⁇ 20 ° C. to 150 ° C.
  • the reaction time is usually in the range of 0.5 to 24 hours.
  • the compound (M1a) can be isolated by performing post-treatment operations such as extraction of the reaction mixture with an organic solvent, and drying and concentration of the organic layer.
  • the isolated compound (M1a) can be further purified by chromatography, recrystallization and the like.
  • the compound (1c) of the present invention can be produced, for example, according to the following scheme. [Wherein the symbols have the same meaning as described above. ]
  • a compound represented by formula (M20) (hereinafter referred to as compound (M20)) can be produced by reacting compound (M10) with ethyl mercaptan in the presence of a base.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether, 1,4-dioxane, aromatic hydrocarbons such as toluene and xylene, acetonitrile, N, N-dimethylformamide. , N-methylpyrrolidone, aprotic polar solvents such as dimethyl sulfoxide, water, and mixtures thereof.
  • Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, and alkali metal hydrides such as sodium hydride.
  • ethyl mercaptan is usually used in a proportion of 2 to 10 mol
  • base is usually used in a proportion of 2 to 10 mol.
  • ethyl mercaptan is used in a proportion of 2.0 to 2.1 mol
  • a base is used in a proportion of 2 to 3 mol with respect to 1 mol of compound (M11).
  • the reaction temperature of the reaction is usually in the range of ⁇ 20 ° C. to 150 ° C.
  • the reaction time is usually in the range of 0.5 to 24 hours.
  • the compound (M20) can be isolated by performing post-treatment operations such as extraction of the reaction mixture with an organic solvent, and drying and concentration of the organic layer.
  • the isolated compound (M20) can be further purified by chromatography, recrystallization and the like.
  • a compound represented by formula (M21) (hereinafter referred to as compound (M21)) can be produced by reacting compound (M20) with an oxidizing agent.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile, alcohols such as methanol and ethanol, acetic acid, water, and mixtures thereof.
  • the oxidizing agent used in the reaction include m-chloroperbenzoic acid and hydrogen peroxide. When hydrogen peroxide is used as the oxidizing agent for the reaction, it is carried out in the presence of a base or a catalyst as necessary.
  • Examples of the base used for the reaction include sodium carbonate.
  • Examples of the catalyst used for the reaction include tungstic acid and sodium tungstate.
  • the oxidizing agent is usually used at a ratio of 2 to 5 mol.
  • the base is generally used at a ratio of 0.01 to 1 mol with respect to 1 mol of the compound (20).
  • the catalyst is generally used in a proportion of 0.01 to 0.5 mol with respect to 1 mol of the compound (20).
  • the reaction temperature of the reaction is usually in the range of 0 to 120 ° C.
  • the reaction time is usually in the range of 0.1 to 12 hours.
  • reaction mixture is extracted with an organic solvent, and the organic layer is washed with an aqueous solution of a reducing agent (for example, sodium sulfite and sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary.
  • a reducing agent for example, sodium sulfite and sodium thiosulfate
  • a base for example, sodium bicarbonate
  • Compound (21) can be isolated by drying and concentrating this organic layer.
  • the isolated compound (M21) can be further purified by chromatography, recrystallization and the like.
  • the compound (1c) of the present invention can be produced by reacting the compound (M21) and the compound (M2) in the presence of a base.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether, and halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene.
  • Aromatic hydrocarbons such as toluene, benzene, xylene, esters such as ethyl acetate and butyl acetate, acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolid
  • Non-protic polar solvents such as non- and dimethyl sulfoxide, nitrogen-containing aromatic compounds such as pyridine and quinoline, and mixtures thereof.
  • Examples of the base used in the reaction include alkali metal or alkaline earth metal hydrides such as sodium hydride, potassium hydride and calcium hydride, alkali metal carbonates such as sodium carbonate and potassium carbonate, or triethylamine and diisopropylene. And organic bases such as propylethylamine, pyridine and 4-dimethylaminopyridine.
  • the compound (M2) is usually used in a proportion of 1 to 2 mol, and the base is usually used in a proportion of 1 to 5 mol.
  • the reaction temperature of the reaction is usually in the range of 0 to 120 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the present compound (1c) can be isolated by collecting the above.
  • the isolated compound (1c) of the present invention can be further purified by recrystallization, chromatography or the like.
  • the compound of the present invention in which R 1 is a C1-C3 alkoxy group (hereinafter referred to as the present compound (1m)) can be produced, for example, according to the following scheme.
  • R a represents a C1-C3 alkyl group
  • V represents a chlorine atom, a bromine atom, or an iodine atom, and other symbols have the same meaning as described above.
  • the compound represented by the formula (M3) (hereinafter referred to as the compound (M3)) can be produced by reacting the compound (M1) and semicarbazide hydrochloride in the presence of a base.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include aprotic polar solvents such as acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, and dimethyl sulfoxide.
  • Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, tertiary amines such as triethylamine and diisopropylethylamine, and nitrogen-containing aromatic compounds such as pyridine and 4-dimethylaminopyridine. It is done.
  • semicarbazide hydrochloride is usually used in a proportion of 1 to 3 mol
  • base is usually used in a proportion of 1 to 10 mol.
  • the reaction temperature is usually in the range of ⁇ 20 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the reaction mixture After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered.
  • the compound (M3) can be isolated by collecting by The isolated compound (M3) can be further purified by chromatography, recrystallization and the like.
  • the compound represented by the formula (M4) (hereinafter referred to as the compound (M4)) can be produced by reacting the compound (M3) with formic acid or trialkyl orthoformate.
  • the trialkyl orthoformate used in the reaction include trimethyl orthoformate and triethyl orthoformate.
  • the reaction is usually performed in the presence of a solvent.
  • Solvents used for the reaction include halogenated hydrocarbons such as 1,2-dichloroethane and chlorobenzene, aromatic hydrocarbons such as toluene, benzene and xylene, N, N-dimethylformamide, N-methylpyrrolidone, 1, Examples include aprotic polar solvents such as 3-dimethyl-2-imidazolidinone and dimethyl sulfoxide, alcohol solvents such as methanol, ethanol and n-butanol, and mixtures thereof.
  • formic acid is usually used at a ratio of 1 to 10 mol per 1 mol of compound (M3).
  • trialkyl orthoformate When trialkyl orthoformate is used in the reaction, trialkyl orthoformate is usually used at a ratio of 1 to 10 moles with respect to 1 mole of compound (M3).
  • the reaction temperature is usually in the range of 0 to 150 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered.
  • the compound (M4) can be isolated by collecting by The isolated compound (M4) can be further purified by recrystallization, chromatography or the like.
  • the compound (1m) of the present invention can be produced by reacting the compound (M4) with a compound represented by the formula (M5) (hereinafter referred to as compound (M5)) in the presence of a base.
  • a compound represented by the formula (M5) hereinafter referred to as compound (M5)
  • Examples of the compound (M5) include iodomethane, bromomethane, iodoethane, chloroethane, 1-iodopropane, 2-iodopropane and the like.
  • the reaction is usually performed in the presence of a solvent.
  • solvent used in the reaction examples include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether, and halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene.
  • Aprotic polar solvents such as hydrogen, aromatic hydrocarbons such as toluene, benzene, xylene, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, dimethyl sulfoxide, and the like These mixtures are mentioned.
  • Examples of the base used in the reaction include alkali metal or alkaline earth metal hydrides such as sodium hydride, potassium hydride and calcium hydride, alkali metal carbonates such as sodium carbonate and potassium carbonate, or triethylamine and diisopropylene. And organic bases such as propylethylamine, pyridine and 4-dimethylaminopyridine.
  • the compound (M5) is usually used in a proportion of 1 to 10 mol
  • the base is usually used in a proportion of 0.1 to 5 mol with respect to 1 mol of the compound (M4) of the present invention.
  • the reaction temperature is usually in the range of ⁇ 20 ° C. to 120 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the reaction mixture After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered.
  • the present compound (1m) can be isolated by collecting by The isolated compound (1m) of the present invention can be further purified by chromatography, recrystallization and the like.
  • Manufacturing method 8 Compound (M8a) can be produced, for example, according to the following scheme.
  • a compound represented by formula (M11) (hereinafter referred to as compound (M11)) is obtained by reacting a compound represented by formula (M20) (hereinafter referred to as compound (M20)) with an acetylating agent. Can be manufactured.
  • the compound in which R 5 is CF 3 is a commercially available compound.
  • a compound in which R 5 is CF 2 CF 3 , CF 2 CF 2 CF 3 can be produced by the method described in International Publication No. 00/07998.
  • compound (M20) a compound in which R 5 is CF (CF 3 ) 2 can be produced by the method described in EP 1006102.
  • a compound in which R 5 is SCF 3 is a commercially available compound.
  • a compound in which R 5 is SCF 2 CF 3 , SCF 2 CF 2 CF 3 , or SCF (CF 3 ) 2 can be produced by the method described in JP-A-10-291973. The reaction is usually performed in the presence of a solvent.
  • solvent used in the reaction examples include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether, and halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene.
  • ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether
  • halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene.
  • Hydrogen aromatic hydrocarbons such as toluene, benzene, xylene, esters such as ethyl acetate and butyl acetate, acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolid
  • Non-protic polar solvents such as non- and dimethyl sulfoxide, nitrogen-containing aromatic compounds such as pyridine and quinoline, and mixtures thereof.
  • a base may be added as necessary.
  • the base used in the reaction include organic bases such as triethylamine, diisopropylpyroethylamine, pyridine and 4-dimethylaminopyridine.
  • Examples of the acetylating agent used in the reaction include acetic anhydride and acetyl chloride.
  • the reaction may be performed using acetic anhydride, acetyl chloride or the like as a solvent.
  • an acetylating agent is usually used at a ratio of 1 to 3 moles per mole of 4-trifluoromethylsulfinyl-aniline.
  • the reaction temperature is usually in the range of ⁇ 30 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the base is usually used at a ratio of 0.01 to 3 mol per 1 mol of 4-trifluoromethylsulfinyl-aniline.
  • the compound (M11) can be isolated by performing post-treatment operations such as addition of the reaction mixture to water, extraction with an organic solvent, and drying and concentration of the organic layer.
  • the isolated compound (M11) can be further purified by chromatography, recrystallization, and the like.
  • a compound represented by formula (M12) (hereinafter referred to as compound (M12)) can be produced by reacting compound (M11) with a nitrating agent.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include halogenated hydrocarbons such as dichloromethane and chloroform, acetic acid, concentrated sulfuric acid, concentrated nitric acid, water, and mixtures thereof.
  • An example of the nitrating agent used in the reaction is concentrated nitric acid.
  • the nitrating agent is usually used at a ratio of 1 to 3 moles relative to 1 mole of the compound (M11).
  • the reaction temperature is usually in the range of ⁇ 10 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound (M12) can be isolated by performing post-treatment operations such as addition of the reaction mixture to water, extraction with an organic solvent, and drying and concentration of the organic layer.
  • the isolated compound (M12) can be further purified by chromatography, recrystallization and the like.
  • a compound represented by formula (M13) (hereinafter referred to as compound (M13)) can be produced by reacting compound (M12) with a methylating agent in the presence of a base.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether, and halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene.
  • Aprotic polar solvents such as hydrogen, aromatic hydrocarbons such as toluene, benzene, xylene, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, dimethyl sulfoxide, and the like These mixtures are mentioned.
  • the base used in the reaction include alkali metal or alkaline earth metal hydrides such as sodium hydride, potassium hydride and calcium hydride, alkali metal carbonates such as sodium carbonate and potassium carbonate, or triethylamine and diisopropylene.
  • organic bases such as propylethylamine, pyridine and 4-dimethylaminopyridine.
  • the methylating agent used in the reaction examples include iodomethane and dimethyl sulfate.
  • the methylating agent is usually used at a ratio of 1 to 5 moles, and the base is usually used at a ratio of 0.1 to 5 moles.
  • the reaction temperature is usually in the range of ⁇ 20 ° C. to 120 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered.
  • the compound (M13) can be isolated by collecting by The isolated compound (M13) can be further purified by chromatography, recrystallization and the like.
  • the compound represented by formula (M14) (hereinafter referred to as compound (M14)) can be produced by subjecting compound (M13) to a hydrolysis reaction in the presence of a base or an acid.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as tetrahydrofuran and 1,4-dioxane, alcohols such as methanol and ethanol, water, and mixtures thereof.
  • the base used in the reaction include alkali metal carbonates such as sodium hydroxide, lithium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, and cesium carbonate.
  • the acid used in the reaction include hydrochloric acid and sulfuric acid.
  • the reaction with respect to 1 mol of compound (13), when a base is used, the base is used in a proportion of 1 to 5 mol, and when an acid is used, the acid is used in a proportion of 0.1 to 5 mol.
  • the reaction temperature is usually in the range of ⁇ 20 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered.
  • the compound (M14) can be isolated by collecting by The isolated compound (M14) can be further purified by chromatography, recrystallization and the like.
  • Compound (M8a) can be produced by reacting compound (M14) with hydrogen in the presence of a hydrogenation catalyst.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, esters such as ethyl acetate and butyl acetate, alcohols such as methanol and ethanol, water And mixtures thereof.
  • the reaction is usually performed in a hydrogen atmosphere at 1 to 100 atm, usually in the presence of a solvent.
  • Examples of the hydrogenation catalyst used in the reaction include transition metal compounds such as palladium carbon, palladium hydroxide, Raney nickel, and platinum oxide.
  • hydrogen is usually used in a proportion of 3 to 100 mol
  • a hydrogenation catalyst is usually used in a proportion of 0.001 to 0.5 mol with respect to 1 mol of compound (M14).
  • the reaction temperature is usually in the range of ⁇ 20 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound (M8a) can be isolated by performing post-treatment operations such as filtration of the reaction mixture, extraction with an organic solvent as necessary, and drying and concentration of the organic layer. The isolated compound (M8a) can be further purified by chromatography, recrystallization and the like.
  • Compound (M8a) can be produced by reacting compound (M14) with a reducing agent.
  • the reaction can be performed, for example, in the presence of a reducing agent, an acid such as hydrochloric acid or acetic acid, and water.
  • the reaction is usually performed in the presence of a solvent.
  • Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, esters such as ethyl acetate and butyl acetate, alcohols such as methanol and ethanol, Examples thereof include aprotic polar solvents such as N, N-dimethylformamide (hereinafter referred to as DMF), N-methylpyrrolidone (hereinafter referred to as NMP), dimethyl sulfoxide (hereinafter referred to as DMSO), and mixtures thereof.
  • Examples of the reducing agent used in the reaction include metal powders such as iron powder, zinc powder, and tin dichloride.
  • the reducing agent is usually used in a proportion of 3 to 10 mol
  • the acid is usually used in a proportion of 0.01 to 0.5 mol
  • the water is used in a proportion of 3 mol or more. It is done.
  • the reaction temperature of the reaction is usually in the range of 0 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound (M8a) can be isolated by performing post-treatment operations such as addition of water to the reaction mixture, extraction with an organic solvent, and drying and concentration of the organic layer.
  • the isolated compound (M8a) can also be purified by chromatography, recrystallization, and the like.
  • Manufacturing method 9 Compound (M8b) can be produced, for example, according to the following scheme. [Wherein q represents 1 or 2. ]
  • a compound represented by formula (M16) (hereinafter referred to as compound (M16)) is obtained by reacting a compound represented by formula (M15) (hereinafter referred to as compound (M15)) with a chlorinating agent. Can be manufactured.
  • Compound (M15) can be produced according to the method of Production Method 10. The reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include aromatic hydrocarbons such as toluene and xylene, aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, and mixtures thereof.
  • the chlorinating agent used in the reaction include thionyl chloride, oxalyl dichloride, phosphorus oxychloride and the like.
  • a chlorinating agent is usually used at a ratio of 1 to 15 mol with respect to 1 mol of the compound (M15).
  • the reaction temperature is usually in the range of 0 to 150 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours. After completion of the reaction, the compound (M16) can be isolated by removing the solvent.
  • the compound represented by the formula (M17) (hereinafter referred to as the compound (M17)) can be produced by reacting the compound (M16) with methylamine.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether, and 1,4-dioxane, aliphatic hydrocarbons such as hexane, heptane, and octane, and aromatics such as toluene and xylene.
  • Aprotic polar solvents such as aromatic hydrocarbons, halogenated hydrocarbons such as chlorobenzene, esters such as ethyl acetate and butyl acetate, acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, dimethyl sulfoxide, and the like
  • the methylamine used for the reaction may be in the form of a gas, an aqueous solution, or an alcohol solution. This reaction can also be performed in presence of a base as needed.
  • Examples of the base used in the reaction include alkali metal or alkaline earth metal hydrides such as sodium hydride, potassium hydride and calcium hydride, alkali metal carbonates such as sodium carbonate and potassium carbonate, or triethylamine and diisopropylene. And organic bases such as propylethylamine, pyridine and 4-dimethylaminopyridine.
  • methylamine is usually used at a ratio of 1 to 10 moles and the base is used at a ratio of 0.01 to 10 moles.
  • the reaction temperature of the reaction is usually in the range of 0 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound (M17) can be isolated by post-treatment such as addition of water to the reaction mixture, extraction with an organic solvent, and drying and concentration of the organic layer.
  • the isolated compound (M17) can also be purified by chromatography, recrystallization, and the like.
  • Compound (M8b) or compound (M8c) can be produced by reacting compound (M17) with hydrogen in the presence of a hydrogenation catalyst.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, esters such as ethyl acetate and butyl acetate, alcohols such as methanol and ethanol, water And mixtures thereof.
  • the reaction is usually performed in a hydrogen atmosphere at 1 to 100 atm, usually in the presence of a solvent.
  • Examples of the hydrogenation catalyst used in the reaction include transition metal compounds such as palladium carbon, palladium hydroxide, Raney nickel, and platinum oxide.
  • hydrogen is usually used in a proportion of 3 to 100 mol
  • a hydrogenation catalyst is usually used in a proportion of 0.001 to 0.5 mol.
  • the reaction temperature is usually in the range of ⁇ 20 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound (M8b) can be isolated by performing post-treatment operations such as filtration of the reaction mixture, extraction with an organic solvent as necessary, and drying and concentration of the organic layer. The isolated compound (M8b) can be further purified by chromatography, recrystallization and the like.
  • Compound (M8b) can be produced by reacting compound (M17) with a reducing agent.
  • the reaction can be performed, for example, in the presence of a reducing agent, an acid such as hydrochloric acid or acetic acid, and water.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, esters such as ethyl acetate and butyl acetate, alcohols such as methanol and ethanol, Examples include aprotic polar solvents such as DMF, NMP, DMSO, and mixtures thereof.
  • the reducing agent used in the reaction examples include metal powders such as iron powder, zinc powder, and tin dichloride.
  • the reducing agent is usually used in a proportion of 3 to 10 mol
  • the acid is usually used in a proportion of 0.01 to 0.5 mol
  • the water is used in a proportion of 3 mol or more. It is done.
  • the reaction temperature of the reaction is usually in the range of 0 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound (M8b) can be isolated by performing post-treatment operations such as addition of water to the reaction mixture, extraction with an organic solvent, and drying and concentration of the organic layer.
  • the isolated compound (M8b) can also be purified by chromatography, recrystallization, and the like.
  • Compound (M8c) can be produced, for example, according to the following scheme. [The symbols in the formula have the same meaning as in formula (1). ]
  • a compound represented by formula (M19) (hereinafter referred to as compound (M19)) is obtained by reacting a compound represented by formula (M18) (hereinafter referred to as compound (M18)) with a nitrating agent. Can be manufactured. The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, acetic acid, concentrated sulfuric acid, concentrated nitric acid, water, and mixtures thereof.
  • the nitrating agent used in the reaction examples include concentrated nitric acid.
  • the nitrating agent is usually used at a ratio of 1 to 3 moles relative to 1 mole of the compound (M18).
  • the reaction temperature is usually in the range of ⁇ 10 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound (M19) can be isolated by performing post-treatment operations such as addition of the reaction mixture to water, extraction with an organic solvent, and drying and concentration of the organic layer.
  • the isolated compound (M19) can be further purified by chromatography, recrystallization and the like.
  • Compound (M8c) can be produced by reacting compound (M19) with hydrogen in the presence of a hydrogenation catalyst.
  • the reaction is usually performed in a hydrogen atmosphere at 1 to 100 atm, usually in the presence of a solvent.
  • the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, esters such as ethyl acetate and butyl acetate, alcohols such as methanol and ethanol, water And mixtures thereof.
  • the hydrogenation catalyst used in the reaction include transition metal compounds such as palladium carbon, palladium hydroxide, Raney nickel, and platinum oxide.
  • the reaction with respect to 1 mole of the compound (M19), hydrogen is usually used at a ratio of 3 moles, and the hydrogenation catalyst is usually used at a ratio of 0.001 to 0.5 moles.
  • the reaction temperature is usually in the range of ⁇ 20 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound (M8c) can be isolated by performing post-treatment operations such as filtration of the reaction mixture, extraction with an organic solvent as necessary, and drying and concentration of the organic layer.
  • the isolated compound (M8c) can be further purified by chromatography, recrystallization, and the like.
  • Compound (M8c) can be produced by reacting compound (M19) with a reducing agent.
  • the reaction can be performed, for example, in the presence of a reducing agent, an acid such as hydrochloric acid or acetic acid, and water.
  • the reaction is usually performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, esters such as ethyl acetate and butyl acetate, alcohols such as methanol and ethanol, Examples include aprotic polar solvents such as DMF, NMP, DMSO, and mixtures thereof.
  • the reducing agent used in the reaction examples include metal powders such as iron powder, zinc powder, and tin dichloride.
  • the reducing agent is usually used in a proportion of 3 to 10 mol
  • the acid is usually used in a proportion of 0.01 to 0.5 mol
  • the water is used in a proportion of 3 mol or more. It is done.
  • the reaction temperature of the reaction is usually in the range of 0 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound (M8c) can be isolated by performing post-treatment operations such as addition of water to the reaction mixture, extraction with an organic solvent, and drying and concentration of the organic layer.
  • the isolated compound (M8c) can also be purified by chromatography, recrystallization, and the like.
  • Manufacturing method 11 Compound (M18b) in which R 5 is S (O) R 6 in formula (M18) (hereinafter referred to as compound (M18b)), and Compound in which R 5 is S (O) 2 R 6 in formula (M18) (M18c) (hereinafter referred to as compound (M18c)) is obtained by reacting compound (M18a) (hereinafter referred to as compound (M18a)) in which R 5 is SR 6 in compound (M18) with an oxidizing agent. Can be manufactured. The reaction is carried out according to the reaction described in Production Example 1 by substituting compound (M18a) for the present compound (1a) in production method 1 and compound (M18b) for the present compound (1b). can do.
  • Compound (M18) can be produced by reacting compound (M20) with a diazotizing agent in the presence of an acidic aqueous solution.
  • the reaction is performed in the presence of a solvent.
  • the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether and 1,4-dioxane, alcohols such as methanol and ethanol, aprotic polar solvents such as acetonitrile, DMF, NMP and DMSO, water And mixtures thereof.
  • the diazotizing agent used in the reaction include sodium nitrite.
  • the acidic aqueous solution used for the reaction examples include sulfuric acid, hydrochloric acid, acetic acid, and a mixture thereof.
  • the diazotizing agent is usually used in a proportion of 1 to 10 mol and the acid in a proportion of 1 to 100 mol.
  • the reaction temperature of the reaction is usually in the range of 0 to 100 ° C.
  • the reaction time is usually in the range of 0.1 to 24 hours.
  • the compound (M18) can be isolated by performing post-treatment operations such as addition of water to the reaction mixture, extraction with an organic solvent, and drying and concentration of the organic layer.
  • the isolated compound (M18) can also be purified by chromatography, recrystallization, and the like.
  • R 5 is CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3].
  • R 5 is CF 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3].
  • R 5 is CF 2 CF 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
  • R 5 is CF (CF 3 ) 2 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
  • R 5 is S (O) CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
  • R 5 is S (O) 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Invention compounds.
  • R 5 is SCF 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3].
  • R 5 is S (O) CF 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] The compound of the present invention.
  • R 5 is S (O) 2 CF 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] A compound of the present invention.
  • R 5 is SCF 2 CF 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
  • R 5 is S (O) CF 2 CF 2 CF 3 , A is NCH 3 , and n and R 1 are the combinations according to any one of [Table 1] to [Table 3] The compound of the present invention.
  • R 5 is S (O) 2 CF 2 CF 2 CF 3 , A is NCH 3 , and n and R 1 are described in any one of [Table 1] to [Table 3] The compound of the present invention which is a combination.
  • R 5 is SCF (CF 3 ) 2 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
  • R 5 is S (O) CF (CF 3 ) 2 , A is NCH 3 , and n and R 1 are the combinations according to any one of [Table 1] to [Table 3] The compound of the present invention.
  • R 5 is S (O) 2 CF (CF 3 ) 2 , A is NCH 3 , and n and R 1 are described in any one of [Table 1] to [Table 3] The compound of the present invention which is a combination.
  • R 5 is CF 3
  • A is an oxygen atom
  • n and R 1 are a combination described in any of [Table 1] to [Table 3].
  • R 5 is CF 2 CF 3
  • A is an oxygen atom
  • n and R 1 are combinations according to any one of [Table 1] to [Table 3].
  • R 5 is CF 2 CF 2 CF 3
  • A is an oxygen atom
  • n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
  • R 5 is CF (CF 3 ) 2 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
  • the compound of the present invention in which, in the formula (1), R 5 is SCF 3 , A is an oxygen atom, and n and R 1 are a combination described in any one of [Table 1] to [Table 3].
  • R 5 is S (O) CF 3
  • A is an oxygen atom
  • n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
  • R 5 is S (O) 2 CF 3 , A is an oxygen atom, and n and R 1 are combinations described in any of [Table 1] to [Table 3] Invention compounds.
  • the compound of the present invention in which, in the formula (1), R 5 is SCF 2 CF 3 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3].
  • R 5 is S (O) CF 2 CF 3 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3] The compound of the present invention.
  • R 5 is S (O) 2 CF 2 CF 3 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3] A compound of the present invention.
  • R 5 is SCF 2 CF 2 CF 3 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
  • R 5 is S (O) CF 2 CF 2 CF 3 , A is an oxygen atom, and n and R 1 are the combinations according to any one of [Table 1] to [Table 3] The compound of the present invention.
  • R 5 is S (O) 2 CF 2 CF 2 CF 3 , A is an oxygen atom, and n and R 1 are any one of [Table 1] to [Table 3] The compound of the present invention which is a combination.
  • R 5 is SCF (CF 3 ) 2 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
  • R 5 is S (O) CF (CF 3 ) 2 , A is an oxygen atom, and n and R 1 are the combinations according to any one of [Table 1] to [Table 3] The compound of the present invention.
  • R 5 is S (O) 2 CF (CF 3 ) 2 , A is an oxygen atom, and n and R 1 are any one of [Table 1] to [Table 3] The compound of the present invention.
  • R 5 is S (O) 2 CF (CF 3 ) 2 , A is an oxygen atom, and n and R 1 are any one of [Table 1]
  • A is NCH 3 , R 6 is CF 3 , and R 1 is a combination according to any one of Table 1 to Table 3.
  • A is NCH 3
  • R 6 is CF 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3].
  • A is NCH 3 , R 6 is CF (CF 3 ) 2 , and R 1 is a combination described in any of [Table 1] to [Table 3].
  • A is NCH 3 , R 6 is SCF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3].
  • A is NCH 3 , R 6 is S (O) CF 3 , and R 1 is a combination according to any one of Table 1 to Table 3.
  • A is NCH 3 , R 6 is S (O) 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] .
  • A is NCH 3 , R 6 is SCF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3].
  • A is NCH 3
  • R 6 is S (O) CF 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3] Compound.
  • A is NCH 3
  • R 6 is S (O) 2 CF 2 CF 3
  • R 1 is a combination described in any of [Table 1] to [Table 3] Invention compounds.
  • A is NCH 3
  • R 6 is SCF 2 CF 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3].
  • A is NCH 3
  • R 6 is S (O) CF 2 CF 2 CF 3
  • R 1 is a combination described in any of [Table 1] to [Table 3]
  • the compound of the present invention In the formula (1B), A is NCH 3 , R 6 is S (O) 2 CF 2 CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] A compound of the present invention.
  • A is NCH 3
  • R 6 is SCF (CF 3 ) 2
  • R 1 is a combination according to any one of Table 1 to Table 3.
  • A is NCH 3
  • R 6 is S (O) CF (CF 3 ) 2
  • R 1 is a combination according to any one of [Table 1] to [Table 3]
  • the compound of the present invention in the formula (1B), A is NCH 3 , R 6 is S (O) 2 CF (CF 3 ) 2 , and R 1 is a combination according to any one of [Table 1] to [Table 3]
  • a compound of the present invention In the formula (1B), A is an oxygen atom, R 6 is CF 3 , and R 1 is a combination according to any one of Table 1 to Table 3.
  • A is an oxygen atom
  • R 6 is CF 2 CF 3
  • R 1 is a combination according to any one of Table 1 to Table 3.
  • A is an oxygen atom
  • R 6 is CF 2 CF 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3].
  • the compound of the present invention in which, in the formula (1B), A is an oxygen atom, R 6 is CF (CF 3 ) 2 , and R 1 is a combination described in any of [Table 1] to [Table 3].
  • A is an oxygen atom
  • R 6 is SCF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3].
  • A is an oxygen atom
  • R 6 is S (O) CF 3
  • R 1 is a combination described in any of [Table 1] to [Table 3].
  • A is an oxygen atom
  • R 6 is S (O) 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3] .
  • A is an oxygen atom
  • R 6 is SCF 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3].
  • A is an oxygen atom
  • R 6 is S (O) CF 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3] Compound.
  • A is an oxygen atom
  • R 6 is S (O) 2 CF 2 CF 3
  • R 1 is a combination described in any of [Table 1] to [Table 3] Invention compounds.
  • A is an oxygen atom
  • R 6 is SCF 2 CF 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3].
  • A is an oxygen atom
  • R 6 is S (O) CF 2 CF 2 CF 3
  • R 1 is a combination described in any of [Table 1] to [Table 3].
  • the compound of the present invention In the formula (1B), A is an oxygen atom, R 6 is S (O) 2 CF 2 CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3]
  • A is an oxygen atom
  • R 6 is SCF (CF 3 ) 2
  • R 1 is a combination according to any one of [Table 1] to [Table 3].
  • A is an oxygen atom
  • R 6 is S (O) CF (CF 3 ) 2
  • R 1 is a combination described in any of [Table 1] to [Table 3]
  • A is an oxygen atom
  • R 6 is S (O) 2 CF (CF 3 ) 2
  • R 1 is a combination according to any one of [Table 1] to [Table 3] A compound of the present invention.
  • A is NCH 3
  • R 6 is S (O) 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3] .
  • A is NCH 3
  • R 6 is S (O) CF 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3] Compound.
  • A is NCH 3
  • R 6 is S (O) 2 CF 2 CF 3
  • R 1 is a combination described in any of [Table 1] to [Table 3] Invention compounds.
  • A is NCH 3
  • R 6 is SCF 2 CF 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3].
  • A is NCH 3
  • R 6 is S (O) CF 2 CF 2 CF 3
  • R 1 is a combination described in any of [Table 1] to [Table 3] The compound of the present invention.
  • A is NCH 3
  • R 6 is S (O) 2 CF 2 CF 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3]
  • a compound of the present invention in which, in the formula (1C), A is NCH 3 , R 6 is SCF (CF 3 ) 2 and R 1 is a combination described in any of [Table 1] to [Table 3].
  • A is NCH 3
  • R 6 is S (O) CF (CF 3 ) 2
  • R 1 is a combination described in any of [Table 1] to [Table 3]
  • A is NCH 3
  • R 6 is S (O) 2 CF (CF 3 ) 2
  • R 1 is a combination according to any one of [Table 1] to [Table 3]
  • a compound of the present invention in the formula (1C), the compound of the present invention wherein A is an oxygen atom, R 6 is CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
  • A is an oxygen atom
  • R 6 is S (O) CF 3
  • R 1 is a combination described in any of [Table 1] to [Table 3].
  • A is an oxygen atom
  • R 6 is S (O) 2 CF 3
  • R 1 is a combination according to any one of [Table 1] to [Table 3] .
  • A is an oxygen atom
  • R 6 is S (O) CF 2 CF 3
  • R 1 is a combination described in any of [Table 1] to [Table 3] Compound.
  • A is an oxygen atom
  • R 6 is S (O) 2 CF 2 CF 3
  • R 1 is a combination described in any of [Table 1] to [Table 3] Invention compounds.
  • the compound of the present invention in which, in the formula (1C), A is an oxygen atom, R 6 is SCF 2 CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
  • A is an oxygen atom
  • R 6 is S (O) CF 2 CF 2 CF 3
  • R 1 is a combination described in any one of [Table 1] to [Table 3]
  • the compound of the present invention In the formula (1C), A is an oxygen atom, R 6 is S (O) 2 CF 2 CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] A compound of the present invention.
  • A is an oxygen atom
  • R 6 is S (O) CF (CF 3 ) 2
  • R 1 is a combination according to any one of [Table 1] to [Table 3]
  • A is an oxygen atom
  • R 6 is S (O) 2 CF (CF 3 ) 2
  • R 1 is a combination according to any one of [Table 1] to [Table 3]
  • pests for which the compounds of the present invention are effective include harmful arthropods such as harmful insects and harmful mites, and harmful linear animals such as nematodes. Specific examples of such pests include the following.
  • Hemiptera small brown planthopper (Laodelphax striatellus), brown planthopper (Nilaparvata lugens), planthoppers such as Sejirounka (Sogatella furcifera), green rice leafhopper (Nephotettix cincticeps), Taiwan green rice leafhopper (Nephotettix virescens), tea Roh green leafhopper such as leafhopper (Empoasca onukii) Cotton aphids (Aphis gossypi), peach aphids (Myus persicae), radish aphids (Brevicorine brassicae), aphid spiraecola, tulip beetle aphids (M) crosifum euphorbiae, potato beetle aphids (Auracorthum solani), wheat beetle aphids (Rhopalosiphum padi), citrus aphids (Toxopter
  • Stink bugs such as stink bugs (Riptortus clavetus), spider helicopter bugs (Leptocorisa chinensis), bark beetles (Eysarcoris parvus), winged beetle (Halyomorpha mista), and the like vaporariorum), sweetpotato whitefly (Bemisia tabaci), mandarin orange whitefly (Dialeurodes citri), whiteflies such as mandarin orange spiny whitefly (Aleurocanthus spiniferus), Acamar scale insects (Aonidiella aurantii), Sanho zero scale insects (Comstockaspis perniciosa), citrus snow scale (Unaspis citri ), Ruby Beetle (Ceroplastes rubens), Iceria scale insect (Icerya purchasi), Fujino scale insect (Pranococcus kraunhiae), Pseudococcus longispin (Pseudococcus longis
  • Lepidoptera rice stem borer (Chilo suppressalis), Sankameiga (Tryporyza incertulas), leaf roller (Cnaphalocrocis medinalis), Watanomeiga (Notarcha derogata), Indian meal moth (Plodia interpunctella), the European corn borer (Ostrinia furnacalis), high Madara Roh moth (Hellula undalis), Shibatsutoga (Pediasia teterrulus) and other moths, Spodoptera litura, Spodoptera exigua, Ayuyoto (Pseudaletia sepata), Madam Gritters such as Strassicae, Agrotis ipsilon, Tamanaginuwaba (Plusia nigrisigna), Trichopulsia, Heliotis, Helicoberpa, etc.
  • Thrips Frankliniella occidentalis, Thrips peri, Citrus dorsalis, and Thrips thrips.
  • Diptera Culex pipiens palens, Culex quaters, and other squids such as Culex quinquefasciaus, etc .; Houseflies such as Anopheles, Chironomidae, Musca domestica, Muscina stabulans, etc., Drosophila, Drosophila, Drosophila, Delaplata, Timaelae Ribae (Agromyza oryzae), rice Hime leafminer (Hydrellia griseola), tomato leafminer, (Liriomyza sativae), legume leafminer (Liriomyza trifolii), leafminer such as the pea (Chromatomyia horticola), chloropidae such as Inekimoguribae (Chlorops oryzae), melon fly (Dacus cucurbitae), fruit flies such as Ceratitis capitata, fruit flies such as Drosophila,
  • Coleoptera Western corn rootworm (Diabrotica virgifera virgifera), corn root worms such as Southern corn rootworm (Diabrotica undecimpunctata howardi), cupreous chafer (Anomala cuprea), rufocuprea (Anomala rufocuprea), beetles such as Japanese beetle (Popillia japonica) , Maysweville (Sytophilus zeamais), Rice weevil (Lissohoptrus oryzophilus), Azuki beetle (Callosobrchuchus Kunststoffsis), Green weevil (Echinocnemus squatium) omus grandis), weevils such as grass reed weevil (Sphenophorus venatus), Chai Loco Meno mealworm (Tenebrio molitor), mealworm such as red flour beetle (Tribolium castaneum), Inedorooimushi (Oulema or
  • Tosama grasshopper Locusta migratoria
  • Kera Gryllotalpa africana
  • Oxya yezoensis Species: Tosama grasshopper (Locusta migratoria), Kera (Gryllotalpa africana), Oxya yezoensis, Lobster (Oxya japonica), and crickets.
  • Lepidoptera Cat fleas (Ctenocephalides felis), dog fleas (Ctenocephalides canis), human fleas (Pulex irritans), keops mouse fleas (Xenopsilla cheopes) and the like. *
  • Anoplura body louse (Pediculus humanus corporis), head lice (Pediculus humanus humanus), crab louse (Phthirus pubis), Ushijirami (Haematopinus eurysternus), Hitsujijirami (Dalmalinia ovis), Butajirami (Haematopinus suis), Inujirami (Linognathus setosus) and the like. *
  • Lepidoptera sheep lice (Dalmalinia ovis), cattle lice (Dalmalinia bovis), chicken lice (Menonpon gallinae), dog lice (Trichodictes canis), cat wolf squirr
  • Hymenoptera Monomorium phalaosis, Formica fusca japonica, Ruriari (Ochetellus pungens), Psomylem puns, Pepperm sperm. Ants such as Argentine ants (Linepithema humile), wasps such as wasps, scallops, and wasps such as wasp (Athalia rosae) and Japanese bee (Athalia japonica).
  • Cockroaches German cockroaches (Blatella germanica), Black cockroaches (Periplaneta fligninosa), Cockroach cockroaches (Periplaneta americana), Japanese cockroaches (Periplaneta brunat)
  • Isoptera Yamato termite (Reticulitermes speratus), Formosan subterranean termite (Coptotermes formosanus), the United States drywood termites (Incisitermes minor), Daikoku termites (Cryptotermes domesticus), Taiwan termites (Odontotermes formosanus), Kou Shun termite (Neotermes koshunensis), Satsuma termites (Glyptotermes satsumensis), termites termites (Glyptotermes nakajimai), termites termites (Glyptotermes fuscus), termites termites (Glyptotermes kodamai) Termites (Glyptotermes kushimensis), giant termite (Hodotermopsis japonica), Kou Shu Ye termite (Coptotermes guangzhoensis), Amami termites (Reticulitermes miyatakei), R.
  • Mite order Tetanychus urticae, Tetanychus kanzawai, utani mite (Ponyychus urmi), mite mite (p) Rabbit mites (Aculops lycopersici), Rabbit mites (Calacarus carinatus), Rabbit mites (Acaphylla theavagrans), Scarlet mite (Eriophys chibaensis), Apple crustaceans (Aulus dachi) Dust mites, such as mites, Polyphagotarsonemus latus, Scots mites, Bremen spider mites, Hemiphysalis mites, Haemphysalis mite, Haemphysalis longis Dermacentor variabilis, Ixodes ovatus, Ixes persulcatus, Black legged tick (Ixodes scapularis), American larva tick (Amblyomama amer) canum), Boophilus microplus (Bo
  • pteronyssinus (Dermatophagoides ptrenyssnus) Lion mites, such as Cheyletus eruditus, Stag beetle tick (Cheyletus malaccensis), Scarlet tick (Cheyletus mooreii), Tiger tickle (Cheeletiell) mite mites such as a yasguri, mite mites (Octoectes cynotis), mites mites such as Sacroptes scabiei, mite mites such as Demodex canis, mite mites, b Species such as Ornithonysus sylvairum and Dermanyssus gallinae, and Tsutsugamushi such as Leptotrombidium akamushi.
  • Spider such as Chiracanthium japonicum and Latrodictus hasseltii Lip and limb class: Geeu (Thereunema hilgendorfi), Tobizukade (Scorpendra subspinipes) and the like. Double leg class: Oxidus gracilis, Nedyopus tambanus, etc. Isopods: Armadillium vulgare, etc. Gastropoda: Limax marginatus, Limax flavus, etc.
  • Nematodes rice Shin Galle nematode (Aphelenchoides besseyi), strawberry menu nematode (Nothotylenchus acris), sweet potato root-knot nematode (Meloidogyne incognita), northern root-knot nematode (Meloidogyne hapla), Java root-knot nematode (Meloidogyne javanica), soybean cyst nematode (Heterodera glycines), Potato cyst nematode (Globodera rostochiensis), southern nematode crested pea (Pratylenchus coffeae), barley nematode nematode (Pratylenchus neglectus).
  • Pests include pests that have reduced drug sensitivity to existing pesticides, that is, have acquired drug resistance.
  • the pest control agent of the present invention contains the compound of the present invention and an inert carrier.
  • the pest control agent of the present invention is usually a mixture of the compound of the present invention and an inert carrier such as a solid carrier, liquid carrier, gaseous carrier, etc.
  • the pest control agent of the present invention usually contains 0.01 to 95% by weight of the compound of the present invention.
  • solid carriers used for formulation include clays (kaolin clay, diatomaceous earth, bentonite, fusami clay, acidic clay), synthetic hydrous silicon oxide, talc, ceramics, and other inorganic minerals (sericite, quartz, sulfur).
  • Polyester resins such as polyethylene terephthalate, nylon resins such as nylon-6, nylon-11, and nylon-66, polyamide resins, polyvinyl chloride, polyvinylidene chloride, and vinyl chloride-propylene copolymers).
  • liquid carrier examples include water, alcohols (methanol, ethanol, isopropyl alcohol, butanol, hexanol, benzyl alcohol, ethylene glycol, propylene glycol, phenoxyethanol, etc.), ketones (acetone, methyl ethyl ketone, cyclohexanone, etc.), aromatic hydrocarbons (Toluene, xylene, ethylbenzene, dodecylbenzene, phenylxylylethane, methylnaphthalene, etc.), aliphatic hydrocarbons (hexane, cyclohexane, kerosene, light oil, etc.), esters (ethyl acetate, butyl acetate, isopropyl myristate, Ethyl oleate, diisopropyl adipate, diisobutyl adipate, propylene glycol monomethyl ether acetate, etc.), n
  • Acid amides N, N-dimethylformamide, N, N-dimethylacetamide, etc.
  • halogenated hydrocarbons diichloromethane, trichloroethane, carbon tetrachloride, etc.
  • sulfoxides dimethylsulfoxide, etc.
  • propylene carbonate and vegetable oil Soybean oil, cottonseed oil, etc.
  • gaseous carrier examples include fluorocarbon, butane gas, LPG (liquefied petroleum gas), dimethyl ether, and carbon dioxide gas.
  • surfactant examples include nonionic surfactants such as polyoxyethylene alkyl ether, polyoxyethylene alkyl aryl ether, and polyethylene glycol fatty acid ester, and anions such as alkyl sulfonate, alkyl benzene sulfonate, and alkyl sulfate. Surfactant is mentioned.
  • formulation adjuvants include sticking agents, dispersants, colorants, antifreezes and stabilizers, such as casein, gelatin, sugars (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin Derivatives, bentonite, synthetic water-soluble polymers (polyvinyl alcohol, polyvinyl pyrrolidone, polyacrylic acids, etc.), glycerin, PAP (isopropyl acid phosphate), BHT (2,6-di-tert-butyl-4-methylphenol), BHA (mixture of 2-tert-butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol).
  • sticking agents such as casein, gelatin, sugars (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin Derivatives, bentonite, synthetic water-soluble polymers (polyvinyl alcohol, polyvinyl pyrrolidone, polyacryl
  • the base material of the resin preparation examples include vinyl chloride polymers, polyurethanes, etc., and these base materials include phthalic acid esters (dimethyl phthalate, dioctyl phthalate, etc.) and adipic acid esters as necessary. Further, a plasticizer such as stearic acid may be added.
  • the resin formulation is obtained by kneading the compound in the base material using a normal kneading apparatus, and then molding by injection molding, extrusion molding, press molding, etc., and if necessary, through steps such as molding, cutting, It can be processed into resin preparations such as plate, film, tape, net, and string.
  • These resin preparations are processed, for example, as animal collars, animal ear tags, sheet preparations, attracting strings, or gardening supports.
  • the bait base include cereal flour, vegetable oil, sugar, crystalline cellulose and the like, and if necessary, antioxidants such as dibutylhydroxytoluene and nordihydroguaiaretic acid, and preservatives such as dehydroacetic acid.
  • antioxidants such as dibutylhydroxytoluene and nordihydroguaiaretic acid
  • preservatives such as dehydroacetic acid.
  • Additives for preventing accidental eating by children and pets such as pepper powder, pests such as cheese flavor, onion flavor and peanut oil are added.
  • the pest control method of the present invention is carried out by applying an effective amount of the compound of the present invention to pests directly and / or to pest habitats (plants, soil, households, animal bodies, etc.).
  • the pest control method of the present invention is usually used in the form of the pest control agent of the present invention.
  • salts formed by the compounds of the present invention with strong acids such as sulfuric acid, methanesulfonic acid and p-toluenesulfonic acid also have excellent control activity against pests.
  • the application amount is usually 1 to 10,000 g as the amount of the compound of the present invention per 10,000 m 2 .
  • the pest control agent of the present invention is formulated into an emulsion, a wettable powder, a flowable agent, etc., it is usually diluted with water so that the active ingredient concentration is 0.01 to 10,000 ppm. Granules, powders and the like are usually applied as they are.
  • preparations and water dilutions of the preparations may be applied directly to pests or plants such as plants to be protected from pests, and in order to control pests that inhabit cultivated soil. You may apply to.
  • the soil When applied to soil, the soil may be the soil where the plant is cultivated or the soil where the plant is to be cultivated.
  • the resin preparation processed into a sheet or string can also be used by a method such as wrapping around a crop, stretching it in the vicinity of the crop, or laying it on the stock soil.
  • Examples of the place where the pest control agent of the present invention is used include paddy field, upland field, tea garden, orchard, and non-agricultural land.
  • the pest control agent of the present invention can also be used in a seedling tray, a seedling box, a seedling culture soil, a seedling mat, and a hydroponic solution in a hydroponic farm.
  • the cultivation method of plants in paddy fields and upland fields may be plowing cultivation or non-plowing cultivation.
  • the amount applied is the amount of the compound of the present invention per area of 1 m 2 when applied on the surface, usually 0.01.
  • the amount of the compound of the present invention per 1 m 3 of space is usually 0.01 to 500 mg when applied to a space.
  • the pest control agent of the present invention is formulated into an emulsion, a wettable powder, a flowable agent, etc., it is usually diluted with water so that the active ingredient concentration is 0.1 to 10,000 ppm. Apply oils, aerosols, smoke, poison baits, etc. as they are.
  • the harmful arthropod control agent of the present invention When used to control ectoparasites of cattle, horses, pigs, sheep, goats, chickens, small animals such as dogs, cats, rats, mice, etc., it is well known in veterinary medicine. Can be used on animals.
  • systemic suppression for example, administration by tablet, feed mixing, suppository, injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.) is intended for non-systemic suppression.
  • an oil agent or an aqueous liquid is sprayed, a pour-on treatment or a spot-on treatment is performed, the animal is washed with a shampoo preparation, or a resin preparation is attached to the animal with a collar or ear tag.
  • the amount of the compound of the present invention is usually in the range of 0.1 to 1,000 mg per 1 kg body weight of the animal.
  • the pest control agent of the present invention can be used in farmland where the following plants (hereinafter referred to as the present plant) are cultivated.
  • Cereals corn, rice, wheat, barley, rye, triticale, oats, sorghum, cotton, soybeans, peanuts, peanuts, cypress (green beans), lentils, azuki beans, cowpeas, mung bean, safflower beans, red bean, moss beans, tepareen, Broad bean, pea, chickpea, lentil, lupine, pigeon bean, buckwheat, sugar beet, rapeseed, sunflower, sugar cane, tobacco, etc.
  • Vegetables Eggplant vegetables (eggplants, tomatoes, peppers, peppers, bell peppers, potatoes, etc.), cucurbits vegetables (cucumbers, pumpkins, zucchini, watermelons, melons, etc.), cruciferous vegetables (radish, turnip, horseradish, kohlrabi, Chinese cabbage, cabbage, mustard, broccoli, cauliflower, etc.), Asteraceae vegetables (burdock, garlic, artichoke, lettuce, etc.), liliaceae vegetables (eg, leek, onion, garlic, asparagus), celery family vegetables (carrot, parsley, celery) , American Bow Fu, etc.), Rubiaceae vegetables (spinach, chard, etc.), Lamiaceae vegetables (perilla, mint, basil, lavender, etc.), strawberry, sweet potato, yam, taro, etc.
  • cucurbits vegetables cucumbers, pumpkins, zucchini, watermelons, melons, etc.
  • cruciferous vegetables radish, turnip, horseradish,
  • Fruit trees berries (apples, pears, Japanese pears, quince, quince, etc.), nuclear fruits (peaches, plums, nectarines, ume, sweet cherry, apricots, prunes, etc.), citrus (satsuma mandarin, orange, lemon, lime, grapefruit) ), Nuts (chestnut, walnut, hazel, almond, pistachio, cashew nut, macadamia nut, etc.), berries (blueberry, cranberry, blackberry, raspberry, etc.), grape, oyster, olive, loquat, banana, coffee, Date palm, coconut palm, oil palm etc.
  • Trees other than fruit trees tea, mulberry, flowering trees (Satsuki, camellia, hydrangea, sasanqua, shikimi, sakura, yurinoki, crape myrtle, eustoma, etc.), roadside trees (ash, birch, dogwood, eucalyptus, ginkgo, lilac, maple, oak) , Poplar, redwood, fu, sycamore, zelkova, blackfish, Japanese amberjack, moths, pine, pine, spruce, yew, elm, Japanese cypress, etc.), coral jug, dogwood, cedar, cypress, croton, masaki, kanamochi, etc.
  • the plant includes plants bred by hybrid technology.
  • the present plant includes a genetically modified plant prepared by a genetic recombination technique.
  • This plant also includes plants to which resistance to herbicides is imparted by genetic recombination techniques or classical breeding methods.
  • the plant further includes a plant imparted with an ability to produce a selective toxin against pests by a genetic recombination technique.
  • This plant includes a plant imparted with an ability to produce an anti-pathogenic substance by genetic recombination technology.
  • This plant includes plants to which useful traits such as oil component modification and amino acid content enhancing traits have been imparted.
  • the pest control agent of the present invention As a method of applying the pest control agent of the present invention to this plant to be protected from damage such as feeding by pests, specifically, application to the foliage, flower vases or ears of plants such as foliage spraying Application to seeds of plants or vegetative propagation organs (for example, seed buds, bulbs, tubers, bulbs, stem fragments, etc.); application to plant seedlings (including cuttings).
  • foliage spraying Application to seeds of plants or vegetative propagation organs (for example, seed buds, bulbs, tubers, bulbs, stem fragments, etc.); application to plant seedlings (including cuttings).
  • Examples of the method for applying the pest control agent of the present invention to the foliage, flower vases or ears of plants include application methods applied to the surface of plants such as foliage spray, trunk spray, etc., and before flowering, during flowering A method of spraying on the vase or the whole plant at the flowering time including after flowering is mentioned, and a method of spraying on the ear of the heading time or the whole plant when the plant is cereal.
  • Examples of the method for applying the pest control agent of the present invention to plant seeds or vegetative propagation organs include, for example, a method of coating, smearing or applying to seeds or vegetative propagation organs, and seeds or vegetative propagation organs in liquid formulations.
  • Examples thereof include a dipping method and a method of coating seeds or vegetative propagation organs (for example, a film coating method, a pellet coating method, etc.).
  • the amount of the compound of the present invention is usually applied in the range of 0.2 to 5,000 g, preferably 0.5 to 1,000 g per 100 kg of plant seeds or vegetative propagation organs.
  • Preferred dosage forms are aqueous liquid suspension preparations such as emulsions, wettable powders, flowables, and microcapsules.
  • Plants to which the method is applied include, among these plants, soybeans, corn, cotton, wheat, barley, rye, triticale, oats, rice, sorghum, peanuts, peanuts except soybeans and peanuts, sugar beet, rapeseed, It is preferably applied to sunflower, potato, sugar cane and vegetables. When applied to sugarcane, sugarcane stalk fragments may be used in sugarcane cultivation.
  • the pest control agent of the present invention can be mixed or used in combination with known insecticides, acaricides, nematicides, fungicides, plant growth regulators and synergists.
  • the pest control agent of the present invention can be used in combination with known herbicides. Examples of active ingredients of such insecticides, acaricides, nematicides, fungicides, herbicides and synergists are shown below.
  • Insecticides Organophosphorus Compounds Acephate, Aluminum Phosphide, Butathiofos, Cadosafos, Chlorethoxyfos, Chlorfenvinphos, Chlorfenvinphos (Chlorpyrifos), Chlorpyrifos-methyl (Chlorpyrifos-methyl), Cyanophos (Cyanophos: CYAP), Diazinon (Diazinon), DCIP (Dichlorodiisopropylene ether), Diclofenthion (V), Dichlorfenthion (V) ), Dimethoate, dimethylvinphos, disulfoton, EPN, etion, ethoprofos, etrimfos, fention (MPP), EP, Phosthiazate, formothion, hydrogen phosphide, isofenphos, isoxathion, malathion, methulfenfos, methulf
  • pyrethroid compounds acrinathrin, allethrin, benfluthrin, beta-cyfluthrin, bifenthrin, cycloprotorin, fluprothrin (cycloprothrin) , Cypermethrin, deltamethrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucitrate lucytrinate, flufenprox, flumethrin, fluvalinate, halfenprox, imiprothrin, permethrin, praretrin, praretrin resmethrin, sigma-cypermethrin, silafluofen, tefluthrin, tralomethrin, transfluthrin, tetramethrin ethrin), phenothrin, cyphenothrin, alpha-cypermethrin, zeta-c
  • Neonicotinoid compounds imidacloprid (imidac1oprid), nitenpyram (nitenpyram), acetamiprid (acetamipride), thiamethoxam, thiacloprid (thiacloprid), dinoteurin (dinothurine) (6) Benzoylurea compound Chlorfluazuron, bistrifluron, diafenthiuron, diflubenzuron, fluazuron, flucycloxuron, flucyclolone (Flufenoxuron), hexaflumuron, lufenuron, novaluron, novifluuron, teflubenzuron, triflumuron, and triflumuron.
  • Phenylpyrazole compounds Acetoprole, etiprole, fipronil, vaniliprole, pyriprole, and pyrafluprole.
  • Bt toxin Live spores and produced crystal toxins derived from Bacillus thuringiensis, and mixtures thereof;
  • Hydrazine compounds Chromafenozide, halofenozide, methoxyphenozide, and tebufenozide.
  • Insecticide Active Ingredients Machine oil, nicotine-sulfate; avermectin, bromopropyrate, buprofezin, chlorfenapyr, chlorphenapyr Ritranol, cyromazine, DD (1,3-Dichloropropene), emamectin benzoate, fenazaquin, flupirroprene, flupyrazolen , Indoxacarb, methoxadiazone, milbemycin-A, pymetrozine, pyridalyl, pyriprosul, spiromidol, spinodulsulfide tolfenpyrad, triazamate, flubendiamide, repimectin, arsenous acid, benclothiaz, lime nitrogen calcium lime ulfide, chlordane, DDT, DSP, flufenerim, flonicamid, flurimfen, formatenate, metham-ammonium, metam-ammonium
  • Active ingredients of acaricides acequinocyl, amitraz, benzoximate, bifenaate, phenisobromolate (BS), chinomethionate (BS), chinomethionate (BS) chlorfenson, clofentezine, cyflumetofene, kelsen (dicofol), etoxazole, fenbutatin oxide (fenbutafen), fenothiocarbene roximate, fluacrylpyrim, fluproxyfen, hexythiazox, propargite (BPPS), polynactin complex (pyridene), pyridaben (pyriben) (Tetradifon), spirodiclofen, spiromesifen, spirotetramat, amidoflumet, and cenopyrafen.
  • BS phenisobromolate
  • BS chinomethionate
  • BS chinomethionate
  • Active ingredients of nematicides DCIP, fostiazate, levamisole hydrochloride, methylisothiocyanate, morantel tartrate, and imiciafos.
  • Active ingredients of fungicides Propiconazole, Prothioconazole, Triadimenol, Prochloraz, Penconazole, Tebuconazole, Tebuconazole, Tebuconazole , Bromuconazole, epoxiconazole, difenoconazole, cyproconazole, metconazole, triflumazole, triflumizole Tetraconazole, microbutanil, fenbuconazole, hexaconazole, fluquinconazole, triticonazole, triticonazole, triticonazole, triticonazole Azole fungicidal compounds such as flutriafol; Cyclic amine bactericidal compounds such as fenpropimorph, tridemorph, fenpropidin; Benzimidazole fungicidal compounds such as carbendezim, benomyl, thiabendazole, thiophanate-methyl; Procymid
  • Hydroxybenzonitrile herbicidal compounds bromoxynil and ioxynil.
  • Dinitroaniline herbicidal compounds pendimethalin, prodiamine, and trifluralin.
  • Organophosphorus herbicidal compounds amiprofos-methyl, butamifos, bensulide, piperophos, anilofos, glyphosate, glufosinate, glufosinate, glufosinate P (glufosinate-P), and bialaphos.
  • Carbamate herbicidal compounds di-allate, tri-allate, EPTC, butyrate, beniocarb, esprocarb, molinate, dimepiperate (Swep), chlorpropham, phenmedifam, phenisopham, piributicarb, and asuram.
  • Acid amide herbicidal compounds propanil, propyzamide, bromobutide, and etobanzanide.
  • Chloroacetanilide herbicidal compounds acetochlor, acechlor, butachlor, dimethenamide, propachlor, metazachlor, metrachlor or totrachlor pretilachlor), tenylchlor (theny1ch1or), and petoxamide.
  • Diphenyl ether herbicidal compounds aciflufen-sodium, bifenox, oxyfluorfen, lactofen, fomesafen, clomethoxythonifen, and chloromethoxypheny.
  • Trione oxime herbicidal compounds alloxydim-sodium, cetoxydim, butoxydim, crestodim, cloxydimim, cycloxidim, texydimym (Traxydim), and profoxydim.
  • a sulfonylurea herbicidal compound chlorsulfuron, sulfomethuron-methyl, metsulfuron-methyl, chlorimuron-ethyl, trivenuron methyl (18) tribenuron-methyl, trisulfuron, bensulfuron-methyl, thifensulfuron-methyl, pyrazosulfuron-methyl, urmisyl-uryl-uryl-uryl Nicosulfuron (nico) ulfuron, amidosulfuron, cinosulfuron, imazosulfuron, rimsulfuron, halosulfuron (thulfuron), prosulfuron (thulsulfuron), prosulfuron (thulsulfuron) , Triflusulfuron-methyl, flazasulfuron, cyclosulfamuron, flupirsulfuron, sulfosulfurium, sulfosulfurimuron Azulsulfur
  • the present compound 1 1 H-NMR (DMSO-D 6 ) ⁇ : 9.57 (1H, s), 8.74 (1H, d), 8.46 (1H, s), 8.31 (1H, d), 8.17 (1H, d ), 8.00 (1H, d), 7.76 (1H, dd), 3.97-3.88 (5H, m), 1.24 (3H, t).
  • the obtained reaction mixture was poured into 1N aqueous hydrochloric acid solution, and the precipitated solid was collected by filtration. The obtained solid was washed with water and dried to obtain 9.8 g of a solid G.
  • a mixture of 13 g of iron powder, 19 mL of acetic acid, 200 mL of tetrahydrofuran, and 28 mL of water was heated to 65 ° C., and a mixed solution of 14 g of solid G and 50 mL of tetrahydrofuran was added dropwise with stirring. After completion of dropping, the mixture was stirred at 65 ° C. for 3 hours. The resulting reaction mixture was filtered through Celite (registered trademark) and washed with tetrahydrofuran.
  • a part represents a weight part.
  • Formulation Example 1 10 parts of any one of the compounds 1 to 19 of the present invention are dissolved in a mixture of 35 parts of xylene and 35 parts of N, N-dimethylformamide, and 14 parts of polyoxyethylene styryl phenyl ether and calcium dodecylbenzenesulfonate are dissolved therein. Add 6 parts and mix to obtain each formulation.
  • Formulation Example 2 4 parts of sodium lauryl sulfate, 2 parts of calcium lignin sulfonate, 20 parts of synthetic silicon hydroxide fine powder and 54 parts of diatomaceous earth are mixed, and 20 parts of any one of the compounds 1 to 19 of the present invention are added and mixed. Get a wettable powder.
  • Formulation Example 3 1 part of synthetic silicon hydrous fine powder, 2 parts of calcium lignin sulfonate, 30 parts of bentonite and 65 parts of kaolin clay are mixed with 2 parts of any one of the compounds 1 to 19 of the present invention. Next, an appropriate amount of water is added to the mixture, and the mixture is further stirred, granulated with a granulator, and dried by ventilation to obtain each granule.
  • Formulation Example 4 1 part of any one of the compounds 1 to 19 of the present invention is dissolved in an appropriate amount of acetone, and 5 parts of a synthetic silicon hydroxide fine powder, 0.3 part of isopropyl acid phosphate and 93.7 parts of fusami clay are added, The mixture is thoroughly mixed and acetone is removed by evaporation to obtain each powder.
  • Formulation Example 5 35 parts of a mixture of polyoxyethylene alkyl ether sulfate ammonium salt and white carbon (weight ratio 19), 10 parts of any one of the compounds 1 to 19 of the present invention, and 55 parts of water are mixed and finely divided by a wet pulverization method. Each flowable agent is obtained by grinding.
  • Formulation Example 6 0.1 part of any one of the compounds 1 to 19 of the present invention is dissolved in a mixture of 5 parts of xylene and 5 parts of trichloroethane, and this is mixed with 89.9 parts of deodorized kerosene to obtain each oil agent.
  • Formulation Example 7 10 mg of any one of the compounds 1 to 19 of the present invention is dissolved in 0.5 ml of acetone, and this solution is added dropwise to 5 g of animal solid feed powder (solid feed powder CE-2 for breeding breeding, Nippon Claire Co., Ltd.). And mix evenly. Then acetone is evaporated to dryness to obtain each poisonous bait.
  • animal solid feed powder solid feed powder CE-2 for breeding breeding, Nippon Claire Co., Ltd.
  • Formulation Example 8 0.1 part of any one of the compounds 1 to 19 of the present invention and 49.9 parts of neothiozole (Chuo Kasei Co., Ltd.) are put in an aerosol can, and after mounting an aerosol valve, 25 parts of dimethyl ether and 25 parts of LPG are filled. Shake and attach an actuator to obtain an oil aerosol.
  • Formulation Example 9 0.6 part of any one of compounds 1 to 19 of the present invention, 0.01 part of BHT (2,6-di-tert-butyl-4-methylphenol), 5 parts of xylene, 3.39 parts of deodorized kerosene and emulsifier ⁇ Rheodor MO-60 (manufactured by Kao Corporation) ⁇ After mixing 1 part and 50 parts of distilled water into an aerosol container and attaching a valve, 40 parts of propellant (LPG) was added through the valve. Pressure filling to obtain an aqueous aerosol.
  • BHT 2,6-di-tert-butyl-4-methylphenol
  • xylene 3.39 parts of deodorized kerosene and emulsifier ⁇ Rheodor MO-60 (manufactured by Kao Corporation) ⁇
  • LPG propellant
  • Formulation Example 10 0.1 g of any one of the compounds 1 to 19 of the present invention is mixed with 2 ml of propylene glycol, impregnated into a porous ceramic plate of 4.0 ⁇ 4.0 cm and thickness of 1.2 cm, and a heating smoke Get.
  • Formulation Example 11 5 parts of any one of the present compounds 1 to 19 and an ethylene-methyl methacrylate copolymer (ratio of methyl methacrylate in the copolymer: 10% by weight, ACRIFT (registered trademark) WD301, manufactured by Sumitomo Chemical Co., Ltd.) 95
  • the part is melt-kneaded with a closed pressure kneader (manufactured by Moriyama Seisakusho), and the resulting kneaded product is extruded from an extrusion molding machine through a molding die to obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm.
  • Formulation Example 12 5 parts of any one of the compounds 1 to 19 of the present invention and 95 parts of a soft vinyl chloride resin are melt-kneaded with a closed pressure kneader (manufactured by Moriyama Seisakusho), and the resulting kneaded product is passed from an extrusion molding machine through a molding die. To obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm.
  • Formulation Example 13 Any one of the compounds 1 to 19 of the present invention 100 mg, lactose 68.75 mg, corn starch 237.5 mg, microcrystalline cellulose 43.75 mg, polyvinylpyrrolidone 18.75 mg, sodium carboxymethyl starch 28.75 mg, and magnesium stearate Mix 2.5 mg and compress the resulting mixture to an appropriate size to obtain tablets.
  • Formulation Example 14 Any one of the compounds 1 to 19 of the present invention 25 mg, lactose 60 mg, corn starch 25 mg, carmellose calcium 6 mg, and 5% hydroxypropylmethylcellulose are mixed in an appropriate amount, and the resulting mixture is hard shell gelatin capsule or hydroxypropylmethylcellulose capsule To obtain capsules.
  • Formulation Example 15 Any one of the compounds 1 to 19 of the present invention 100 mg, fumaric acid 500 mg, sodium chloride 2000 mg, methylparaben 150 mg, propylparaben 50 mg, granule sugar 25000 mg, sorbitol (70% solution) 13000 mg, VeegumK (VanderbiltCo.) 100 mg, flavor 35 mg, And distilled water is added to 500 mg of the colorant so that the final volume becomes 100 ml, and mixed to obtain a suspension for oral administration.
  • VanderbiltCo. VeegumK
  • Formulation Example 16 5% by weight of any one of the compounds 1 to 19 of the present invention is dissolved in 5% by weight of polysorbate 85, 3% by weight of benzyl alcohol, and 30% by weight of propylene glycol, and the pH of this solution is 6.0 to 6.5. After adding a phosphate buffer so that it becomes, the remainder is added with water to obtain a solution for oral administration.
  • Formulation Example 17 5% by weight of aluminum distearate in 57% by weight of fractionated coconut oil and 3% by weight of polysorbate 85 is added and dispersed by heating. This is cooled to room temperature and 25% by weight of saccharin is dispersed in the oily vehicle. To this, 10% by weight of any one of the compounds 1 to 19 of the present invention is allocated to obtain a paste preparation for oral administration.
  • Formulation Example 18 5% by weight of any one of the compounds 1 to 19 of the present invention is mixed with 95% by weight of limestone powder, and granules for oral administration are obtained using a wet granulation method.
  • Formulation Example 19 5 parts of any one of the compounds 1 to 19 of the present invention are dissolved in 80 parts of diethylene glycol monoethyl ether, and 15 parts of propylene carbonate is mixed therewith to obtain a spot-on solution.
  • Formulation Example 20 10 parts of any one of the compounds 1 to 19 of the present invention are dissolved in 70 parts of diethylene glycol monoethyl ether, and 20 parts of 2-octyldodecanol is mixed with this to obtain a pour-on solution.
  • Formulation Example 22 Any one of the compounds 1 to 19 of the present invention 0.15% by weight, animal feed 95% by weight, and 4.85% by weight of a mixture comprising dicalcium phosphate, diatomaceous earth, Aerosil, and carbonate (or chalk) are sufficiently stirred. Mix to obtain animal feed premix.
  • Formulation Example 23 7.2 g of any one of the compounds 1 to 19 of the present invention and 92.8 g of Fosco (registered trademark) S-55 (manufactured by Maruishi Pharmaceutical Co., Ltd.) are dissolved and mixed at 100 ° C., poured into a suppository, and cooled. Solidify to obtain a suppository.
  • Fosco registered trademark
  • S-55 manufactured by Maruishi Pharmaceutical Co., Ltd.
  • a part represents a weight part.
  • Formulation Example 1A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the compound 1 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 2A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 2 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 3A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the compound 3 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 4A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 4 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 5A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 5 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 6A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of compound 6 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 7A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 7 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 8A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 8 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 9A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the compound 9 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 10A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 10 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 11A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 11 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 12A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 12 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 13A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 13 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 14A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the compound 14 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 15A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 15 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 16A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 16 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 17A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 17 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 18A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 18 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 19A 0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the compound 19 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 20A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of Compound 1 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 21A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 2 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 22A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 3 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 23A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 4 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 24A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of Compound 5 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 25A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 6 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 26A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 7 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 27A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of Compound 8 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 28A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 9 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 29A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of compound 10 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 30A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 11 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 31A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 12 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 32A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 13 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 33A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 14 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 34A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 15 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 35A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 16 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 36A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 17 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 37A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 18 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 38A 10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 19 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 39A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of Compound 1 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 40A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of compound 2 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 41A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of compound 3 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 42A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 4 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 43A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of Compound 5 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 44A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of compound 6 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 45A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 7 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 46A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 8 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 47A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 9 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 48A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 10 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 49A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 11 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 50A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 12 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 51A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of compound 13 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 52A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 14 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 53A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 15 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 54A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 16 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 55A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of compound 17 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 56A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 18 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Formulation Example 57A 4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 19 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
  • Test example 1 Each formulation of the present compound 2,3,4,5,11,12,13,14,15 and 16 obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 200 ppm, A test chemical solution was prepared. Meanwhile, about 30 Aphis gossypi (all stages) were inoculated into cucumber seedlings (first true leaf development stage) planted in plastic cups and left for 1 day. The seedlings were sprayed with 20 ml of the test chemical solution. Six days after spraying, the number of live cotton aphids that parasitized on the leaves of the cucumber was examined, and the control value was determined by the following formula.
  • Control value (%) ⁇ 1 ⁇ (Cb ⁇ Tai) / (Cai ⁇ Tb) ⁇ ⁇ 100
  • the character in a formula represents the following meaning.
  • Cb number of insects before treatment in the untreated group
  • Cai number of live parasites when observed in the untreated group
  • Tb number of insects before treatment in the treated group
  • Tai number of live parasitic insects during observation of the treated group
  • the group means a group in which a preparation containing no compound of the present invention in Preparation Example 5 was sprayed with a test chemical solution diluted with the same amount of water as the treatment group.
  • all of the treatment sections using the test chemical solutions of the compounds 2, 3, 4, 5, 11, 12, 13, 14, 15 and 16 of the present invention showed a control value of 90% or more.
  • Test example 2 Each formulation of the present compounds 11, 13, 14 and 16 obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 200 ppm, and a test drug solution was prepared.
  • cucumber seedlings planted in plastic cups were irrigated with 5 ml of the test chemical solution and kept in a greenhouse at 25 ° C. for 7 days. After inoculating about 30 Aphis gossypi (all stages) on the cucumber leaf surface and keeping it in the greenhouse for another 6 days, the number of live aphids on the cucumber leaf was investigated. The control value was calculated by the following formula.
  • Control value (%) ⁇ 1 ⁇ (Cb ⁇ Tai) / (Cai ⁇ Tb) ⁇ ⁇ 100
  • the character in a formula represents the following meaning.
  • Cai number of live parasites when observed in the untreated group
  • Tb number of insects before treatment in the treated group
  • Tai number of live parasitic insects during observation of the treated group
  • the group means a group in which a preparation containing no compound of the present invention in Preparation Example 5 was sprayed with a test chemical solution diluted with the same amount of water as the treatment group.
  • all of the treatment sections using the test chemical solutions of the compounds 11, 13, 14 and 16 of the present invention exhibited a control value of 90% or more.
  • Test example 3 Each formulation of the present compounds 3, 14 and 15 obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 200 ppm, respectively, to prepare a test drug solution. 10 ml of the test chemical solution is sprayed on rice seedlings in the second leaf development stage planted in a polyethylene cup. After air-drying, 20 3-4 instar larvae of Nilaparvata lugens are released and stored in a greenhouse at 25 ° C. Six days later, the number of surviving insects that were infested with rice was examined, and the control value was determined by the following formula.
  • Control value (%) ⁇ 1 ⁇ (Cb ⁇ Tai) / (Cai ⁇ Tb) ⁇ ⁇ 100
  • the character in a formula represents the following meaning.
  • Cai number of live parasites when observed in the untreated group
  • Tb number of insects before treatment in the treated group
  • Tai number of live parasitic insects during observation of the treated group
  • the group means a group in which a preparation containing no compound of the present invention in Preparation Example 5 was sprayed with a test chemical solution diluted with the same amount of water as the treatment group.
  • all of the treatment groups using the test chemical solutions of the compounds 3, 14 and 15 of the present invention showed a control value of 90% or more.
  • Test example 4 Each preparation of the compounds 2, 3, 11 and 14 of the present invention obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 200 ppm, and a test drug solution was prepared. On the other hand, 5 ml of the test drug solution was irrigated to rice seedlings planted in plastic cups (2 weeks after sowing, in the second leaf development stage) and kept in a 25 ° C. greenhouse for 7 days. After releasing 20 3-4 instar larvae of the green planthopper (Nilaparvata lugens) and keeping it in the greenhouse for another 6 days, the number of surviving insects parasitic on the rice leaves was investigated, and the control value was calculated by the following formula: Asked.
  • Control value (%) ⁇ 1 ⁇ (Cb ⁇ Tai) / (Cai ⁇ Tb) ⁇ ⁇ 100
  • the character in a formula represents the following meaning.
  • Cai number of live parasites when observed in the untreated group
  • Tb number of insects before treatment in the treated group
  • Tai number of live parasitic insects during observation of the treated group
  • the group means a group in which a preparation containing no compound of the present invention in Preparation Example 5 was sprayed with a test chemical solution diluted with the same amount of water as the treatment group.
  • all of the treatment groups using the test chemical solutions of the compounds 2, 3, 11 and 14 of the present invention showed a control value of 90% or more.
  • Test Example 5 Each preparation of the compound of the present invention obtained in Formulation Example 5 is diluted with water so that the active ingredient concentration is 200 ppm to prepare a test drug solution.
  • adult tobacco whitefly (Bemisia tabaci) is released on tomato seedlings (third true leaf development stage) planted in a polyethylene cup and allowed to lay eggs for about 72 hours.
  • the tomato seedlings are kept in a greenhouse for 8 days, and the test chemical is sprayed at a rate of 20 ml / cup to the place where the larva has hatched from the delivered eggs, and kept in the greenhouse at 25 ° C. Seven days later, the number of surviving larvae on the tomato leaves is examined to calculate the mortality rate.
  • Test Example 6 Each formulation of the compound of the present invention 2,3,4,5,11,12,13,14,15,16,17 and 18 obtained in Formulation Example 5 is mixed with water so that the active ingredient concentration is 200 ppm.
  • the test drug solution was prepared.
  • the test chemical solution was sprayed at a rate of 20 mL / cup on a three-leaf cabbage planted in a polyethylene cup. After the drug solution was dried, the foliage was cut out and accommodated in a 50 mL cup, and 5 second-instar larvae (Plutella xylostella) were released and capped. After storing at 25 ° C., the number of dead insects was counted after 5 days, and the death rate was calculated from the following formula.
  • Death rate (%) (Number of dead insects / number of test insects) ⁇ 100
  • Test Example 7 Each formulation of the compound of the present invention obtained in Formulation Example 5 is diluted with water so that the active ingredient concentration becomes 200 ppm, respectively, and a test spray solution is prepared.
  • an apple is planted in a plastic cup and grown until the seventh or eighth true leaf develops.
  • the apple is sprayed with the test chemical at a rate of 20 mL / cup. After the chemical solution is dried, 60 first-instar larvae of Adoxophys orana fascita are released, and the bottom is covered with a plastic cup with a cut-out filter paper. After 7 days, the number of dead insects is examined and the death rate is calculated.
  • Test Example 9 Each formulation of the present compounds 4, 5 and 14 obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 500 ppm, respectively, to prepare a test drug solution.
  • a filter paper of the same size is placed on the bottom of a polyethylene cup having a diameter of 5.5 cm, 0.7 ml of the test chemical solution is dropped on the filter paper, and 30 mg of sucrose is uniformly added as food.
  • Test Example 10 Each formulation of the present compound 4, 5, 14, 15, 16, 17, 18 and 19 obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 500 ppm, respectively, and a test drug solution was prepared. Prepared. 0.7 ml of the test chemical solution was added to 100 ml of ion-exchanged water (active ingredient concentration: 3.5 ppm). Twenty dead larvae of Culex pipiens pallens were released into the solution, and after 1 day, the viability was investigated, the number of dead worms was counted, and the mortality rate was determined.
  • Death rate (%) (Number of dead insects / number of test insects) ⁇ 100 As a result, all of the treatment groups using the test chemical solutions of the compounds 4, 5, 14, 15, 16, 17, 18 and 19 of the present invention showed a death rate of 95% or more.
  • Test Example 12 5 mg of the compound of the present invention is dissolved in 5 mL of propylene carbonate so as to be 0.1% w / v to prepare a test drug solution.
  • mice were inoculated with 30 test mites (Mite mite, young mite). Remove non-parasitic ticks before dripping.
  • 200 ⁇ L of the test drug solution is administered dropwise to the entire body surface of the mouse using a pipette.
  • 200 ⁇ L of propylene carbonate alone is administered to the control group. Repeat 3 times per group. Two days after the instillation, the lethality of the test mite is investigated, and the mortality is calculated.
  • the control agent of the present invention has a control effect on pests and is useful as an active ingredient of pests.

Abstract

A condensed heterocyclic compound that can be represented by formula (1) (in which A represents NCH3 or an oxygen atom; R1 represents a hydrogen atom, a C1-3 alkyl group that may contain one or more halogen atoms, a halogen atom, a C1-3 alkoxy group, a C2-4 alkoxycarbonyl group, S(O)mR2, NR3R4, a nitro group, or a cyano group; R2 represents a C1-3 alkyl group; R3 and R4 each independently represent a hydrogen atom or a C1-3 alkyl group; R5 represents a C1-3 perfluoroalkyl group or S(O)p-R6; R6 represents a C1-3 perfluoroalkyl group; n represents 0, 1, or 2; m represents 0, 1, or 2; and p represents 0, 1 or 2) exhibits excellent pest-control efficacy.

Description

縮合複素環化合物Fused heterocyclic compounds
 本発明は、ある種の縮合複素環化合物及びその有害生物防除用途に関する。 The present invention relates to certain condensed heterocyclic compounds and their use for pest control.
 これまでに有害生物の防除を目的として、様々な化合物が検討されており、実用に供されている。
 また、ある種の縮合複素環化合物(例えば、特許文献1参照)が知られている。
So far, various compounds have been studied and put into practical use for the purpose of controlling pests.
Also, certain types of fused heterocyclic compounds (for example, see Patent Document 1) are known.
国際公開2013/018928号International Publication No. 2013/018928
 本発明は、有害生物に対して優れた防除効力を有する化合物及びその化合物を用いた有害生物の防除方法を提供することを課題とする。 An object of the present invention is to provide a compound having an excellent control effect against pests and a method for controlling pests using the compound.
 本発明者等は上記の課題を解決すべく検討した結果、下記式(1)で示される縮合複素環化合物が有害生物に対して優れた防除効力を有することを見出した。 As a result of studies to solve the above problems, the present inventors have found that the condensed heterocyclic compound represented by the following formula (1) has an excellent control effect against pests.
 本発明は、以下のとおりである。
[1] 式(1)
Figure JPOXMLDOC01-appb-I000002

[式中、
AはNCH又は酸素原子を表し、
は、水素原子、1個以上のハロゲン原子を有していてもよいC1-C3アルキル基、ハロゲン原子、C1-C3アルコキシ基、C2-C4アルコキシカルボニル基、S(O)、NR、ニトロ基又はシアノ基を表し、
は、C1-C3アルキル基を表し、
およびRは、各々独立して水素原子又はC1-C3アルキル基を表し、
はC1-C3パーフルオロアルキル基又はS(O)-Rを表し、
はC1-C3パーフルオロアルキル基を表し、
nは0,1又は2を表し、
mは0,1又は2を表し、
pは0,1又は2を表す。]
で示される縮合複素環化合物(以下、本発明化合物と記す)。
[2 ]AがNCHである、[1]記載の化合物。
[3] Aが酸素原子である、[1]記載の化合物。
[4] Rが、水素原子、1個以上のハロゲン原子を有していてもよいC1-C3アルキル基、ハロゲン原子、C1-C3アルコキシ基、又はS(O)である[1]~[3]いずれか一に記載の化合物。
[5] Rが、水素原子、塩素原子、臭素原子、メチル基、トリフルオロメチル基、メトキシ基、メチルスルファニル基、メチルスルフィニル基、又はメチルスルホニル基である[1]~[3]いずれか一に記載の化合物。
[6] Rが、トリフルオロメチル基又はS(O)-CF基である[1]~[5]いずれか一に記載の化合物。
[7] [1]~[6]いずれかに記載の化合物と、不活性担体とを含有する有害生物防除組成物。
[8][1]~[6]いずれかに記載の化合物の有効量を有害生物又は有害生物の生息場所に施用する有害生物の防除方法。
The present invention is as follows.
[1] Formula (1)
Figure JPOXMLDOC01-appb-I000002

[Where:
A represents NCH 3 or an oxygen atom,
R 1 is a hydrogen atom, a C1-C3 alkyl group optionally having one or more halogen atoms, a halogen atom, a C1-C3 alkoxy group, a C2-C4 alkoxycarbonyl group, S (O) m R 2 , NR 3 R 4 represents a nitro group or a cyano group,
R 2 represents a C1-C3 alkyl group,
R 3 and R 4 each independently represents a hydrogen atom or a C1-C3 alkyl group,
R 5 represents a C1-C3 perfluoroalkyl group or S (O) p —R 6 ,
R 6 represents a C1-C3 perfluoroalkyl group,
n represents 0, 1 or 2,
m represents 0, 1 or 2;
p represents 0, 1 or 2. ]
A condensed heterocyclic compound represented by the following (hereinafter referred to as the present compound).
[2] The compound according to [1], wherein A is NCH 3 .
[3] The compound according to [1], wherein A is an oxygen atom.
[4] R 1 is a hydrogen atom, a C1-C3 alkyl group optionally having one or more halogen atoms, a halogen atom, a C1-C3 alkoxy group, or S (O) m R 2 [1] ] To [3] The compound according to any one of the above.
[5] Any of [1] to [3], wherein R 1 is a hydrogen atom, a chlorine atom, a bromine atom, a methyl group, a trifluoromethyl group, a methoxy group, a methylsulfanyl group, a methylsulfinyl group, or a methylsulfonyl group A compound according to 1.
[6] The compound according to any one of [1] to [5], wherein R 5 is a trifluoromethyl group or a S (O) p —CF 3 group.
[7] A pest control composition comprising the compound according to any one of [1] to [6] and an inert carrier.
[8] A method for controlling pests, which comprises applying an effective amount of the compound according to any one of [1] to [6] to a pest or a pest habitat.
 本発明化合物は、有害生物に対して優れた防除活性を有することから、有害生物防除剤の有効成分として有用である。 The compound of the present invention is useful as an active ingredient of a pest control agent because it has an excellent control activity against pests.
本発明化合物において、「ハロゲン原子」とはフッ素原子、塩素原子、臭素原子及びヨウ素原子を意味する。 In the compound of the present invention, “halogen atom” means a fluorine atom, a chlorine atom, a bromine atom and an iodine atom.
本発明化合物において「C1-C3アルキル基」としては、メチル基、エチル基、プロピル基、及びイソプロピル基が挙げられる。
 本発明化合物において「1個以上のハロゲン原子を有していてもよいC1-C3アルキル基」とは、C1-C3アルキル基の少なくとも1の水素原子がハロゲン原子で置換されていてもよいC1-C3アルキル基を表し、例えばフルオロメチル基、クロロメチル基、ブロモメチル基、ヨードメチル基、ジフルオロメチル基、ジクロロメチル基、トリフルオロメチル基、クロロジフルオロメチル基、ブロモジフルオロメチル基、トリクロロメチル基、2-フルオロエチル基、2-クロロエチル基、2-ブロモエチル基、2,2-ジフルオロエチル基、2,2,2-トリフルオロエチル基、ペンタフルオロエチル基、ヘプタフルオロプロピル基及びヘプタフルオロイソプロピル基が挙げられる。
In the compound of the present invention, examples of the “C1-C3 alkyl group” include a methyl group, an ethyl group, a propyl group, and an isopropyl group.
In the compound of the present invention, the “C1-C3 alkyl group optionally having one or more halogen atoms” refers to a C1-C3 alkyl group in which at least one hydrogen atom may be substituted with a halogen atom. Represents a C3 alkyl group, for example, fluoromethyl group, chloromethyl group, bromomethyl group, iodomethyl group, difluoromethyl group, dichloromethyl group, trifluoromethyl group, chlorodifluoromethyl group, bromodifluoromethyl group, trichloromethyl group, 2- Examples include fluoroethyl group, 2-chloroethyl group, 2-bromoethyl group, 2,2-difluoroethyl group, 2,2,2-trifluoroethyl group, pentafluoroethyl group, heptafluoropropyl group and heptafluoroisopropyl group. .
 「C1-C3パーフルオロアルキル基」とは、すべての水素原子がフッ素原子で置換されたC1-C3アルキル基を表し、具体的にはトリフルオロメチル基、ペンタフルオロエチル基、ヘプタフルオロプロピル基、ヘプタフルオロイソプロピル基が挙げられる。 The “C1-C3 perfluoroalkyl group” represents a C1-C3 alkyl group in which all hydrogen atoms are substituted with fluorine atoms, specifically, a trifluoromethyl group, a pentafluoroethyl group, a heptafluoropropyl group, A heptafluoroisopropyl group is mentioned.
本発明化合物において「C1-C3アルコキシ基」としては、メトキシ基、エトキシ基、プロピルオキシ基、及びイソプロピルオキシ基が挙げられる。 In the compounds of the present invention, examples of the “C1-C3 alkoxy group” include a methoxy group, an ethoxy group, a propyloxy group, and an isopropyloxy group.
本発明化合物において「C1-C3アルキルアミノ基」としては、メチルアミノ基、エチルアミノ基、プロピルアミノ基、及びイソプロピルアミノ基が挙げられる。 In the compound of the present invention, examples of the “C1-C3 alkylamino group” include a methylamino group, an ethylamino group, a propylamino group, and an isopropylamino group.
本発明化合物において「ジ(C1-C3アルキル)アミノ基」としては、N,N-ジメチルアミノ基、N,N-ジエチルアミノ基、N,N-ジプロピルアミノ基、N,N-ジイソプロピルアミノ基、N-メチル-N-エチルアミノ基、N-メチル-N-プロピルアミノ基、N-メチル-N-イソプロピルアミノ基、N-エチル-N-プロピルアミノ基、及びN-エチル-N-イソプロピルアミノ基が挙げられる。 In the compound of the present invention, the “di (C1-C3 alkyl) amino group” includes N, N-dimethylamino group, N, N-diethylamino group, N, N-dipropylamino group, N, N-diisopropylamino group, N-methyl-N-ethylamino group, N-methyl-N-propylamino group, N-methyl-N-isopropylamino group, N-ethyl-N-propylamino group, and N-ethyl-N-isopropylamino group Is mentioned.
本発明化合物において「C2-C4アルコキシカルボニル基」とは、C1-C3アルコキシ基とカルボニル基とが結合した基を表し、メトキシカルボニル基、エトキシカルボニル基、プロポキシカルボニル基、イソプロポキシカルボニル基を表す。 In the compound of the present invention, “C2-C4 alkoxycarbonyl group” represents a group in which a C1-C3 alkoxy group and a carbonyl group are bonded, and represents a methoxycarbonyl group, an ethoxycarbonyl group, a propoxycarbonyl group, or an isopropoxycarbonyl group.
 本発明化合物において「S(O)」とは、mが0であるC1-C3アルキルスルファニル基、mが1であるアルキルスルフィニル基及びmが2であるアルキルスルホニル基を表す。
 C1-C3アルキルスルファニル基とは、メチルスルファニル基、エチルスルファニル基、プロピルスルファニル基、及びイソプロピルスルファニル基を表す。
 C1-C3アルキルスルフィニル基とは、メチルスルフィニル基、エチルスルフィニル基、プロピルスルフィニル基、及びイソプロピルスルフィニル基を表す。
 C1-C3アルキルスルホニル基とは、メチルスルホニル基、エチルスルホニル基、プロピルスルホニル基、及びイソプロピルスルホニル基を表す。
In the compound of the present invention, “S (O) m R 2 ” represents a C1-C3 alkylsulfanyl group in which m is 0, an alkylsulfinyl group in which m is 1 and an alkylsulfonyl group in which m is 2.
The C1-C3 alkylsulfanyl group represents a methylsulfanyl group, an ethylsulfanyl group, a propylsulfanyl group, and an isopropylsulfanyl group.
The C1-C3 alkylsulfinyl group represents a methylsulfinyl group, an ethylsulfinyl group, a propylsulfinyl group, and an isopropylsulfinyl group.
The C1-C3 alkylsulfonyl group represents a methylsulfonyl group, an ethylsulfonyl group, a propylsulfonyl group, and an isopropylsulfonyl group.
本発明化合物の態様としては、例えば、以下の化合物が挙げられる。 As an aspect of this invention compound, the following compounds are mentioned, for example.
式(1)において、n=0である化合物;
式(1)において、n=1である化合物;
式(1)において、n=2である化合物;
A compound in which n = 0 in formula (1);
A compound wherein n = 1 in formula (1);
A compound wherein n = 2 in the formula (1);
式(1)において、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、RがCFである化合物;
式(1)において、RがS(O)-Rである化合物;
式(1)において、RがS(O)-CFである化合物
In the formula (1), compounds wherein R 5 is C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein R 5 is CF 3 ;
In the formula (1), compounds wherein R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein R 5 is S (O) p —CF 3
式(1)において、Rが水素原子、又はハロゲン原子である化合物;
式(1)において、Rが水素原子である化合物;
式(1)において、Rがハロゲン原子である化合物;
式(1)において、Rが塩素原子である化合物;
式(1)において、Rが1個以上のハロゲン原子を有していてもよいC1-C3アルキル基である化合物;
式(1)において、RがC1-C3アルキル基である化合物;
式(1)において、Rがメチル基である化合物;
式(1)において、RがS(O)である化合物;
式(1)において、RがC1-C3アルキルスルファニル基、C1-C3アルキルスルフィニル基、又はC1-C3アルキルスルホニル基である化合物; 
式(1)において、Rがメチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基である化合物; 
式(1)において、Rがメチルスルファニル基、又はメチルスルホニル基である化合物;
式(1)において、RがNRである化合物;
式(1)において、Rがアミノ基、C1-C3アルキルアミノ基、ジ(C1-C3アルキル)アミノ基又はニトロ基である化合物;
式(1)において、Rがアミノ基である化合物;
In the formula (1), compounds wherein R 1 is a hydrogen atom or a halogen atom;
In the formula (1), compounds wherein R 1 is a hydrogen atom;
In the formula (1), compounds wherein R 1 is a halogen atom;
In the formula (1), compounds wherein R 1 is a chlorine atom;
In the formula (1), compounds wherein R 1 is a C1-C3 alkyl group optionally having one or more halogen atoms;
In the formula (1), compounds wherein R 1 is a C1-C3 alkyl group;
In the formula (1), compounds wherein R 1 is a methyl group;
In the formula (1), compounds wherein R 1 is S (O) m R 2 ;
In the formula (1), compounds wherein R 1 is a C1-C3 alkylsulfanyl group, a C1-C3 alkylsulfinyl group, or a C1-C3 alkylsulfonyl group;
In the formula (1), compounds wherein R 1 is a methylsulfanyl group, a methylsulfinyl group or a methylsulfonyl group;
In the formula (1), compounds wherein R 1 is a methylsulfanyl group or a methylsulfonyl group;
In the formula (1), compounds wherein R 1 is NR 3 R 4 ;
In the formula (1), compounds wherein R 1 is an amino group, a C1-C3 alkylamino group, a di (C1-C3 alkyl) amino group or a nitro group;
In the formula (1), compounds wherein R 1 is an amino group;
式(1)において、AがNCHであり、n=2である化合物;
式(1)において、Aが酸素原子であり、n=2である化合物;
In the formula (1), compounds wherein A is NCH 3 and n = 2;
In the formula (1), compounds wherein A is an oxygen atom and n = 2;
式(1)において、RがC1-C3パーフルオロアルキル基であり、n=2である化合物;
式(1)において、RがCFであり、n=2である化合物;
式(1)において、RがS(O)-Rであり、n=2である化合物;
式(1)において、RがS(O)-CFであり、n=2である化合物
In the formula (1), compounds wherein R 5 is a C1-C3 perfluoroalkyl group and n = 2;
In the formula (1), compounds wherein R 5 is CF 3 and n = 2;
In the formula (1), compounds wherein R 5 is S (O) p —R 6 and n = 2;
In the formula (1), compounds wherein R 5 is S (O) p —CF 3 and n = 2
式(1)において、AがNCHであり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、AがNCHであり、RがCFである化合物;
式(1)において、AがNCHであり、RがS(O)p-Rである化合物;
式(1)において、AがNCHであり、RがS(O)p-CFである化合物;
式(1)において、Aが酸素原子であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、Aが酸素原子であり、RがCFである化合物;
式(1)において、Aが酸素原子であり、RがS(O)-Rである化合物;
式(1)において、Aが酸素原子であり、RがS(O)-CFである化合物
In the formula (1), compounds wherein A is NCH 3 and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is NCH 3 and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 and R 5 is S (O) p—R 6 ;
In the formula (1), compounds wherein A is NCH 3 and R 5 is S (O) p-CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is an oxygen atom and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is an oxygen atom and R 5 is S (O) p —CF 3
式(1)において、Rが水素原子、又はハロゲン原子であり、AがNCHである化合物;
式(1)において、Rが水素原子であり、AがNCHである化合物;
式(1)において、Rがハロゲン原子であり、AがNCHである化合物;
式(1)において、Rが塩素原子であり、AがNCHである化合物;
式(1)において、Rが1個以上のハロゲン原子を有していてもよいC1-C3アルキル基であり、AがNCHである化合物;
式(1)において、RがC1-C3アルキル基であり、AがNCHである化合物;
式(1)において、Rがメチル基であり、AがNCHである化合物;
式(1)において、RがS(O)であり、AがNCHである化合物;
式(1)において、RがC1-C3アルキルスルファニル基、C1-C3アルキルスルフィニル基、又はC1-C3アルキルスルホニル基であり、AがNCHである化合物; 
式(1)において、Rがメチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基であり、AがNCHである化合物; 
式(1)において、Rがメチルスルファニル基、又はメチルスルホニル基であり、AがNCHである化合物;
式(1)において、RがNRであり、AがNCHである化合物;
式(1)において、Rがアミノ基、C1-C3アルキルアミノ基、ジ(C1-C3アルキル)アミノ基又はニトロ基であり、AがNCHである化合物;
式(1)において、Rがアミノ基であり、AがNCHである化合物;
In the formula (1), compounds wherein R 1 is a hydrogen atom or a halogen atom, and A is NCH 3 ;
In the formula (1), compounds wherein R 1 is a hydrogen atom, and A is NCH 3 ;
In the formula (1), compounds wherein R 1 is a halogen atom and A is NCH 3 ;
In the formula (1), compounds wherein R 1 is a chlorine atom and A is NCH 3 ;
In the formula (1), compounds wherein R 1 is a C1-C3 alkyl group optionally having one or more halogen atoms, and A is NCH 3 ;
In the formula (1), compounds wherein R 1 is a C1-C3 alkyl group and A is NCH 3 ;
In formula (1), R 1 is a methyl group, compounds wherein A is NCH 3;
In the formula (1), compounds wherein R 1 is S (O) m R 2 and A is NCH 3 ;
In the formula (1), compounds wherein R 1 is a C1-C3 alkylsulfanyl group, a C1-C3 alkylsulfinyl group, or a C1-C3 alkylsulfonyl group, and A is NCH 3 ;
In formula (1), R 1 is methylsulfanyl group, a methylsulfinyl group or a methylsulfonyl group, compounds wherein A is NCH 3;
In the formula (1), compounds wherein R 1 is a methylsulfanyl group or a methylsulfonyl group, and A is NCH 3 ;
In the formula (1), compounds wherein R 1 is NR 3 R 4 and A is NCH 3 ;
In the formula (1), compounds wherein R 1 is an amino group, a C1-C3 alkylamino group, a di (C1-C3 alkyl) amino group or a nitro group, and A is NCH 3 ;
In the formula (1), compounds wherein R 1 is an amino group, and A is NCH 3 ;
式(1)において、Rが水素原子、又はハロゲン原子であり、Aが酸素原子である化合物;
式(1)において、Rが水素原子であり、Aが酸素原子である化合物;
式(1)において、Rがハロゲン原子であり、Aが酸素原子である化合物;
式(1)において、Rが塩素原子であり、Aが酸素原子である化合物;
式(1)において、Rが1個以上のハロゲン原子を有していてもよいC1-C3アルキル基であり、Aが酸素原子である化合物;
式(1)において、RがC1-C3アルキル基であり、Aが酸素原子である化合物;
式(1)において、Rがメチル基であり、Aが酸素原子である化合物;式(1)において、RがS(O)であり、Aが酸素原子である化合物;
式(1)において、RがC1-C3アルキルスルファニル基、C1-C3アルキルスルフィニル基、又はC1-C3アルキルスルホニル基であり、Aが酸素原子である化合物; 
式(1)において、Rがメチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基であり、Aが酸素原子である化合物; 
式(1)において、Rがメチルスルファニル基、又はメチルスルホニル基であり、Aが酸素原子である化合物;
式(1)において、RがNRであり、Aが酸素原子である化合物;
式(1)において、Rがアミノ基、C1-C3アルキルアミノ基、ジ(C1-C3アルキル)アミノ基又はニトロ基であり、Aが酸素原子である化合物;
式(1)において、Rがアミノ基であり、Aが酸素原子である化合物;
In the formula (1), compounds wherein R 1 is a hydrogen atom or a halogen atom, and A is an oxygen atom;
In the formula (1), compounds wherein R 1 is a hydrogen atom, and A is an oxygen atom;
In the formula (1), compounds wherein R 1 is a halogen atom and A is an oxygen atom;
In the formula (1), compounds wherein R 1 is a chlorine atom and A is an oxygen atom;
In the formula (1), compounds wherein R 1 is a C1-C3 alkyl group optionally having one or more halogen atoms, and A is an oxygen atom;
In the formula (1), compounds wherein R 1 is a C1-C3 alkyl group, and A is an oxygen atom;
In the formula (1), a compound in which R 1 is a methyl group and A is an oxygen atom; in the formula (1), a compound in which R 1 is S (O) m R 2 and A is an oxygen atom;
In the formula (1), compounds wherein R 1 is a C1-C3 alkylsulfanyl group, a C1-C3 alkylsulfinyl group, or a C1-C3 alkylsulfonyl group, and A is an oxygen atom;
In the formula (1), compounds wherein R 1 is a methylsulfanyl group, a methylsulfinyl group or a methylsulfonyl group, and A is an oxygen atom;
In the formula (1), compounds wherein R 1 is a methylsulfanyl group or a methylsulfonyl group, and A is an oxygen atom;
In the formula (1), compounds wherein R 1 is NR 3 R 4 and A is an oxygen atom;
In the formula (1), compounds wherein R 1 is an amino group, a C1-C3 alkylamino group, a di (C1-C3 alkyl) amino group or a nitro group, and A is an oxygen atom;
In the formula (1), compounds wherein R 1 is an amino group, and A is an oxygen atom;
式(1)において、AがNCHであり、n=2であり、RがCFである化合物;
式(1)において、AがNCHであり、n=2であり、RがS(O)pCFである化合物;
式(1)において、Aが酸素原子であり、n=2であり、RがCFである化合物;
式(1)において、Aが酸素原子であり、n=2であり、RがS(O)pCFである化合物;
In the formula (1), compounds wherein A is NCH 3 , n = 2 and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , n = 2 and R 5 is S (O) p CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, n = 2, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, n = 2, and R 5 is S (O) p CF 3 ;
式(1)において、AがNCHであり、Rが水素原子、1個以上のハロゲン原子を有していてもよいC1-C3アルキル基、ハロゲン原子、アミノ基又はS(O)であり、RがC1-C3パーフルオロアルキル基又はS(O)であり、nが0、1又は2である化合物;
式(1)において、AがNCHであり、Rが水素原子、C1-C3アルキル基、ハロゲン原子、アミノ基又はS(O)であり、RがCF又はS(O)CFであり、nが0、1又は2である化合物;
式(1)において、AがNCHであり、Rが水素原子、塩素原子、メチル基、アミノ基、メチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基であり、RがCF又はS(O)CFであり、n=2である化合物;
In the formula (1), A is NCH 3 , R 1 is a hydrogen atom, a C1-C3 alkyl group optionally having one or more halogen atoms, a halogen atom, an amino group, or S (O) m R A compound wherein R 5 is a C1-C3 perfluoroalkyl group or S (O) p R 6 and n is 0, 1 or 2;
In formula (1), A is NCH 3 , R 1 is a hydrogen atom, a C1-C3 alkyl group, a halogen atom, an amino group, or S (O) m R 2 , and R 5 is CF 3 or S (O ) P CF 3 and n is 0, 1 or 2;
In Formula (1), A is NCH 3 , R 1 is a hydrogen atom, a chlorine atom, a methyl group, an amino group, a methylsulfanyl group, a methylsulfinyl group, or a methylsulfonyl group, and R 5 is CF 3 or S ( O) p CF 3 and n = 2 compound;
式(1)において、Aが酸素原子であり、Rが水素原子、1個以上のハロゲン原子を有していてもよいC1-C3アルキル基、ハロゲン原子、アミノ基又はS(O)であり、RがC1-C3パーフルオロアルキル基又はS(O)であり、nが0、1又は2である化合物;
式(1)において、Aが酸素原子であり、Rが水素原子、C1-C3アルキル基、ハロゲン原子、アミノ基又はS(O)であり、RがCF又はS(O)CFであり、nが0、1又は2である化合物;
式(1)において、Aが酸素原子であり、Rが水素原子、塩素原子、メチル基、アミノ基、メチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基であり、RがCF又はS(O)CFであり、n=2である化合物;
In the formula (1), A is an oxygen atom, R 1 is a hydrogen atom, a C1-C3 alkyl group optionally having one or more halogen atoms, a halogen atom, an amino group, or S (O) m R A compound in which R 5 is a C1-C3 perfluoroalkyl group or S (O) p R 6 , and n is 0, 1 or 2;
In formula (1), A is an oxygen atom, R 1 is a hydrogen atom, a C1-C3 alkyl group, a halogen atom, an amino group, or S (O) m R 2 , and R 5 is CF 3 or S (O ) P CF 3 and n is 0, 1 or 2;
In Formula (1), A is an oxygen atom, R 1 is a hydrogen atom, a chlorine atom, a methyl group, an amino group, a methylsulfanyl group, a methylsulfinyl group, or a methylsulfonyl group, and R 5 is CF 3 or S ( O) p CF 3 and n = 2 compound;
式(1)において、AがNCHであり、Rが水素原子、又はハロゲン原子であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、AがNCHであり、Rが水素原子であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、AがNCHであり、Rがハロゲン原子であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、AがNCHであり、Rが塩素原子であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、AがNCHであり、Rが1個以上のハロゲン原子を有していてもよいC1-C3アルキル基であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、AがNCHであり、RがC1-C3アルキル基であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、AがNCHであり、Rがメチル基であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、AがNCHであり、RがS(O)であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、AがNCHであり、RがC1-C3アルキルスルファニル基、C1-C3アルキルスルフィニル基、又はC1-C3アルキルスルホニル基であり、RがC1-C3パーフルオロアルキル基である化合物; 
式(1)において、AがNCHであり、Rがメチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基であり、RがC1-C3パーフルオロアルキル基である化合物; 
式(1)において、AがNCHであり、Rがメチルスルファニル基、又はメチルスルホニル基であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、AがNCHであり、RがNRであり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、AがNCHであり、Rがアミノ基、C1-C3アルキルアミノ基、ジ(C1-C3アルキル)アミノ基又はニトロ基であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、AがNCHであり、Rがアミノ基であり、RがC1-C3パーフルオロアルキル基である化合物;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a hydrogen atom or a halogen atom, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a hydrogen atom, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a halogen atom, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a chlorine atom, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a C1-C3 alkyl group optionally having one or more halogen atoms, and R 5 is a C1-C3 perfluoroalkyl group ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a C1-C3 alkyl group, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a methyl group, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is NCH 3 , R 1 is S (O) m R 2 , and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), A is NCH 3 , R 1 is a C1-C3 alkylsulfanyl group, a C1-C3 alkylsulfinyl group, or a C1-C3 alkylsulfonyl group, and R 5 is a C1-C3 perfluoroalkyl group. A compound which is
In the formula (1), compounds wherein A is NCH 3 , R 1 is a methylsulfanyl group, a methylsulfinyl group or a methylsulfonyl group, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a methylsulfanyl group or a methylsulfonyl group, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is NCH 3 , R 1 is NR 3 R 4 and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), A is NCH 3, R 1 is an amino group, C1-C3 alkylamino group, di is (C1-C3 alkyl) amino group or a nitro group, R 5 is C1-C3 perfluoroalkyl A compound which is a group;
In the formula (1), compounds wherein A is NCH 3 , R 1 is an amino group, and R 5 is a C1-C3 perfluoroalkyl group;
式(1)において、AがNCHであり、Rが水素原子、又はハロゲン原子であり、RがCFである化合物;
式(1)において、AがNCHであり、Rが水素原子であり、RがCFである化合物;
式(1)において、AがNCHであり、Rがハロゲン原子であり、RがCFである化合物;
式(1)において、AがNCHであり、Rが塩素原子であり、RがCFである化合物;
式(1)において、AがNCHであり、Rが1個以上のハロゲン原子を有していてもよいC1-C3アルキル基であり、RがCFである化合物;
式(1)において、AがNCHであり、RがC1-C3アルキル基であり、RがCFである化合物;
式(1)において、AがNCHであり、Rがメチル基であり、RがCFである化合物;
式(1)において、AがNCHであり、RがS(O)であり、RがCFである化合物;
式(1)において、AがNCHであり、RがC1-C3アルキルスルファニル基、C1-C3アルキルスルフィニル基、又はC1-C3アルキルスルホニル基であり、RがCFである化合物; 
式(1)において、AがNCHであり、Rがメチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基であり、RがCFである化合物; 
式(1)において、AがNCHであり、Rがメチルスルファニル基、又はメチルスルホニル基であり、RがCFである化合物;
式(1)において、AがNCHであり、RがNRであり、RがCFである化合物;
式(1)において、AがNCHであり、Rがアミノ基、C1-C3アルキルアミノ基、ジ(C1-C3アルキル)アミノ基又はニトロ基であり、RがCFである化合物;
式(1)において、AがNCHであり、Rがアミノ基であり、RがCFである化合物;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a hydrogen atom or a halogen atom, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a hydrogen atom, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a halogen atom, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a chlorine atom, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a C1-C3 alkyl group optionally having one or more halogen atoms, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a C1-C3 alkyl group, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a methyl group, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is S (O) m R 2 , and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a C1-C3 alkylsulfanyl group, a C1-C3 alkylsulfinyl group, or a C1-C3 alkylsulfonyl group, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a methylsulfanyl group, methylsulfinyl group or methylsulfonyl group, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a methylsulfanyl group or a methylsulfonyl group, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is NR 3 R 4 and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is an amino group, a C1-C3 alkylamino group, a di (C1-C3 alkyl) amino group or a nitro group, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is an amino group, and R 5 is CF 3 ;
式(1)において、AがNCHであり、Rが水素原子、又はハロゲン原子であり、RがS(O)-Rである化合物;
式(1)において、AがNCHであり、Rが水素原子であり、RがS(O)-Rである化合物;
式(1)において、AがNCHであり、Rがハロゲン原子であり、RがS(O)-Rである化合物;
式(1)において、AがNCHであり、Rが塩素原子であり、RがS(O)-Rである化合物;
式(1)において、AがNCHであり、Rが1個以上のハロゲン原子を有していてもよいC1-C3アルキル基であり、RがS(O)-Rである化合物;
式(1)において、AがNCHであり、RがC1-C3アルキル基であり、RがS(O)-Rである化合物;
式(1)において、AがNCHであり、Rがメチル基であり、RがS(O)-Rである化合物;
式(1)において、AがNCHであり、RがS(O)であり、RがS(O)-Rである化合物;
式(1)において、AがNCHであり、RがC1-C3アルキルスルファニル基、C1-C3アルキルスルフィニル基、又はC1-C3アルキルスルホニル基であり、RがS(O)-Rである化合物; 
式(1)において、AがNCHであり、Rがメチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基であり、RがS(O)-Rである化合物; 
式(1)において、AがNCHであり、Rがメチルスルファニル基、又はメチルスルホニル基であり、RがS(O)-Rである化合物;
式(1)において、AがNCHであり、RがNRであり、RがS(O)-Rである化合物;
式(1)において、AがNCHであり、Rがアミノ基、C1-C3アルキルアミノ基、ジ(C1-C3アルキル)アミノ基又はニトロ基であり、RがS(O)-Rである化合物;
式(1)において、AがNCHであり、Rがアミノ基であり、RがS(O)-Rである化合物;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a hydrogen atom or a halogen atom, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a hydrogen atom, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a halogen atom, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a chlorine atom, and R 5 is S (O) p —R 6 ;
In formula (1), A is NCH 3 , R 1 is a C1-C3 alkyl group optionally having one or more halogen atoms, and R 5 is S (O) p —R 6 . Compound;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a C1-C3 alkyl group, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a methyl group, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is S (O) m R 2 , and R 5 is S (O) p —R 6 ;
In Formula (1), A is NCH 3 , R 1 is a C1-C3 alkylsulfanyl group, a C1-C3 alkylsulfinyl group, or a C1-C3 alkylsulfonyl group, and R 5 is S (O) p —R 6 is a compound;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a methylsulfanyl group, a methylsulfinyl group or a methylsulfonyl group, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a methylsulfanyl group or a methylsulfonyl group, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is NR 3 R 4 , and R 5 is S (O) p —R 6 ;
In the formula (1), A is NCH 3 , R 1 is an amino group, a C1-C3 alkylamino group, a di (C1-C3 alkyl) amino group or a nitro group, and R 5 is S (O) p −. The compound which is R 6 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is an amino group, and R 5 is S (O) p —R 6 ;
式(1)において、AがNCHであり、Rが水素原子、又はハロゲン原子であり、RがS(O)CFである化合物;
式(1)において、AがNCHであり、Rが水素原子であり、RがS(O)CFである化合物;
式(1)において、AがNCHであり、Rがハロゲン原子であり、RがS(O)CFである化合物;
式(1)において、AがNCHであり、Rが塩素原子であり、RがS(O)CFである化合物;
式(1)において、AがNCHであり、Rが1個以上のハロゲン原子を有していてもよいC1-C3アルキル基であり、RがS(O)CFである化合物;
式(1)において、AがNCHであり、RがC1-C3アルキル基であり、RがS(O)CFである化合物;
式(1)において、AがNCHであり、Rがメチル基であり、RがS(O)CFである化合物;
式(1)において、AがNCHであり、RがS(O)であり、RがS(O)CFである化合物;
式(1)において、AがNCHであり、RがC1-C3アルキルスルファニル基、C1-C3アルキルスルフィニル基、又はC1-C3アルキルスルホニル基であり、RがS(O)CFである化合物; 
式(1)において、AがNCHであり、Rがメチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基であり、RがS(O)CFである化合物; 
式(1)において、AがNCHであり、Rがメチルスルファニル基、又はメチルスルホニル基であり、RがS(O)CFである化合物;
式(1)において、AがNCHであり、RがNRであり、RがS(O)CFである化合物;
式(1)において、AがNCHであり、Rがアミノ基、C1-C3アルキルアミノ基、ジ(C1-C3アルキル)アミノ基又はニトロ基であり、RがS(O)CFである化合物;
式(1)において、AがNCHであり、Rがアミノ基であり、RがS(O)CFである化合物;
In the formula (1), a compound wherein A is NCH 3 , R 1 is a hydrogen atom or a halogen atom, and R 5 is S (O) p CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a hydrogen atom, and R 5 is S (O) p CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a halogen atom, and R 5 is S (O) p CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a chlorine atom, and R 5 is S (O) p CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a C1-C3 alkyl group optionally having one or more halogen atoms, and R 5 is S (O) p CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a C1-C3 alkyl group, and R 5 is S (O) p CF 3 ;
In the formula (1), A is NCH 3, R 1 is a methyl group, R 5 is an S (O) p CF 3;
In the formula (1), compounds wherein A is NCH 3 , R 1 is S (O) m R 2 , and R 5 is S (O) p CF 3 ;
In Formula (1), A is NCH 3 , R 1 is a C1-C3 alkylsulfanyl group, a C1-C3 alkylsulfinyl group, or a C1-C3 alkylsulfonyl group, and R 5 is S (O) p CF 3 A compound which is
In the formula (1), compounds wherein A is NCH 3 , R 1 is a methylsulfanyl group, a methylsulfinyl group or a methylsulfonyl group, and R 5 is S (O) p CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is a methylsulfanyl group or a methylsulfonyl group, and R 5 is S (O) p CF 3 ;
In the formula (1), compounds wherein A is NCH 3 , R 1 is NR 3 R 4 , and R 5 is S (O) p CF 3 ;
In the formula (1), A is NCH 3 , R 1 is an amino group, a C1-C3 alkylamino group, a di (C1-C3 alkyl) amino group or a nitro group, and R 5 is S (O) p CF 3 is a compound;
In the formula (1), compounds wherein A is NCH 3 , R 1 is an amino group, and R 5 is S (O) p CF 3 ;
式(1)において、Aが酸素原子であり、Rが水素原子、又はハロゲン原子であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、Aが酸素原子であり、Rが水素原子であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、Aが酸素原子であり、Rがハロゲン原子であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、Aが酸素原子であり、Rが塩素原子であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、Aが酸素原子であり、Rが1個以上のハロゲン原子を有していてもよいC1-C3アルキル基であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、Aが酸素原子であり、RがC1-C3アルキル基であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、Aが酸素原子であり、Rがメチル基であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、Aが酸素原子であり、RがS(O)であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、Aが酸素原子であり、RがC1-C3アルキルスルファニル基、C1-C3アルキルスルフィニル基、又はC1-C3アルキルスルホニル基であり、RがC1-C3パーフルオロアルキル基である化合物; 
式(1)において、Aが酸素原子であり、Rがメチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基であり、RがC1-C3パーフルオロアルキル基である化合物; 
式(1)において、Aが酸素原子であり、Rがメチルスルファニル基、又はメチルスルホニル基であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、Aが酸素原子であり、RがNRであり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、Aが酸素原子であり、Rがアミノ基、C1-C3アルキルアミノ基、ジ(C1-C3アルキル)アミノ基又はニトロ基であり、RがC1-C3パーフルオロアルキル基である化合物;
式(1)において、Aが酸素原子であり、Rがアミノ基であり、RがC1-C3パーフルオロアルキル基である化合物;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a hydrogen atom or a halogen atom, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), a compound wherein A is an oxygen atom, R 1 is a hydrogen atom, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a halogen atom, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), a compound wherein A is an oxygen atom, R 1 is a chlorine atom, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), a compound in which A is an oxygen atom, R 1 is a C1-C3 alkyl group optionally having one or more halogen atoms, and R 5 is a C1-C3 perfluoroalkyl group ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a C1-C3 alkyl group, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), a compound wherein A is an oxygen atom, R 1 is a methyl group, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is S (O) m R 2 and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), A is an oxygen atom, R 1 is a C1-C3 alkylsulfanyl group, a C1-C3 alkylsulfinyl group, or a C1-C3 alkylsulfonyl group, and R 5 is a C1-C3 perfluoroalkyl group. A compound which is
In the formula (1), a compound wherein A is an oxygen atom, R 1 is a methylsulfanyl group, a methylsulfinyl group or a methylsulfonyl group, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), a compound wherein A is an oxygen atom, R 1 is a methylsulfanyl group or a methylsulfonyl group, and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is NR 3 R 4 and R 5 is a C1-C3 perfluoroalkyl group;
In the formula (1), A is an oxygen atom, R 1 is an amino group, a C1-C3 alkylamino group, a di (C1-C3 alkyl) amino group or a nitro group, and R 5 is a C1-C3 perfluoroalkyl. A compound that is a group;
In the formula (1), a compound wherein A is an oxygen atom, R 1 is an amino group, and R 5 is a C1-C3 perfluoroalkyl group;
式(1)において、Aが酸素原子であり、Rが水素原子、又はハロゲン原子であり、RがCFである化合物;
式(1)において、Aが酸素原子であり、Rが水素原子であり、RがCFである化合物;
式(1)において、Aが酸素原子であり、Rがハロゲン原子であり、RがCFである化合物;
式(1)において、Aが酸素原子であり、Rが塩素原子であり、RがCFである化合物;
式(1)において、Aが酸素原子であり、Rが1個以上のハロゲン原子を有していてもよいC1-C3アルキル基であり、RがCFである化合物;
式(1)において、Aが酸素原子であり、RがC1-C3アルキル基であり、RがCFである化合物;
式(1)において、Aが酸素原子であり、Rがメチル基であり、RがCFである化合物;
式(1)において、Aが酸素原子であり、RがS(O)であり、RがCFである化合物;
式(1)において、Aが酸素原子であり、RがC1-C3アルキルスルファニル基、C1-C3アルキルスルフィニル基、又はC1-C3アルキルスルホニル基であり、RがCFである化合物; 
式(1)において、Aが酸素原子であり、Rがメチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基であり、RがCFである化合物; 
式(1)において、Aが酸素原子であり、Rがメチルスルファニル基、又はメチルスルホニル基であり、RがCFである化合物;
式(1)において、Aが酸素原子であり、RがNRであり、RがCFである化合物;
式(1)において、Aが酸素原子であり、Rがアミノ基、C1-C3アルキルアミノ基、ジ(C1-C3アルキル)アミノ基又はニトロ基であり、RがCFである化合物;
式(1)において、Aが酸素原子であり、Rがアミノ基であり、RがCFである化合物;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a hydrogen atom or a halogen atom, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a hydrogen atom, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a halogen atom, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a chlorine atom, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a C1-C3 alkyl group optionally having one or more halogen atoms, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a C1-C3 alkyl group, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a methyl group, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is S (O) m R 2 , and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a C1-C3 alkylsulfanyl group, a C1-C3 alkylsulfinyl group or a C1-C3 alkylsulfonyl group, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a methylsulfanyl group, a methylsulfinyl group or a methylsulfonyl group, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a methylsulfanyl group or a methylsulfonyl group, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is NR 3 R 4 , and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is an amino group, a C1-C3 alkylamino group, a di (C1-C3 alkyl) amino group or a nitro group, and R 5 is CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is an amino group, and R 5 is CF 3 ;
式(1)において、Aが酸素原子であり、Rが水素原子、又はハロゲン原子であり、RがS(O)-Rである化合物;
式(1)において、Aが酸素原子であり、Rが水素原子であり、RがS(O)-Rである化合物;
式(1)において、Aが酸素原子であり、Rがハロゲン原子であり、RがS(O)-Rである化合物;
式(1)において、Aが酸素原子であり、Rが塩素原子であり、RがS(O)-Rである化合物;
式(1)において、Aが酸素原子であり、Rが1個以上のハロゲン原子を有していてもよいC1-C3アルキル基であり、RがS(O)-Rである化合物;
式(1)において、Aが酸素原子であり、RがC1-C3アルキル基であり、RがS(O)-Rである化合物;
式(1)において、Aが酸素原子であり、Rがメチル基であり、RがS(O)-Rである化合物;
式(1)において、Aが酸素原子であり、RがS(O)であり、RがS(O)-Rである化合物;
式(1)において、Aが酸素原子であり、RがC1-C3アルキルスルファニル基、C1-C3アルキルスルフィニル基、又はC1-C3アルキルスルホニル基であり、RがS(O)-Rである化合物; 
式(1)において、Aが酸素原子であり、Rがメチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基であり、RがS(O)-Rである化合物; 
式(1)において、Aが酸素原子であり、Rがメチルスルファニル基、又はメチルスルホニル基であり、RがS(O)-Rである化合物;
式(1)において、Aが酸素原子であり、RがNRであり、RがS(O)-Rである化合物;
式(1)において、Aが酸素原子であり、Rがアミノ基、C1-C3アルキルアミノ基、ジ(C1-C3アルキル)アミノ基又はニトロ基であり、RがS(O)-Rである化合物;
式(1)において、Aが酸素原子であり、Rがアミノ基であり、RがS(O)-Rである化合物;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a hydrogen atom or a halogen atom, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a hydrogen atom, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a halogen atom, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a chlorine atom, and R 5 is S (O) p —R 6 ;
In the formula (1), A is an oxygen atom, R 1 is a C1-C3 alkyl group optionally having one or more halogen atoms, and R 5 is S (O) p —R 6 . Compound;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a C1-C3 alkyl group, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a methyl group, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is S (O) m R 2 , and R 5 is S (O) p —R 6 ;
In Formula (1), A is an oxygen atom, R 1 is a C1-C3 alkylsulfanyl group, a C1-C3 alkylsulfinyl group, or a C1-C3 alkylsulfonyl group, and R 5 is S (O) p —R 6 is a compound;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a methylsulfanyl group, a methylsulfinyl group or a methylsulfonyl group, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a methylsulfanyl group or a methylsulfonyl group, and R 5 is S (O) p —R 6 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is NR 3 R 4 , and R 5 is S (O) p —R 6 ;
In the formula (1), A is an oxygen atom, R 1 is an amino group, a C1-C3 alkylamino group, a di (C1-C3 alkyl) amino group or a nitro group, and R 5 is S (O) p −. The compound which is R 6 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is an amino group, and R 5 is S (O) p —R 6 ;
式(1)において、Aが酸素原子であり、Rが水素原子、又はハロゲン原子であり、RがS(O)CFである化合物;
式(1)において、Aが酸素原子であり、Rが水素原子であり、RがS(O)CFである化合物;
式(1)において、Aが酸素原子であり、Rがハロゲン原子であり、RがS(O)CFである化合物;
式(1)において、Aが酸素原子であり、Rが塩素原子であり、RがS(O)CFである化合物;
式(1)において、Aが酸素原子であり、Rが1個以上のハロゲン原子を有していてもよいC1-C3アルキル基であり、RがS(O)CFである化合物;
式(1)において、Aが酸素原子であり、RがC1-C3アルキル基であり、RがS(O)CFである化合物;
式(1)において、Aが酸素原子であり、Rがメチル基であり、RがS(O)CFである化合物;
式(1)において、Aが酸素原子であり、RがS(O)であり、RがS(O)CFである化合物;
式(1)において、Aが酸素原子であり、RがC1-C3アルキルスルファニル基、C1-C3アルキルスルフィニル基、又はC1-C3アルキルスルホニル基であり、RがS(O)CFである化合物; 
式(1)において、Aが酸素原子であり、Rがメチルスルファニル基、メチルスルフィニル基又はメチルスルホニル基であり、RがS(O)CFである化合物; 
式(1)において、Aが酸素原子であり、Rがメチルスルファニル基、又はメチルスルホニル基であり、RがS(O)CFである化合物;
式(1)において、Aが酸素原子であり、RがNRであり、RがS(O)CFである化合物;
式(1)において、Aが酸素原子であり、Rがアミノ基、C1-C3アルキルアミノ基、ジ(C1-C3アルキル)アミノ基又はニトロ基であり、RがS(O)CFである化合物;
式(1)において、Aが酸素原子であり、Rがアミノ基であり、RがS(O)CFである化合物;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a hydrogen atom or a halogen atom, and R 5 is S (O) p CF 3 ;
In the formula (1), A is an oxygen atom, R 1 is hydrogen atom, R 5 is an S (O) p CF 3;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a halogen atom, and R 5 is S (O) p CF 3 ;
In the formula (1), a compound wherein A is an oxygen atom, R 1 is a chlorine atom, and R 5 is S (O) p CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a C1-C3 alkyl group optionally having one or more halogen atoms, and R 5 is S (O) p CF 3 ;
In the formula (1), compounds wherein A is an oxygen atom, R 1 is a C1-C3 alkyl group, and R 5 is S (O) p CF 3 ;
In formula (1), a compound wherein A is an oxygen atom, R 1 is a methyl group, and R 5 is S (O) p CF 3 ;
In the formula (1), a compound wherein A is an oxygen atom, R 1 is S (O) m R 2 , and R 5 is S (O) p CF 3 ;
In Formula (1), A is an oxygen atom, R 1 is a C1-C3 alkylsulfanyl group, a C1-C3 alkylsulfinyl group, or a C1-C3 alkylsulfonyl group, and R 5 is S (O) p CF 3 A compound which is
In formula (1), a compound wherein A is an oxygen atom, R 1 is a methylsulfanyl group, a methylsulfinyl group or a methylsulfonyl group, and R 5 is S (O) p CF 3 ;
In the formula (1), a compound in which A is an oxygen atom, R 1 is a methylsulfanyl group or a methylsulfonyl group, and R 5 is S (O) p CF 3 ;
In the formula (1), A is an oxygen atom, R 1 is NR 3 R 4, R 5 is an S (O) p CF 3;
In the formula (1), A is an oxygen atom, R 1 is an amino group, a C1-C3 alkylamino group, a di (C1-C3 alkyl) amino group or a nitro group, and R 5 is S (O) p CF 3 is a compound;
In formula (1), a compound wherein A is an oxygen atom, R 1 is an amino group, and R 5 is S (O) p CF 3 ;
 次に、本発明化合物の製造法について説明する。 Next, a method for producing the compound of the present invention will be described.
 本発明化合物及び製造中間体化合物は、例えば、以下の製造法1~製造法11に記載のいずれかの方法により製造することができる。 The compound of the present invention and the production intermediate compound can be produced, for example, by any of the production methods 1 to 11 described below.
製造法1
 式(1)において、n=1である本発明化合物(1b)(以下本発明化合物(1b)と記す。)、および式(1)においてn=2である本発明化合物(1c)(以下本発明化合物(1c)と記す。)は、式(1)においてn=0である本発明化合物(1a)(以下本発明化合物(1a)と記す。)と酸化剤とを反応させることにより製造することができる。

Figure JPOXMLDOC01-appb-I000003
[式中、記号は式(1)と同じ意味を表す。]
Manufacturing method 1
The present compound (1b) in which n = 1 in the formula (1) (hereinafter referred to as the present compound (1b)), and the present compound (1c) in which n = 2 in the formula (1) (hereinafter referred to as the present compound). Inventive compound (1c) is prepared by reacting present compound (1a) (hereinafter referred to as present compound (1a)) in which n = 0 in formula (1) with an oxidizing agent. be able to.

Figure JPOXMLDOC01-appb-I000003
[Wherein the symbols have the same meaning as in formula (1). ]
まず、本発明化合物(1a)から本発明化合物(1b)を製造する方法について記載する。
 該反応は、溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えばジクロロメタン、クロロホルム等の脂肪族ハロゲン化炭化水素類、アセトニトリル等のニトリル類、メタノール、エタノール等のアルコール類、酢酸、水及びこれらの混合物が挙げられる。
 反応に用いられる酸化剤としては、例えば過ヨウ素酸ナトリウム、m-クロロ過安息香酸、及び過酸化水素が挙げられる。
 酸化剤として過酸化水素を用いる場合は、必要に応じて塩基、又は触媒を加えてもよい。
 反応に用いられる塩基としては、炭酸ナトリウム等が挙げられる。
 反応に用いられる触媒としては、例えばタングステン酸、タングステン酸ナトリウムが挙げられる。
 該反応には、本発明化合物(1a)1モルに対して、酸化剤が通常1~1.2モルの割合で用いられる。
 該反応には、本発明化合物(1a)1モルに対して、塩基が通常0.01~1モルの割合で用いる。
該反応には、本発明化合物(1a)1モルに対して、触媒が通常0.01~0.5モルの割合で用いられる。
 該反応の反応温度は、通常-20~80℃の範囲である。該反応の反応時間は通常0.1~12時間の範囲である。
 反応終了後は、反応混合物を有機溶媒で抽出し、有機層を必要に応じて還元剤(例えば亜硫酸ナトリウム、チオ硫酸ナトリウム)の水溶液、及び塩基(例えば炭酸水素ナトリウム)の水溶液で洗浄する。洗浄した有機層を乾燥、濃縮することにより、本発明化合物(1b)を単離することができる。単離された本発明化合物(1b)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
First, a method for producing the present compound (1b) from the present compound (1a) will be described.
The reaction is performed in the presence of a solvent.
Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile, alcohols such as methanol and ethanol, acetic acid, water, and mixtures thereof.
Examples of the oxidizing agent used in the reaction include sodium periodate, m-chloroperbenzoic acid, and hydrogen peroxide.
When hydrogen peroxide is used as the oxidizing agent, a base or a catalyst may be added as necessary.
Examples of the base used for the reaction include sodium carbonate.
Examples of the catalyst used for the reaction include tungstic acid and sodium tungstate.
In the reaction, with respect to 1 mol of the compound (1a) of the present invention, an oxidizing agent is usually used in a proportion of 1 to 1.2 mol.
In the reaction, the base is generally used at a ratio of 0.01 to 1 mol per 1 mol of the compound (1a) of the present invention.
In the reaction, the catalyst is generally used in a proportion of 0.01 to 0.5 mol per 1 mol of the compound (1a) of the present invention.
The reaction temperature is usually in the range of −20 to 80 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
After completion of the reaction, the reaction mixture is extracted with an organic solvent, and the organic layer is washed with an aqueous solution of a reducing agent (for example, sodium sulfite and sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary. The compound (1b) of the present invention can be isolated by drying and concentrating the washed organic layer. The isolated compound (1b) of the present invention can be further purified by chromatography, recrystallization and the like.
つぎに、本発明化合物(1b)から本発明化合物(1c)を製造する方法について記載する。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えばジクロロメタン、クロロホルム等の脂肪族ハロゲン化炭化水素類、アセトニトリル等のニトリル類、メタノール、エタノール等のアルコール類、酢酸、水及びこれらの混合物が挙げられる。
 反応に用いられる酸化剤としては、例えばm-クロロ過安息香酸および過酸化水素が挙げられる。
酸化剤として過酸化水素を用いる場合は、必要に応じて塩基、又は触媒を加えてもよい。
反応に用いられる塩基としては、炭酸ナトリウム等が挙げられる。
 反応に用いられる触媒としては、例えばタングステン酸ナトリウムが挙げられる。
 該反応には、本発明化合物(1b)1モルに対して、酸化剤が通常1~4モルの割合で用いられる。好ましくは、本発明化合物(1b)1モルに対して、酸化剤が1~2モルの割合で用いられる。
 該反応には、本発明化合物(1b)1モルに対して、塩基が通常0.01~1モルの割合で用いる。
該反応には、本発明化合物(1b)1モルに対して、触媒が通常0.01~0.5モルの割合で用いられる。
 該反応の反応温度は、通常-20~120℃の範囲である。該反応の反応時間は通常0.1~12時間の範囲である。
 反応終了後は、反応混合物を有機溶媒で抽出し、有機層を必要に応じて還元剤(例えば亜硫酸ナトリウム、チオ硫酸ナトリウム)の水溶液、及び塩基(例えば炭酸水素ナトリウム)の水溶液で洗浄する。この有機層を乾燥、濃縮を行うことにより、本発明化合物(1c)を単離することができる。本発明化合物(1c)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
Next, a method for producing the present compound (1c) from the present compound (1b) will be described.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile, alcohols such as methanol and ethanol, acetic acid, water, and mixtures thereof.
Examples of the oxidizing agent used in the reaction include m-chloroperbenzoic acid and hydrogen peroxide.
When hydrogen peroxide is used as the oxidizing agent, a base or a catalyst may be added as necessary.
Examples of the base used for the reaction include sodium carbonate.
Examples of the catalyst used in the reaction include sodium tungstate.
In the reaction, the oxidizing agent is usually used at a ratio of 1 to 4 moles with respect to 1 mole of the compound (1b) of the present invention. Preferably, the oxidizing agent is used in a ratio of 1 to 2 moles relative to 1 mole of the compound (1b) of the present invention.
In the reaction, the base is generally used at a ratio of 0.01 to 1 mol per 1 mol of the compound (1b) of the present invention.
In the reaction, the catalyst is generally used in a proportion of 0.01 to 0.5 mol with respect to 1 mol of the compound (1b) of the present invention.
The reaction temperature is usually in the range of −20 to 120 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
After completion of the reaction, the reaction mixture is extracted with an organic solvent, and the organic layer is washed with an aqueous solution of a reducing agent (for example, sodium sulfite and sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary. The compound (1c) of the present invention can be isolated by drying and concentrating the organic layer. The compound (1c) of the present invention can be further purified by chromatography, recrystallization and the like.
 また、本発明化合物(1c)は、本発明化合物(1a)と酸化剤とを反応させることで、一段階反応(ワンポット)で製造することができる。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えばジクロロメタン、クロロホルム等の脂肪族ハロゲン化炭化水素類、アセトニトリル等のニトリル類、メタノール、エタノール等のアルコール類、酢酸、水及びこれらの混合物が挙げられる。
 反応に用いられる酸化剤としては、例えばm-クロロ過安息香酸および過酸化水素が挙げられる。
該反応の酸化剤として過酸化水素を用いる場合は、必要に応じて塩基、又は触媒の存在下で行う。
反応に用いられる塩基としては、炭酸ナトリウム等が挙げられる。
 反応に用いられる触媒としては、例えばタングステン酸、タングステン酸ナトリウムが挙げられる。
 該反応には、本発明化合物(1a)1モルに対して、酸化剤が通常2~5モルの割合で用いられる。
 該反応には、本発明化合物(1a)1モルに対して、塩基が通常0.01~1モルの割合で用いる。
該反応には、本発明化合物(1a)1モルに対して、触媒が通常0.01~0.5モルの割合で用いられる。
該反応の反応温度は、通常0~120℃の範囲である。該反応の反応時間は通常0.1~12時間の範囲である。
 反応終了後は、反応混合物を有機溶媒で抽出し、有機層を必要に応じて還元剤(例えば亜硫酸ナトリウム、チオ硫酸ナトリウム)の水溶液、及び塩基(例えば炭酸水素ナトリウム)の水溶液で洗浄する。この有機層を、乾燥、濃縮を行うことにより、本発明化合物(1c)を単離することができる。単離された本発明化合物(1c)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
Moreover, this invention compound (1c) can be manufactured by a one-step reaction (one pot) by making this invention compound (1a) and an oxidizing agent react.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile, alcohols such as methanol and ethanol, acetic acid, water, and mixtures thereof.
Examples of the oxidizing agent used in the reaction include m-chloroperbenzoic acid and hydrogen peroxide.
When hydrogen peroxide is used as the oxidizing agent for the reaction, it is carried out in the presence of a base or a catalyst as necessary.
Examples of the base used for the reaction include sodium carbonate.
Examples of the catalyst used for the reaction include tungstic acid and sodium tungstate.
In the reaction, with respect to 1 mole of the compound (1a) of the present invention, an oxidizing agent is usually used at a ratio of 2 to 5 moles.
In the reaction, the base is generally used at a ratio of 0.01 to 1 mol per 1 mol of the compound (1a) of the present invention.
In the reaction, the catalyst is generally used in a proportion of 0.01 to 0.5 mol per 1 mol of the compound (1a) of the present invention.
The reaction temperature of the reaction is usually in the range of 0 to 120 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
After completion of the reaction, the reaction mixture is extracted with an organic solvent, and the organic layer is washed with an aqueous solution of a reducing agent (for example, sodium sulfite and sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary. The compound (1c) of the present invention can be isolated by drying and concentrating the organic layer. The isolated compound (1c) of the present invention can be further purified by chromatography, recrystallization and the like.
製造法2
本発明化合物は、式(M1)で示される化合物(以下、化合物(M1)と記載する。)と式(M2)で示される化合物(以下、化合物(M2)と記載する。)とを塩基の存在下で反応させることにより製造することができる。
Figure JPOXMLDOC01-appb-I000004
[式中、Xはハロゲン原子を表し、その他の記号は式(1)と同じ意味を表す。]
化合物(M2)は公知であるか、公知の方法に準じて製造することができる。
 本発明化合物(1a)~本発明化合物(1c)は、この反応に準じて製造することができる。
該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えば1,4-ジオキサン、ジエチルエーテル、テトラヒドロフラン、tert-ブチルメチルエーテル等のエーテル類、ジクロロメタン、クロロホルム、四塩化炭素、1,2-ジクロロエタン、クロロベンゼン等のハロゲン化炭化水素類、トルエン、ベンゼン、キシレン等の芳香族炭化水素類、酢酸エチル、酢酸ブチル等のエステル類、アセトニトリル、N,N-ジメチルホルムアミド、N-メチルピロリドン、1,3-ジメチル-2-イミダゾリジノン、ジメチルスルホキシド等の非プロトン性極性溶媒、ピリジン、キノリン等の含窒素芳香族化合物類及びこれらの混合物が挙げられる。
 反応に用いられる塩基としては、例えば水素化ナトリウム、水素化カリウム、水素化カルシウム等のアルカリ金属もしくはアルカリ土類金属の水素化物、炭酸ナトリウム、炭酸カリウム等のアルカリ金属炭酸塩類、又はトリエチルアミン、ジイソピロピルエチルアミン、ピリジン、4-ジメチルアミノピリジン等の有機塩基が挙げられる。
該反応には、化合物(M1)1モルに対して、化合物(M2)が通常1~2モルの割合、塩基が通常1~5モルの割合で用いられる。
 該反応の反応温度は、通常、0~120℃の範囲である。該反応の反応時間は、通常、0.1~24時間の範囲である。
 反応終了後は、反応混合物を水に加えてから有機溶媒抽出し、有機層を濃縮する;反応混合物を水に加えて生じた固体を濾過により集める;又は、反応混合物中に生成した固体を濾過により集めることにより本発明化合物を単離することができる。単離された本発明化合物は、再結晶、クロマトグラフィ-等により更に精製することもできる。
Manufacturing method 2
The compound of the present invention comprises a compound represented by formula (M1) (hereinafter referred to as compound (M1)) and a compound represented by formula (M2) (hereinafter referred to as compound (M2)) as a base. It can manufacture by making it react in presence.
Figure JPOXMLDOC01-appb-I000004
[Wherein, X represents a halogen atom, and other symbols have the same meaning as in formula (1). ]
Compound (M2) is known or can be produced according to a known method.
The present compound (1a) to the present compound (1c) can be produced according to this reaction.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether, and halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene. Hydrogen, aromatic hydrocarbons such as toluene, benzene, xylene, esters such as ethyl acetate and butyl acetate, acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolid Non-protic polar solvents such as non- and dimethyl sulfoxide, nitrogen-containing aromatic compounds such as pyridine and quinoline, and mixtures thereof.
Examples of the base used in the reaction include alkali metal or alkaline earth metal hydrides such as sodium hydride, potassium hydride and calcium hydride, alkali metal carbonates such as sodium carbonate and potassium carbonate, or triethylamine and diisopropylene. And organic bases such as propylethylamine, pyridine and 4-dimethylaminopyridine.
In the reaction, with respect to 1 mol of the compound (M1), the compound (M2) is usually used in a proportion of 1 to 2 mol, and the base is usually used in a proportion of 1 to 5 mol.
The reaction temperature of the reaction is usually in the range of 0 to 120 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered. The compound of the present invention can be isolated by collecting by The isolated compound of the present invention can be further purified by recrystallization, chromatography or the like.
製造法3
 化合物(M1)においてn=1である化合物(M1b)(以下化合物(M1b)と記す。)、および化合物(M1)においてn=2である化合物(M1c)(以下化合物(M1c)と記す。)は、化合物(M1)においてn=0である化合物(M1a)(以下化合物(M1a)と記す。)と酸化剤とを反応させることにより製造することができる。
Figure JPOXMLDOC01-appb-I000005
[式中、記号は前記と同じ意味を表す。]
 該反応は、製造法1における本発明化合物(1a)を化合物(M1a)に代え、または本発明化合物(1b)を(M1b)に代えることにより、製造例1に記載の反応に準じて製造することができる。
Production method 3
Compound (M1b) where n = 1 in compound (M1) (hereinafter referred to as compound (M1b)), and Compound (M1c) where n = 2 in compound (M1) (hereinafter referred to as compound (M1c)) Can be produced by reacting a compound (M1a) in which n = 0 in the compound (M1) (hereinafter referred to as compound (M1a)) with an oxidizing agent.
Figure JPOXMLDOC01-appb-I000005
[Wherein the symbols have the same meaning as described above. ]
This reaction is produced according to the reaction described in Production Example 1 by substituting compound (M1a) for the present compound (1a) in production method 1 or substituting (M1b) for the present compound (1b). be able to.
製造法4
 化合物(M1a)は、例えば下記のスキームに従って製造することができる。

Figure JPOXMLDOC01-appb-I000006
[式中、記号は前記と同じ意味を表す。]
Manufacturing method 4
Compound (M1a) can be produced, for example, according to the following scheme.

Figure JPOXMLDOC01-appb-I000006
[Wherein the symbols have the same meaning as described above. ]
 式(M7)で示される化合物(以下、化合物(M7)と記す。)は、式(M6)で示される化合物(以下、化合物(M6)と記す。2つのXは同一のハロゲン原子を表す。)と塩素化剤とを反応させることにより製造することができる。
 化合物(M6)としては、例えば3,6-ジフルオロ-ピリジン-2-カルボン酸、3,6-ジクロロ-ピリジン-2-カルボン酸が挙げられ、いずれも市販の化合物である。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えばトルエン、キシレン等の芳香族炭化水素類、ジクロロメタン、クロロホルム等の脂肪族ハロゲン化炭化水素類及びこれらの混合物が挙げられる。
 反応に用いられる塩素化剤としては、塩化チオニル、二塩化オキサリル、オキシ塩化リン等が挙げられる。
 該反応には、化合物(M6)1モルに対して、塩素化剤が通常1~15モルの割合で用いられる。
 該反応の反応温度は、通常0~150℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、溶媒を留去することにより、化合物(M7)を単離することができる。
A compound represented by formula (M7) (hereinafter referred to as compound (M7)) is represented by a compound represented by formula (M6) (hereinafter referred to as compound (M6)), and two Xs represent the same halogen atom. ) And a chlorinating agent.
Examples of the compound (M6) include 3,6-difluoro-pyridine-2-carboxylic acid and 3,6-dichloro-pyridine-2-carboxylic acid, both of which are commercially available compounds.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include aromatic hydrocarbons such as toluene and xylene, aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, and mixtures thereof.
Examples of the chlorinating agent used in the reaction include thionyl chloride, oxalyl dichloride, phosphorus oxychloride and the like.
In the reaction, a chlorinating agent is usually used at a ratio of 1 to 15 mol with respect to 1 mol of the compound (M6).
The reaction temperature is usually in the range of 0 to 150 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M7) can be isolated by removing the solvent.
 式(M9)で示される化合物(以下、化合物(M9)と記す。)は、化合物(M7)と式(M8)で示される化合物(以下、化合物(M8)と記す。)とを反応させることにより製造することができる。
 化合物(M8)において、RがCFでありAがNCHであるN-メチル-4-トリフルオロメチル-ベンゼン-1,2-ジアミンは、国際公開第2010/125985号明細書に記載の方法で製造することができる。
 化合物(M8)において、RがCFCF、CFCFCF、CF(CF、又はSRであり、AがNCHである化合物(M8a)((以下化合物(M8a)と記す。))は製造例8に記載の方法で製造することができる。
 化合物(M8)においてRがS(O)R又はS(O)ありAがNCHである化合物(M8b)(以下化合物(M8b)と記す。)は製造法9に記載の方法で製造することができる。
化合物(M8)において、RがCFでありAが酸素原子である2-アミノ-4-トリフルオロメチル-フェノールは、米国特許第5780483号明細書に記載の方法で製造することができる。
 化合物(M8)において、RがRがCFCF、CFCFCF、CF(CF、SR、S(O)R、又はS(O)であり、Aが酸素原子である化合物(M8c)(以下化合物(M8c)と記す。)は製造法10に記載の方法で製造することができる。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えばテトラヒドロフラン、エチレングリコールジメチルエーテル、tert-ブチルメチルエーテル、1,4-ジオキサン等のエーテル類、ヘキサン、ヘプタン、オクタン等の脂肪族炭化水素類、トルエン、キシレン等の芳香族炭化水素類、クロロベンゼン等のハロゲン化炭化水素類、酢酸エチル、酢酸ブチル等のエステル類、アセトニトリル等のニトリル類、N,N-ジメチルホルムアミド、N-メチルピロリドン、ジメチルスルホキシド等の非プロトン性極性溶媒及びこれらの混合物が挙げられる。
 該反応は、必要に応じて塩基を加えてもよい。
 反応に用いられる塩基としては、炭酸ナトリウム、炭酸カリウム等のアルカリ金属炭酸塩類、トリエチルアミン、N,N-ジイソプロピルエチルアミン等の第3級アミン類及びピリジン、4-ジメチルアミノピリジン等の含窒素芳香族化合物類等が挙げられる。
 該反応には、化合物(M8)1モルに対して、化合物(M7)が通常1~3モルの割合、塩基が通常1~10モルの割合で用いられる。
 該反応の反応温度は、通常-20~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物に水を加えた後、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M9)を単離することができる。単離された化合物(M9)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
A compound represented by formula (M9) (hereinafter referred to as compound (M9)) is obtained by reacting compound (M7) with a compound represented by formula (M8) (hereinafter referred to as compound (M8)). Can be manufactured.
In the compound (M8), N 1 -methyl-4-trifluoromethyl-benzene-1,2-diamine in which R 5 is CF 3 and A is NCH 3 is described in WO2010 / 125985 It can be manufactured by the method.
In the compound (M8), a compound (M8a) in which R 5 is CF 2 CF 3 , CF 2 CF 2 CF 3 , CF (CF 3 ) 2 , or SR 6 and A is NCH 3 (hereinafter referred to as compound (M8a )) Can be produced by the method described in Production Example 8.
Compound (M8b) in which R 5 is S (O) R 6 or S (O) 2 R 6 and A is NCH 3 in Compound (M8) (hereinafter referred to as Compound (M8b)) is described in Production Method 9. It can be manufactured by the method.
In compound (M8), 2-amino-4-trifluoromethyl-phenol in which R 5 is CF 3 and A is an oxygen atom can be produced by the method described in US Pat. No. 5,780,483.
In compound (M8), R 5 is R 5 is CF 2 CF 3 , CF 2 CF 2 CF 3 , CF (CF 3 ) 2 , SR 6 , S (O) R 6 , or S (O) 2 R 6 The compound (M8c) in which A is an oxygen atom (hereinafter referred to as the compound (M8c)) can be produced by the method described in Production Method 10.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether, and 1,4-dioxane, aliphatic hydrocarbons such as hexane, heptane, and octane, and aromatics such as toluene and xylene. Aprotic polarities such as aromatic hydrocarbons, halogenated hydrocarbons such as chlorobenzene, esters such as ethyl acetate and butyl acetate, nitriles such as acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone and dimethyl sulfoxide Examples include solvents and mixtures thereof.
In the reaction, a base may be added as necessary.
Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, tertiary amines such as triethylamine and N, N-diisopropylethylamine, and nitrogen-containing aromatic compounds such as pyridine and 4-dimethylaminopyridine. And the like.
In the reaction, with respect to 1 mol of the compound (M8), the compound (M7) is usually used in a proportion of 1 to 3 mol, and the base is usually used in a proportion of 1 to 10 mol.
The reaction temperature is usually in the range of −20 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M9) can be isolated by post-treatment such as addition of water to the reaction mixture, extraction with an organic solvent, and drying and concentration of the organic layer. The isolated compound (M9) can be further purified by chromatography, recrystallization and the like.
 また、化合物(M9)は、化合物(M6)と化合物(M8)とを縮合剤の存在下で反応させることにより、一段階反応(ワンポット)で製造することもできる。
 該反応は、溶媒の存在下で行われる。
反応に用いられる溶媒としては、例えば、1,4-ジオキサン、ジエチルエーテル、テトラヒドロフラン、tert-ブチルメチルエーテル等のエーテル類、ジクロロメタン、クロロホルム、四塩化炭素、1,2-ジクロロエタン、クロロベンゼン等のハロゲン化炭化水素類、トルエン、ベンゼン、キシレン等の芳香族炭化水素類、酢酸エチル、酢酸ブチル等のエステル類、アセトニトリル、N,N-ジメチルホルムアミド、N-メチルピロリドン、1,3-ジメチル-2-イミダゾリジノン、ジメチルスルホキシド等の非プロトン性極性溶媒、ピリジン、キノリン等の含窒素芳香族化合物類及びこれらの混合物が挙げられる。
 反応に用いられる縮合剤としては、例えば1-エチル-3-(3-ジメチルアミノプロピル)カルボジイミド塩酸塩(以下EDCIと記す。)、1,3-ジシクロヘキシルカルボジイミド等のカルボジイミド類が挙げられる。
 該反応は、必要に応じて触媒を加えてもよい。
 反応に用いられる触媒としては、例えば1-ヒドロキシベンゾトリアゾール(以下HOBtと記す。)が挙げられる。
 該反応には、化合物(M8)1モルに対して、化合物(M6)が通常1~2モルの割合、縮合剤が通常1~5モルの割合、触媒が通常0.01~1モルの割合で用いられる。
 該反応の反応温度は、通常、0~120℃の範囲である。該反応の反応時間は、通常、0.1~24時間の範囲である。
 反応終了後は、反応混合物を水に加えてから有機溶媒抽出し、有機層を濃縮する;反応混合物を水に加えて生じた固体を濾過により集める;又は、反応混合物中に生成した固体を濾過により集めることにより化合物(M9)を単離することができる。単離された化合物(M9)は、再結晶、クロマトグラフィ-等により更に精製することもできる。
Compound (M9) can also be produced in a one-step reaction (one pot) by reacting compound (M6) and compound (M8) in the presence of a condensing agent.
The reaction is performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran, and tert-butyl methyl ether, and halogenations such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane, and chlorobenzene. Hydrocarbons, aromatic hydrocarbons such as toluene, benzene and xylene, esters such as ethyl acetate and butyl acetate, acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazo Examples thereof include aprotic polar solvents such as lizinone and dimethyl sulfoxide, nitrogen-containing aromatic compounds such as pyridine and quinoline, and mixtures thereof.
Examples of the condensing agent used in the reaction include carbodiimides such as 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride (hereinafter referred to as EDCI) and 1,3-dicyclohexylcarbodiimide.
In the reaction, a catalyst may be added as necessary.
Examples of the catalyst used in the reaction include 1-hydroxybenzotriazole (hereinafter referred to as HOBt).
In the reaction, with respect to 1 mole of the compound (M8), the ratio of the compound (M6) is usually 1 to 2 moles, the condensing agent is usually 1 to 5 moles, and the catalyst is usually 0.01 to 1 mole. Used in
The reaction temperature of the reaction is usually in the range of 0 to 120 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered. The compound (M9) can be isolated by collecting by The isolated compound (M9) can be further purified by recrystallization, chromatography or the like.
 式(M10)で示される化合物(以下、化合物(M10)と記す。2つのXは同一のハロゲン原子を表す。)は、化合物(M9)を分子内縮合させることにより製造することができる。
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えば1,4-ジオキサン、ジエチルエーテル、テトラヒドロフラン、tert-ブチルメチルエーテル等のエーテル類、ジクロロメタン、クロロホルム、四塩化炭素、1,2-ジクロロエタン、クロロベンゼン等のハロゲン化炭化水素類、トルエン、ベンゼン、キシレン等の芳香族炭化水素類、酢酸エチル、酢酸ブチル等のエステル類、アセトニトリル等のニトリル類、N,N-ジメチルホルムアミド、N-メチルピロリドン、1,3-ジメチル-2-イミダゾリジノン、ジメチルスルホキシド等の非プロトン性極性溶媒、ピリジン、キノリン等の含窒素芳香族化合物類及びこれらの混合物が挙げられる。
 該反応は必要に応じて、縮合剤、酸、塩基又は塩素化剤を加えてもよい。
 反応に用いられる縮合剤としては、例えば無水酢酸、トリフルオロ酢酸無水物、1-エチル-3-(3-ジメチルアミノプロピル)カルボジイミド塩酸塩、トリフェニルホスフィンと塩基と四塩化炭素もしくは四臭化炭素との混合物、及びトリフェニルホスフィンとアゾジエステル類(例えばアゾジカルボン酸ジエチル)との混合物が挙げられる。
 反応に用いられる酸としては、例えばパラトルエンスルホン酸等のスルホン酸類、酢酸等のカルボン酸類、及びポリリン酸が挙げられる。
 反応に用いられる塩基としては、例えばピリジン、ピコリン、2,6-ルチジン、1,8-ジアザビシクロ〔5.4.0〕-7-ウンデセン、1,5-ジアザビシクロ〔4.3.0〕-5-ノネン等の含窒素複素環化合物、トリエチルアミン、N,N-ジイソプロピルエチルアミン等の第3級アミン類、リン酸三カリウム、炭酸カリウム、水素化ナトリウム等のアルカリ金属炭酸塩類が挙げられる。
 反応に用いられる塩素化剤としては、例えばオキシ塩化リンが挙げられる。
 該反応には、化合物(M9)1モルに対して、縮合剤を用いる場合には縮合剤が通常1~5モルの割合、酸を用いる場合には酸が通常0.1モル~5モルの割合、塩基を用いる場合には塩基が通常1モル~5モルの割合、塩素化剤を用いる場合には塩素化剤が通常1モル~5モルの割合で用いられる。
 該反応の反応温度は、通常、0~200℃の範囲である。該反応の反応時間は、通常、0.1~24時間の範囲である。
 反応終了後は、反応混合物を水に加えてから有機溶媒抽出し、有機層を濃縮する;反応混合物を水に加えて生じた固体を濾過により集める;又は、反応混合物中に生成した固体を濾過により集めることにより化合物(M10)を単離することができる。単離された化合物(M10)は、再結晶、クロマトグラフィ-等により更に精製することもできる。
A compound represented by formula (M10) (hereinafter referred to as compound (M10). Two Xs represent the same halogen atom) can be produced by intramolecular condensation of compound (M9).
The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether, and halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene. Hydrogen, aromatic hydrocarbons such as toluene, benzene and xylene, esters such as ethyl acetate and butyl acetate, nitriles such as acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl- Examples include aprotic polar solvents such as 2-imidazolidinone and dimethyl sulfoxide, nitrogen-containing aromatic compounds such as pyridine and quinoline, and mixtures thereof.
In the reaction, a condensing agent, an acid, a base, or a chlorinating agent may be added as necessary.
Examples of the condensing agent used in the reaction include acetic anhydride, trifluoroacetic anhydride, 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride, triphenylphosphine and base, and carbon tetrachloride or carbon tetrabromide. And mixtures of triphenylphosphine and azodiesters (eg diethyl azodicarboxylate).
Examples of the acid used for the reaction include sulfonic acids such as paratoluenesulfonic acid, carboxylic acids such as acetic acid, and polyphosphoric acid.
Examples of the base used in the reaction include pyridine, picoline, 2,6-lutidine, 1,8-diazabicyclo [5.4.0] -7-undecene, 1,5-diazabicyclo [4.3.0] -5. -Nitrogen-containing heterocyclic compounds such as nonene, tertiary amines such as triethylamine and N, N-diisopropylethylamine, and alkali metal carbonates such as tripotassium phosphate, potassium carbonate and sodium hydride.
Examples of the chlorinating agent used in the reaction include phosphorus oxychloride.
In the reaction, with respect to 1 mol of the compound (M9), when a condensing agent is used, the ratio of the condensing agent is usually 1 to 5 mol, and when an acid is used, the acid is usually 0.1 mol to 5 mol. When a base is used, the base is usually used in a proportion of 1 to 5 mol, and when a chlorinating agent is used, the chlorinating agent is usually used in a proportion of 1 to 5 mol.
The reaction temperature of the reaction is usually in the range of 0 to 200 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered. The compound (M10) can be isolated by collecting by The isolated compound (M10) can be further purified by recrystallization, chromatography or the like.
 化合物(M1a)は、化合物(M10)とエチルメルカプタンとを塩基の存在下で反応させることにより製造することができる。
 該反応は、溶媒の存在下で行われる。
反応に用いられる溶媒としては、例えばテトラヒドロフラン、エチレングリコールジメチルエーテル、tert-ブチルメチルエーテル、1,4-ジオキサン等のエーテル類、トルエン、キシレン等の芳香族炭化水素類、アセトニトリル、N,N-ジメチルホルムアミド、N-メチルピロリドン、ジメチルスルホキシド等の非プロトン性極性溶媒、水及びこれらの混合物が挙げられる。
 反応に用いられる塩基としては、例えば炭酸ナトリウム、炭酸カリウム等のアルカリ金属炭酸塩類、水素化ナトリウム等のアルカリ金属水素化物類が挙げられる。
 該反応には、化合物(M10)1モルに対して、エチルメルカプタンが通常1~10モルの割合、塩基が通常1~10モルの割合で用いられる。好ましくは、化合物(M11)1モルに対して、エチルメルカプタンが1.0~1.1モルの割合、塩基が1~2モルの割合で用いられる。
 該反応の反応温度は、通常-20℃~150℃の範囲である。該反応の反応時間は通常0.5~24時間の範囲である。
 反応終了後は、反応混合物を有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M1a)を単離することができる。単離された化合物(M1a)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
Compound (M1a) can be produced by reacting compound (M10) with ethyl mercaptan in the presence of a base.
The reaction is performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether, 1,4-dioxane, aromatic hydrocarbons such as toluene and xylene, acetonitrile, N, N-dimethylformamide. , N-methylpyrrolidone, aprotic polar solvents such as dimethyl sulfoxide, water, and mixtures thereof.
Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, and alkali metal hydrides such as sodium hydride.
In the reaction, with respect to 1 mol of the compound (M10), ethyl mercaptan is usually used in a proportion of 1 to 10 mol, and base is usually used in a proportion of 1 to 10 mol. Preferably, ethyl mercaptan is used in a proportion of 1.0 to 1.1 mol and a base is used in a proportion of 1 to 2 mol with respect to 1 mol of compound (M11).
The reaction temperature of the reaction is usually in the range of −20 ° C. to 150 ° C. The reaction time is usually in the range of 0.5 to 24 hours.
After completion of the reaction, the compound (M1a) can be isolated by performing post-treatment operations such as extraction of the reaction mixture with an organic solvent, and drying and concentration of the organic layer. The isolated compound (M1a) can be further purified by chromatography, recrystallization and the like.
 製造法5
本発明化合物(1c)は、例えば下記のスキームに従って製造することができる。
Figure JPOXMLDOC01-appb-I000007
[式中、記号は前記と同じ意味を表す。]
Manufacturing method 5
The compound (1c) of the present invention can be produced, for example, according to the following scheme.
Figure JPOXMLDOC01-appb-I000007
[Wherein the symbols have the same meaning as described above. ]
 式(M20)で表される化合物(以下化合物(M20)と記す。)は、化合物(M10)とエチルメルカプタンとを、塩基存在下で反応させることにより製造することができる。
 該反応は、通常溶媒の存在下で行われる。反応に用いられる溶媒としては、例えばテトラヒドロフラン、エチレングリコールジメチルエーテル、tert-ブチルメチルエーテル、1,4-ジオキサン等のエーテル類、トルエン、キシレン等の芳香族炭化水素類、アセトニトリル、N,N-ジメチルホルムアミド、N-メチルピロリドン、ジメチルスルホキシド等の非プロトン性極性溶媒、水及びこれらの混合物が挙げられる。
 反応に用いられる塩基としては、例えば炭酸ナトリウム、炭酸カリウム等のアルカリ金属炭酸塩類、水素化ナトリウム等のアルカリ金属水素化物類が挙げられる。
 該反応には、化合物(M10)1モルに対して、エチルメルカプタンが通常2~10モルの割合、塩基が通常2~10モルの割合で用いられる。好ましくは、化合物(M11)1モルに対して、エチルメルカプタンが2.0~2.1モルの割合、塩基が2~3モルの割合で用いられる。
 該反応の反応温度は、通常-20℃~150℃の範囲である。該反応の反応時間は通常0.5~24時間の範囲である。
 反応終了後は、反応混合物を有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M20)を単離することができる。単離された化合物(M20)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
A compound represented by formula (M20) (hereinafter referred to as compound (M20)) can be produced by reacting compound (M10) with ethyl mercaptan in the presence of a base.
The reaction is usually performed in the presence of a solvent. Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether, 1,4-dioxane, aromatic hydrocarbons such as toluene and xylene, acetonitrile, N, N-dimethylformamide. , N-methylpyrrolidone, aprotic polar solvents such as dimethyl sulfoxide, water, and mixtures thereof.
Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, and alkali metal hydrides such as sodium hydride.
In the reaction, with respect to 1 mol of the compound (M10), ethyl mercaptan is usually used in a proportion of 2 to 10 mol, and base is usually used in a proportion of 2 to 10 mol. Preferably, ethyl mercaptan is used in a proportion of 2.0 to 2.1 mol and a base is used in a proportion of 2 to 3 mol with respect to 1 mol of compound (M11).
The reaction temperature of the reaction is usually in the range of −20 ° C. to 150 ° C. The reaction time is usually in the range of 0.5 to 24 hours.
After completion of the reaction, the compound (M20) can be isolated by performing post-treatment operations such as extraction of the reaction mixture with an organic solvent, and drying and concentration of the organic layer. The isolated compound (M20) can be further purified by chromatography, recrystallization and the like.
 式(M21)で表される化合物(以下化合物(M21)と記す。)は、化合物(M20)と酸化剤とを反応させることにより製造することができる。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えばジクロロメタン、クロロホルム等の脂肪族ハロゲン化炭化水素類、アセトニトリル等のニトリル類、メタノール、エタノール等のアルコール類、酢酸、水及びこれらの混合物が挙げられる。
 反応に用いられる酸化剤としては、例えばm-クロロ過安息香酸および過酸化水素が挙げられる。
該反応の酸化剤として過酸化水素を用いる場合は、必要に応じて塩基、又は触媒の存在下で行う。
反応に用いられる塩基としては、炭酸ナトリウム等が挙げられる。
 反応に用いられる触媒としては、例えばタングステン酸、タングステン酸ナトリウムが挙げられる。
 該反応には、化合物(M20)1モルに対して、酸化剤が通常2~5モルの割合で用いられる。
 該反応には、化合物(20)1モルに対して、塩基が通常0.01~1モルの割合で用いる。
 該反応には、化合物(20)1モルに対して、触媒が通常0.01~0.5モルの割合で用いられる。
 該反応の反応温度は、通常0~120℃の範囲である。該反応の反応時間は通常0.1~12時間の範囲である。
 反応終了後は、反応混合物を有機溶媒で抽出し、有機層を必要に応じて還元剤(例えば亜硫酸ナトリウム、チオ硫酸ナトリウム)の水溶液、及び塩基(例えば炭酸水素ナトリウム)の水溶液で洗浄する。この有機層を、乾燥、濃縮を行うことにより、化合物(21)を単離することができる。単離された化合物(M21)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
A compound represented by formula (M21) (hereinafter referred to as compound (M21)) can be produced by reacting compound (M20) with an oxidizing agent.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, nitriles such as acetonitrile, alcohols such as methanol and ethanol, acetic acid, water, and mixtures thereof.
Examples of the oxidizing agent used in the reaction include m-chloroperbenzoic acid and hydrogen peroxide.
When hydrogen peroxide is used as the oxidizing agent for the reaction, it is carried out in the presence of a base or a catalyst as necessary.
Examples of the base used for the reaction include sodium carbonate.
Examples of the catalyst used for the reaction include tungstic acid and sodium tungstate.
In the reaction, with respect to 1 mol of the compound (M20), the oxidizing agent is usually used at a ratio of 2 to 5 mol.
In the reaction, the base is generally used at a ratio of 0.01 to 1 mol with respect to 1 mol of the compound (20).
In the reaction, the catalyst is generally used in a proportion of 0.01 to 0.5 mol with respect to 1 mol of the compound (20).
The reaction temperature of the reaction is usually in the range of 0 to 120 ° C. The reaction time is usually in the range of 0.1 to 12 hours.
After completion of the reaction, the reaction mixture is extracted with an organic solvent, and the organic layer is washed with an aqueous solution of a reducing agent (for example, sodium sulfite and sodium thiosulfate) and an aqueous solution of a base (for example, sodium bicarbonate) as necessary. Compound (21) can be isolated by drying and concentrating this organic layer. The isolated compound (M21) can be further purified by chromatography, recrystallization and the like.
 本発明化合物(1c)は、化合物(M21)と化合物(M2)とを塩基の存在下で反応させることにより製造することができる。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えば1,4-ジオキサン、ジエチルエーテル、テトラヒドロフラン、tert-ブチルメチルエーテル等のエーテル類、ジクロロメタン、クロロホルム、四塩化炭素、1,2-ジクロロエタン、クロロベンゼン等のハロゲン化炭化水素類、トルエン、ベンゼン、キシレン等の芳香族炭化水素類、酢酸エチル、酢酸ブチル等のエステル類、アセトニトリル、N,N-ジメチルホルムアミド、N-メチルピロリドン、1,3-ジメチル-2-イミダゾリジノン、ジメチルスルホキシド等の非プロトン性極性溶媒、ピリジン、キノリン等の含窒素芳香族化合物類及びこれらの混合物が挙げられる。
 反応に用いられる塩基としては、例えば水素化ナトリウム、水素化カリウム、水素化カルシウム等のアルカリ金属もしくはアルカリ土類金属の水素化物、炭酸ナトリウム、炭酸カリウム等のアルカリ金属炭酸塩類、又はトリエチルアミン、ジイソピロピルエチルアミン、ピリジン、4-ジメチルアミノピリジン等の有機塩基が挙げられる。
 該反応には、化合物(M21)1モルに対して、化合物(M2)が通常1~2モルの割合、塩基が通常1~5モルの割合で用いられる。
 該反応の反応温度は、通常、0~120℃の範囲である。該反応の反応時間は、通常、0.1~24時間の範囲である。
 反応終了後は、反応混合物を水に加えてから有機溶媒抽出し、有機層を濃縮する;反応混合物を水に加えて生じた固体を濾過により集める;又は、反応混合物中に生成した固体を濾過により集めることにより本発明化合物(1c)を単離することができる。単離された本発明化合物(1c)は、再結晶、クロマトグラフィ-等により更に精製することもできる
The compound (1c) of the present invention can be produced by reacting the compound (M21) and the compound (M2) in the presence of a base.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether, and halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene. Hydrogen, aromatic hydrocarbons such as toluene, benzene, xylene, esters such as ethyl acetate and butyl acetate, acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolid Non-protic polar solvents such as non- and dimethyl sulfoxide, nitrogen-containing aromatic compounds such as pyridine and quinoline, and mixtures thereof.
Examples of the base used in the reaction include alkali metal or alkaline earth metal hydrides such as sodium hydride, potassium hydride and calcium hydride, alkali metal carbonates such as sodium carbonate and potassium carbonate, or triethylamine and diisopropylene. And organic bases such as propylethylamine, pyridine and 4-dimethylaminopyridine.
In the reaction, with respect to 1 mol of the compound (M21), the compound (M2) is usually used in a proportion of 1 to 2 mol, and the base is usually used in a proportion of 1 to 5 mol.
The reaction temperature of the reaction is usually in the range of 0 to 120 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered. The present compound (1c) can be isolated by collecting the above. The isolated compound (1c) of the present invention can be further purified by recrystallization, chromatography or the like.
製造法6
 式(1)において、RがC1-C3アルコキシ基である本発明化合物(以下本発明化合物(1m)と記す。)は、例えば下記のスキームに従って製造することができる。
Figure JPOXMLDOC01-appb-I000008
[式中、RはC1-C3のアルキル基を表し、Vは塩素原子、臭素原子又はヨウ素原子を表し、その他の記号は前記と同じ意味を表す。]
Manufacturing method 6
In the formula (1), the compound of the present invention in which R 1 is a C1-C3 alkoxy group (hereinafter referred to as the present compound (1m)) can be produced, for example, according to the following scheme.
Figure JPOXMLDOC01-appb-I000008
[Wherein, R a represents a C1-C3 alkyl group, V represents a chlorine atom, a bromine atom, or an iodine atom, and other symbols have the same meaning as described above. ]
 式(M3)で示される化合物(以下、化合物(M3)と記載する。)は、化合物(M1)とセミカルバジド塩酸塩とを、塩基の存在下で反応させることにより製造することができる。
 該反応は通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、アセトニトリル、N,N-ジメチルホルムアミド、N-メチルピロリドン、1,3-ジメチル-2-イミダゾリジノン、ジメチルスルホキシド等の非プロトン性極性溶媒が挙げられる。
反応に用いられる塩基としては、炭酸ナトリウム、炭酸カリウム等のアルカリ金属炭酸塩類、トリエチルアミン、ジイソプロピルエチルアミン等の第3級アミン類及びピリジン、4-ジメチルアミノピリジン等の含窒素芳香族化合物類等が挙げられる。
該反応には、化合物(M1)1モルに対して、セミカルバジド塩酸塩が通常1~3モルの割合、塩基が通常1~10モルの割合で用いられる。
 該反応の反応温度は、通常-20~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物を水に加えてから有機溶媒抽出し、有機層を濃縮する;反応混合物を水に加えて生じた固体を濾過により集める;又は、反応混合物中に生成した固体を濾過により集めることにより化合物(M3)を単離することができる。単離された化合物(M3)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
The compound represented by the formula (M3) (hereinafter referred to as the compound (M3)) can be produced by reacting the compound (M1) and semicarbazide hydrochloride in the presence of a base.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include aprotic polar solvents such as acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, and dimethyl sulfoxide.
Examples of the base used in the reaction include alkali metal carbonates such as sodium carbonate and potassium carbonate, tertiary amines such as triethylamine and diisopropylethylamine, and nitrogen-containing aromatic compounds such as pyridine and 4-dimethylaminopyridine. It is done.
In the reaction, with respect to 1 mol of the compound (M1), semicarbazide hydrochloride is usually used in a proportion of 1 to 3 mol, and base is usually used in a proportion of 1 to 10 mol.
The reaction temperature is usually in the range of −20 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered. The compound (M3) can be isolated by collecting by The isolated compound (M3) can be further purified by chromatography, recrystallization and the like.
 式(M4)で示される化合物(以下、化合物(M4)と記載する。)は、化合物(M3)とギ酸又はオルトギ酸トリアルキルとを反応させることにより製造する事ができる。
反応に用いられるオルトギ酸トリアルキルとしては、例えばオルトギ酸トリメチル、及びオルトギ酸トリエチルが挙げられる。
 該反応は、通常溶媒の存在下行われる。
 反応に用いられる溶媒としては、1,2-ジクロロエタン、クロロベンゼン等のハロゲン化炭化水素類、トルエン、ベンゼン、キシレン等の芳香族炭化水素類、N,N-ジメチルホルムアミド、N-メチルピロリドン、1,3-ジメチル-2-イミダゾリジノン、ジメチルスルホキシド等の非プロトン性極性溶媒、メタノール、エタノール、n-ブタノール等のアルコール溶媒及びこれらの混合物が挙げられる。
 該反応にギ酸を用いる場合、化合物(M3)1モルに対して、ギ酸が通常1~10モルの割合で用いられる。
 該反応にオルトギ酸トリアルキルを用いる場合、化合物(M3)1モルに対して、オルトギ酸トリアルキルが通常1~10モルの割合で用いられる。
 該反応の反応温度は、通常0~150℃の範囲である。該反応の反応時間は、通常、0.1~24時間の範囲である。
 反応終了後は、反応混合物を水に加えてから有機溶媒抽出し、有機層を濃縮する;反応混合物を水に加えて生じた固体を濾過により集める;又は、反応混合物中に生成した固体を濾過により集めることにより化合物(M4)を単離することができる。単離された化合物(M4)は、再結晶、クロマトグラフィ-等により更に精製することもできる。
The compound represented by the formula (M4) (hereinafter referred to as the compound (M4)) can be produced by reacting the compound (M3) with formic acid or trialkyl orthoformate.
Examples of the trialkyl orthoformate used in the reaction include trimethyl orthoformate and triethyl orthoformate.
The reaction is usually performed in the presence of a solvent.
Solvents used for the reaction include halogenated hydrocarbons such as 1,2-dichloroethane and chlorobenzene, aromatic hydrocarbons such as toluene, benzene and xylene, N, N-dimethylformamide, N-methylpyrrolidone, 1, Examples include aprotic polar solvents such as 3-dimethyl-2-imidazolidinone and dimethyl sulfoxide, alcohol solvents such as methanol, ethanol and n-butanol, and mixtures thereof.
When formic acid is used in the reaction, formic acid is usually used at a ratio of 1 to 10 mol per 1 mol of compound (M3).
When trialkyl orthoformate is used in the reaction, trialkyl orthoformate is usually used at a ratio of 1 to 10 moles with respect to 1 mole of compound (M3).
The reaction temperature is usually in the range of 0 to 150 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered. The compound (M4) can be isolated by collecting by The isolated compound (M4) can be further purified by recrystallization, chromatography or the like.
本発明化合物(1m)は、化合物(M4)と式(M5)で示される化合物(以下、化合物(M5)と記す。)とを、塩基の存在下で反応させることにより製造することができる。
化合物(M5)としては、ヨードメタン、ブロモメタン、ヨードエタン、クロロエタン、1-ヨードプロパン、2-ヨードプロパン等が挙げられる。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えば1,4-ジオキサン、ジエチルエーテル、テトラヒドロフラン、tert-ブチルメチルエーテル等のエーテル類、ジクロロメタン、クロロホルム、四塩化炭素、1,2-ジクロロエタン、クロロベンゼン等のハロゲン化炭化水素類、トルエン、ベンゼン、キシレン等の芳香族炭化水素類、N,N-ジメチルホルムアミド、N-メチルピロリドン、1,3-ジメチル-2-イミダゾリジノン、ジメチルスルホキシド等の非プロトン性極性溶媒及びこれらの混合物が挙げられる。
 反応に用いられる塩基としては、例えば水素化ナトリウム、水素化カリウム、水素化カルシウム等のアルカリ金属もしくはアルカリ土類金属の水素化物、炭酸ナトリウム、炭酸カリウム等のアルカリ金属炭酸塩類、又はトリエチルアミン、ジイソピロピルエチルアミン、ピリジン、4-ジメチルアミノピリジン等の有機塩基が挙げられる。
該反応には、本発明化合物(M4)1モルに対して、化合物(M5)が通常1~10モルの割合で用いられ、塩基が通常0.1~5モルの割合で用いられる。
 該反応の反応温度は、通常-20℃~120℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物を水に加えてから有機溶媒抽出し、有機層を濃縮する;反応混合物を水に加えて生じた固体を濾過により集める;又は、反応混合物中に生成した固体を濾過により集めることにより本発明化合物(1m)を単離することができる。単離された本発明化合物(1m)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
The compound (1m) of the present invention can be produced by reacting the compound (M4) with a compound represented by the formula (M5) (hereinafter referred to as compound (M5)) in the presence of a base.
Examples of the compound (M5) include iodomethane, bromomethane, iodoethane, chloroethane, 1-iodopropane, 2-iodopropane and the like.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether, and halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene. Aprotic polar solvents such as hydrogen, aromatic hydrocarbons such as toluene, benzene, xylene, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, dimethyl sulfoxide, and the like These mixtures are mentioned.
Examples of the base used in the reaction include alkali metal or alkaline earth metal hydrides such as sodium hydride, potassium hydride and calcium hydride, alkali metal carbonates such as sodium carbonate and potassium carbonate, or triethylamine and diisopropylene. And organic bases such as propylethylamine, pyridine and 4-dimethylaminopyridine.
In the reaction, the compound (M5) is usually used in a proportion of 1 to 10 mol, and the base is usually used in a proportion of 0.1 to 5 mol with respect to 1 mol of the compound (M4) of the present invention.
The reaction temperature is usually in the range of −20 ° C. to 120 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered. The present compound (1m) can be isolated by collecting by The isolated compound (1m) of the present invention can be further purified by chromatography, recrystallization and the like.
製造法7
 式(1)において、n=2でありRがS(O)でありmが2である本発明化合物(1r)(以下本発明化合物(1r)と記す。)、および式(1)において、n=2でありRがS(O)でありmが1である本発明化合物(1q)(以下本発明化合物(1q)と記す。)は、式(1)において、n=2でありRがS(O)でありmが0である本発明化合物(1o)(以下本発明化合物(1o)と記す。)と酸化剤とを反応させることにより製造することができる。
Figure JPOXMLDOC01-appb-I000009
[式中、記号は前記と同じ意味を表す。]
 該反応は、製造法1における本発明化合物(1a)を本発明化合物(1o)に代え、並びに本発明化合物(1b)を本発明化合物(1q)に代えることにより、製造例1に記載の反応に準じて製造することができる。
Manufacturing method 7
In the formula (1), the compound of the present invention (1r) in which n = 2, R 1 is S (O) m R 2 and m is 2 (hereinafter referred to as the present compound (1r)), and the formula (1) In 1), the present compound (1q) (hereinafter referred to as the present compound (1q)) in which n = 2, R 1 is S (O) m R 2 and m is 1 is represented by the formula (1) In the present invention, n = 2, R 1 is S (O) m R 2 and m is 0, and the present compound (1o) (hereinafter referred to as the present compound (1o)) is reacted with an oxidizing agent. Can be manufactured.
Figure JPOXMLDOC01-appb-I000009
[Wherein the symbols have the same meaning as described above. ]
This reaction is carried out by replacing the compound (1a) of the present invention in the production method 1 with the compound (1o) of the present invention and replacing the compound (1b) of the present invention with the compound (1q) of the present invention. It can be manufactured according to.
製造法8
化合物(M8a)は、例えば下記のスキームに従って製造することができる。
Figure JPOXMLDOC01-appb-I000010
Manufacturing method 8
Compound (M8a) can be produced, for example, according to the following scheme.
Figure JPOXMLDOC01-appb-I000010
式(M11)で表される化合物(以下化合物(M11)と記す。)は、式(M20)で表される化合物(以下化合物(M20)と記す。)とアセチル化剤とを反応させることにより製造することができる。
化合物(M20)において、RがCFである化合物は市販の化合物である。
化合物(M20)において、RがCFCF,CFCFCFである化合物は、国際公開第00/07998号記載の方法で製造することができる。
化合物(M20)において、RがCF(CFである化合物は、欧州特許出願公開第1006102号明細書記載の方法で製造することができる。
化合物(M20)において、RがSCFである化合物は市販の化合物である。
化合物(M20)において、RがSCFCF、SCFCFCF,およびSCF(CFである化合物は、特開平10-291973号公報記載の方法で製造することができる。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えば1,4-ジオキサン、ジエチルエーテル、テトラヒドロフラン、tert-ブチルメチルエーテル等のエーテル類、ジクロロメタン、クロロホルム、四塩化炭素、1,2-ジクロロエタン、クロロベンゼン等のハロゲン化炭化水素類、トルエン、ベンゼン、キシレン等の芳香族炭化水素類、酢酸エチル、酢酸ブチル等のエステル類、アセトニトリル、N,N-ジメチルホルムアミド、N-メチルピロリドン、1,3-ジメチル-2-イミダゾリジノン、ジメチルスルホキシド等の非プロトン性極性溶媒、ピリジン、キノリン等の含窒素芳香族化合物類及びこれらの混合物が挙げられる。
 該反応は必要に応じて塩基を加えてもよい。
 反応に用いられる塩基としては、例えばトリエチルアミン、ジイソピロピルエチルアミン、ピリジン、4-ジメチルアミノピリジン等の有機塩基が挙げられる。
 反応に用いられるアセチル化剤としては、例えば酢酸無水物、塩化アセチル等が挙げられる。
 該反応は、酢酸無水物、塩化アセチル等を溶媒として反応を行ってもよい。
 該反応には、4-トリフルオロメチルスルフィニル-アニリン1モルに対して、アセチル化剤が通常1~3モルの割合で用いられる。
 該反応の反応温度は、通常-30~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 該反応に塩基を用いる場合は、4-トリフルオロメチルスルフィニル-アニリン1モルに対して、塩基が通常0.01~3モルの割合で用いられる。
 反応終了後は、反応混合物を水に加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M11)を単離することができる。単離された化合物(M11)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
A compound represented by formula (M11) (hereinafter referred to as compound (M11)) is obtained by reacting a compound represented by formula (M20) (hereinafter referred to as compound (M20)) with an acetylating agent. Can be manufactured.
In the compound (M20), the compound in which R 5 is CF 3 is a commercially available compound.
In compound (M20), a compound in which R 5 is CF 2 CF 3 , CF 2 CF 2 CF 3 can be produced by the method described in International Publication No. 00/07998.
In compound (M20), a compound in which R 5 is CF (CF 3 ) 2 can be produced by the method described in EP 1006102.
In the compound (M20), a compound in which R 5 is SCF 3 is a commercially available compound.
In compound (M20), a compound in which R 5 is SCF 2 CF 3 , SCF 2 CF 2 CF 3 , or SCF (CF 3 ) 2 can be produced by the method described in JP-A-10-291973.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether, and halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene. Hydrogen, aromatic hydrocarbons such as toluene, benzene, xylene, esters such as ethyl acetate and butyl acetate, acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolid Non-protic polar solvents such as non- and dimethyl sulfoxide, nitrogen-containing aromatic compounds such as pyridine and quinoline, and mixtures thereof.
In the reaction, a base may be added as necessary.
Examples of the base used in the reaction include organic bases such as triethylamine, diisopropylpyroethylamine, pyridine and 4-dimethylaminopyridine.
Examples of the acetylating agent used in the reaction include acetic anhydride and acetyl chloride.
The reaction may be performed using acetic anhydride, acetyl chloride or the like as a solvent.
In the reaction, an acetylating agent is usually used at a ratio of 1 to 3 moles per mole of 4-trifluoromethylsulfinyl-aniline.
The reaction temperature is usually in the range of −30 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
When a base is used in the reaction, the base is usually used at a ratio of 0.01 to 3 mol per 1 mol of 4-trifluoromethylsulfinyl-aniline.
After completion of the reaction, the compound (M11) can be isolated by performing post-treatment operations such as addition of the reaction mixture to water, extraction with an organic solvent, and drying and concentration of the organic layer. The isolated compound (M11) can be further purified by chromatography, recrystallization, and the like.
 式(M12)で表される化合物(以下化合物(M12)と記す。)は、化合物(M11)とニトロ化剤とを反応させることにより製造することができる。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えばジクロロメタン、クロロホルム等のハロゲン化炭化水素類、酢酸、濃硫酸、濃硝酸、水及びこれらの混合物が挙げられる。
 反応に用いられるニトロ化剤としては、例えば濃硝酸が挙げられる。
 該反応には、化合物(M11)1モルに対して、ニトロ化剤が通常1~3モルの割合で用いられる。
 該反応の反応温度は、通常-10~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物を水に加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M12)を単離することができる。単離された化合物(M12)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
A compound represented by formula (M12) (hereinafter referred to as compound (M12)) can be produced by reacting compound (M11) with a nitrating agent.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include halogenated hydrocarbons such as dichloromethane and chloroform, acetic acid, concentrated sulfuric acid, concentrated nitric acid, water, and mixtures thereof.
An example of the nitrating agent used in the reaction is concentrated nitric acid.
In the reaction, the nitrating agent is usually used at a ratio of 1 to 3 moles relative to 1 mole of the compound (M11).
The reaction temperature is usually in the range of −10 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M12) can be isolated by performing post-treatment operations such as addition of the reaction mixture to water, extraction with an organic solvent, and drying and concentration of the organic layer. The isolated compound (M12) can be further purified by chromatography, recrystallization and the like.
式(M13)で表される化合物(以下化合物(M13)と記す。)は、化合物(M12)とメチル化剤とを、塩基の存在下で反応させることにより製造することができる。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えば1,4-ジオキサン、ジエチルエーテル、テトラヒドロフラン、tert-ブチルメチルエーテル等のエーテル類、ジクロロメタン、クロロホルム、四塩化炭素、1,2-ジクロロエタン、クロロベンゼン等のハロゲン化炭化水素類、トルエン、ベンゼン、キシレン等の芳香族炭化水素類、N,N-ジメチルホルムアミド、N-メチルピロリドン、1,3-ジメチル-2-イミダゾリジノン、ジメチルスルホキシド等の非プロトン性極性溶媒及びこれらの混合物が挙げられる。
 反応に用いられる塩基としては、例えば水素化ナトリウム、水素化カリウム、水素化カルシウム等のアルカリ金属もしくはアルカリ土類金属の水素化物、炭酸ナトリウム、炭酸カリウム等のアルカリ金属炭酸塩類、又はトリエチルアミン、ジイソピロピルエチルアミン、ピリジン、4-ジメチルアミノピリジン等の有機塩基が挙げられる。
 該反応に用いられるメチル化剤としては、ヨードメタン、ジメチル硫酸などが挙げられる。
該反応には、化合物(M12)1モルに対して、メチル化剤が通常1~5モルの割合で用いられ、塩基が通常0.1~5モルの割合で用いられる。
 該反応の反応温度は、通常-20℃~120℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物を水に加えてから有機溶媒抽出し、有機層を濃縮する;反応混合物を水に加えて生じた固体を濾過により集める;又は、反応混合物中に生成した固体を濾過により集めることにより化合物(M13)を単離することができる。単離された化合物(M13)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
A compound represented by formula (M13) (hereinafter referred to as compound (M13)) can be produced by reacting compound (M12) with a methylating agent in the presence of a base.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as 1,4-dioxane, diethyl ether, tetrahydrofuran and tert-butyl methyl ether, and halogenated carbonization such as dichloromethane, chloroform, carbon tetrachloride, 1,2-dichloroethane and chlorobenzene. Aprotic polar solvents such as hydrogen, aromatic hydrocarbons such as toluene, benzene, xylene, N, N-dimethylformamide, N-methylpyrrolidone, 1,3-dimethyl-2-imidazolidinone, dimethyl sulfoxide, and the like These mixtures are mentioned.
Examples of the base used in the reaction include alkali metal or alkaline earth metal hydrides such as sodium hydride, potassium hydride and calcium hydride, alkali metal carbonates such as sodium carbonate and potassium carbonate, or triethylamine and diisopropylene. And organic bases such as propylethylamine, pyridine and 4-dimethylaminopyridine.
Examples of the methylating agent used in the reaction include iodomethane and dimethyl sulfate.
In the reaction, with respect to 1 mole of the compound (M12), the methylating agent is usually used at a ratio of 1 to 5 moles, and the base is usually used at a ratio of 0.1 to 5 moles.
The reaction temperature is usually in the range of −20 ° C. to 120 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered. The compound (M13) can be isolated by collecting by The isolated compound (M13) can be further purified by chromatography, recrystallization and the like.
式(M14)で示される化合物(以下化合物(M14)と記す。)は、化合物(M13)を塩基又は酸の存在下、加水分解反応を行うことにより製造することができる。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えばテトラヒドロフラン、1,4-ジオキサン等のエーテル類、メタノール、エタノール等のアルコール類、水及びこれらの混合物が挙げられる。
 反応に用いられる塩基としては、水酸化ナトリウム、水酸化リチウム、水酸化カリウム、炭酸ナトリウム、炭酸カリウム、炭酸セシウム等のアルカリ金属炭酸塩類が挙げられる。
 反応に用いられる酸としては、塩酸、硫酸等が挙げられる。
 該反応には、化合物(13)1モルに対して、塩基を用いる場合は塩基が1~5モル、酸を用いる場合は酸が0.1~5モルの割合で用いられる。
 該反応の反応温度は、通常-20~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物を水に加えてから有機溶媒抽出し、有機層を濃縮する;反応混合物を水に加えて生じた固体を濾過により集める;又は、反応混合物中に生成した固体を濾過により集めることにより化合物(M14)を単離することができる。単離された化合物(M14)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
The compound represented by formula (M14) (hereinafter referred to as compound (M14)) can be produced by subjecting compound (M13) to a hydrolysis reaction in the presence of a base or an acid.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as tetrahydrofuran and 1,4-dioxane, alcohols such as methanol and ethanol, water, and mixtures thereof.
Examples of the base used in the reaction include alkali metal carbonates such as sodium hydroxide, lithium hydroxide, potassium hydroxide, sodium carbonate, potassium carbonate, and cesium carbonate.
Examples of the acid used in the reaction include hydrochloric acid and sulfuric acid.
In the reaction, with respect to 1 mol of compound (13), when a base is used, the base is used in a proportion of 1 to 5 mol, and when an acid is used, the acid is used in a proportion of 0.1 to 5 mol.
The reaction temperature is usually in the range of −20 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the reaction mixture is added to water and extracted with an organic solvent, and the organic layer is concentrated; the reaction mixture is added to water and the resulting solid is collected by filtration; or the solid produced in the reaction mixture is filtered. The compound (M14) can be isolated by collecting by The isolated compound (M14) can be further purified by chromatography, recrystallization and the like.
 化合物(M8a)は、化合物(M14)と水素とを、水素添加触媒の存在下に反応させることにより製造することができる。
 該反応は、通常溶媒の存在下行われる。
 反応に用いられる溶媒としては、例えばテトラヒドロフラン、エチレングリコールジメチルエーテル、tert-ブチルメチルエーテル、1,4-ジオキサン等のエーテル類、酢酸エチル、酢酸ブチル等のエステル類、メタノール、エタノール等のアルコール類、水及びこれらの混合物が挙げられる。
 該反応は、通常1~100気圧の水素雰囲気下、通常溶媒の存在下で行われる。
 反応に用いられる水素添加触媒としては、例えばパラジウム炭素、水酸化パラジウム、ラネーニッケル、酸化白金等の遷移金属化合物が挙げられる。
 該反応には、化合物(M14)1モルに対して、水素が通常3~100モルの割合、水素添加触媒が通常0.001~0.5モルの割合で用いられる。
 該反応の反応温度は、通常-20~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物をろ過し、必要に応じて有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M8a)を単離することができる。単離された化合物(M8a)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
Compound (M8a) can be produced by reacting compound (M14) with hydrogen in the presence of a hydrogenation catalyst.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, esters such as ethyl acetate and butyl acetate, alcohols such as methanol and ethanol, water And mixtures thereof.
The reaction is usually performed in a hydrogen atmosphere at 1 to 100 atm, usually in the presence of a solvent.
Examples of the hydrogenation catalyst used in the reaction include transition metal compounds such as palladium carbon, palladium hydroxide, Raney nickel, and platinum oxide.
In the reaction, hydrogen is usually used in a proportion of 3 to 100 mol, and a hydrogenation catalyst is usually used in a proportion of 0.001 to 0.5 mol with respect to 1 mol of compound (M14).
The reaction temperature is usually in the range of −20 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M8a) can be isolated by performing post-treatment operations such as filtration of the reaction mixture, extraction with an organic solvent as necessary, and drying and concentration of the organic layer. The isolated compound (M8a) can be further purified by chromatography, recrystallization and the like.
また化合物(M8a)は、化合物(M14)と還元剤とを反応させることにより製造することができる。
 該反応は例えば還元剤と塩酸、酢酸等の酸と水との存在下で行うことができる。
 該反応は通常溶媒の存在下で行われる。
 該反応に用いられる溶媒としては、例えばテトラヒドロフラン、エチレングリコールジメチルエーテル、tert-ブチルメチルエーテル、1,4-ジオキサン等のエーテル類、酢酸エチル、酢酸ブチル等のエステル類、メタノール、エタノール等のアルコール類、N,N-ジメチルホルムアミド(以下、DMFと記す)、N-メチルピロリドン(以下、NMPと記す)、ジメチルスルホキシド(以下、DMSOと記す)等の非プロトン性極性溶媒及びこれらの混合物が挙げられる。
 反応に用いられる還元剤としては、例えば鉄粉、亜鉛粉末及び二塩化スズ等の金属粉が挙げられる。
 該反応には、化合物(M14)1モルに対して、還元剤が通常3~10モルの割合、酸が通常0.01モル~0.5モルの割合、水が3モル以上の割合で用いられる。
 該反応の反応温度は通常0~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物に水を加えた後、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M8a)を単離することができる。単離された化合物(M8a)は、クロマトグラフィー、再結晶等により精製することもできる。
Compound (M8a) can be produced by reacting compound (M14) with a reducing agent.
The reaction can be performed, for example, in the presence of a reducing agent, an acid such as hydrochloric acid or acetic acid, and water.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, esters such as ethyl acetate and butyl acetate, alcohols such as methanol and ethanol, Examples thereof include aprotic polar solvents such as N, N-dimethylformamide (hereinafter referred to as DMF), N-methylpyrrolidone (hereinafter referred to as NMP), dimethyl sulfoxide (hereinafter referred to as DMSO), and mixtures thereof.
Examples of the reducing agent used in the reaction include metal powders such as iron powder, zinc powder, and tin dichloride.
In the reaction, with respect to 1 mol of the compound (M14), the reducing agent is usually used in a proportion of 3 to 10 mol, the acid is usually used in a proportion of 0.01 to 0.5 mol, and the water is used in a proportion of 3 mol or more. It is done.
The reaction temperature of the reaction is usually in the range of 0 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M8a) can be isolated by performing post-treatment operations such as addition of water to the reaction mixture, extraction with an organic solvent, and drying and concentration of the organic layer. The isolated compound (M8a) can also be purified by chromatography, recrystallization, and the like.
製造法9
化合物(M8b)は、例えば下記のスキームに従って製造することができる。

Figure JPOXMLDOC01-appb-I000011
[式中、qは1又は2を表す。]
Manufacturing method 9
Compound (M8b) can be produced, for example, according to the following scheme.

Figure JPOXMLDOC01-appb-I000011
[Wherein q represents 1 or 2. ]
 式(M16)で表される化合物(以下化合物(M16)と記す。)は、式(M15)で表される化合物(以下化合物(M15)と記す。)と塩素化剤とを反応させることにより製造することができる。
 化合物(M15)は、製造法10の方法に準じて製造することができる。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えばトルエン、キシレン等の芳香族炭化水素類、ジクロロメタン、クロロホルム等の脂肪族ハロゲン化炭化水素類及びこれらの混合物が挙げられる。
 反応に用いられる塩素化剤としては、塩化チオニル、二塩化オキサリル、オキシ塩化リン等が挙げられる。
 該反応には、化合物(M15)1モルに対して、塩素化剤が通常1~15モルの割合で用いられる。
 該反応の反応温度は、通常0~150℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、溶媒を留去することにより、化合物(M16)を単離することができる。
A compound represented by formula (M16) (hereinafter referred to as compound (M16)) is obtained by reacting a compound represented by formula (M15) (hereinafter referred to as compound (M15)) with a chlorinating agent. Can be manufactured.
Compound (M15) can be produced according to the method of Production Method 10.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include aromatic hydrocarbons such as toluene and xylene, aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, and mixtures thereof.
Examples of the chlorinating agent used in the reaction include thionyl chloride, oxalyl dichloride, phosphorus oxychloride and the like.
In the reaction, a chlorinating agent is usually used at a ratio of 1 to 15 mol with respect to 1 mol of the compound (M15).
The reaction temperature is usually in the range of 0 to 150 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M16) can be isolated by removing the solvent.
 式(M17)で表される化合物(以下化合物(M17)と記す。)は、化合物(M16)とメチルアミンとを反応させることにより製造することができる。
 該反応は、通常溶媒の存在下で行われる。
反応に用いられる溶媒としては、例えばテトラヒドロフラン、エチレングリコールジメチルエーテル、tert-ブチルメチルエーテル、1,4-ジオキサン等のエーテル類、ヘキサン、ヘプタン、オクタン等の脂肪族炭化水素類、トルエン、キシレン等の芳香族炭化水素類、クロロベンゼン等のハロゲン化炭化水素類、酢酸エチル、酢酸ブチル等のエステル類、アセトニトリル、N,N-ジメチルホルムアミド、N-メチルピロリドン、ジメチルスルホキシド等の非プロトン性極性溶媒及びこれらの混合物が挙げられる。
該反応に用いられるメチルアミンは、ガス状であっても水溶液であっても、アルコール溶液であってもよい。
該反応は必要に応じて塩基の存在下で行うこともできる。
 反応に用いられる塩基としては、例えば水素化ナトリウム、水素化カリウム、水素化カルシウム等のアルカリ金属もしくはアルカリ土類金属の水素化物、炭酸ナトリウム、炭酸カリウム等のアルカリ金属炭酸塩類、又はトリエチルアミン、ジイソピロピルエチルアミン、ピリジン、4-ジメチルアミノピリジン等の有機塩基が挙げられる。
該反応には、化合物(M16)1モルに対して、メチルアミンが通常1~10モルの割合、塩基が0.01~10モルの割合で用いられる。
 該反応の反応温度は通常0~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物に水を加えた後、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M17)を単離することができる。単離された化合物(M17)は、クロマトグラフィー、再結晶等により精製することもできる。
The compound represented by the formula (M17) (hereinafter referred to as the compound (M17)) can be produced by reacting the compound (M16) with methylamine.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether, and 1,4-dioxane, aliphatic hydrocarbons such as hexane, heptane, and octane, and aromatics such as toluene and xylene. Aprotic polar solvents such as aromatic hydrocarbons, halogenated hydrocarbons such as chlorobenzene, esters such as ethyl acetate and butyl acetate, acetonitrile, N, N-dimethylformamide, N-methylpyrrolidone, dimethyl sulfoxide, and the like A mixture is mentioned.
The methylamine used for the reaction may be in the form of a gas, an aqueous solution, or an alcohol solution.
This reaction can also be performed in presence of a base as needed.
Examples of the base used in the reaction include alkali metal or alkaline earth metal hydrides such as sodium hydride, potassium hydride and calcium hydride, alkali metal carbonates such as sodium carbonate and potassium carbonate, or triethylamine and diisopropylene. And organic bases such as propylethylamine, pyridine and 4-dimethylaminopyridine.
In the reaction, with respect to 1 mole of the compound (M16), methylamine is usually used at a ratio of 1 to 10 moles and the base is used at a ratio of 0.01 to 10 moles.
The reaction temperature of the reaction is usually in the range of 0 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M17) can be isolated by post-treatment such as addition of water to the reaction mixture, extraction with an organic solvent, and drying and concentration of the organic layer. The isolated compound (M17) can also be purified by chromatography, recrystallization, and the like.
化合物(M8b)又は化合物(M8c)は、化合物(M17)と水素とを、水素添加触媒の存在下に反応させることにより製造することができる。
該反応は、通常溶媒の存在下行われる。
 反応に用いられる溶媒としては、例えばテトラヒドロフラン、エチレングリコールジメチルエーテル、tert-ブチルメチルエーテル、1,4-ジオキサン等のエーテル類、酢酸エチル、酢酸ブチル等のエステル類、メタノール、エタノール等のアルコール類、水及びこれらの混合物が挙げられる。
 該反応は、通常1~100気圧の水素雰囲気下、通常溶媒の存在下で行われる。
 反応に用いられる水素添加触媒としては、例えばパラジウム炭素、水酸化パラジウム、ラネーニッケル、酸化白金等の遷移金属化合物が挙げられる。
 該反応には、化合物(M17)1モルに対して、水素が通常3~100モルの割合、水素添加触媒が通常0.001~0.5モルの割合で用いられる。
 該反応の反応温度は、通常-20~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物をろ過し、必要に応じて有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M8b)を単離することができる。単離された化合物(M8b)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
Compound (M8b) or compound (M8c) can be produced by reacting compound (M17) with hydrogen in the presence of a hydrogenation catalyst.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, esters such as ethyl acetate and butyl acetate, alcohols such as methanol and ethanol, water And mixtures thereof.
The reaction is usually performed in a hydrogen atmosphere at 1 to 100 atm, usually in the presence of a solvent.
Examples of the hydrogenation catalyst used in the reaction include transition metal compounds such as palladium carbon, palladium hydroxide, Raney nickel, and platinum oxide.
In the reaction, with respect to 1 mol of the compound (M17), hydrogen is usually used in a proportion of 3 to 100 mol, and a hydrogenation catalyst is usually used in a proportion of 0.001 to 0.5 mol.
The reaction temperature is usually in the range of −20 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M8b) can be isolated by performing post-treatment operations such as filtration of the reaction mixture, extraction with an organic solvent as necessary, and drying and concentration of the organic layer. The isolated compound (M8b) can be further purified by chromatography, recrystallization and the like.
化合物(M8b)は、化合物(M17)と還元剤とを反応させることにより製造することができる。
 該反応は例えば還元剤と塩酸、酢酸等の酸と水との存在下で行うことができる。
 該反応は通常溶媒の存在下で行われる。
 該反応に用いられる溶媒としては、例えばテトラヒドロフラン、エチレングリコールジメチルエーテル、tert-ブチルメチルエーテル、1,4-ジオキサン等のエーテル類、酢酸エチル、酢酸ブチル等のエステル類、メタノール、エタノール等のアルコール類、DMF、NMP、DMSO等の非プロトン性極性溶媒及びこれらの混合物が挙げられる。
 反応に用いられる還元剤としては、例えば鉄粉、亜鉛粉末及び二塩化スズ等の金属粉が挙げられる。
 該反応には、化合物(M17)1モルに対して、還元剤が通常3~10モルの割合、酸が通常0.01モル~0.5モルの割合、水が3モル以上の割合で用いられる。
 該反応の反応温度は通常0~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物に水を加えた後、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M8b)を単離することができる。単離された化合物(M8b)は、クロマトグラフィー、再結晶等により精製することもできる。
Compound (M8b) can be produced by reacting compound (M17) with a reducing agent.
The reaction can be performed, for example, in the presence of a reducing agent, an acid such as hydrochloric acid or acetic acid, and water.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, esters such as ethyl acetate and butyl acetate, alcohols such as methanol and ethanol, Examples include aprotic polar solvents such as DMF, NMP, DMSO, and mixtures thereof.
Examples of the reducing agent used in the reaction include metal powders such as iron powder, zinc powder, and tin dichloride.
In the reaction, with respect to 1 mol of the compound (M17), the reducing agent is usually used in a proportion of 3 to 10 mol, the acid is usually used in a proportion of 0.01 to 0.5 mol, and the water is used in a proportion of 3 mol or more. It is done.
The reaction temperature of the reaction is usually in the range of 0 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M8b) can be isolated by performing post-treatment operations such as addition of water to the reaction mixture, extraction with an organic solvent, and drying and concentration of the organic layer. The isolated compound (M8b) can also be purified by chromatography, recrystallization, and the like.
製造法10
 化合物(M8c)は、例えば下記のスキームに従って製造することができる。
       
Figure JPOXMLDOC01-appb-I000012
[式中の記号は式(1)と同じ意味を表す。]
 式(M19)で表される化合物(以下化合物(M19)と記す。)は、式(M18)で表される化合物(以下化合物(M18)と記す。)とニトロ化剤とを反応させることにより製造することができる。
 該反応は、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えばジクロロメタン、クロロホルム等の脂肪族ハロゲン化炭化水素類、酢酸、濃硫酸、濃硝酸、水及びこれらの混合物が挙げられる。
 反応に用いられるニトロ化剤としては、例えば濃硝酸等が挙げられる。
 該反応には、化合物(M18)1モルに対して、ニトロ化剤が通常1~3モルの割合で用いられる。
 該反応の反応温度は、通常-10~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物を水に加え、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M19)を単離することができる。単離された化合物(M19)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
Manufacturing method 10
Compound (M8c) can be produced, for example, according to the following scheme.

Figure JPOXMLDOC01-appb-I000012
[The symbols in the formula have the same meaning as in formula (1). ]
A compound represented by formula (M19) (hereinafter referred to as compound (M19)) is obtained by reacting a compound represented by formula (M18) (hereinafter referred to as compound (M18)) with a nitrating agent. Can be manufactured.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include aliphatic halogenated hydrocarbons such as dichloromethane and chloroform, acetic acid, concentrated sulfuric acid, concentrated nitric acid, water, and mixtures thereof.
Examples of the nitrating agent used in the reaction include concentrated nitric acid.
In the reaction, the nitrating agent is usually used at a ratio of 1 to 3 moles relative to 1 mole of the compound (M18).
The reaction temperature is usually in the range of −10 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M19) can be isolated by performing post-treatment operations such as addition of the reaction mixture to water, extraction with an organic solvent, and drying and concentration of the organic layer. The isolated compound (M19) can be further purified by chromatography, recrystallization and the like.
化合物(M8c)は、化合物(M19)と水素とを、水素添加触媒の存在下に反応させることにより製造することができる。
 該反応は、通常1~100気圧の水素雰囲気下、通常溶媒の存在下で行われる。
 反応に用いられる溶媒としては、例えばテトラヒドロフラン、エチレングリコールジメチルエーテル、tert-ブチルメチルエーテル、1,4-ジオキサン等のエーテル類、酢酸エチル、酢酸ブチル等のエステル類、メタノール、エタノール等のアルコール類、水及びこれらの混合物が挙げられる。
 反応に用いられる水素添加触媒としては、例えばパラジウム炭素、水酸化パラジウム、ラネーニッケル、酸化白金等の遷移金属化合物が挙げられる。
 該反応には、化合物(M19)1モルに対して、水素が通常3モルの割合、水素添加触媒が通常0.001~0.5モルの割合で用いられる。
 該反応の反応温度は、通常-20~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物をろ過し、必要に応じて有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M8c)を単離することができる。単離された化合物(M8c)は、クロマトグラフィー、再結晶等によりさらに精製することもできる。
Compound (M8c) can be produced by reacting compound (M19) with hydrogen in the presence of a hydrogenation catalyst.
The reaction is usually performed in a hydrogen atmosphere at 1 to 100 atm, usually in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, esters such as ethyl acetate and butyl acetate, alcohols such as methanol and ethanol, water And mixtures thereof.
Examples of the hydrogenation catalyst used in the reaction include transition metal compounds such as palladium carbon, palladium hydroxide, Raney nickel, and platinum oxide.
In the reaction, with respect to 1 mole of the compound (M19), hydrogen is usually used at a ratio of 3 moles, and the hydrogenation catalyst is usually used at a ratio of 0.001 to 0.5 moles.
The reaction temperature is usually in the range of −20 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M8c) can be isolated by performing post-treatment operations such as filtration of the reaction mixture, extraction with an organic solvent as necessary, and drying and concentration of the organic layer. The isolated compound (M8c) can be further purified by chromatography, recrystallization, and the like.
また化合物(M8c)は、化合物(M19)と還元剤とを反応させることにより製造することができる。
 該反応は例えば還元剤と塩酸、酢酸等の酸と水との存在下で行うことができる。
 該反応は通常溶媒の存在下で行われる。
 該反応に用いられる溶媒としては、例えばテトラヒドロフラン、エチレングリコールジメチルエーテル、tert-ブチルメチルエーテル、1,4-ジオキサン等のエーテル類、酢酸エチル、酢酸ブチル等のエステル類、メタノール、エタノール等のアルコール類、DMF、NMP、DMSO等の非プロトン性極性溶媒及びこれらの混合物が挙げられる。
 反応に用いられる還元剤としては、例えば鉄粉、亜鉛粉末及び二塩化スズ等の金属粉が挙げられる。
 該反応には、化合物(M19)1モルに対して、還元剤が通常3~10モルの割合、酸が通常0.01モル~0.5モルの割合、水が3モル以上の割合で用いられる。
 該反応の反応温度は通常0~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物に水を加えた後、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M8c)を単離することができる。単離された化合物(M8c)は、クロマトグラフィー、再結晶等により精製することもできる。
Compound (M8c) can be produced by reacting compound (M19) with a reducing agent.
The reaction can be performed, for example, in the presence of a reducing agent, an acid such as hydrochloric acid or acetic acid, and water.
The reaction is usually performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether, tert-butyl methyl ether and 1,4-dioxane, esters such as ethyl acetate and butyl acetate, alcohols such as methanol and ethanol, Examples include aprotic polar solvents such as DMF, NMP, DMSO, and mixtures thereof.
Examples of the reducing agent used in the reaction include metal powders such as iron powder, zinc powder, and tin dichloride.
In the reaction, with respect to 1 mol of the compound (M19), the reducing agent is usually used in a proportion of 3 to 10 mol, the acid is usually used in a proportion of 0.01 to 0.5 mol, and the water is used in a proportion of 3 mol or more. It is done.
The reaction temperature of the reaction is usually in the range of 0 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M8c) can be isolated by performing post-treatment operations such as addition of water to the reaction mixture, extraction with an organic solvent, and drying and concentration of the organic layer. The isolated compound (M8c) can also be purified by chromatography, recrystallization, and the like.
製造法11
式(M18)においてRがS(O)Rである化合物(M18b)(以下化合物(M18b)と記す。)、及び式(M18)においてRがS(O)である化合物(M18c)(以下化合物(M18c)と記す。)は、化合物(M18)においてRがSRである化合物(M18a)(以下化合物(M18a)と記す。)と酸化剤とを反応させることにより製造することができる。
Figure JPOXMLDOC01-appb-I000013
 該反応は、製造法1における本発明化合物(1a)に代えて化合物(M18a)、及び本発明化合物(1b)を化合物(M18b)に代えることにより、製造例1に記載の反応に準じて製造することができる。
Manufacturing method 11
Compound (M18b) in which R 5 is S (O) R 6 in formula (M18) (hereinafter referred to as compound (M18b)), and Compound in which R 5 is S (O) 2 R 6 in formula (M18) (M18c) (hereinafter referred to as compound (M18c)) is obtained by reacting compound (M18a) (hereinafter referred to as compound (M18a)) in which R 5 is SR 6 in compound (M18) with an oxidizing agent. Can be manufactured.
Figure JPOXMLDOC01-appb-I000013
The reaction is carried out according to the reaction described in Production Example 1 by substituting compound (M18a) for the present compound (1a) in production method 1 and compound (M18b) for the present compound (1b). can do.
製造法12
 化合物(M18)は、化合物(M20)とジアゾ化剤とを酸性水溶液の存在下で反応させることにより製造することができる。
Figure JPOXMLDOC01-appb-I000014
 該反応は、溶媒の存在下で行われる。
 該反応に用いられる溶媒としては、例えばテトラヒドロフラン、エチレングリコールジメチルエーテル、1,4-ジオキサン等のエーテル類、メタノール、エタノール等のアルコール類、アセトニトリル、DMF、NMP、DMSO等の非プロトン性極性溶媒、水及びこれらの混合物が挙げられる。
 反応に用いられるジアゾ化剤としては、例えば亜硝酸ナトリウムが挙げられる。
 反応に用いられる酸性水溶液としては、硫酸、塩酸、酢酸、及びこれらの混合物が挙げられる。
 該反応には、化合物(M20)1モルに対して、ジアゾ化剤が通常1~10モルの割合、酸が1~100モルの割合で用いられる。
 該反応の反応温度は通常0~100℃の範囲である。該反応の反応時間は通常0.1~24時間の範囲である。
 反応終了後は、反応混合物に水を加えた後、有機溶媒で抽出し、有機層を乾燥、濃縮する等の後処理操作を行うことにより、化合物(M18)を単離することができる。単離された化合物(M18)は、クロマトグラフィー、再結晶等により精製することもできる。
Production method 12
Compound (M18) can be produced by reacting compound (M20) with a diazotizing agent in the presence of an acidic aqueous solution.
Figure JPOXMLDOC01-appb-I000014
The reaction is performed in the presence of a solvent.
Examples of the solvent used in the reaction include ethers such as tetrahydrofuran, ethylene glycol dimethyl ether and 1,4-dioxane, alcohols such as methanol and ethanol, aprotic polar solvents such as acetonitrile, DMF, NMP and DMSO, water And mixtures thereof.
Examples of the diazotizing agent used in the reaction include sodium nitrite.
Examples of the acidic aqueous solution used for the reaction include sulfuric acid, hydrochloric acid, acetic acid, and a mixture thereof.
In the reaction, with respect to 1 mol of the compound (M20), the diazotizing agent is usually used in a proportion of 1 to 10 mol and the acid in a proportion of 1 to 100 mol.
The reaction temperature of the reaction is usually in the range of 0 to 100 ° C. The reaction time is usually in the range of 0.1 to 24 hours.
After completion of the reaction, the compound (M18) can be isolated by performing post-treatment operations such as addition of water to the reaction mixture, extraction with an organic solvent, and drying and concentration of the organic layer. The isolated compound (M18) can also be purified by chromatography, recrystallization, and the like.
 次に、本発明化合物の具体例を以下に示す。
Figure JPOXMLDOC01-appb-I000015
式(1)において、RがCFであり、AがNCHであり、nおよびRが[表1]~[表3]に記載の組み合わせである本発明化合物。
Next, specific examples of the compound of the present invention are shown below.
Figure JPOXMLDOC01-appb-I000015
The compound of the present invention in which in formula (1), R 5 is CF 3 , A is NCH 3 , and n and R 1 are combinations described in [Table 1] to [Table 3].
Figure JPOXMLDOC01-appb-T000016
Figure JPOXMLDOC01-appb-T000016
Figure JPOXMLDOC01-appb-T000017
Figure JPOXMLDOC01-appb-T000017
Figure JPOXMLDOC01-appb-T000018
Figure JPOXMLDOC01-appb-T000018
 式(1)において、RがCFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがCFCFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがCFCFCFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがCF(CFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがSCFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがSCFCFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CFCFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CFCFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがSCFCFCFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CFCFCFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CFCFCFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがSCF(CFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CF(CFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CF(CFであり、AがNCHであり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
The compound of the present invention in which, in the formula (1), R 5 is CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3].
In the formula (1), R 5 is CF 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3].
In the formula (1), R 5 is CF 2 CF 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
In the formula (1), R 5 is CF (CF 3 ) 2 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
The compound of the present invention in which in formula (1), R 5 is SCF 3 , A is NCH 3 , and n and R 1 are a combination described in any of [Table 1] to [Table 3].
In the formula (1), R 5 is S (O) CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
In the formula (1), R 5 is S (O) 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Invention compounds.
In the formula (1), R 5 is SCF 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3].
In the formula (1), R 5 is S (O) CF 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] The compound of the present invention.
In the formula (1), R 5 is S (O) 2 CF 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] A compound of the present invention.
In the formula (1), R 5 is SCF 2 CF 2 CF 3 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
In Formula (1), R 5 is S (O) CF 2 CF 2 CF 3 , A is NCH 3 , and n and R 1 are the combinations according to any one of [Table 1] to [Table 3] The compound of the present invention.
In the formula (1), R 5 is S (O) 2 CF 2 CF 2 CF 3 , A is NCH 3 , and n and R 1 are described in any one of [Table 1] to [Table 3] The compound of the present invention which is a combination.
In the formula (1), R 5 is SCF (CF 3 ) 2 , A is NCH 3 , and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
In formula (1), R 5 is S (O) CF (CF 3 ) 2 , A is NCH 3 , and n and R 1 are the combinations according to any one of [Table 1] to [Table 3] The compound of the present invention.
In Formula (1), R 5 is S (O) 2 CF (CF 3 ) 2 , A is NCH 3 , and n and R 1 are described in any one of [Table 1] to [Table 3] The compound of the present invention which is a combination.
 式(1)において、RがCFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがCFCFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがCFCFCFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがCF(CFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがSCFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがSCFCFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CFCFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CFCFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
式(1)において、RがSCFCFCFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CFCFCFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CFCFCFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがSCF(CFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CF(CFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
 式(1)において、RがS(O)CF(CFであり、Aが酸素原子であり、nおよびRが[表1]~[表3]のいずれかに記載の組み合わせである本発明化合物。
The compound of the present invention in which in formula (1), R 5 is CF 3 , A is an oxygen atom, and n and R 1 are a combination described in any of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1), R 5 is CF 2 CF 3 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3].
In the formula (1), R 5 is CF 2 CF 2 CF 3 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
In the formula (1), R 5 is CF (CF 3 ) 2 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
The compound of the present invention in which, in the formula (1), R 5 is SCF 3 , A is an oxygen atom, and n and R 1 are a combination described in any one of [Table 1] to [Table 3].
In the formula (1), R 5 is S (O) CF 3 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
In the formula (1), R 5 is S (O) 2 CF 3 , A is an oxygen atom, and n and R 1 are combinations described in any of [Table 1] to [Table 3] Invention compounds.
The compound of the present invention in which, in the formula (1), R 5 is SCF 2 CF 3 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3].
In the formula (1), R 5 is S (O) CF 2 CF 3 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3] The compound of the present invention.
In the formula (1), R 5 is S (O) 2 CF 2 CF 3 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3] A compound of the present invention.
In the formula (1), R 5 is SCF 2 CF 2 CF 3 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
In formula (1), R 5 is S (O) CF 2 CF 2 CF 3 , A is an oxygen atom, and n and R 1 are the combinations according to any one of [Table 1] to [Table 3] The compound of the present invention.
In the formula (1), R 5 is S (O) 2 CF 2 CF 2 CF 3 , A is an oxygen atom, and n and R 1 are any one of [Table 1] to [Table 3] The compound of the present invention which is a combination.
In the formula (1), R 5 is SCF (CF 3 ) 2 , A is an oxygen atom, and n and R 1 are combinations according to any one of [Table 1] to [Table 3] Compound.
In formula (1), R 5 is S (O) CF (CF 3 ) 2 , A is an oxygen atom, and n and R 1 are the combinations according to any one of [Table 1] to [Table 3] The compound of the present invention.
In Formula (1), R 5 is S (O) 2 CF (CF 3 ) 2 , A is an oxygen atom, and n and R 1 are any one of [Table 1] to [Table 3] The compound of the present invention which is a combination.
 式(1B)
Figure JPOXMLDOC01-appb-I000019
において、AがNCHであり、RがCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがCFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがCF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがSCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがS(O)CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがS(O)CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがSCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがS(O)CFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがS(O)CFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがSCFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがS(O)CFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがS(O)CFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがSCF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがS(O)CF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、AがNCHであり、RがS(O)CF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがCFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがCF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがSCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがS(O)CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがS(O)CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがSCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがS(O)CFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがS(O)CFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがSCFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがS(O)CFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがS(O)CFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがSCF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがS(O)CF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1B)において、Aが酸素原子であり、RがS(O)CF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
Formula (1B)
Figure JPOXMLDOC01-appb-I000019
Wherein A is NCH 3 , R 6 is CF 3 , and R 1 is a combination according to any one of Table 1 to Table 3.
In the formula (1B), A is NCH 3 , R 6 is CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1B), A is NCH 3 , R 6 is CF 2 CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
The compound of the present invention in which in formula (1B), A is NCH 3 , R 6 is CF (CF 3 ) 2 , and R 1 is a combination described in any of [Table 1] to [Table 3].
In the formula (1B), A is NCH 3 , R 6 is SCF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3].
In the formula (1B), A is NCH 3 , R 6 is S (O) CF 3 , and R 1 is a combination according to any one of Table 1 to Table 3.
In the formula (1B), A is NCH 3 , R 6 is S (O) 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] .
In the formula (1B), A is NCH 3 , R 6 is SCF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3].
In the formula (1B), A is NCH 3 , R 6 is S (O) CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] Compound.
In the formula (1B), A is NCH 3 , R 6 is S (O) 2 CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3] Invention compounds.
In the formula (1B), A is NCH 3 , R 6 is SCF 2 CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3].
In the formula (1B), A is NCH 3 , R 6 is S (O) CF 2 CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3] The compound of the present invention.
In the formula (1B), A is NCH 3 , R 6 is S (O) 2 CF 2 CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] A compound of the present invention.
In the formula (1B), A is NCH 3 , R 6 is SCF (CF 3 ) 2 , and R 1 is a combination according to any one of Table 1 to Table 3.
In the formula (1B), A is NCH 3 , R 6 is S (O) CF (CF 3 ) 2 , and R 1 is a combination according to any one of [Table 1] to [Table 3] The compound of the present invention.
In the formula (1B), A is NCH 3 , R 6 is S (O) 2 CF (CF 3 ) 2 , and R 1 is a combination according to any one of [Table 1] to [Table 3] A compound of the present invention.
In the formula (1B), A is an oxygen atom, R 6 is CF 3 , and R 1 is a combination according to any one of Table 1 to Table 3.
In the formula (1B), A is an oxygen atom, R 6 is CF 2 CF 3 , and R 1 is a combination according to any one of Table 1 to Table 3.
In the formula (1B), A is an oxygen atom, R 6 is CF 2 CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1B), A is an oxygen atom, R 6 is CF (CF 3 ) 2 , and R 1 is a combination described in any of [Table 1] to [Table 3].
In the formula (1B), A is an oxygen atom, R 6 is SCF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1B), A is an oxygen atom, R 6 is S (O) CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
In the formula (1B), A is an oxygen atom, R 6 is S (O) 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] .
In the formula (1B), A is an oxygen atom, R 6 is SCF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3].
In the formula (1B), A is an oxygen atom, R 6 is S (O) CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] Compound.
In the formula (1B), A is an oxygen atom, R 6 is S (O) 2 CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3] Invention compounds.
In the formula (1B), A is an oxygen atom, R 6 is SCF 2 CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3].
In the formula (1B), A is an oxygen atom, R 6 is S (O) CF 2 CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3]. The compound of the present invention.
In the formula (1B), A is an oxygen atom, R 6 is S (O) 2 CF 2 CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] A compound of the present invention.
In the formula (1B), A is an oxygen atom, R 6 is SCF (CF 3 ) 2 , and R 1 is a combination according to any one of [Table 1] to [Table 3].
In the formula (1B), A is an oxygen atom, R 6 is S (O) CF (CF 3 ) 2 , and R 1 is a combination described in any of [Table 1] to [Table 3] The compound of the present invention.
In the formula (1B), A is an oxygen atom, R 6 is S (O) 2 CF (CF 3 ) 2 , and R 1 is a combination according to any one of [Table 1] to [Table 3] A compound of the present invention.
 式(1C)
Figure JPOXMLDOC01-appb-I000020
において、AがNCHであり、RがCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがCFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがCF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがSCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがS(O)CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがS(O)CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがSCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがS(O)CFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがS(O)CFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがSCFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがS(O)CFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがS(O)CFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがSCF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがS(O)CF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、AがNCHであり、RがS(O)CF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがCFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがCF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがSCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがS(O)CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがS(O)CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがSCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがS(O)CFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがS(O)CFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがSCFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがS(O)CFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがS(O)CFCFCFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがSCF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがS(O)CF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
 式(1C)において、Aが酸素原子であり、RがS(O)CF(CFであり、Rが〔表1〕~〔表3〕のいずれかに記載の組み合わせである本発明化合物。
Formula (1C)
Figure JPOXMLDOC01-appb-I000020
Wherein A is NCH 3 , R 6 is CF 3 , and R 1 is a combination according to any one of Table 1 to Table 3.
The compound of the present invention in which, in the formula (1C), A is NCH 3 , R 6 is CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1C), A is NCH 3 , R 6 is CF 2 CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1C), A is NCH 3 , R 6 is CF (CF 3 ) 2 , and R 1 is a combination described in any of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1C), A is NCH 3 , R 6 is SCF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1C), A is NCH 3 , R 6 is S (O) CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
In the formula (1C), A is NCH 3 , R 6 is S (O) 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] .
The compound of the present invention in which, in the formula (1C), A is NCH 3 , R 6 is SCF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
In the formula (1C), A is NCH 3 , R 6 is S (O) CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] Compound.
In the formula (1C), A is NCH 3 , R 6 is S (O) 2 CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3] Invention compounds.
In the formula (1C), A is NCH 3 , R 6 is SCF 2 CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3].
In the formula (1C), A is NCH 3 , R 6 is S (O) CF 2 CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3] The compound of the present invention.
In the formula (1C), A is NCH 3 , R 6 is S (O) 2 CF 2 CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] A compound of the present invention.
The compound of the present invention in which, in the formula (1C), A is NCH 3 , R 6 is SCF (CF 3 ) 2 and R 1 is a combination described in any of [Table 1] to [Table 3].
In the formula (1C), A is NCH 3 , R 6 is S (O) CF (CF 3 ) 2 , and R 1 is a combination described in any of [Table 1] to [Table 3] The compound of the present invention.
In the formula (1C), A is NCH 3 , R 6 is S (O) 2 CF (CF 3 ) 2 , and R 1 is a combination according to any one of [Table 1] to [Table 3] A compound of the present invention.
In the formula (1C), the compound of the present invention wherein A is an oxygen atom, R 6 is CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1C), A is an oxygen atom, R 6 is CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1C), A is an oxygen atom, R 6 is CF 2 CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1C), A is an oxygen atom, R 6 is CF (CF 3 ) 2 , and R 1 is a combination described in any of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1C), A is an oxygen atom, R 6 is SCF 3 and R 1 is a combination according to any one of [Table 1] to [Table 3].
The compound of the present invention in which, in the formula (1C), A is an oxygen atom, R 6 is S (O) CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
In the formula (1C), A is an oxygen atom, R 6 is S (O) 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] .
The compound of the present invention in which, in the formula (1C), A is an oxygen atom, R 6 is SCF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
In the formula (1C), A is an oxygen atom, R 6 is S (O) CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3] Compound.
In the formula (1C), A is an oxygen atom, R 6 is S (O) 2 CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3] Invention compounds.
The compound of the present invention in which, in the formula (1C), A is an oxygen atom, R 6 is SCF 2 CF 2 CF 3 , and R 1 is a combination described in any of [Table 1] to [Table 3].
In Formula (1C), A is an oxygen atom, R 6 is S (O) CF 2 CF 2 CF 3 , and R 1 is a combination described in any one of [Table 1] to [Table 3] The compound of the present invention.
In the formula (1C), A is an oxygen atom, R 6 is S (O) 2 CF 2 CF 2 CF 3 , and R 1 is a combination according to any one of [Table 1] to [Table 3] A compound of the present invention.
The compound of the present invention in which, in the formula (1C), A is an oxygen atom, R 6 is SCF (CF 3 ) 2 , and R 1 is a combination described in any of [Table 1] to [Table 3].
In the formula (1C), A is an oxygen atom, R 6 is S (O) CF (CF 3 ) 2 , and R 1 is a combination according to any one of [Table 1] to [Table 3] The compound of the present invention.
In the formula (1C), A is an oxygen atom, R 6 is S (O) 2 CF (CF 3 ) 2 , and R 1 is a combination according to any one of [Table 1] to [Table 3] A compound of the present invention.
 本発明化合物が効力を有する有害生物としては、例えば、有害昆虫類や有害ダニ類等の有害節足動物及び線虫等の有害線形動物が挙げられる。かかる有害生物としては、具体的には例えば、以下のものが挙げられる。 Examples of pests for which the compounds of the present invention are effective include harmful arthropods such as harmful insects and harmful mites, and harmful linear animals such as nematodes. Specific examples of such pests include the following.
半翅目:ヒメトビウンカ(Laodelphax striatellus)、トビイロウンカ(Nilaparvata lugens)、セジロウンカ(Sogatella furcifera)等のウンカ類、ツマグロヨコバイ(Nephotettix cincticeps)、タイワンツマグロヨコバイ(Nephotettix virescens)、チャノミドリヒメヨコバイ(Empoasca onukii)等のヨコバイ類、ワタアブラムシ(Aphis gossypii)、モモアカアブラムシ(Myzus persicae)、ダイコンアブラムシ(Brevicoryne brassicae)、ユキヤナギアブラムシ(Aphis spiraecola)、チューリップヒゲナガアブラムシ(Macrosiphum euphorbiae)、ジャガイモヒゲナガアブラムシ(Aulacorthum solani)、ムギクビレアブラムシ(Rhopalosiphum padi)、ミカンクロアブラムシ(Toxoptera citricidus)、モモコフキアブラムシ(Hyalopterus pruni)等のアブラムシ類、アオクサカメムシ(Nezara antennata)、ホソヘリカメムシ(Riptortus clavetus)、クモヘリカメムシ(Leptocorisa chinensis)、トゲシラホシカメムシ(Eysarcoris parvus)、クサギカメムシ(Halyomorpha mista)等のカメムシ類、オンシツコナジラミ(Trialeurodes vaporariorum)、タバココナジラミ(Bemisia tabaci)、ミカンコナジラミ(Dialeurodes citri)、ミカントゲコナジラミ(Aleurocanthus spiniferus)等のコナジラミ類、アカマルカイガラムシ(Aonidiella aurantii)、サンホーゼカイガラムシ(Comstockaspis perniciosa)、シトラススノースケール(Unaspis citri)、ルビーロウムシ(Ceroplastes rubens)、イセリヤカイガラムシ(Icerya purchasi)、フジコナカイガラムシ(Planococcus kraunhiae)、クワコナカイガラムシ(Pseudococcus longispinis)、クワシロカイガラムシ(Pseudaulacaspis pentagona)等のカイガラムシ類、グンバイムシ類、トコジラミ(Cimex lectularius)等のトコジラミ類、及びキジラミ類。 Hemiptera: small brown planthopper (Laodelphax striatellus), brown planthopper (Nilaparvata lugens), planthoppers such as Sejirounka (Sogatella furcifera), green rice leafhopper (Nephotettix cincticeps), Taiwan green rice leafhopper (Nephotettix virescens), tea Roh green leafhopper such as leafhopper (Empoasca onukii) Cotton aphids (Aphis gossypi), peach aphids (Myus persicae), radish aphids (Brevicorine brassicae), aphid spiraecola, tulip beetle aphids (M) crosifum euphorbiae, potato beetle aphids (Auracorthum solani), wheat beetle aphids (Rhopalosiphum padi), citrus aphids (Toxoptera citricidus), peach beetles, etc. Stink bugs such as stink bugs (Riptortus clavetus), spider helicopter bugs (Leptocorisa chinensis), bark beetles (Eysarcoris parvus), winged beetle (Halyomorpha mista), and the like vaporariorum), sweetpotato whitefly (Bemisia tabaci), mandarin orange whitefly (Dialeurodes citri), whiteflies such as mandarin orange spiny whitefly (Aleurocanthus spiniferus), Acamar scale insects (Aonidiella aurantii), Sanho zero scale insects (Comstockaspis perniciosa), citrus snow scale (Unaspis citri ), Ruby Beetle (Ceroplastes rubens), Iceria scale insect (Icerya purchasi), Fujino scale insect (Pranococcus kraunhiae), Pseudococcus longispin (Pseudococcus longispin) is), scale insects such as Pseudauracapaspis pentagona, bed bugs, bed bugs such as bedbugs (Cimex electularius), and cetaceans.
 鱗翅目:ニカメイガ(Chilo suppressalis)、サンカメイガ(Tryporyza incertulas)、コブノメイガ(Cnaphalocrocis medinalis)、ワタノメイガ(Notarcha derogata)、ノシメマダラメイガ(Plodia interpunctella)、アワノメイガ(Ostrinia furnacalis)、ハイマダラノメイガ(Hellula undalis)、シバツトガ(Pediasia teterrellus)等のメイガ類、ハスモンヨトウ(Spodoptera litura)、シロイチモジヨトウ(Spodoptera exigua)、アワヨトウ(Pseudaletia separata)、ヨトウガ(Mamestra brassicae)、タマナヤガ(Agrotis ipsilon),タマナギンウワバ(Plusia nigrisigna),トリコプルシア属、ヘリオティス属、ヘリコベルパ属等のヤガ類、モンシロチョウ(Pieris rapae)等のシロチョウ類、アドキソフィエス属、ナシヒメシンクイ(Grapholita molesta)、マメシンクイガ(Leguminivora glycinivorella),アズキサヤムシガ(Matsumuraeses azukivora)、リンゴコカクモンハマキ(Adoxophyes orana fasciata)、チャノコカクモンハマキ(Adoxophyes honmai.)、チャハマキ(Homona magnanima)、ミダレカクモンハマキ(Archips fuscocupreanus)、コドリンガ(Cydia pomonella)等のハマキガ類、チャノホソガ(Caloptilia theivora)、キンモンホソガ(Phyllonorycter ringoneella)のホソガ類、モモシンクイガ(Carposina niponensis)等のシンクイガ類、リオネティア属等のハモグリガ類、リマントリア属、ユープロクティス属等のドクガ類、コナガ(Plutella xylostella)等のスガ類、ワタアカミムシ(Pectinophora gossypiella)ジャガイモガ(Phthorimaea operculella)等のキバガ類、アメリカシロヒトリ(Hyphantria cunea)等のヒトリガ類、及びイガ(Tinea translucens)、コイガ(Tineola bisselliella)等のヒロズコガ類。 Lepidoptera: rice stem borer (Chilo suppressalis), Sankameiga (Tryporyza incertulas), leaf roller (Cnaphalocrocis medinalis), Watanomeiga (Notarcha derogata), Indian meal moth (Plodia interpunctella), the European corn borer (Ostrinia furnacalis), high Madara Roh moth (Hellula undalis), Shibatsutoga (Pediasia teterrulus) and other moths, Spodoptera litura, Spodoptera exigua, Ayuyoto (Pseudaletia sepata), Madam Gritters such as Strassicae, Agrotis ipsilon, Tamanaginuwaba (Plusia nigrisigna), Trichopulsia, Heliotis, Helicoberpa, etc. (Leguminivora, Glycinivolora), Azusa yamushiga (Matsumuraeses azukivivora), Apple wolfberry (Adoxophyes), Orana fasmoata (Adomophymomochia). Scallops of the genus Acer, the genus of the genus Cypridia, the genus of the genus, the genus of the genus, the genus of the genus, the moss of the genus moth, Doctors of the genus Limantria and Euproctinis, Sugas such as Plutella xylostella, Pterinophora gossypiella potato moth (Phthorimaea operculella), etc .; Chunea) and other tigers such as iga (Tinea translucens) and tiger bisselliella.
 アザミウマ目:ミカンキイロアザミウマ(Frankliniella occidentalis)、ミナミキイロアザミウマ(Thrips parmi)、チャノキイロアザミウマ(Scirtothrips dorsalis)、ネギアザミウマ(Thrips tabaci)、ヒラズハナアザミウマ(Frankliniella intonsa)等のアザミウマ類。 Thrips: Frankliniella occidentalis, Thrips parmi, Citrus dorsalis, and Thrips thrips.
 双翅目:アカイエカ(Culex pipiens pallens)、コガタアカイエカ(Culex tritaeniorhynchus)、ネッタイイエカ(Culex quinquefasciatus)等のイエカ類、ネッタイシマカ(Aedes aegypti)、ヒトスジシマカ(Aedes albopictus)等のエーデス属、シナハマダラカ(Anopheles sinensis)等のアノフェレス属、ユスリカ類、イエバエ(Musca domestica)、オオイエバエ(Muscina stabulans)等のイエバエ類、クロバエ類、ニクバエ類、ヒメイエバエ類、タネバエ(Delia platura)、タマネギバエ(Delia antiqua)等のハナバエ類、イネハモグリバエ(Agromyza oryzae)、イネヒメハモグリバエ(Hydrellia griseola)、トマトハモグリバエ、(Liriomyza sativae)、マメハモグリバエ(Liriomyza trifolii)、ナモグリバエ(Chromatomyia horticola)等のハモグリバエ類、イネキモグリバエ(Chlorops oryzae)等のキモグリバエ類、ウリミバエ(Dacus cucurbitae)、チチュウカイミバエ(Ceratitis capitata)等のミバエ類、ショウジョウバエ類、オオキモンノミバエ(Megaselia spiracularis)等のノミバエ類、オオチョウバエ(Clogmia albipunctata)等のチョウバエ類、クロバネキノコバエ類、ブユ類、ウシアブ(Tabanus trigonus)等のアブ類、シラミバエ類及びサシバエ類。 Diptera: Culex pipiens palens, Culex quaters, and other squids such as Culex quinquefasciaus, etc .; Houseflies such as Anopheles, Chironomidae, Musca domestica, Muscina stabulans, etc., Drosophila, Drosophila, Drosophila, Delaplata, Timaelae Ribae (Agromyza oryzae), rice Hime leafminer (Hydrellia griseola), tomato leafminer, (Liriomyza sativae), legume leafminer (Liriomyza trifolii), leafminer such as the pea (Chromatomyia horticola), chloropidae such as Inekimoguribae (Chlorops oryzae), melon fly (Dacus cucurbitae), fruit flies such as Ceratitis capitata, fruit flies such as Drosophila, flea flies, Megaseria spiracularis, Clogmial butterflies, etc. S, sciaridae acids, blackfly acids, Abu such as gadfly (Tabanus trigonus), keds acids and stable flies such.
鞘翅目:ウエスタンコーンルートワーム(Diabrotica virgifera virgifera)、サザンコーンルートワーム(Diabrotica undecimpunctata howardi)等のコーンルートワーム類、ドウガネブイブイ(Anomala cuprea)、ヒメコガネ(Anomala rufocuprea)、マメコガネ(Popillia japonica)等のコガネムシ類、メイズウィービル(Sitophilus zeamais)、イネミズゾウムシ(Lissorhoptrus oryzophilus)、アズキゾウムシ(Callosobruchuys chienensis)、イネゾウムシ(Echinocnemus squameus)、ワタミゾウムシ(Anthonomus grandis)、シバオサゾウムシ(Sphenophorus venatus)等のゾウムシ類、チャイロコメノゴミムシダマシ(Tenebrio molitor)、コクヌストモドキ(Tribolium castaneum)等のゴミムシダマシ類、
イネドロオイムシ(Oulema oryzae)、ウリハムシ(Aulacophora femoralis)、キスジノミハムシ(Phyllotreta striolata)、コロラドハムシ(Leptinotarsa decemlineata)等のハムシ類、ヒメマルカツオブシムシ(Anthrenus verbasci)、ハラジロカツオブシムシ(Dermestes maculates)等のカツオブシムシ類、タバコシバンムシ(Lasioderma serricorne)等のシバンムシ類、ニジュウヤホシテントウ(Epilachna vigintioctopunctata)等のエピラクナ類、ヒラタキクイムシ(Lyctus brunneus)、マツノキクイムシ(Tomicus piniperda)等のキクイムシ類、ナガシンクイムシ類、ヒョウホンムシ類、ゴマダラカミキリ(Anoplophora malasiaca)等のカミキリムシ類、コメツキムシ類(Agriotes spp.)、及びアオバアリガタハネカクシ(Paederus fuscipes)。
Coleoptera: Western corn rootworm (Diabrotica virgifera virgifera), corn root worms such as Southern corn rootworm (Diabrotica undecimpunctata howardi), cupreous chafer (Anomala cuprea), rufocuprea (Anomala rufocuprea), beetles such as Japanese beetle (Popillia japonica) , Maysweville (Sytophilus zeamais), Rice weevil (Lissohoptrus oryzophilus), Azuki beetle (Callosobrchuchus chiensis), Green weevil (Echinocnemus squatium) omus grandis), weevils such as grass reed weevil (Sphenophorus venatus), Chai Loco Meno mealworm (Tenebrio molitor), mealworm such as red flour beetle (Tribolium castaneum),
Inedorooimushi (Oulema oryzae), cucurbit leaf beetle (Aulacophora femoralis), Kisujinomihamushi (Phyllotreta striolata), beetles such as Colorado potato beetle (Leptinotarsa decemlineata), varied carpet beetle (Anthrenus verbasci), carpet beetle such as Hara Giro beetle (Dermestes maculates), cigarette beetle (Lasiderma serricorne) and the like, Epilachna vigintioctopuncta and other epilacunas, Lyctus brunneus and pine beetle (Pompicus) erda), bark beetles, leopard beetles, longhorn beetles (Anoprophora malasiaca), longhorn beetles (Agriotes spp.), and blue scallops (ed) p.
 直翅目:トノサマバッタ(Locusta migratoria)、ケラ(Gryllotalpa africana)、コバネイナゴ(Oxya yezoensis)、ハネナガイナゴ(Oxya japonica)、及びコオロギ類。 Species: Tosama grasshopper (Locusta migratoria), Kera (Gryllotalpa africana), Oxya yezoensis, Lobster (Oxya japonica), and crickets.
隠翅目:ネコノミ(Ctenocephalides felis),イヌノミ(Ctenocephalides canis),ヒトノミ(Pulex irritans),ケオプスネズミノミ(Xenopsylla cheopis)等。  Lepidoptera: Cat fleas (Ctenocephalides felis), dog fleas (Ctenocephalides canis), human fleas (Pulex irritans), keops mouse fleas (Xenopsilla cheopes) and the like. *
シラミ目:コロモジラミ(Pediculus humanus corporis),アタマジラミ(Pediculus humanus humanus)、ケジラミ (Phthirus pubis),ウシジラミ(Haematopinus eurysternus),ヒツジジラミ(Dalmalinia ovis),ブタジラミ(Haematopinus suis)、イヌジラミ(Linognathus setosus)等。  Anoplura: body louse (Pediculus humanus corporis), head lice (Pediculus humanus humanus), crab louse (Phthirus pubis), Ushijirami (Haematopinus eurysternus), Hitsujijirami (Dalmalinia ovis), Butajirami (Haematopinus suis), Inujirami (Linognathus setosus) and the like. *
ハジラミ目:ヒツジハジラミ(Dalmalinia ovis)、ウシハジラミ(Dalmalinia bovis)、ニワトリハジラミ(Menopon gallinae)、イヌハジラミ(Trichodectes canis)、ネコハジラミ(Felicola subrostrata)等 Lepidoptera: sheep lice (Dalmalinia ovis), cattle lice (Dalmalinia bovis), chicken lice (Menonpon gallinae), dog lice (Trichodictes canis), cat wolf squirr
 膜翅目: イエヒメアリ(Monomorium pharaosis)、クロヤマアリ(Formica fusca japonica)、ルリアリ(Ochetellus glaber)、アミメアリ(Pristomyrmex pungens)、オオズアリ(Pheidole noda)、ハキリアリ(Acromyrmex spp.)、ファイヤーアント(Solenopsis spp.)、アルゼンチンアリ(Linepithema humile)等のアリ類、スズメバチ類、アリガタバチ類、及びカブラハバチ(Athalia rosae)、ニホンカブラバチ(Athalia japonica)等のハバチ類。 Hymenoptera: Monomorium phalaosis, Formica fusca japonica, Ruriari (Ochetellus pungens), Psomylem puns, Pepperm sperm. Ants such as Argentine ants (Linepithema humile), wasps such as wasps, scallops, and wasps such as wasp (Athalia rosae) and Japanese bee (Athalia japonica).
 ゴキブリ目:チャバネゴキブリ(Blattella germanica)、クロゴキブリ(Periplaneta fuliginosa)、ワモンゴキブリ(Periplaneta americana)、トビイロゴキブリ(Periplaneta brunnea)、トウヨウゴキブリ(Blatta orientalis)。 Cockroaches: German cockroaches (Blatella germanica), Black cockroaches (Periplaneta fligninosa), Cockroach cockroaches (Periplaneta americana), Japanese cockroaches (Periplaneta brunat)
シロアリ目:ヤマトシロアリ(Reticulitermes speratus),イエシロアリ(Coptotermes formosanus),アメリカカンザイシロアリ(Incisitermes minor),ダイコクシロアリ(Cryptotermes domesticus),タイワンシロアリ(Odontotermes formosanus),コウシュンシロアリ(Neotermes koshunensis),サツマシロアリ(Glyptotermes satsumensis),ナカジマシロアリ(Glyptotermes nakajimai),カタンシロアリ(Glyptotermes fuscus),コダマシロアリ(Glyptotermes kodamai),クシモトシロアリ(Glyptotermes kushimensis),オオシロアリ(Hodotermopsis japonica),コウシュウイエシロアリ(Coptotermes guangzhoensis),アマミシロアリ(Reticulitermes miyatakei),キアシシロアリ(Reticulitermes flaviceps amamianus),カンモンシロアリ(Reticulitermes sp. ),タカサゴシロアリ(Nasutitermes takasagoensis),ニトベシロアリ(Pericapritermes nitobei),ムシャシロアリ(Sinocapritermes mushae)等。 Isoptera: Yamato termite (Reticulitermes speratus), Formosan subterranean termite (Coptotermes formosanus), the United States drywood termites (Incisitermes minor), Daikoku termites (Cryptotermes domesticus), Taiwan termites (Odontotermes formosanus), Kou Shun termite (Neotermes koshunensis), Satsuma termites (Glyptotermes satsumensis), termites termites (Glyptotermes nakajimai), termites termites (Glyptotermes fuscus), termites termites (Glyptotermes kodamai) Termites (Glyptotermes kushimensis), giant termite (Hodotermopsis japonica), Kou Shu Ye termite (Coptotermes guangzhoensis), Amami termites (Reticulitermes miyatakei), R. flavipes (Reticulitermes flaviceps amamianus), Kang Mont termites (Reticulitermes sp.), Takasago termite (Nasutitermes takasagoensis) , Nitrobe termites (Pericapritermes nitobei), Musha termites (Sinocapritermes mushae), and the like.
 ダニ目:ナミハダニ(Tetranychus urticae)、カンザワハダニ(Tetranychus kanzawai)、ミカンハダニ(Panonychus citri)リンゴハダニ(Panonychus ulmi)、オリゴニカス属等のハダニ類、ミカンサビダニ(Aculops pelekassi)、リュウキュウミカンサビダニ(Phyllocoptruta citri)、トマトサビダニ(Aculops lycopersici)、チャノサビダニ(Calacarus carinatus)、チャノナガサビダニ(Acaphylla theavagrans)、ニセナシサビダニ(Eriophyes chibaensis)、リンゴサビダニ(Aculus schlechtendali)等のフシダニ類、チャノホコリダニ(Polyphagotarsonemus latus)等のホコリダニ類、ミナミヒメハダニ(Brevipalpus phoenicis)等のヒメハダニ類、ケナガハダニ類、フタトゲチマダニ(Haemaphysalis longicornis)、ヤマトチマダニ(Haemaphysalis flava)、タイワンカクマダニ(Dermacentor taiwanicus)、アメリカンイヌカクマダニ(Dermacentor variabilis)、ヤマトマダニ(Ixodes ovatus)、シュルツマダニ(Ixodes persulcatus)、ブラックレッグドチック(Ixodes scapularis)、アメリカキララマダニ(Amblyomma americanum)、オウシマダニ(Boophilus microplus)、クリイロコイタマダニ(Rhipicephalus sanguineus)等のマダニ類、ケナガコナダニ(Tyrophagus putrescentiae)、ホウレンソウケナガコナダニ(Tyrophagus similis)等のコナダニ類、コナヒョウヒダニ(Dermatophagoides farinae)、ヤケヒョウヒダニ(Dermatophagoides ptrenyssnus)等のヒョウヒダニ類、ホソツメダニ(Cheyletus eruditus)、クワガタツメダニ(Cheyletus malaccensis)、ミナミツメダニ(Cheyletus moorei)、イヌツメダニ(Cheyletiella yasguri)等のツメダニ類、ミミヒゼンダニ(Octodectes cynotis)、ヒゼンダニ(Sacroptes scabiei)等のヒゼンダニ類,イヌニキビダニ(Demodex canis)等のニキビダニ類,ズツキダニ類、ササラダニ類、イエダニ(Ornithonyssus bacoti)、トリサシダニ(Ornithonyssus sylvairum)、ワクモ(Dermanyssus gallinae)等のワクモ類、アオツツガムシ(Leptotrombidium akamushi)等のツツガムシ類。
クモ目:カバキコマチグモ(Chiracanthium japonicum)、セアカゴケグモ(Latrodectus hasseltii)等のクモ類。
唇脚綱類:ゲジ(Thereuonema hilgendorfi),トビズムカデ(Scolopendra subspinipes)等。
倍脚綱類:ヤケヤスデ(Oxidus gracilis),アカヤスデ(Nedyopus tambanus)等。 
等脚目類:オカダンゴムシ(Armadillidium vulgare)等。
腹足綱類:チャコウラナメクジ(Limax marginatus),キイロコウラナメクジ(Limax flavus)等。
Mite order: Tetanychus urticae, Tetanychus kanzawai, utani mite (Ponyychus urmi), mite mite (p) Rabbit mites (Aculops lycopersici), Rabbit mites (Calacarus carinatus), Rabbit mites (Acaphylla theavagrans), Scarlet mite (Eriophys chibaensis), Apple crustaceans (Aulus dachi) Dust mites, such as mites, Polyphagotarsonemus latus, Scots mites, Bremen spider mites, Hemiphysalis mites, Haemphysalis mite, Haemphysalis longis Dermacentor variabilis, Ixodes ovatus, Ixes persulcatus, Black legged tick (Ixodes scapularis), American larva tick (Amblyomama amer) canum), Boophilus microplus (Boophilus microplus), ticks such as Rhipicephalus sanguineus (Rhipicephalus sanguineus), Tyrophagus (Tyrophagus putrescentiae), grain mites such as Tyrophagus (Tyrophagus similis), farinae (Dermatophagoides farinae), D. pteronyssinus (Dermatophagoides ptrenyssnus) Leopard mites, such as Cheyletus eruditus, Stag beetle tick (Cheyletus malaccensis), Scarlet tick (Cheyletus mooreii), Tiger tickle (Cheeletiell) mite mites such as a yasguri, mite mites (Octoectes cynotis), mites mites such as Sacroptes scabiei, mite mites such as Demodex canis, mite mites, b Species such as Ornithonysus sylvairum and Dermanyssus gallinae, and Tsutsugamushi such as Leptotrombidium akamushi.
Spider: Spiders such as Chiracanthium japonicum and Latrodictus hasseltii
Lip and limb class: Geeu (Thereunema hilgendorfi), Tobizukade (Scorpendra subspinipes) and the like.
Double leg class: Oxidus gracilis, Nedyopus tambanus, etc.
Isopods: Armadillium vulgare, etc.
Gastropoda: Limax marginatus, Limax flavus, etc.
 線虫類:イネシンガレセンチュウ(Aphelenchoides besseyi)、イチゴメセンチュウ(Nothotylenchus acris)、サツマイモネコブセンチュウ(Meloidogyne incognita)、キタネコブセンチュウ(Meloidogyne hapla)、ジャワネコブセンチュウ(Meloidogyne javanica)、ダイズシストセンチュウ(Heterodera glycines)、ジャガイモシストセンチュウ(Globodera rostochiensis)、ミナミネグサレセンチュウ(Pratylenchus coffeae)、ムギネグサレセンチュウ(Pratylenchus neglectus)。 Nematodes: rice Shin Galle nematode (Aphelenchoides besseyi), strawberry menu nematode (Nothotylenchus acris), sweet potato root-knot nematode (Meloidogyne incognita), northern root-knot nematode (Meloidogyne hapla), Java root-knot nematode (Meloidogyne javanica), soybean cyst nematode (Heterodera glycines), Potato cyst nematode (Globodera rostochiensis), southern nematode crested pea (Pratylenchus coffeae), barley nematode nematode (Pratylenchus neglectus).
 有害生物は、既存の殺虫剤に対する薬剤感受性が低下した、即ち薬剤抵抗性を獲得した有害生物を含む。 Pests include pests that have reduced drug sensitivity to existing pesticides, that is, have acquired drug resistance.
 本発明の有害生物防除剤は、本発明化合物と不活性担体とを含有する。本発明の有害生物防除剤は、通常、本発明化合物と固体担体、液体担体、ガス状担体等の不活性担体とを混合し、必要に応じて界面活性剤、その他の製剤用補助剤を添加して、乳剤、油剤、粉剤、ドライフロアブル剤、微粒剤、粒剤、水和剤、水溶剤、フロアブル剤、マイクロカプセル剤、エアゾール剤、燻煙剤、毒餌剤、樹脂製剤、シャンプー剤、ペースト状製剤、泡沫剤、炭酸ガス製剤、錠剤等に製剤化されて使用される。これらの製剤は蚊取り線香、電気蚊取りマット、液体蚊取り製剤、燻煙剤、燻蒸剤、シート製剤、スポットオン剤、経口処理剤に加工されて、使用されることもある。
 本発明の有害生物防除剤は、本発明化合物を通常0.01~95重量%含有する。
The pest control agent of the present invention contains the compound of the present invention and an inert carrier. The pest control agent of the present invention is usually a mixture of the compound of the present invention and an inert carrier such as a solid carrier, liquid carrier, gaseous carrier, etc. Emulsions, oils, powders, dry flowables, fine granules, granules, wettable powders, aqueous solvents, flowables, microcapsules, aerosols, smokers, poison baits, resin preparations, shampoos, pastes It is formulated into a pharmaceutical preparation, foam preparation, carbon dioxide preparation, tablet and the like. These preparations may be used after being processed into mosquito coils, electric mosquito mats, liquid mosquito traps, fumigants, fumigants, sheet preparations, spot-on agents, or oral treatments.
The pest control agent of the present invention usually contains 0.01 to 95% by weight of the compound of the present invention.
 製剤化の際に用いられる固体担体としては、例えば粘土類(カオリンクレー、珪藻土、ベントナイト、フバサミクレー、酸性白土等)、合成含水酸化珪素、タルク、セラミック、その他の無機鉱物(セリサイト、石英、硫黄、活性炭、炭酸カルシウム、水和シリカ等)、化学肥料(硫安、燐安、硝安、尿素、塩安等)等の微粉末及び粒状物等、並びに合成樹脂(ポリプロピレン、ポリアクリロニトリル、ポリメタクリル酸メチル、ポリエチレンテレフタレート等のポリエステル樹脂、ナイロン-6、ナイロン-11、ナイロン-66等のナイロン樹脂、ポリアミド樹脂、ポリ塩化ビニル、ポリ塩化ビニリデン、塩化ビニル-プロピレン共重合体等)があげられる。 Examples of solid carriers used for formulation include clays (kaolin clay, diatomaceous earth, bentonite, fusami clay, acidic clay), synthetic hydrous silicon oxide, talc, ceramics, and other inorganic minerals (sericite, quartz, sulfur). , Activated carbon, calcium carbonate, hydrated silica, etc.), fine powders and granules of chemical fertilizers (ammonium sulfate, phosphorous acid, ammonium nitrate, urea, ammonium chloride, etc.), and synthetic resins (polypropylene, polyacrylonitrile, polymethyl methacrylate) Polyester resins such as polyethylene terephthalate, nylon resins such as nylon-6, nylon-11, and nylon-66, polyamide resins, polyvinyl chloride, polyvinylidene chloride, and vinyl chloride-propylene copolymers).
 液体担体としては、例えば水、アルコール類(メタノール、エタノール、イソプロピルアルコール、ブタノール、ヘキサノール、ベンジルアルコール、エチレングリコール、プロピレングリコール、フェノキシエタノール等)、ケトン類(アセトン、メチルエチルケトン、シクロヘキサノン等)、芳香族炭化水素類(トルエン、キシレン、エチルベンゼン、ドデシルベンゼン、フェニルキシリルエタン、メチルナフタレン等)、脂肪族炭化水素類(ヘキサン、シクロヘキサン、灯油、軽油等)、エステル類(酢酸エチル、酢酸ブチル、ミリスチン酸イソプロピル、オレイン酸エチル、アジピン酸ジイソプロピル、アジピン酸ジイソブチル、プロピレングリコールモノメチルエーテルアセテート等)、ニトリル類(アセトニトリル、イソブチロニトリル等)、エーテル類(ジイソプロピルエーテル、1,4-ジオキサン、エチレングリコールジメチルエーテル、ジエチレングリコールジメチルエーテル、ジエチレングリコールモノメチルエーテル、プロピレングリコールモノメチルエーテル、ジプロピレングリコールモノメチルエーテル、3-メトキシ-3-メチル-1-ブタノール等)、酸アミド類(N,N-ジメチルホルムアミド、N,N-ジメチルアセトアミド等)、ハロゲン化炭化水素類(ジクロロメタン、トリクロロエタン、四塩化炭素等)、スルホキシド類(ジメチルスルホキシド等)、炭酸プロピレン及び植物油(大豆油、綿実油等)が挙げられる。 Examples of the liquid carrier include water, alcohols (methanol, ethanol, isopropyl alcohol, butanol, hexanol, benzyl alcohol, ethylene glycol, propylene glycol, phenoxyethanol, etc.), ketones (acetone, methyl ethyl ketone, cyclohexanone, etc.), aromatic hydrocarbons (Toluene, xylene, ethylbenzene, dodecylbenzene, phenylxylylethane, methylnaphthalene, etc.), aliphatic hydrocarbons (hexane, cyclohexane, kerosene, light oil, etc.), esters (ethyl acetate, butyl acetate, isopropyl myristate, Ethyl oleate, diisopropyl adipate, diisobutyl adipate, propylene glycol monomethyl ether acetate, etc.), nitriles (acetonitrile, isobutyrate) Nitriles), ethers (diisopropyl ether, 1,4-dioxane, ethylene glycol dimethyl ether, diethylene glycol dimethyl ether, diethylene glycol monomethyl ether, propylene glycol monomethyl ether, dipropylene glycol monomethyl ether, 3-methoxy-3-methyl-1-butanol, etc. ), Acid amides (N, N-dimethylformamide, N, N-dimethylacetamide, etc.), halogenated hydrocarbons (dichloromethane, trichloroethane, carbon tetrachloride, etc.), sulfoxides (dimethylsulfoxide, etc.), propylene carbonate and vegetable oil (Soybean oil, cottonseed oil, etc.).
 ガス状担体としては、例えばフルオロカーボン、ブタンガス、LPG(液化石油ガス)、ジメチルエーテル及び炭酸ガスがあげられる。 Examples of the gaseous carrier include fluorocarbon, butane gas, LPG (liquefied petroleum gas), dimethyl ether, and carbon dioxide gas.
 界面活性剤としては、例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレンアルキルアリールエーテル、ポリエチレングリコール脂肪酸エステル等の非イオン界面活性剤、及びアルキルスルホン酸塩、アルキルベンゼンスルホン酸塩、アルキル硫酸塩等の陰イオン界面活性剤が挙げられる。 Examples of the surfactant include nonionic surfactants such as polyoxyethylene alkyl ether, polyoxyethylene alkyl aryl ether, and polyethylene glycol fatty acid ester, and anions such as alkyl sulfonate, alkyl benzene sulfonate, and alkyl sulfate. Surfactant is mentioned.
 その他の製剤用補助剤としては、固着剤、分散剤、着色剤、不凍剤及び安定剤等、具体的には例えばカゼイン、ゼラチン、糖類(でんぷん、アラビアガム、セルロース誘導体、アルギン酸等)、リグニン誘導体、ベントナイト、合成水溶性高分子(ポリビニルアルコール、ポリビニルピロリドン、ポリアクリル酸類等)、グリセリン、PAP(酸性りん酸イソプロピル)、BHT(2,6-ジ-tert-ブチル-4-メチルフェノール)、BHA(2-tert-ブチル-4-メトキシフェノールと3-tert-ブチル-4-メトキシフェノールとの混合物)が挙げられる。 Other formulation adjuvants include sticking agents, dispersants, colorants, antifreezes and stabilizers, such as casein, gelatin, sugars (starch, gum arabic, cellulose derivatives, alginic acid, etc.), lignin Derivatives, bentonite, synthetic water-soluble polymers (polyvinyl alcohol, polyvinyl pyrrolidone, polyacrylic acids, etc.), glycerin, PAP (isopropyl acid phosphate), BHT (2,6-di-tert-butyl-4-methylphenol), BHA (mixture of 2-tert-butyl-4-methoxyphenol and 3-tert-butyl-4-methoxyphenol).
 樹脂製剤の基材としては、例えば塩化ビニル系重合体、ポリウレタン等を挙げることができ、これらの基材には必要によりフタル酸エステル類(フタル酸ジメチル、フタル酸ジオクチル等)、アジピン酸エステル類、ステアリン酸等の可塑剤が添加されていてもよい。樹脂製剤は該基材中に化合物を通常の混練装置を用いて混練した後、射出成型、押出成型、プレス成型等により成型することにより得られ、必要により更に成型、裁断等の工程を経て、板状、フィルム状、テープ状、網状、ひも状等の樹脂製剤に加工できる。これらの樹脂製剤は、例えば動物用首輪、動物用イヤータッグ、シート製剤、誘引ひも、園芸用支柱として加工される。
 毒餌の基材としては、例えば穀物粉、植物油、糖、結晶セルロース等が挙げられ、更に必要に応じて、ジブチルヒドロキシトルエン、ノルジヒドログアイアレチン酸等の酸化防止剤、デヒドロ酢酸等の保存料、トウガラシ末等の子供やペットによる誤食防止剤、チーズ香料、タマネギ香料ピーナッツオイル等の害虫誘引性香料等が添加される。
Examples of the base material of the resin preparation include vinyl chloride polymers, polyurethanes, etc., and these base materials include phthalic acid esters (dimethyl phthalate, dioctyl phthalate, etc.) and adipic acid esters as necessary. Further, a plasticizer such as stearic acid may be added. The resin formulation is obtained by kneading the compound in the base material using a normal kneading apparatus, and then molding by injection molding, extrusion molding, press molding, etc., and if necessary, through steps such as molding, cutting, It can be processed into resin preparations such as plate, film, tape, net, and string. These resin preparations are processed, for example, as animal collars, animal ear tags, sheet preparations, attracting strings, or gardening supports.
Examples of the bait base include cereal flour, vegetable oil, sugar, crystalline cellulose and the like, and if necessary, antioxidants such as dibutylhydroxytoluene and nordihydroguaiaretic acid, and preservatives such as dehydroacetic acid. Additives for preventing accidental eating by children and pets such as pepper powder, pests such as cheese flavor, onion flavor and peanut oil are added.
 本発明の有害生物防除方法は、本発明化合物の有効量を有害生物に直接、及び/又は、有害生物の生息場所(植物、土壌、家屋内、動物体等)に施用することにより行われる。本発明の有害生物防除方法には、通常、本発明の有害生物防除剤の形態で用いられる。また、本発明化合物が硫酸、メタンスルホン酸、p-トルエンスルホン酸等の強酸と形成する塩も、有害生物に対して優れた防除活性を有する。 The pest control method of the present invention is carried out by applying an effective amount of the compound of the present invention to pests directly and / or to pest habitats (plants, soil, households, animal bodies, etc.). The pest control method of the present invention is usually used in the form of the pest control agent of the present invention. In addition, salts formed by the compounds of the present invention with strong acids such as sulfuric acid, methanesulfonic acid and p-toluenesulfonic acid also have excellent control activity against pests.
 本発明の有害生物防除剤を農業分野の有害生物防除に用いる場合、その施用量は、10,000mあたりの本発明化合物量で通常1~10,000gである。本発明の有害生物防除剤が乳剤、水和剤、フロアブル剤等に製剤化されている場合は、通常、有効成分濃度が0.01~10,000ppmとなるように水で希釈して施用し、粒剤、粉剤等は、通常、そのまま施用する。 When the pest control agent of the present invention is used for pest control in the agricultural field, the application amount is usually 1 to 10,000 g as the amount of the compound of the present invention per 10,000 m 2 . When the pest control agent of the present invention is formulated into an emulsion, a wettable powder, a flowable agent, etc., it is usually diluted with water so that the active ingredient concentration is 0.01 to 10,000 ppm. Granules, powders and the like are usually applied as they are.
 これらの製剤や製剤の水希釈液は、有害生物又は有害生物から保護すべき植物等の植物に直接散布してもよく、また耕作地の土壌に生息する有害生物を防除するために、該土壌に施用してもよい。土壌に施用する場合は、該土壌は該植物を栽培している土壌であっても、該植物を栽培する予定の土壌であってもよい。 These preparations and water dilutions of the preparations may be applied directly to pests or plants such as plants to be protected from pests, and in order to control pests that inhabit cultivated soil. You may apply to. When applied to soil, the soil may be the soil where the plant is cultivated or the soil where the plant is to be cultivated.
 シート状やひも状に加工した樹脂製剤は、作物に巻き付ける、作物近傍に張り渡す、株元土壌に敷く等の方法により使用することもできる。
 本発明の有害生物防除剤を使用する場所としては、水田、畑地、茶園、果樹園、非農耕地が挙げられる。また、本発明の有害生物防除剤を、育苗トレイ、育苗箱、育苗培土、育苗マット、及び、水耕農場における水耕液等において使用することもできる。水田および畑地における植物の栽培方法は、耕起栽培であっても、不耕起栽培であってもよい。
The resin preparation processed into a sheet or string can also be used by a method such as wrapping around a crop, stretching it in the vicinity of the crop, or laying it on the stock soil.
Examples of the place where the pest control agent of the present invention is used include paddy field, upland field, tea garden, orchard, and non-agricultural land. The pest control agent of the present invention can also be used in a seedling tray, a seedling box, a seedling culture soil, a seedling mat, and a hydroponic solution in a hydroponic farm. The cultivation method of plants in paddy fields and upland fields may be plowing cultivation or non-plowing cultivation.
 本発明の有害生物防除剤を家屋内に生息する有害生物の防除に用いる場合、その施用量は、面上に施用する場合は、面積1mあたりの本発明化合物量で、通常、0.01~1.000mgであり、空間に施用する場合は、空間1mあたりの本発明化合物量で、通常、0.01~500mgである。本発明の有害生物防除剤が乳剤、水和剤、フロアブル剤等に製剤化されている場合は、通常有効成分濃度が0.1~10,000ppmとなるように水で希釈して施用し、油剤、エアゾール剤、燻煙剤、毒餌剤等はそのまま施用する。 When the pest control agent of the present invention is used for controlling pests living in the house, the amount applied is the amount of the compound of the present invention per area of 1 m 2 when applied on the surface, usually 0.01. The amount of the compound of the present invention per 1 m 3 of space is usually 0.01 to 500 mg when applied to a space. When the pest control agent of the present invention is formulated into an emulsion, a wettable powder, a flowable agent, etc., it is usually diluted with water so that the active ingredient concentration is 0.1 to 10,000 ppm. Apply oils, aerosols, smoke, poison baits, etc. as they are.
 本発明の有害節足動物防除剤をウシ、ウマ、ブタ、ヒツジ、ヤギ、ニワトリ用の家畜、イヌ、ネコ、ラット、マウス等の小動物の外部寄生虫防除に用いる場合は、獣医学的に公知の方法で動物に使用することができる。具体的な使用方法としては、全身抑制を目的にする場合には、例えば錠剤、飼料混入、坐薬、注射(筋肉内、皮下、静脈内、腹腔内等)により投与され、非全身的抑制を目的とする場合には、例えば油剤若しくは水性液剤を噴霧する、ポアオン処理若しくはスポットオン処理を行う、シャンプー製剤で動物を洗う又は樹脂製剤を首輪や耳札にして動物に付ける等の方法により用いられる。動物体に投与する場合の本発明化合物の量は、通常動物の体重1kgに対して、0.1~1,000mgの範囲である。 When the harmful arthropod control agent of the present invention is used to control ectoparasites of cattle, horses, pigs, sheep, goats, chickens, small animals such as dogs, cats, rats, mice, etc., it is well known in veterinary medicine. Can be used on animals. As a specific method of use, for the purpose of systemic suppression, for example, administration by tablet, feed mixing, suppository, injection (intramuscular, subcutaneous, intravenous, intraperitoneal, etc.) is intended for non-systemic suppression. In this case, for example, an oil agent or an aqueous liquid is sprayed, a pour-on treatment or a spot-on treatment is performed, the animal is washed with a shampoo preparation, or a resin preparation is attached to the animal with a collar or ear tag. When administered to an animal body, the amount of the compound of the present invention is usually in the range of 0.1 to 1,000 mg per 1 kg body weight of the animal.
 本発明の有害生物防除剤は、下記に挙げる植物(以下、本植物と記す。)が栽培されている農地で使用することができる。
 穀類:トウモロコシ、イネ、コムギ、オオムギ、ライムギ、ライコムギ、エンバク、ソルガム、ワタ、ダイズ、ピーナッツ、ラッカセイ、サイトウ(インゲンマメ)、ライマメ、アズキ、ササゲ、リョクトウ、ウラドマメ、ベニバナインゲン、タケアズキ、モスビーン、テパリービーン、ソラマメ、エンドウ、ヒヨコマメ、レンズマメ、ルーピン、キマメ、ソバ、テンサイ、ナタネ、ヒマワリ、サトウキビ、タバコ等。
 野菜;ナス科野菜(ナス、トマト、ピーマン、トウガラシ、ベルペッパー、ジャガイモ等)、ウリ科野菜(キュウリ、カボチャ、ズッキーニ、スイカ、メロン等)、アブラナ科野菜(ダイコン、カブ、セイヨウワサビ、コールラビ、ハクサイ、キャベツ、カラシナ、ブロッコリー、カリフラワー等)、キク科野菜(ゴボウ、シュンギク、アーティチョーク、レタス等)、ユリ科野菜(ネギ、タマネギ、ニンニク、アスパラガス等)、セリ科野菜(ニンジン、パセリ、セロリ、アメリカボウフウ等)、アカザ科野菜(ホウレンソウ、フダンソウ等)、シソ科野菜(シソ、ミント、バジル、ラベンダー等)、イチゴ、サツマイモ、ヤマノイモ、サトイモ等。
 果樹:仁果類(リンゴ、セイヨウナシ、ニホンナシ、カリン、マルメロ等)、核果類(モモ、スモモ、ネクタリン、ウメ、オウトウ、アンズ、プルーン等)、カンキツ類(ウンシュウミカン、オレンジ、レモン、ライム、グレープフルーツ等)、堅果類(クリ、クルミ、ハシバミ、アーモンド、ピスタチオ、カシューナッツ、マカダミアナッツ等)、液果類(ブルーベリー、クランベリー、ブラックベリー、ラズベリー等)、ブドウ、カキ、オリーブ、ビワ、バナナ、コーヒー、ナツメヤシ、ココヤシ、アブラヤシ等。
 果樹以外の樹木:チャ、クワ、花木類(サツキ、ツバキ、アジサイ、サザンカ、シキミ、サクラ、ユリノキ、サルスベリ、キンモクセイ等)、街路樹(トネリコ、カバノキ、ハナミズキ、ユーカリ、イチョウ、ライラック、カエデ、カシ、ポプラ、ハナズオウ、フウ、プラタナス、ケヤキ、クロベ、モミノキ、ツガ、ネズ、マツ、トウヒ、イチイ、ニレ、トチノキ等)、サンゴジュ、イヌマキ、スギ、ヒノキ、クロトン、マサキ、カナメモチ、等。
 芝生:シバ類(ノシバ、コウライシバ等)、バミューダグラス類(ギョウギシバ等)、ベントグラス類(コヌカグサ、ハイコヌカグサ、イトコヌカグサ等)、ブルーグラス類(ナガハグサ、オオスズメノカタビラ等)、フェスク類(オニウシノケグサ、イトウシノケグサ、ハイウシノケグサ等)、ライグラス類(ネズミムギ、 ホソムギ等)、カモガヤ、オオアワガエリ等。
 飼料作物:アルファルファ等。
 その他:花卉類(バラ、カーネーション、キク、トルコギキョウ、カスミソウ、ガーベラ、マリーゴールド、サルビア、ペチュニア、バーベナ、チューリップ、アスター、リンドウ、ユリ、パンジー、シクラメン、ラン、スズラン、ラベンダー、ストック、ハボタン、プリムラ、ポインセチア、グラジオラス、カトレア、デージー、シンビジューム、ベゴニア等)、バイオ燃料植物(ヤトロファ、クルカス、ベニバナ、アマナズナ類、スイッチグラス、ミスカンサス、クサヨシ、ダンチク、ケナフ、キャッサバ、ヤナギ、藻類等)、観葉植物等。
The pest control agent of the present invention can be used in farmland where the following plants (hereinafter referred to as the present plant) are cultivated.
Cereals: corn, rice, wheat, barley, rye, triticale, oats, sorghum, cotton, soybeans, peanuts, peanuts, cypress (green beans), lentils, azuki beans, cowpeas, mung bean, safflower beans, red bean, moss beans, tepareen, Broad bean, pea, chickpea, lentil, lupine, pigeon bean, buckwheat, sugar beet, rapeseed, sunflower, sugar cane, tobacco, etc.
Vegetables: Eggplant vegetables (eggplants, tomatoes, peppers, peppers, bell peppers, potatoes, etc.), cucurbits vegetables (cucumbers, pumpkins, zucchini, watermelons, melons, etc.), cruciferous vegetables (radish, turnip, horseradish, kohlrabi, Chinese cabbage, cabbage, mustard, broccoli, cauliflower, etc.), Asteraceae vegetables (burdock, garlic, artichoke, lettuce, etc.), liliaceae vegetables (eg, leek, onion, garlic, asparagus), celery family vegetables (carrot, parsley, celery) , American Bow Fu, etc.), Rubiaceae vegetables (spinach, chard, etc.), Lamiaceae vegetables (perilla, mint, basil, lavender, etc.), strawberry, sweet potato, yam, taro, etc.
Fruit trees: berries (apples, pears, Japanese pears, quince, quince, etc.), nuclear fruits (peaches, plums, nectarines, ume, sweet cherry, apricots, prunes, etc.), citrus (satsuma mandarin, orange, lemon, lime, grapefruit) ), Nuts (chestnut, walnut, hazel, almond, pistachio, cashew nut, macadamia nut, etc.), berries (blueberry, cranberry, blackberry, raspberry, etc.), grape, oyster, olive, loquat, banana, coffee, Date palm, coconut palm, oil palm etc.
Trees other than fruit trees: tea, mulberry, flowering trees (Satsuki, camellia, hydrangea, sasanqua, shikimi, sakura, yurinoki, crape myrtle, eustoma, etc.), roadside trees (ash, birch, dogwood, eucalyptus, ginkgo, lilac, maple, oak) , Poplar, redwood, fu, sycamore, zelkova, blackfish, Japanese amberjack, moths, pine, pine, spruce, yew, elm, Japanese cypress, etc.), coral jug, dogwood, cedar, cypress, croton, masaki, kanamochi, etc.
Lawn: Shiba (Nasis, Pleurotus, etc.), Bermudagrass (Neurodonidae, etc.), Bentgrass (Oleoptera, Hykonukagusa, Odonoptera, etc.), Bluegrass (Nagahagusa, Oosuzunokatabira, etc.), Fescue (Oonishi nokegusa, Drosophila, etc.) , Grass, etc.), ryegrass (rat, wheat, etc.), anemonefish, and blue whale.
Forage crops: alfalfa, etc.
Other: Flowers (Rose, Carnation, Chrysanthemum, Eustoma, Gypsophila, Gerbera, Marigold, Salvia, Petunia, Verbena, Tulip, Aster, Gentian, Lily, Pansy, Cyclamen, Orchid, Lily of the valley, Lavender, Stock, Habutton, Primula, Poinsettia, gladiolus, cattleya, daisy, symbidium, begonia, etc.), biofuel plants (Jatropha, Curcas, safflower, Amanazuna, switchgrass, Miscanthus, Kusanoshi, Danchiku, Kenaf, cassava, willow, algae, etc.), ornamental plants, etc. .
 本植物には、ハイブリッド技術により育種された植物も含まれる。
 また、本植物には、遺伝子組換え技術により作成された遺伝子組換え植物も含まれる。
 本植物には、遺伝子組換え技術、または、古典的な育種法により、除草剤に対する耐性が付与された植物も含まれる。
 本植物には、更に遺伝子組換え技術により、有害生物に対する選択的毒素を産生する能力が付与された植物も含まれる。
 本植物には、遺伝子組換え技術により、抗病原性物質を産生する能力が付与された植物も含まれる。
 本植物には、油糧成分改質やアミノ酸含量増強形質などの有用形質を付与された植物も含まれる。
The plant includes plants bred by hybrid technology.
In addition, the present plant includes a genetically modified plant prepared by a genetic recombination technique.
This plant also includes plants to which resistance to herbicides is imparted by genetic recombination techniques or classical breeding methods.
The plant further includes a plant imparted with an ability to produce a selective toxin against pests by a genetic recombination technique.
This plant includes a plant imparted with an ability to produce an anti-pathogenic substance by genetic recombination technology.
This plant includes plants to which useful traits such as oil component modification and amino acid content enhancing traits have been imparted.
 本発明の有害生物防除剤を、有害生物による摂食等の被害から保護しようとする本植物に施用する方法としては、具体的には、茎葉散布等の植物の茎葉、花器又は穂への施用;植物の種子又は栄養繁殖器官(例えば、種芋、球根、塊茎、鱗茎、茎断片等)への施用;植物の苗(挿し木を含む)への施用が挙げられる。 As a method of applying the pest control agent of the present invention to this plant to be protected from damage such as feeding by pests, specifically, application to the foliage, flower vases or ears of plants such as foliage spraying Application to seeds of plants or vegetative propagation organs (for example, seed buds, bulbs, tubers, bulbs, stem fragments, etc.); application to plant seedlings (including cuttings).
 本発明の有害生物防除剤を植物の茎葉、花器又は穂へ施用する方法としては、例えば、茎葉散布、樹幹散布等の植物の表面に施用する施用方法が挙げられ、また、開花前、開花中、開花後を含む開花時期における花器あるいは植物全体に散布する方法が挙げられ、また、植物が穀類である場合は出穂時期の穂あるいは植物全体に散布する方法が挙げられる。
 本発明の有害生物防除剤を植物の種子又は栄養繁殖器官に施用する方法としては、例えば、種子又は栄養繁殖器官に粉衣、塗沫または塗布する方法、液状の製剤に種子又は栄養繁殖器官を浸漬させる方法、及び、種子又は栄養繁殖器官をコートする方法(例えば、フィルムコート法、ペレットコート法等)が挙げられる。該方法において、本発明化合物の量は植物の種子又は栄養繁殖器官100kgあたり通常0.2~5,000g、好ましくは0.5~1,000gの範囲で施用される。好ましい剤型は乳剤、水和剤、フロアブル剤、マイクロカプセル剤等の水性の液体懸濁製剤である。該方法が適用される植物としては、本植物の中でも、特にダイズ、トウモロコシ、ワタ、コムギ、オオムギ、ライムギ、ライコムギ、エンバク、イネ、ソルガム、ラッカセイ、ダイズ及びラッカセイを除くマメ類、テンサイ、ナタネ、ヒマワリ、バレイショ、サトウキビ及び野菜類に好ましく適用される。サトウキビに適用する場合、サトウキビの栽培において、サトウキビの茎断片を使用してもよい。
Examples of the method for applying the pest control agent of the present invention to the foliage, flower vases or ears of plants include application methods applied to the surface of plants such as foliage spray, trunk spray, etc., and before flowering, during flowering A method of spraying on the vase or the whole plant at the flowering time including after flowering is mentioned, and a method of spraying on the ear of the heading time or the whole plant when the plant is cereal.
Examples of the method for applying the pest control agent of the present invention to plant seeds or vegetative propagation organs include, for example, a method of coating, smearing or applying to seeds or vegetative propagation organs, and seeds or vegetative propagation organs in liquid formulations. Examples thereof include a dipping method and a method of coating seeds or vegetative propagation organs (for example, a film coating method, a pellet coating method, etc.). In the method, the amount of the compound of the present invention is usually applied in the range of 0.2 to 5,000 g, preferably 0.5 to 1,000 g per 100 kg of plant seeds or vegetative propagation organs. Preferred dosage forms are aqueous liquid suspension preparations such as emulsions, wettable powders, flowables, and microcapsules. Plants to which the method is applied include, among these plants, soybeans, corn, cotton, wheat, barley, rye, triticale, oats, rice, sorghum, peanuts, peanuts except soybeans and peanuts, sugar beet, rapeseed, It is preferably applied to sunflower, potato, sugar cane and vegetables. When applied to sugarcane, sugarcane stalk fragments may be used in sugarcane cultivation.
 本発明の有害生物防除剤は、公知な殺虫剤、殺ダニ剤、殺線虫剤、殺菌剤、植物成長調節剤及び共力剤と混用又は併用することができる。また、本発明の有害生物防除剤は、公知な除草剤と併用することができる。かかる殺虫剤、殺ダニ剤、殺線虫剤、殺菌剤、除草剤及び共力剤の有効成分の例を以下に示す。 The pest control agent of the present invention can be mixed or used in combination with known insecticides, acaricides, nematicides, fungicides, plant growth regulators and synergists. The pest control agent of the present invention can be used in combination with known herbicides. Examples of active ingredients of such insecticides, acaricides, nematicides, fungicides, herbicides and synergists are shown below.
 殺虫剤の有効成分
(1)有機リン化合物
 アセフェート(acephate)、りん化アルミニウム(Aluminium phosphide)、ブタチオホス(butathiofos)、キャドサホス(cadusafos)、クロルエトキシホス(chlorethoxyfos)、クロルフェンビンホス(ch1orfenvinphos)、クロルピリホス(chlorpyrifos)、クロルピリホスメチル(chlorpyrifos-methyl)、シアノホス(cyanophos:CYAP)、ダイアジノン(diazinon)、DCIP(dichlorodiisopropyl ether)、ジクロフェンチオン(dichlofenthion:ECP)、ジクロルボス(dichlorvos:DDVP)、ジメトエート(dimethoate)、ジメチルビンホス(dimethylvinphos)、ジスルホトン(disulfoton)、EPN、エチオン(ethion)、エトプロホス(ethoprophos)、エトリムホス(etrimfos)、フェンチオン(fenthion:MPP)、フエニトロチオン(fenitrothion:MEP)、ホスチアゼート(fosthiazate)、ホルモチオン(formothion)、りん化水素(Hydrogen phosphide)、イソフェンホス(isofenphos)、イソキサチオン(isoxathion)、マラチオン(malathion)、メスルフェンホス(mesulfenfos)、メチダチオン(methidathion:DMTP)、モノクロトホス(monocrotophos)、ナレッド(naled:BRP)、オキシデプロホス(oxydeprofos:ESP)、パラチオン(parathion)、ホサロン(phosalone)、ホスメット(phosmet:PMP)、ピリミホスメチル(pirimiphos-methy1)、ピリダフェンチオン(pyridafenthion)、キナルホス(quinalphos)、フェントエート(phenthoate)、プロフェノホス(profenofos)、プロパホス(propaphos)、プロチオホス(prothiofos)、ピラクロホス(pyraclorfos)、サリチオン(salithion)、スルプロホス(sulprofos)、テブピリムホス(tebupirimfos)、テメホス(temephos)、テトラクロルビンホス(tetrach1orvinphos)、テルブホス(terbufos)、チオメトン(thiometon)、トリクロルホン(trichlorphon:DEP)、バミドチオン(vamidothion)、フォレート(phorate)、及びカズサホス(cadusafos)。
(2)カーバメート化合物
 アラニカルブ(alanycarb)、ベンダイオカルブ(bendiocarb)、ベンフラカルブ(benfuracarb)、BPMC、カルバリル(carbary1)、カルボフラン(carbofuran)、カルボスルファン(carbosulfan)、クロエトカルブ(cloethocarb)、エチオフェンカルブ(ethiofencarb)、フェノブカルブ(fenobucarb)、フェノチオカルブ(fenothiocarb)、フェノキシカルブ(fenoxycarb)、フラチオカルブ(furathiocarb)、イソプロカルブ(isoprocarb:MIPC)、メトルカルブ(metolcarb)、 メソミル(methomyl)、メチオカルブ(methiocarb)、NAC、オキサミル(oxamyl)、ピリミカーブ(pirimicarb)、プロポキスル(propoxur:PHC)、XMC、チオジカルブ(thiodicarb)、 キシリルカルブ(xylylcarb)、及びアルジカルブ(aldicarb)。
Active Ingredients of Insecticides (1) Organophosphorus Compounds Acephate, Aluminum Phosphide, Butathiofos, Cadosafos, Chlorethoxyfos, Chlorfenvinphos, Chlorfenvinphos (Chlorpyrifos), Chlorpyrifos-methyl (Chlorpyrifos-methyl), Cyanophos (Cyanophos: CYAP), Diazinon (Diazinon), DCIP (Dichlorodiisopropylene ether), Diclofenthion (V), Dichlorfenthion (V) ), Dimethoate, dimethylvinphos, disulfoton, EPN, etion, ethoprofos, etrimfos, fention (MPP), EP, Phosthiazate, formothion, hydrogen phosphide, isofenphos, isoxathion, malathion, methulfenfos, methulfenfos, methulfenfos MTP), monocrotophos, nared (BRP), oxydeprofos (ESP), parathion, fosarone, phosmet (PMP), pirimiphosmethyl (pirimifion) (Pyridafention), quinalphos, phentoate, profenofos, propafos, prothiofos, pyrachlorfos, sulthiophos, sulthiophos tebupirimfos), temephos (temephos), tetrachlorvinphos bottle phosphite (tetrach1orvinphos), terbufos (terbufos), thiometon (thiometon), trichlorfon (trichlorphon: DEP), vamidothion (vamidothion), folate (phorate), and cadusafos (cadusafos).
(2) Carbamate compounds alaniccarb, bendiocarb, benfuracarb, BPMC, carbaryl (carbary1), carbofuran, carbothofen, loecarb , Fenobucarb, phenothiocarb, phenoxycarb, furathiocarb, isoprocarb (MIPC), methocarb (metolcarb) hiocarb), NAC, oxamyl (oxamyl), pirimicarb (pirimicarb), propoxur (propoxur: PHC), XMC, thiodicarb (thiodicarb), xylylcarb (xylylcarb), and aldicarb (aldicarb).
(3)ピレスロイド化合物
 アクリナトリン(acrinathrin)、アレスリン(allethrin)、ベンフルスリン(benfluthrin)、ベータ-シフルトリン(beta-cyfluthrin)、ビフェントリン(bifenthrin)、シクロプロトリン(cycloprothrin)、シフルトリン(cyfluthrin)、シハロトリン(cyhalothrin)、シペルメトリン(cypermethrin)、デルタメトリン(deltamethrin)、エスフェンバレレート(esfenvalerate)、エトフェンプロックス(ethofenprox) 、フェンプロパトリン(fenpropathrin)、フェンバレレート(fenvalerate)、フルシトリネート(flucythrinate)、フルフェンプロックス(flufenoprox)、フルメスリン(flumethrin)、フルバリネート(fluvalinate)、ハルフェンプロックス(halfenprox)、イミプロトリン(imiprothrin)、ペルメトリン(permethrin)、プラレトリン(prallethrin)、ピレトリン(pyrethrins)、レスメトリン(resmethrin)、シグマ-サイパーメスリン(sigma-cypermethrin)、シラフルオフェン(silafluofen)、テフルトリン(tefluthrin)、トラロメトリン(tralomethrin)、トランスフルトリン(transfluthrin)、テトラメトリン(tetramethrin)、フェノトリン(phenothrin)、シフェノトリン(cyphenothrin)、アルファシペルメトリン(alpha-cypermethrin)、ゼータシペルメトリン(zeta-cypermethrin)、ラムダシハロトリン(lambda-cyhalothrin)、ガンマシハロトリン(gamma-cyhalothrin)、フラメトリン(furamethrin)、タウフルバリネート(tau-fluvalinate)、メトフルトリン(metofluthrin)、プロフルトリン(profluthrin)、ジメフルトリン(dimefluthrin)、2,3,5,6-テトラフルオロ-4-(メトキシメチル)ベンジル(EZ)-(1RS,3RS;1RS,3SR)-2,2-ジメチル-3-プロプ-1-エニルシクロプロパンカルボキシレート、2,3,5,6-テトラフルオロ-4-メチルベンジル(EZ)-(1RS,3RS;1RS,3SR)-2,2-ジメチル-3-プロプ-1-エニルシクロプロパンカルボキシレート、及び2,3,5,6-テトラフルオロ-4-(メトキシメチル)ベンジル(1RS,3RS;1RS,3SR)-2,2-ジメチル-3-(2-メチル-1-プロペニル)シクロプロパンカルボキシレート、2,3,5,6-テトラフルオロ-4-(メトキシメチル)ベンジル(EZ)-(1RS,3RS;1RS,3SR)-2,2-ジメチル-3-(2-シアノ-1-プロペニル)シクロプロパンカルボキシレート。
(4)ネライストキシン化合物
 カルタップ(cartap)、ベンスルタップ(bensu1tap)、チオシクラム(thiocyclam)、モノスルタップ(monosultap)、及びビスルタップ(bisultap)。
(3) pyrethroid compounds acrinathrin, allethrin, benfluthrin, beta-cyfluthrin, bifenthrin, cycloprotorin, fluprothrin (cycloprothrin) , Cypermethrin, deltamethrin, esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucitrate lucytrinate, flufenprox, flumethrin, fluvalinate, halfenprox, imiprothrin, permethrin, praretrin, praretrin resmethrin, sigma-cypermethrin, silafluofen, tefluthrin, tralomethrin, transfluthrin, tetramethrin ethrin), phenothrin, cyphenothrin, alpha-cypermethrin, zeta-cypermethrin, lambda cihalothrin (lambda-halothrin) ), Furamethrin, tau-fluvalinate, methfluthrin, profluthrin, dimethylfluthrin, 2,3,5,6-tetrafluoro-4- (methoxymethyl) benzyl ( EZ)-(1RS, 3RS; 1RS, 3S ) -2,2-dimethyl-3-prop-1-enylcyclopropanecarboxylate, 2,3,5,6-tetrafluoro-4-methylbenzyl (EZ)-(1RS, 3RS; 1RS, 3SR) -2 , 2-Dimethyl-3-prop-1-enylcyclopropanecarboxylate and 2,3,5,6-tetrafluoro-4- (methoxymethyl) benzyl (1RS, 3RS; 1RS, 3SR) -2,2- Dimethyl-3- (2-methyl-1-propenyl) cyclopropanecarboxylate, 2,3,5,6-tetrafluoro-4- (methoxymethyl) benzyl (EZ)-(1RS, 3RS; 1RS, 3SR)- 2,2-Dimethyl-3- (2-cyano-1-propenyl) cyclopropanecarboxylate.
(4) Nereistoxin compounds Cartap, bensultap, thiocyclam, monosultap, and bisultap.
(5)ネオニコチノイド化合物
 イミダクロプリド(imidac1oprid)、ニテンピラム(nitenpyram)、アセタミプリド(acetamiprid)、チアメトキサム(thiamethoxam)、チアクロプリド(thiacloprid)、ジノテフラン(dinotefuran)、及びクロチアニジン(clothianidin)。
(6)ベンゾイル尿素化合物
 クロルフルアズロン(chlorfluazuron)、ビストリフルロン(bistrifluron)、ジアフェンチウロン(diafenthiuron)、ジフルベンズロン(diflubenzuron)、フルアズロン(fluazuron)、フルシクロクスロン(flucycloxuron)、フルフェノクスロン(flufenoxuron)、ヘキサフルムロン(hexaflumuron)、ルフェヌロン(lufenuron)、ノバルロン(novaluron)、ノビフルムロン(noviflumuron)、テフルベンズロン(teflubenzuron)、トリフルムロン(triflumuron)、及びトリアズロン(triazuron)。
(7)フェニルピラゾール化合物
 アセトプロール(acetoprole)、エチプロール(ethiprole)、フィプロニル(fiproni1)、バニリプロール(vaniliprole)、ピリプロール(pyriprole)、及びピラフルプロール(pyrafluprole)。
(8)Btトキシン
 バチルス・チューリンゲンシス菌由来の生芽胞及び産生結晶毒素、及びそれらの混合物;
(9)ヒドラジン化合物
 クロマフェノジド(chromafenozide)、ハロフェノジド(halofenozide)、メトキシフェノジド(methoxyfenozide)、及びテブフェノジド(tebufenozide)。
(10)有機塩素化合物
 アルドリン(aldrin)、ディルドリン(dieldrin)、ジエノクロル(dienochlor)、エンドスルファン(endosulfan)、及びメトキシクロル(methoxychlor)。
(5) Neonicotinoid compounds imidacloprid (imidac1oprid), nitenpyram (nitenpyram), acetamiprid (acetamipride), thiamethoxam, thiacloprid (thiacloprid), dinoteurin (dinothurine)
(6) Benzoylurea compound Chlorfluazuron, bistrifluron, diafenthiuron, diflubenzuron, fluazuron, flucycloxuron, flucyclolone (Flufenoxuron), hexaflumuron, lufenuron, novaluron, novifluuron, teflubenzuron, triflumuron, and triflumuron.
(7) Phenylpyrazole compounds Acetoprole, etiprole, fipronil, vaniliprole, pyriprole, and pyrafluprole.
(8) Bt toxin Live spores and produced crystal toxins derived from Bacillus thuringiensis, and mixtures thereof;
(9) Hydrazine compounds Chromafenozide, halofenozide, methoxyphenozide, and tebufenozide.
(10) Organochlorine compounds Aldrin, dieldrin, dienochlor, endosulfan, and methoxychlor.
(11)その他の殺虫剤有効成分
 マシン油(machine oil)、硫酸ニコチン(nicotine-sulfate);アベルメクチン(avermectin-B)、ブロモプロピレート(bromopropylate)、ブプロフェジン(buprofezin)、クロルフェナピル(chlorphenapyr)、シアントラニリプロール(cyantraniliprole)、シロマジン(cyromazine)、D-D(1,3-Dichloropropene)、エマメクチンベンゾエート(emamectin-benzoate)、フェナザキン(fenazaquin)、フルピラゾホス(flupyrazofos)、ハイドロプレン(hydroprene)、メトプレン(methoprene)、インドキサカルブ(indoxacarb)、メトキサジアゾン(metoxadiazone)、ミルベマイシンA(milbemycin-A)、ピメトロジン(pymetrozine)、ピリダリル(pyridalyl)、ピリプロキシフェン(pyriproxyfen)、スピノサッド(spinosad)、スルフラミド(sulfluramid)、トルフェンピラド(tolfenpyrad)、トリアゼメイト(triazamate)、フルベンジアミド(flubendiamide)、レピメクチン(lepimectin)、亜ひ酸(Arsenic acid)、ベンクロチアズ(benclothiaz)、石灰窒素(Calcium cyanamide)、石灰硫黄合剤(Calcium polysulfide)、クロルデン(chlordane)、DDT、DSP、フルフェネリウム(flufenerim)、フロニカミド(flonicamid)、フルリムフェン(flurimfen)、ホルメタネート(formetanate)、メタム・アンモニウム(metam-ammonium)、メタム・ナトリウム(metam-sodium)、臭化メチル(Methyl bromide)、オレイン酸カリウム(Potassium oleate)、プロトリフェンビュート(protrifenbute)、スピロメシフェン(spiromesifen)、スルフォキサフロール(sulfoxaflor)、硫黄(Sulfur)、メタフルミゾン(metaflumizone)、スピロテトラマット(spirotetramat)、ピリフルキナゾン(pyrifluquinazone)、スピネトラム(spinetoram)、クロラントラニリプロール(chlorantraniliprole)、トラロピリル(tralopyril)、シアントラニリプロール(cyantraniliprole)、
下記式(K)
Figure JPOXMLDOC01-appb-I000021
〔式中、
 R100は塩素、臭素又はトリフルオロメチル基を表し、
 R200は塩素、臭素又はメチル基を表し、
 R300は塩素、臭素又はシアノ基を表す。〕
で示される化合物、及び
下記式(L)
Figure JPOXMLDOC01-appb-I000022
〔式中、
 R1000は塩素、臭素又はヨウ素を表す。〕
で示される化合物。
(11) Other Insecticide Active Ingredients Machine oil, nicotine-sulfate; avermectin, bromopropyrate, buprofezin, chlorfenapyr, chlorphenapyr Ritranol, cyromazine, DD (1,3-Dichloropropene), emamectin benzoate, fenazaquin, flupirroprene, flupyrazolen , Indoxacarb, methoxadiazone, milbemycin-A, pymetrozine, pyridalyl, pyriprosul, spiromidol, spinodulsulfide tolfenpyrad, triazamate, flubendiamide, repimectin, arsenous acid, benclothiaz, lime nitrogen calcium lime ulfide, chlordane, DDT, DSP, flufenerim, flonicamid, flurimfen, formatenate, metham-ammonium, metam-ammonium sodium, methyl bromide, potassium oleate, protrifenbute, spiromesifen, sulfoxafluor, sulfur, metafluon, sulfur ), Spirotetramat (sp rotetramat), pyrifluquinazon (pyrifluquinazone), spinetoram (spinetoram), chlorantraniliprole (chlorantraniliprole), Toraropiriru (tralopyril), cyan tiger Niri Prowl (cyantraniliprole),
Following formula (K)
Figure JPOXMLDOC01-appb-I000021
[Where,
R 100 represents a chlorine, bromine or trifluoromethyl group,
R 200 represents a chlorine, bromine or methyl group,
R 300 represents chlorine, bromine or a cyano group. ]
And a compound represented by the following formula (L)
Figure JPOXMLDOC01-appb-I000022
[Where,
R 1000 represents chlorine, bromine or iodine. ]
A compound represented by
 殺ダニ剤の有効成分
 アセキノシル(acequinocyl)、アミトラズ(amitraz)、ベンゾキシメート(benzoximate)、ビフェナゼート(bifenaate)、フェニソブロモレート(bromopropylate)、キノメチオネート(chinomethionat)、クロルベンジレート(chlorobenzilate)、CPCBS(chlorfenson)、クロフェンテジン(clofentezine)、シフルメトフェン(cyflumetofen)、ケルセン(ジコホル:dicofol)、エトキサゾール(etoxazole)、酸化フェンブタスズ(fenbutatin oxide)、フェノチオカルブ(fenothiocarb)、フェンピロキシメート(fenpyroximate)、フルアクリピリム(fluacrypyrim)、フルプロキシフェン(fluproxyfen)、ヘキシチアゾクス(hexythiazox)、プロパルギット(propargite:BPPS)、ポリナクチン複合体(polynactins)、ピリダベン(pyridaben)、ピリミジフェン(Pyrimidifen)、テブフェンピラド(tebufenpyrad)、テトラジホン(tetradifon)、スピロディクロフェン(spirodiclofen)、スピロメシフェン(spiromesifen)、スピロテトラマット(spirotetramat)、アミドフルメット(amidoflumet)、及びシエノピラフェン(cyenopyrafen)。
Active ingredients of acaricides: acequinocyl, amitraz, benzoximate, bifenaate, phenisobromolate (BS), chinomethionate (BS), chinomethionate (BS) chlorfenson, clofentezine, cyflumetofene, kelsen (dicofol), etoxazole, fenbutatin oxide (fenbutafen), fenothiocarbene roximate, fluacrylpyrim, fluproxyfen, hexythiazox, propargite (BPPS), polynactin complex (pyridene), pyridaben (pyriben) (Tetradifon), spirodiclofen, spiromesifen, spirotetramat, amidoflumet, and cenopyrafen.
 殺線虫剤の有効成分
 DCIP、フォスチアゼート(fosthiazate)、塩酸レバミゾール(levamisol)、メチルイソチオシアネート(methyisothiocyanate)、酒石酸モランテル(morantel tartarate)、及びイミシアホス(imicyafos)。
Active ingredients of nematicides DCIP, fostiazate, levamisole hydrochloride, methylisothiocyanate, morantel tartrate, and imiciafos.
 殺菌剤の有効成分
 プロピコナゾール(propiconazole)、プロチオコナゾール(prothioconazole)、トリアジメノール(triadimenol)、プロクロラズ(prochloraz)、ペンコナゾール(penconazole)、テブコナゾール(tebuconazole)、フルシラゾール(flusilazole)、ジニコナゾール(diniconazole)、ブロムコナゾール(bromuconazole)、エポキシコナゾール(epoxiconazole)、ジフェノコナゾール(difenoconazole)、シプロコナゾール(cyproconazole)、メトコナゾール(metconazole)、トリフルミゾール(triflumizole)、テトラコナゾール(tetraconazole)、マイクロブタニル(myclobutanil)、フェンブコナゾール(fenbuconazole)、ヘキサコナゾール(hexaconazole)、フルキンコナゾール(fluquinconazole)、トリティコナゾール(triticonazole)、ビテルタノール(bitertanol)、イマザリル(imazalil)、フルトリアホール(flutriafol)等のアゾール殺菌化合物;
フェンプロピモルフ(fenpropimorph)、トリデモルフ(tridemorph)、フェンプロピジン(fenpropidin)等の環状アミン殺菌化合物;
カルベンダジム(carbendezim)、ベノミル(benomyl)、チアベンダゾール(thiabendazole)、チオファネートメチル(thiophanate-methyl)等のベンズイミダゾール殺菌化合物;
プロシミドン(procymidone);シプロディニル(cyprodinil);ピリメタニル(pyrimethanil);ジエトフェンカルブ(diethofencarb);チウラム(thiuram);フルアジナム(fluazinam);マンコゼブ(mancozeb);イプロジオン(iprodione);ビンクロゾリン(vinclozolin);クロロタロニル(chlorothalonil);キャプタン(captan);メパニピリム(mepanipyrim);フェンピクロニル(fenpiclonil);フルジオキソニル(fludioxonil);ジクロフルアニド(dichlofluanid);フォルペット(folpet);クレソキシムメチル(kresoxim-methyl);アゾキシストロビン(azoxystrobin);トリフロキシストロビン(trifloxystrobin);フルオキサストロビン(fluoxastrobin);ピコキシストロビン(picoxystrobin);ピラクロストロビン(pyraclostrobin);ジモキシストロビン(dimoxystrobin);ピリベンカルブ(pyribencarb);スピロキサミン(spiroxamine);キノキシフェン(quinoxyfen);フェンヘキサミド(fenhexamid);ファモキサドン(famoxadone);フェナミドン(fenamidone);ゾキサミド(zoxamide);エタボキサム(ethaboxam);アミスルブロム(amisulbrom);イプロヴァリカルブ(iprovalicarb);ベンチアバリカルブ(benthiavalicarb);シアゾファミド(cyazofamid);マンジプロパミド(mandipropamid);ボスカリド(boscalid);ペンチオピラド(penthiopyrad);メトラフェノン(metrafenone);フルオピラン(fluopiran);ビキサフェン(bixafen);シフルフェナミド(cyflufenamid);プロキナジド(proquinazid);イソチアニル(isotianil)及びチアジニル(tiadinil)。
Active ingredients of fungicides Propiconazole, Prothioconazole, Triadimenol, Prochloraz, Penconazole, Tebuconazole, Tebuconazole, Tebuconazole , Bromuconazole, epoxiconazole, difenoconazole, cyproconazole, metconazole, triflumazole, triflumizole Tetraconazole, microbutanil, fenbuconazole, hexaconazole, fluquinconazole, triticonazole, triticonazole, triticonazole, triticonazole Azole fungicidal compounds such as flutriafol;
Cyclic amine bactericidal compounds such as fenpropimorph, tridemorph, fenpropidin;
Benzimidazole fungicidal compounds such as carbendezim, benomyl, thiabendazole, thiophanate-methyl;
Procymidone; cyprodinil; pyrimethanil; dietofencarb; thiuram; fluazilonyl; Captan; mepanipyrim; fenpiclonil; fludioxonil; diclofluraned; folppet; cresoxime- azoxystrobin; trifloxystrobin; fluoxastrobin; picoxystrobin; pyracrostrobin; dimoxystrobin; dimoxystrobin; dimoxystrobin; Pyribencarb; spiroxamine; quinoxyfen; fenhexamid; famoxadone; fenamidone; samamide; samamide; iprovalicarb; benthiavaricarb; cyazofamid; mandipropamid; boscaliden; (Bifafen); cyflufenamide; proquinazid; isotianil and thiadinil.
 除草剤の有効成分
(1)フェノキシ脂肪酸除草性化合物
2,4-D、MCP、MCPB、フェノチオール(phenothio1)、メコプロップ(mecoprop)、フルロキシピル(fluroxypyr)、トリクロピル(triclopyr)、クロメプロップ(clomeprop)、及びナプロアニリド(naproanilide)。
(2)安息香酸除草性化合物
2,3,6-TBA、ジカンバ(dicamba)、クロピラリド(clopyralid)、ピクロラム(picloram)、アミノピラリド(aminopyralid)、キンクロラック(quinclorac)、及びキンメラック(quinmerac)。
(3)尿素除草性化合物
ジウロン(diuron)、リニュロン(linuron)、クロルトルロン(chlortoluron)、イソプロツロン(isoproturon)、フルオメツロン(fluometuron)、イソウロン(isouron)、テブチウロン(tebuthiuron)、メタベンズチアズロン(methabenzthiazuron)、クミルロン(cumy1uron)、ダイムロン(daimuron)、及びメチルダイムロン(methyl-daimuron)。
(4)トリアジン除草性化合物
アトラジン(atrazine)、アメトリン(ametoryn)、シアナジン(cyanazine)、シマジン(simazine)、プロパジン(propazine)、シメトリン(simetryn)、ジメタメトリン(dimethametryn)、プロメトリン(prometryn)、メトリブジン(metribuzin)、トリアジフラム(triaziflam)、及びインダジフラム(indaziflam)。
(5)ビピリジニウム除草性化合物
パラコート(paraquat)、及びジクワット(diquat)。
Active ingredient of herbicide (1) Phenoxy fatty acid herbicidal compound 2,4-D, MCP, MCPB, phenthiol (phenothio1), mecoprop, fluroxypyr, triclopyr, clomeprop, Naproanilide.
(2) Benzoic acid herbicidal compound 2,3,6-TBA, dicamba, clopyralid, picloram, aminopyralid, quinclorac, and quinmerac.
(3) Urea herbicidal compounds diuron, linuron, chlortoluron, isoproturon, fluometuron, isouron, tebuthiuron, tebuthiuron, metabenthuron , Cumyluron, daimuron, and methyl-daimuron.
(4) Triazine herbicidal compounds atrazine, ametrine, cyanazine, simazine, propazine, simetrin, dimethamethrin (dimethymetrine) ), Triaziflam, and indaziflam.
(5) Bipyridinium herbicidal compound paraquat and diquat.
(6)ヒドロキシベンゾニトリル除草性化合物
ブロモキシニル(bromoxynil)、及びアイオキシニル(ioxynil)。
(7)ジニトロアニリン除草性化合物
ペンディメタリン(pendimethalin)、プロジアミン(prodiamine)、及びトリフルラリン(trifluralin)。
(8)有機リン除草性化合物
アミプロホスメチル(amiprofos-methyl)、ブタミホス(butamifos)、ベンスリド(bensu1ide)、ピペロホス(piperophos)、アニロホス(anilofos)、グリホサート(glyphosate)、グルホシネート(glufosinate)、グルホシネート-P(glufosinate-P)、及びビアラホス(bialaphos)。
(9)カーバメート除草性化合物
ジアレート(di-allate)、トリアレート(tri-allate)、EPTC、ブチレート(butylate)、ベンチオカーブ(benthiocarb)、エスプロカルブ(esprocarb)、モリネート(molinate)、ジメピペレート(dimepiperate)、スエップ(swep)、クロルプロファム(chlorpropham)、フェンメディファム(phenmedipham)、フェニソファム(phenisopham)、ピリブチカルブ(pyributicarb)、及びアシュラム(asulam)。
(10)酸アミド除草性化合物
プロパニル(propanil)、プロピザミド(propyzamide)、ブロモブチド(bromobutide)、及びエトベンザニド(etobenzanid)。
(6) Hydroxybenzonitrile herbicidal compounds bromoxynil and ioxynil.
(7) Dinitroaniline herbicidal compounds pendimethalin, prodiamine, and trifluralin.
(8) Organophosphorus herbicidal compounds amiprofos-methyl, butamifos, bensulide, piperophos, anilofos, glyphosate, glufosinate, glufosinate, glufosinate P (glufosinate-P), and bialaphos.
(9) Carbamate herbicidal compounds: di-allate, tri-allate, EPTC, butyrate, beniocarb, esprocarb, molinate, dimepiperate (Swep), chlorpropham, phenmedifam, phenisopham, piributicarb, and asuram.
(10) Acid amide herbicidal compounds propanil, propyzamide, bromobutide, and etobanzanide.
(11)クロロアセトアニリド除草性化合物
アセトクロール(acetochlor)、アラクロール(alachlor)、ブタクロール(butachlor)、ジメテナミド(dimethenamid)、プロパクロール(propachlor)、メタザクロール(metazachlor)、メトラクロール(metolachlor)、プレチラクロール(pretilachlor)、テニルクロール(theny1ch1or)、及びペトキサミド(pethoxamid)。
(12)ジフェニルエーテル除草性化合物
アシフルオルフェン(acifluorfen-sodium)、ビフェノックス(bifenox)、オキシフルオルフェン(oxyfluorfen)、ラクトフェン(lactofen)、フォメサフェン(fomesafen)、クロメトキシニル(chlomethoxyni1)、及びアクロニフェン(aclonifen)。
(13)環状イミド除草性化合物
オキサジアゾン(oxadiazon)、シニドンエチル(cinidon-ethyl)、カルフェントラゾンエチル(carfentrazone-ethyl)、スルフェントラゾン(surfentrazone)、フルミクロラックペンチル(flumiclorac-pentyl)、フルミオキサジン(flumioxazin)、ピラフルフェンエチル(pyraflufen-ethyl)、オキサジアルギル(oxadiargy1)、ペントキサゾン(pentoxazone)、フルチアセットメチル(fluthiacet-methyl)、ブタフェナシル(butafenacil)、ベンズフェンジゾン(benzfendizone)、ベンカルバゾン(bencarbazone)、及びサフルフェナシル(saflufenacil)。
(14)ピラゾール除草性化合物
ベンゾフェナップ(benzofenap)、ピラゾレート(pyrazo1ate)、ピラゾキシフェン(pyrazoxyfen)、トプラメゾン(topramezone)、及びピラスルホトール(pyrasulfotole)。
(15)トリケトン除草性化合物
イソキサフルトール(isoxaflutole)、ベンゾビシクロン(benzobicyclon)、スルコトリオン(sulcotrione)、メソトリオン(mesotrione)、テンボトリオン(tembotrione)、及びテフリルトリオン(tefuryltrione)。
(16)アリールオキシフェノキシプロピオン酸除草性化合物
クロジナホッププロパルギル(clodinafop-propargyl)、シハロホップブチル(cyhalofop-butyl)、ジクロホップメチル(diclofop-methyl)、フェノキサプロップエチル(fenoxaprop-ethyl)、フルアジホップブチル(fluazifop-butyl)、ハロキシホップメチル(haloxyfop-methyl)、及びキザロホップエチル(quizalofop-ethyl)、メタミホップ(metamifop)。
(17)トリオンオキシム除草性化合物
アロキシジム(alloxydim-sodium)、セトキシジム(sethoxydim)、ブトロキシジム(butroxydim)、クレソジム(clethodim)、クロプロキシジム(cloproxydim)、シクロキシジム(cycloxydim)、テプラロキシジム(tepraloxydim)、トラルコキシジム(tralkoxydim)、及びプロフォキシジム(profoxydim)。
(11) Chloroacetanilide herbicidal compounds acetochlor, acechlor, butachlor, dimethenamide, propachlor, metazachlor, metrachlor or totrachlor pretilachlor), tenylchlor (theny1ch1or), and petoxamide.
(12) Diphenyl ether herbicidal compounds aciflufen-sodium, bifenox, oxyfluorfen, lactofen, fomesafen, clomethoxythonifen, and chloromethoxypheny.
(13) Cyclic imide herbicidal compounds oxadiazon, cinidon-ethyl, carfentrazone-ethyl, sulfentrazone, full-microlac-pentyl, flumi-lacyl-pentyl Oxazine (flumioxazin), pyraflufen-ethyl, oxadiargyl (oxadiargy1), pentoxazone (pentoxazone), fluthiacet-methyl (butafenzilben) zone), and saflufenacil (saflufenacil).
(14) Pyrazole herbicidal compounds benzofenap, pyrazolate, pyrazoxifene, topramzone, and pyrasulfotole.
(15) Triketone herbicidal compounds isoxaflutole, benzobicyclon, sulcotrione, mesotrione, tembotrione, and tefriltrione.
(16) Aryloxyphenoxypropionic acid herbicidal compound clodinafop-propargyl, cyhalofop-butyl, diclohop-methyl, phenoxaprop-ethyl, fenoxaprop-propyl Fluazifop-butyl, haloxyhop-methyl, quizalofop-ethyl, metamihop.
(17) Trione oxime herbicidal compounds alloxydim-sodium, cetoxydim, butoxydim, crestodim, cloxydimim, cycloxidim, texydimym (Traxydim), and profoxydim.
(18)スルホニル尿素除草性化合物
クロルスルフロン(chlorsulfuron)、スルホメツロンメチル(sulfometuron-methyl)、メトスルフロンメチル(metsu1furon-methy1)、クロリムロンエチル(chlorimuron-ethyl)、トリベニュロンメチル(tribenuron-methyl)、トリアスルフロン(triasulfuron)、ベンスルフロンメチル(bensulfuron-methy1)、チフェンスルフロンメチル(thifensulfuron-methyl)、ピラゾスルフロンエチル(pyrazosulfuron-ethy1)、プリミスルフロンメチル(primisulfuron-methyl)、ニコスルフロン(nicosulfuron)、アミドスルフロン(amidosulfuron)、シノスルフロン(cinosulfuron)、イマゾスルフロン(imazosulfuron)、リムスルフロン(rimsulfuron)、ハロスルフロンメチル(ha1osulfuron-methy1)、プロスルフロン(prosulfuron)、エタメトスルフロンメチル(ethametsulfuron-methyl)、トリフルスルフロンメチル(triflusulfuron-methyl)、フラザスルフロン(flazasulfuron)、シクロスルファムロン(cyc1osulfamuron)、フルピルスルフロン(flupyrsulfuron)、スルホスルフロン(sulfosu1furon)、アジムスルフロン(azimsulfuron)、エトキシスルフロン(ethoxysulfuron)、オキサスルフロン(oxasulfuron)、ヨードスルフロンメチルナトリウム(iodosulfuron-methyl-sodium)、フォラムスルフロン(foramsulfuron)、メソスルフロンメチル(mesosulfuron-methyl)、トリフロキシスルフロン(trifloxysulfuron)、トリトスルフロン(tritosulfuron)、オルソスルファムロン(orthosulfamuron)、フルセトスルフロン(flucetosulfuron)、及びプロピリスルフロン(propyrisulfuron)。
(19)イミダゾリノン除草性化合物
イマザメタベンズメチル(imazamethabenz-methyl)、イマザメタピル(imazamethapyr)、イマザモックス(imazamox)、イマザピル(imazapyr)、イマザキン(imazaquin)、及びイマゼタピル(imazethapyr)。
(20)スルホンアミド除草性化合物
フルメトスラム(flumetsulam)、メトスラム(metosulam)、ジクロスラム(diclosulam)、フロラスラム(florasulam)、クロランスラムメチル(cloransulam-methyl)、ペノキススラム(penoxsulam)、及びピロキススラム(pyroxsulam)。
(21)ピリミジニルオキシ安息香酸除草性化合物
ピリチオバックナトリウム(pyrithiobac-sodium)、ビスピリバックナトリウム(bispyribac-sodium)、ピリミノバックメチル(pyriminobac-methy1)、ピリベンゾキシム(pyribenzoxim)、ピリフタリド(pyriftalid)、及びピリミスルファン(pyrimisulfan)。
(22)その他の除草性化合物
ベンタゾン(bentazon)、ブロマシル(bromacil)、ターバシル(terbacil)、クロルチアミド(chlorthiamid)、イソキサベン(isoxaben)、ジノセブ(dinoseb)、アミトロール(amitrole)、シンメチリン(cinmethylin)、トリジファン(tridiphane)、ダラポン(da1apon)、ジフルフェンゾピルナトリウム(diflufenzopyr-sodium)、ジチオピル(dithiopyr)、チアゾピル(thiazopyr)、フルカルバゾンナトリウム(flucarbazone-sodium)、プロポキシカルバゾンナトリウム(propoxycarbazone-sodium)、メフェナセット(mefenacet)、フルフェナセット(flufenacet)、フェントラザミド(fentrazamide)、カフェンストロール(cafenstrole)、インダノファン(indanofan)、オキサジクロメホン(oxaziclomefone)、ベンフレセート(benfuresate)、ACN、ピリデート(pyridate)、クロリダゾン(chloridazon)、ノルフルラゾン(norflurazon)、フルルタモン(flurtamone)、ジフルフェニカン(diflufenican)、ピコリナフェン(picolinafen)、ベフルブタミド(beflubutamid)、クロマゾン(clomazone)、アミカルバゾン(amicarbazone)、ピノキサデン(pinoxaden)、ピラクロニル(pyraclonil)、ピロキサスルホン(pyroxasulfone)、チエンカルバゾンメチル(thiencarbazone-methyl)、アミノシクロピラクロール(aminocyclopyrachlor)、イプフェンカルバゾン(ipfencarbazone)、及びメチオゾリン(methiozolin)。
(18) A sulfonylurea herbicidal compound chlorsulfuron, sulfomethuron-methyl, metsulfuron-methyl, chlorimuron-ethyl, trivenuron methyl (18) tribenuron-methyl, trisulfuron, bensulfuron-methyl, thifensulfuron-methyl, pyrazosulfuron-methyl, urmisyl-uryl-uryl-uryl Nicosulfuron (nico) ulfuron, amidosulfuron, cinosulfuron, imazosulfuron, rimsulfuron, halosulfuron (thulfuron), prosulfuron (thulsulfuron), prosulfuron (thulsulfuron) , Triflusulfuron-methyl, flazasulfuron, cyclosulfamuron, flupirsulfuron, sulfosulfurium, sulfosulfurimuron Azulsulfuron, ethoxysulfuron, oxasulfuron, iodosulfuron-methyl-sodium, foramsulfuron, mesosulfuron, mesulfuron methyl Trisulfursulfuron, tritosulfuron, orthosulfamuron, flucetosulfuron, and propyrisulfuron.
(19) Imidazolinone herbicidal compounds imazametabenz-methyl, imazamethapyr, imazamox, imazapyr, imazapir, imazaquin (i)
(20) Sulfonamide herbicidal compounds flumetslam, metosulam, dicloslam, floraslam, chloransrammethyl, penoxsulox, penoxsulox, and penoxsulox.
(21) Pyrimidinyloxybenzoic acid herbicidal compound pyrithiobac-sodium, bispyribac-sodium, pyriminobac-methyl1, pyribenzoximpy, And pyrimisulfan.
(22) Other herbicidal compounds bentazon, bromacil, terbacil, chlorthiamid, isoxaben, dinoseb, amitrole, cinmethyline, cinmethyline (cinthyl) tripiphane, dalapon (da1apon), diflufenzopyr sodium (diflufenzopyr-sodium), dithiopyr (dithiopyr), thiazopyr (thiazopyr), sodium flucarbazone (proflubazone) Nasset (mefenacet), flufenacet (flufenacet), fentrazamide (fentrazamide), caffenstrole (cafenstrom), indanophan (indanofan), oxadichromemephone (oxaneclomefone), fidarate (benduresate) (Norflurazon), flurtamon, diflufenican, picolinafen, beflubutamide, clomazone, amicarbazone , Pinoxaden (pinoxaden), pyraclonil (pyraclonil), pyroxasulfone (pyroxasulfone), thien-carbazone methyl (thiencarbazone-methyl), amino cyclo Pila crawl (aminocyclopyrachlor), type phen carbazone (ipfencarbazone), and Mechiozorin (methiozolin).
 共力剤の有効成分
 ピペロニル ブトキサイド(piperonyl butoxide)、セサメックス(sesamex)、スルホキシド(sulfoxide)、N-(2-エチルへキシル)-8,9,10-トリノルボルン-5-エン-2,3-ジカルボキシイミド(MGK 264)、N-デクリイミダゾール(N-declyimidazole)、WARF-アンチレジスタント(WARF-antiresistant)、TBPT、TPP、IBP、PSCP、ヨウ化メチル(CHI)、t-フェニルブテノン(t-phenylbutenone)、ジエチルマレエート(diethylmaleate)、DMC、FDMC、ETP、及びETN。
Active ingredient of synergist piperonyl butoxide, sesamex, sulfoxide, N- (2-ethylhexyl) -8,9,10-trinorborn-5-ene-2,3-di Carboximide (MGK 264), N-decrimimidazole, WARF-anti-resistant, TBPT, TPP, IBP, PSCP, methyl iodide (CH 3 I), t-phenyl butyl Tenon (t-phenylbutone), diethyl maleate, DMC, FDMC, ETP, and ETN.
 以下、本発明を製造例、製剤例及び試験例等によりさらに詳しく説明するが、本発明はこれらの例のみに限定されるものではない。
まず、本発明化合物の製造について、製造例を示す。
Hereinafter, although this invention is demonstrated in more detail by a manufacture example, a formulation example, a test example, etc., this invention is not limited only to these examples.
First, a manufacture example is shown about manufacture of this invention compound.
(製造例1)
(1)
 N-メチル-4-トリフルオロメチル-ベンゼン-1,2-ジアミン3.6g、1-エチル-3-(3-ジメチルアミノプロピル)カルボジイミド塩酸塩3.8g、HOBt250mg、及びピリジン37mLの混合物に、氷冷下3,6-ジクロロ-ピリジン-2-カルボン酸3.8gを加えた。室温に昇温し、室温で12時間撹拌した。この反応混合物を水に注ぎ、析出した固体を濾過した。得られた固体を水で洗浄した後、乾燥し、固体A7.3gを得た。
(2)
 固体A7.3gと酢酸40mLとの混合物を、加熱還流下5時間撹拌した。この混合物を室温まで放冷した後、水を加えた。析出した固体をろ取し、減圧乾燥することにより、下記の化合物B6.3gを得た。
Figure JPOXMLDOC01-appb-I000023
化合物B:1H-NMR (CDCl3) δ: 8.17 (1H, d), 7.90 (1H, d), 7.64 (1H, dd), 7.54 (1H, d), 7.46 (1H, d), 3.92 (3H, s).
(3)
 化合物B、水素化ナトリウム(60%、油状)810mg、及びテトラヒドロフラン36mLの混合物に、氷冷下エチルメルカプタン1.4mLを滴下した。この混合物を氷冷下3時間撹拌した後、水を加え、酢酸エチルで抽出した。得られた有機層を無水硫酸ナトリウムで乾燥した後、減圧下乾燥することで、混合物C6.4gを得た。
 この混合物C6.4gおよびクロロホルム61mLの混合物に、氷冷下75%m-クロロ過安息香酸8.5gを加えた。氷冷下12時間撹拌した後、この反応混合物を飽和重層水溶液に加え、クロロホルムで抽出した。有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥し、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、化合物D3.4gを得た。
Figure JPOXMLDOC01-appb-I000024
化合物D: 1H-NMR (CDCl3) δ: 8.46 (1H, d), 8.07 (1H, d), 7.70 (1H, d), 7.65 (1H, dd), 7.55 (1H, d), 3.87 (2H, q), 3.84 (3H, s), 1.37 (3H, t).
(4)
 化合物D300mg、水素化ナトリウム(60%、油状)36mgおよびDMF1.5mLの混合物に、氷冷下1H-1,2,4-トリアゾール77mgを加えた。この反応混合物を氷冷下4時間撹拌した後、この反応混合物に水を加え、酢酸エチルで抽出した。得られた有機層を、無水硫酸ナトリウムで乾燥した後、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記の本発明化合物1を300mg得た。
Figure JPOXMLDOC01-appb-I000025
 本発明化合物1:1H-NMR (DMSO-D6) δ: 9.57 (1H, s), 8.74 (1H, d), 8.46 (1H, s), 8.31 (1H, d), 8.17 (1H, d), 8.00 (1H, d), 7.76 (1H, dd), 3.97-3.88 (5H, m), 1.24 (3H, t).
(Production Example 1)
(1)
In a mixture of 3.6 g N 1 -methyl-4-trifluoromethyl-benzene-1,2-diamine, 3.8 g 1-ethyl-3- (3-dimethylaminopropyl) carbodiimide hydrochloride, 250 mg HOBt, and 37 mL pyridine Under ice cooling, 3.8 g of 3,6-dichloro-pyridine-2-carboxylic acid was added. The mixture was warmed to room temperature and stirred at room temperature for 12 hours. The reaction mixture was poured into water, and the precipitated solid was filtered. The obtained solid was washed with water and dried to obtain 7.3 g of solid A.
(2)
A mixture of 7.3 g of solid A and 40 mL of acetic acid was stirred with heating under reflux for 5 hours. The mixture was allowed to cool to room temperature and water was added. The precipitated solid was collected by filtration and dried under reduced pressure to obtain 6.3 g of the following compound B.
Figure JPOXMLDOC01-appb-I000023
Compound B: 1 H-NMR (CDCl 3 ) δ: 8.17 (1H, d), 7.90 (1H, d), 7.64 (1H, dd), 7.54 (1H, d), 7.46 (1H, d), 3.92 ( 3H, s).
(3)
To a mixture of Compound B, 810 mg of sodium hydride (60%, oily), and 36 mL of tetrahydrofuran, 1.4 mL of ethyl mercaptan was added dropwise under ice cooling. The mixture was stirred for 3 hours under ice-cooling, water was added, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate, and then dried under reduced pressure to obtain 6.4 g of a mixture C.
To a mixture of 6.4 g of this mixture C and 61 mL of chloroform, 8.5 g of 75% m-chloroperbenzoic acid was added under ice cooling. After stirring for 12 hours under ice-cooling, the reaction mixture was added to a saturated aqueous multilayer solution and extracted with chloroform. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and dried under reduced pressure. The resulting residue was subjected to silica gel chromatography to obtain 3.4 g of compound D.
Figure JPOXMLDOC01-appb-I000024
Compound D: 1 H-NMR (CDCl 3 ) δ: 8.46 (1H, d), 8.07 (1H, d), 7.70 (1H, d), 7.65 (1H, dd), 7.55 (1H, d), 3.87 ( 2H, q), 3.84 (3H, s), 1.37 (3H, t).
(4)
To a mixture of 300 mg of compound D, 36 mg of sodium hydride (60%, oily) and 1.5 mL of DMF, 77 mg of 1H-1,2,4-triazole was added under ice cooling. The reaction mixture was stirred for 4 hours under ice cooling, water was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over anhydrous sodium sulfate and then dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 300 mg of the following present compound 1.
Figure JPOXMLDOC01-appb-I000025
The present compound 1: 1 H-NMR (DMSO-D 6 ) δ: 9.57 (1H, s), 8.74 (1H, d), 8.46 (1H, s), 8.31 (1H, d), 8.17 (1H, d ), 8.00 (1H, d), 7.76 (1H, dd), 3.97-3.88 (5H, m), 1.24 (3H, t).
(製造例2)
 1H-1,2,4-トリアゾールに代えて、3-クロロ-1H-1,2,4トリアゾールを用い、製造例1(4)に記載の方法に準じて、下記の本発明化合物2を得た。
Figure JPOXMLDOC01-appb-I000026
 本発明化合物2:1H-NMR (CDCl3) δ: 9.06 (1H, s), 8.72 (1H, d), 8.21 (1H, d), 8.11 (1H, d), 7.69 (1H, dd), 7.59 (1H, d), 3.83-3.78 (5H, m), 1.37 (3H, t).
(Production Example 2)
The following present compound 2 of the present invention is obtained according to the method described in Production Example 1 (4) using 3-chloro-1H-1,2,4 triazole instead of 1H-1,2,4-triazole. It was.
Figure JPOXMLDOC01-appb-I000026
Compound 2 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.06 (1H, s), 8.72 (1H, d), 8.21 (1H, d), 8.11 (1H, d), 7.69 (1H, dd), 7.59 (1H, d), 3.83-3.78 (5H, m), 1.37 (3H, t).
(製造例3)
 1H-1,2,4-トリアゾールに代えて、3-メチル-1H-1,2,4トリアゾールを用い、製造例1(4)に記載の方法に準じて、下記の本発明化合物3を得た。
Figure JPOXMLDOC01-appb-I000027
本発明化合物3:1H-NMR (CDCl3) δ: 9.03 (1H, s), 8.66 (1H, d), 8.19 (1H, d), 8.10 (1H, d), 7.68 (1H, dd), 7.58 (1H, d), 3.83-3.77 (5H, m), 2.54 (3H, s), 1.37 (3H, t).
(Production Example 3)
The following compound 3 of the present invention is obtained according to the method described in Production Example 1 (4) using 3-methyl-1H-1,2,4 triazole instead of 1H-1,2,4-triazole. It was.
Figure JPOXMLDOC01-appb-I000027
Compound 3 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.03 (1H, s), 8.66 (1H, d), 8.19 (1H, d), 8.10 (1H, d), 7.68 (1H, dd), 7.58 (1H, d), 3.83-3.77 (5H, m), 2.54 (3H, s), 1.37 (3H, t).
(製造例4)
(1)
 4-(トリフルオロメチルチオ)-アニリン20g、及びクロロホルム40mLの混合物に、氷冷下で無水酢酸20mLを滴下した。滴下完了後、混合物にクロロホルム40mLを加え、室温で12時間撹拌した。得られた反応混合物に、ヘキサン80mLを加え、析出した固体を濾過し、得られた固体をヘキサンで洗浄することにより、下記の化合物E23gを得た。
Figure JPOXMLDOC01-appb-I000028
化合物E:1H-NMR (CDCl3) δ: 8.28 (1H, d), 7.56 (1H, dd), 6.41 (1H, d), 5.44 (1H, s), 2.96 (3H, d).
(2)
 化合物E22g、及び硫酸96mLの混合物を-10℃に冷却し、同温度で発煙硝酸7.2mL、及び硫酸24mLの混合物を滴下し、0℃にした。氷冷下、反応混合物を6時間撹拌した後、この反応混合物を水に注ぎ、クロロホルムで抽出した。有機層を水で洗浄し、硫酸ナトリウムで乾燥した後、減圧乾燥した。得られた残渣を、シリカゲルクロマトグラフィーに付し、下記の化合物F10gを得た。
Figure JPOXMLDOC01-appb-I000029
化合物F:1H-NMR (CDCl3) δ: 10.46 (1H, s), 8.93 (1H, d), 8.53 (1H, d), 7.90 (1H, dd), 2.33 (3H, s).
(3)
 化合物F10g、及びDMF121mLの混合物に、氷冷下水素化ナトリウム(60%、油状)1.6gを加え、0℃に冷却した。この混合物に、氷冷下ヨードメタン2.4mL、及びDMF20mLの混合溶液を滴下した。滴下完了後、室温に昇温し4時間撹拌した。得られた反応混合物を1N塩酸水溶液に注ぎ、酢酸エチルで抽出した。得られた有機層を、0.5N塩酸水溶液、飽和塩化ナトリウム水溶液で洗浄し、硫酸ナトリウムで乾燥した後、減圧下乾燥した。
得られた残渣を、メタノール55mL、及び水18mLの混合液で希釈した。この溶液に、氷冷下で水酸化ナトリウム5.8gを加え、室温で12時間撹拌した。得られた反応混合物を1N塩酸水溶液に注ぎ、析出した固体をろ取した。得られた固体を水で洗浄し、乾燥することにより固体G9.8gを得た。
(4)
 鉄粉13g、酢酸19mL、テトラヒドロフラン200mL、及び水28mLの混合物を65℃に加熱し、撹拌しながら固体G14g、及びテトラヒドロフラン50mLの混合溶液を滴下した。滴下完了後、65℃で3時間撹拌した。得られた反応混合物をセライト(登録商標)濾過し、テトラヒドロフランで洗浄した。得られたろ液を、減圧下乾燥した。得られた残渣を飽和重層水溶液で希釈した後、酢酸エチルで抽出した。得られた有機層を、硫酸ナトリウムで乾燥した後、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記の化合物H13gを得た。
Figure JPOXMLDOC01-appb-I000030
化合物H:1H-NMR (CDCl3) δ: 7.16 (1H, dd), 6.98 (1H, d), 6.61 (1H, d), 3.78 (1H, s), 3.30 (2H, s), 2.89 (3H, s).
(5)
 化合物H5.0g、3,6-ジクロロ-ピリジン-2-カルボン酸4.8g、HOBt300mg、及びピリジン45mLの混合物に、氷冷下EDCI4.8gを加えた。反応混合物を室温で12時間撹拌した後、反応混合物を水に注いだ。析出した固体をろ取し、水で洗浄した後に乾燥し、固体I 8.0gを得た。
(6)
 固体I 8.0gと酢酸20mLとの混合物を、加熱還流下1.5時間撹拌した。得られた反応混合物を水に注ぎ、酢酸エチルで抽出した。得られた有機層を水、飽和炭酸水素ナトリウム水溶液、飽和塩化ナトリウムで順次洗浄し、硫酸ナトリウムで乾燥した後に、減圧下乾燥した。得られた固体をヘキサンで洗浄し、ろ取することにより下記化合物J7.0gを得た。
Figure JPOXMLDOC01-appb-I000031
化合物J:1H-NMR (CDCl3) δ: 8.22 (1H, d), 7.89 (1H, d), 7.66 (1H, dd), 7.49 (1H, d), 7.45 (1H, d), 3.90 (3H, s).
(7)
 化合物J6.9g、テトラヒドロフラン30mL、及び水素化ナトリウム(60%、油状)800mgの混合物を-10℃に冷却し、そこにエチルメルカプタン1.4mLおよびテトラヒドロフラン7mLの混合物を滴下した。滴下終了後室温に昇温し、7時間撹拌した。得られた反応混合物を、飽和炭酸水素ナトリウム水溶液に注ぎ、酢酸エチルで抽出した。得られた有機層を硫酸ナトリウムで乾燥後、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記化合物K770mgを得た。
Figure JPOXMLDOC01-appb-I000032
化合物K:1H-NMR (CDCl3) δ: 8.22 (1H, d), 7.72 (1H, d), 7.64 (1H, dd), 7.47 (1H, d), 7.38 (1H, d), 3.98 (3H, s), 2.95 (2H, q), 1.35 (3H, t).
 (8)
 化合物K770mg、及びクロロホルム8mLの混合物に、氷冷下m-クロロ過安息香酸(75%)470mgを加えた。氷冷下1時間撹拌した後、氷冷下炭酸水素ナトリウム320mg、水1mLおよびm-クロロ過安息香酸(75%)460mgを順次加えた。氷冷下5時間撹拌した後、この反応混合物に飽和炭酸水素ナトリウム水溶液および亜硫酸ナトリウムを加えた。この混合物をクロロホルムで抽出し、得られた有機層を硫酸ナトリウムで乾燥し、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記化合物L550mgを得た。
Figure JPOXMLDOC01-appb-I000033
化合物L:1H-NMR (CDCl3) δ: 8.46 (1H, d), 8.12 (1H, d), 7.70 (1H, d), 7.67 (1H, dd), 7.50 (1H, d), 3.87 (2H, q), 3.82 (3H, s), 1.37 (3H, t).
(9)
 化合物L270mg、DMF3mL、及び水素化ナトリウム(60%、油状)38mgの混合物に、氷冷下1H-1,2,4-トリアゾール52mgを加えた。室温に昇温し、2時間撹拌した。この反応混合物に飽和炭酸水素ナトリウム水溶液を加え、酢酸エチルで抽出した。得られた有機層を硫酸ナトリウムで乾燥した後、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記本発明化合物4を280mg得た。
Figure JPOXMLDOC01-appb-I000034
本発明化合物4:1H-NMR (CDCl3) δ: 9.15 (1H, s), 8.71 (1H, d), 8.28 (1H, d), 8.20 (1H, s), 8.16 (1H, d), 7.71 (1H, dd), 7.54 (1H, d), 3.85-3.79 (5H, m), 1.38 (3H, t).
(Production Example 4)
(1)
To a mixture of 20 g of 4- (trifluoromethylthio) -aniline and 40 mL of chloroform, 20 mL of acetic anhydride was added dropwise under ice cooling. After completion of the dropwise addition, 40 mL of chloroform was added to the mixture and stirred at room temperature for 12 hours. 80 mL of hexane was added to the obtained reaction mixture, the precipitated solid was filtered, and the obtained solid was washed with hexane to obtain 23 g of the following compound E.
Figure JPOXMLDOC01-appb-I000028
Compound E: 1 H-NMR (CDCl 3) δ: 8.28 (1H, d), 7.56 (1H, dd), 6.41 (1H, d), 5.44 (1H, s), 2.96 (3H, d).
(2)
A mixture of 22 g of Compound E and 96 mL of sulfuric acid was cooled to −10 ° C., and at the same temperature, a mixture of fuming nitric acid 7.2 mL and sulfuric acid 24 mL was added dropwise to reach 0 ° C. The reaction mixture was stirred for 6 hours under ice-cooling, and the reaction mixture was poured into water and extracted with chloroform. The organic layer was washed with water, dried over sodium sulfate, and then dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 10 g of the following compound F.
Figure JPOXMLDOC01-appb-I000029
Compound F: 1 H-NMR (CDCl 3 ) δ: 10.46 (1H, s), 8.93 (1H, d), 8.53 (1H, d), 7.90 (1H, dd), 2.33 (3H, s).
(3)
To a mixture of 10 g of compound F and 121 mL of DMF, 1.6 g of sodium hydride (60%, oily) was added under ice cooling, and the mixture was cooled to 0 ° C. To this mixture, a mixed solution of 2.4 mL of iodomethane and 20 mL of DMF was added dropwise under ice cooling. After completion of dropping, the mixture was warmed to room temperature and stirred for 4 hours. The obtained reaction mixture was poured into 1N aqueous hydrochloric acid and extracted with ethyl acetate. The obtained organic layer was washed with a 0.5N aqueous hydrochloric acid solution and a saturated aqueous sodium chloride solution, dried over sodium sulfate, and then dried under reduced pressure.
The obtained residue was diluted with a mixed solution of 55 mL of methanol and 18 mL of water. To this solution was added 5.8 g of sodium hydroxide under ice cooling, and the mixture was stirred at room temperature for 12 hours. The obtained reaction mixture was poured into 1N aqueous hydrochloric acid solution, and the precipitated solid was collected by filtration. The obtained solid was washed with water and dried to obtain 9.8 g of a solid G.
(4)
A mixture of 13 g of iron powder, 19 mL of acetic acid, 200 mL of tetrahydrofuran, and 28 mL of water was heated to 65 ° C., and a mixed solution of 14 g of solid G and 50 mL of tetrahydrofuran was added dropwise with stirring. After completion of dropping, the mixture was stirred at 65 ° C. for 3 hours. The resulting reaction mixture was filtered through Celite (registered trademark) and washed with tetrahydrofuran. The obtained filtrate was dried under reduced pressure. The obtained residue was diluted with a saturated aqueous solution, and extracted with ethyl acetate. The obtained organic layer was dried over sodium sulfate and then dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain the following compound H13 g.
Figure JPOXMLDOC01-appb-I000030
Compound H: 1 H-NMR (CDCl 3 ) δ: 7.16 (1H, dd), 6.98 (1H, d), 6.61 (1H, d), 3.78 (1H, s), 3.30 (2H, s), 2.89 ( 3H, s).
(5)
To a mixture of Compound H 5.0 g, 3,6-dichloro-pyridine-2-carboxylic acid 4.8 g, HOBt 300 mg, and pyridine 45 mL, EDCI 4.8 g was added under ice cooling. After stirring the reaction mixture at room temperature for 12 hours, the reaction mixture was poured into water. The precipitated solid was collected by filtration, washed with water and dried to obtain 8.0 g of solid I.
(6)
A mixture of 8.0 g of solid I and 20 mL of acetic acid was stirred with heating under reflux for 1.5 hours. The resulting reaction mixture was poured into water and extracted with ethyl acetate. The obtained organic layer was washed successively with water, saturated aqueous sodium hydrogen carbonate solution and saturated sodium chloride, dried over sodium sulfate, and then dried under reduced pressure. The obtained solid was washed with hexane and collected by filtration to obtain 7.0 g of the following compound J.
Figure JPOXMLDOC01-appb-I000031
Compound J: 1 H-NMR (CDCl 3 ) δ: 8.22 (1H, d), 7.89 (1H, d), 7.66 (1H, dd), 7.49 (1H, d), 7.45 (1H, d), 3.90 ( 3H, s).
(7)
A mixture of Compound J (6.9 g), tetrahydrofuran (30 mL) and sodium hydride (60%, oily) 800 mg was cooled to −10 ° C., and a mixture of ethyl mercaptan (1.4 mL) and tetrahydrofuran (7 mL) was added dropwise thereto. After completion of dropping, the mixture was warmed to room temperature and stirred for 7 hours. The resulting reaction mixture was poured into a saturated aqueous sodium hydrogen carbonate solution and extracted with ethyl acetate. The obtained organic layer was dried over sodium sulfate and then dried under reduced pressure. The resulting residue was subjected to silica gel chromatography to obtain 770 mg of the following compound K.
Figure JPOXMLDOC01-appb-I000032
Compound K: 1 H-NMR (CDCl 3 ) δ: 8.22 (1H, d), 7.72 (1H, d), 7.64 (1H, dd), 7.47 (1H, d), 7.38 (1H, d), 3.98 ( 3H, s), 2.95 (2H, q), 1.35 (3H, t).
(8)
To a mixture of 770 mg of Compound K and 8 mL of chloroform, 470 mg of m-chloroperbenzoic acid (75%) was added under ice cooling. After stirring for 1 hour under ice cooling, 320 mg of sodium hydrogen carbonate, 1 mL of water and 460 mg of m-chloroperbenzoic acid (75%) were sequentially added under ice cooling. After stirring for 5 hours under ice cooling, a saturated aqueous sodium hydrogen carbonate solution and sodium sulfite were added to the reaction mixture. This mixture was extracted with chloroform, and the resulting organic layer was dried over sodium sulfate and dried under reduced pressure. The obtained residue was subjected to silica gel chromatography, so as to obtain the following compound L550 mg.
Figure JPOXMLDOC01-appb-I000033
Compound L: 1 H-NMR (CDCl 3 ) δ: 8.46 (1H, d), 8.12 (1H, d), 7.70 (1H, d), 7.67 (1H, dd), 7.50 (1H, d), 3.87 ( 2H, q), 3.82 (3H, s), 1.37 (3H, t).
(9)
To a mixture of Compound L270 mg, DMF 3 mL, and sodium hydride (60%, oily) 38 mg, 52 mg of 1H-1,2,4-triazole was added under ice cooling. The mixture was warmed to room temperature and stirred for 2 hours. Saturated aqueous sodium hydrogen carbonate solution was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over sodium sulfate and then dried under reduced pressure. The resulting residue was subjected to silica gel chromatography to obtain 280 mg of the following present compound 4.
Figure JPOXMLDOC01-appb-I000034
Compound 4 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.15 (1H, s), 8.71 (1H, d), 8.28 (1H, d), 8.20 (1H, s), 8.16 (1H, d), 7.71 (1H, dd), 7.54 (1H, d), 3.85-3.79 (5H, m), 1.38 (3H, t).
(製造例5)
 1H-1,2,4-トリアゾールに代えて、3-クロロ-1H-1,2,4トリアゾールを用い、製造例4(9)記載の方法に準じて下記の本発明化合物5を得た。
Figure JPOXMLDOC01-appb-I000035
本発明化合物5:1H-NMR (CDCl3) δ: 9.05 (1H, s), 8.71 (1H, d), 8.20 (1H, d), 8.15 (1H, d), 7.71 (1H, dd), 7.54 (1H, d), 3.84-3.77 (5H, m), 1.37 (3H, t).
(Production Example 5)
The following compound 5 of the present invention was obtained according to the method described in Production Example 4 (9) using 3-chloro-1H-1,2,4 triazole instead of 1H-1,2,4-triazole.
Figure JPOXMLDOC01-appb-I000035
Compound 5 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.05 (1H, s), 8.71 (1H, d), 8.20 (1H, d), 8.15 (1H, d), 7.71 (1H, dd), 7.54 (1H, d), 3.84-3.77 (5H, m), 1.37 (3H, t).
(製造例6)
(1)
 化合物J2.2g、DMF12mL、及び水素化ナトリウム(60%、油状)510mgの混合物を0℃に冷却し、同温度でエチルメルカプタン0.90mLを滴下した。この反応混合物を室温に昇温し、室温で12時間撹拌した。得られた反応混合物を水に注ぎ、析出した固体をろ取し、得られた固体を水で洗浄し、乾燥することにより下記化合物M2.3gを得た。
Figure JPOXMLDOC01-appb-I000036
化合物M:1H-NMR (CDCl3) δ: 8.22 (1H, d), 7.65-7.59 (2H, m), 7.47 (1H, dd), 7.24 (1H, d), 3.92 (3H, s), 3.16 (2H, q), 2.90 (2H, q), 1.35 (3H, t), 1.29 (3H, t).
(2)
 化合物M 5.9g、及びクロロホルム 70mLの混合物に、氷冷下m-クロロ過安息香酸(70%)12gを加えた。この反応混合物を室温に昇温し、12時間撹拌した。得られた反応混合物に飽和炭酸水素ナトリウム水溶液および亜硫酸ナトリウムを加え、室温で1時間撹拌した。この混合物をクロロホルムで抽出し、得られた有機層を水、飽和塩化ナトリウム水溶液で洗浄し、硫酸ナトリウムで乾燥した後に、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記化合物N2.2gを得た。
Figure JPOXMLDOC01-appb-I000037
化合物N:1H-NMR (CDCl3) δ: 8.81 (1H, d), 8.43 (1H, d), 8.14 (1H, d), 7.71 (1H, dd), 7.54 (1H, d), 3.97 (2H, q), 3.85 (3H, s), 3.46 (2H, q), 1.41 (3H, t), 1.36 (3H, t).
(3)
 化合物N2.1g、及びクロロホルム22mLの混合物に、氷冷下m-クロロ過安息香酸(75%)1.0gを加えた。氷冷下2時間撹拌した後、この反応混合物にさらにm-クロロ過安息香酸(75%)1.0gを加えた。室温に昇温し、12時間撹拌した後、この反応混合物に飽和炭酸水素ナトリウム水溶液および亜硫酸ナトリウムを加え、クロロホルムで抽出した。得られた有機層を硫酸ナトリウムで乾燥した後、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記化合物O 2.1gを得た。
Figure JPOXMLDOC01-appb-I000038
化合物O:1H-NMR (CDCl3) δ: 8.83 (1H, d), 8.46 (1H, d), 8.31 (1H, d), 7.83 (1H, dd), 7.73 (1H, d), 3.97 (2H, q), 3.90 (3H, s), 3.47 (2H, q), 1.46-1.33 (6H, m).
(4)
 化合物O 350mg、DMF1.5mL、及び水素化ナトリウム(60%、油状)53mgの混合物に、氷冷下1H-1,2,4-トリアゾール37mgを加えた。室温に昇温し、5時間撹拌した。得られた反応混合物に飽和炭酸水素ナトリウム水溶液を加え、酢酸エチルで抽出した。得られた有機層を、硫酸ナトリウムで乾燥した後、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記本発明化合物6を260mg得た。
Figure JPOXMLDOC01-appb-I000039
本発明化合物6:1H-NMR (CDCl3) δ: 9.16 (1H, s), 8.72 (1H, d), 8.33-8.28 (2H, m), 8.20 (1H, s), 7.84 (1H, dd), 7.73 (1H, d), 3.87 (3H, s), 3.82 (2H, q), 1.38 (3H, t).
(Production Example 6)
(1)
A mixture of 2.2 g of Compound J, 12 mL of DMF, and 510 mg of sodium hydride (60%, oily) was cooled to 0 ° C., and 0.90 mL of ethyl mercaptan was added dropwise at the same temperature. The reaction mixture was warmed to room temperature and stirred at room temperature for 12 hours. The obtained reaction mixture was poured into water, the precipitated solid was collected by filtration, and the obtained solid was washed with water and dried to obtain 2.3 g of the following compound M.
Figure JPOXMLDOC01-appb-I000036
Compound M: 1 H-NMR (CDCl 3 ) δ: 8.22 (1H, d), 7.65-7.59 (2H, m), 7.47 (1H, dd), 7.24 (1H, d), 3.92 (3H, s), 3.16 (2H, q), 2.90 (2H, q), 1.35 (3H, t), 1.29 (3H, t).
(2)
To a mixture of 5.9 g of Compound M and 70 mL of chloroform, 12 g of m-chloroperbenzoic acid (70%) was added under ice cooling. The reaction mixture was warmed to room temperature and stirred for 12 hours. A saturated aqueous sodium hydrogen carbonate solution and sodium sulfite were added to the obtained reaction mixture, and the mixture was stirred at room temperature for 1 hour. This mixture was extracted with chloroform, and the resulting organic layer was washed with water and a saturated aqueous sodium chloride solution, dried over sodium sulfate, and then dried under reduced pressure. The resulting residue was subjected to silica gel chromatography to obtain 2.2 g of the following compound N.
Figure JPOXMLDOC01-appb-I000037
Compound N: 1 H-NMR (CDCl 3 ) δ: 8.81 (1H, d), 8.43 (1H, d), 8.14 (1H, d), 7.71 (1H, dd), 7.54 (1H, d), 3.97 ( 2H, q), 3.85 (3H, s), 3.46 (2H, q), 1.41 (3H, t), 1.36 (3H, t).
(3)
To a mixture of 2.1 g of compound N and 22 mL of chloroform, 1.0 g of m-chloroperbenzoic acid (75%) was added under ice cooling. After stirring for 2 hours under ice cooling, 1.0 g of m-chloroperbenzoic acid (75%) was further added to the reaction mixture. After warming to room temperature and stirring for 12 hours, a saturated aqueous sodium hydrogen carbonate solution and sodium sulfite were added to the reaction mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over sodium sulfate and then dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 2.1 g of the following compound O.
Figure JPOXMLDOC01-appb-I000038
Compound O: 1 H-NMR (CDCl 3 ) δ: 8.83 (1H, d), 8.46 (1H, d), 8.31 (1H, d), 7.83 (1H, dd), 7.73 (1H, d), 3.97 ( 2H, q), 3.90 (3H, s), 3.47 (2H, q), 1.46-1.33 (6H, m).
(4)
To a mixture of 350 mg of Compound O, 1.5 mL of DMF, and 53 mg of sodium hydride (60%, oily), 37 mg of 1H-1,2,4-triazole was added under ice cooling. The mixture was warmed to room temperature and stirred for 5 hours. A saturated aqueous sodium hydrogen carbonate solution was added to the obtained reaction mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over sodium sulfate and then dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 260 mg of the following present compound 6.
Figure JPOXMLDOC01-appb-I000039
The present invention Compound 6: 1 H-NMR (CDCl 3) δ: 9.16 (1H, s), 8.72 (1H, d), 8.33-8.28 (2H, m), 8.20 (1H, s), 7.84 (1H, dd ), 7.73 (1H, d), 3.87 (3H, s), 3.82 (2H, q), 1.38 (3H, t).
(製造例7)
 1H-1,2,4-トリアゾールに代えて、3-クロロ-1H-1,2,4-トリアゾールを用い、製造例6(4)に記載の方法に準じて、下記本発明化合物7を得た。
Figure JPOXMLDOC01-appb-I000040
本発明化合物7:1H-NMR (CDCl3) δ: 9.06 (1H, s), 8.73 (1H, d), 8.31 (1H, s), 8.23 (1H, d), 7.84 (1H, d), 7.73 (1H, d), 3.86 (3H, s), 3.80 (2H, q), 1.38 (3H, t).
(Production Example 7)
The following compound 7 of the present invention is obtained according to the method described in Production Example 6 (4) using 3-chloro-1H-1,2,4-triazole instead of 1H-1,2,4-triazole. It was.
Figure JPOXMLDOC01-appb-I000040
Compound 7 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.06 (1H, s), 8.73 (1H, d), 8.31 (1H, s), 8.23 (1H, d), 7.84 (1H, d), 7.73 (1H, d), 3.86 (3H, s), 3.80 (2H, q), 1.38 (3H, t).
(製造例8)
(1)
 化合物M2.3g、アセトニトリル25mL、及びタングステン酸ナトリウム2水和物330mgの混合物を60℃に加熱し、撹拌しながら30%過酸化水素水8mLを滴下した。滴下完了後、60℃で7時間撹拌した。得られた反応混合物を室温まで放冷後、飽和炭酸水素ナトリウム水溶液および亜硫酸ナトリウムを加え、酢酸エチルで抽出した。得られた有機層を飽和塩化ナトリウム水溶液で洗浄し、硫酸ナトリウムで乾燥した後に、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記化合物P1.5gを得た。
Figure JPOXMLDOC01-appb-I000041
化合物P:1H-NMR (DMSO-D6) δ: 8.89 (1H, d), 8.60 (1H, d), 8.56 (1H, d), 8.21 (1H, d), 8.13 (1H, dd), 3.96 (2H, q), 3.91 (3H, s), 3.60 (2H, q), 1.28-1.15 (6H, m).
(2)
 化合物P200mg、DMF1mL、及び水素化ナトリウム(60%、油状)20mgの混合物に、氷冷下1H-1,2,4-トリアゾール33mgを加えた。室温に昇温し、5時間撹拌した。得られた反応混合物に飽和炭酸水素ナトリウム水溶液を加え、酢酸エチルで抽出した。得られた有機層を、硫酸ナトリウムで乾燥した後、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記本発明化合物8を190mg得た。
Figure JPOXMLDOC01-appb-I000042
本発明化合物8:1H-NMR (CDCl3) δ: 9.14 (1H, s), 8.72 (1H, d), 8.56 (1H, s), 8.32 (1H, d), 8.21 (1H, s), 8.07 (1H, d), 7.75 (1H, d), 3.88 (3H, d), 3.79 (2H, q), 1.39 (3H, t).
(Production Example 8)
(1)
A mixture of 2.3 g of Compound M, 25 mL of acetonitrile, and 330 mg of sodium tungstate dihydrate was heated to 60 ° C., and 8 mL of 30% aqueous hydrogen peroxide was added dropwise with stirring. After completion of dropping, the mixture was stirred at 60 ° C. for 7 hours. The resulting reaction mixture was allowed to cool to room temperature, saturated aqueous sodium hydrogen carbonate solution and sodium sulfite were added, and the mixture was extracted with ethyl acetate. The obtained organic layer was washed with a saturated aqueous sodium chloride solution, dried over sodium sulfate, and then dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 1.5 g of the following compound P.
Figure JPOXMLDOC01-appb-I000041
Compound P: 1 H-NMR (DMSO-D 6 ) δ: 8.89 (1H, d), 8.60 (1H, d), 8.56 (1H, d), 8.21 (1H, d), 8.13 (1H, dd), 3.96 (2H, q), 3.91 (3H, s), 3.60 (2H, q), 1.28-1.15 (6H, m).
(2)
To a mixture of 200 mg of Compound P, 1 mL of DMF, and 20 mg of sodium hydride (60%, oily), 33 mg of 1H-1,2,4-triazole was added under ice cooling. The mixture was warmed to room temperature and stirred for 5 hours. A saturated aqueous sodium hydrogen carbonate solution was added to the obtained reaction mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over sodium sulfate and then dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 190 mg of the following present compound 8.
Figure JPOXMLDOC01-appb-I000042
Present compound 8: 1 H-NMR (CDCl 3) δ: 9.14 (1H, s), 8.72 (1H, d), 8.56 (1H, s), 8.32 (1H, d), 8.21 (1H, s), 8.07 (1H, d), 7.75 (1H, d), 3.88 (3H, d), 3.79 (2H, q), 1.39 (3H, t).
(製造例9)
1H-1,2,4-トリアゾールに代えて、3-クロロ-1H-1,2,4-トリアゾールを用い、製造例8(2)に記載の方法に準じて、下記本発明化合物9を得た。
Figure JPOXMLDOC01-appb-I000043
本発明化合物9:1H-NMR (CDCl3) δ: 9.05 (1H, s), 8.73 (1H, d), 8.55 (1H, d), 8.25 (1H, d), 8.06 (1H, dd), 7.75 (1H, d), 3.88 (3H, s), 3.78 (2H, q), 1.39 (3H, t).
(Production Example 9)
The following compound 9 of the present invention is obtained according to the method described in Preparation Example 8 (2) using 3-chloro-1H-1,2,4-triazole instead of 1H-1,2,4-triazole. It was.
Figure JPOXMLDOC01-appb-I000043
Compound 9 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.05 (1H, s), 8.73 (1H, d), 8.55 (1H, d), 8.25 (1H, d), 8.06 (1H, dd), 7.75 (1H, d), 3.88 (3H, s), 3.78 (2H, q), 1.39 (3H, t).
(製造例10)
 化合物P200mg、DMF0.8mL、及び水素化ナトリウム(60%、油状)20mgの混合物に、氷冷下3-メチルチオ-1H-1,2,4-トリアゾール57mgを加えた。室温に昇温し、5時間撹拌した。得られた反応混合物に飽和炭酸水素ナトリウム水溶液を加え、酢酸エチルで抽出した。得られた有機層を、硫酸ナトリウムで乾燥した後、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記本発明化合物10を120mg得た。
Figure JPOXMLDOC01-appb-I000044
本発明化合物10:1H-NMR (CDCl3) δ: 9.04 (1H, s), 8.68 (1H, d), 8.56 (1H, s), 8.22 (1H, d), 8.07 (1H, d), 7.74 (1H, d), 3.86 (3H, s), 3.77 (2H, q), 2.71 (3H, s), 1.38 (3H, t).
(Production Example 10)
To a mixture of 200 mg of Compound P, 0.8 mL of DMF, and 20 mg of sodium hydride (60%, oily), 57 mg of 3-methylthio-1H-1,2,4-triazole was added under ice cooling. The mixture was warmed to room temperature and stirred for 5 hours. A saturated aqueous sodium hydrogen carbonate solution was added to the obtained reaction mixture, and the mixture was extracted with ethyl acetate. The obtained organic layer was dried over sodium sulfate and then dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 120 mg of the following present compound 10.
Figure JPOXMLDOC01-appb-I000044
Compound 10 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.04 (1H, s), 8.68 (1H, d), 8.56 (1H, s), 8.22 (1H, d), 8.07 (1H, d), 7.74 (1H, d), 3.86 (3H, s), 3.77 (2H, q), 2.71 (3H, s), 1.38 (3H, t).
(製造例11)
本発明化合物10を120mg、及びクロロホルム5mLの混合物に、氷冷下m-クロロ過安息香酸(75%)120mgを加えた。室温に昇温し、12時間撹拌した。得られた反応混合物に、飽和炭酸水素ナトリウム水溶液および亜硫酸ナトリウムを加え、クロロホルムで抽出した。得られた有機層を硫酸ナトリウムで乾燥した後、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記本発明化合物11を80mg得た。
Figure JPOXMLDOC01-appb-I000045
本発明化合物11:1H-NMR (CDCl3) δ: 9.25 (1H, s), 8.80 (1H, d), 8.57 (1H, d), 8.42 (1H, d), 8.09 (1H, dd), 7.76 (1H, d), 3.88 (3H, s), 3.79 (2H, q), 3.39 (3H, s), 1.40 (3H, t).
(Production Example 11)
To a mixture of 120 mg of the present compound 10 and 5 mL of chloroform, 120 mg of m-chloroperbenzoic acid (75%) was added under ice cooling. The mixture was warmed to room temperature and stirred for 12 hours. A saturated aqueous sodium hydrogen carbonate solution and sodium sulfite were added to the obtained reaction mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over sodium sulfate and then dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 80 mg of the following present compound 11.
Figure JPOXMLDOC01-appb-I000045
Compound 11 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.25 (1H, s), 8.80 (1H, d), 8.57 (1H, d), 8.42 (1H, d), 8.09 (1H, dd), 7.76 (1H, d), 3.88 (3H, s), 3.79 (2H, q), 3.39 (3H, s), 1.40 (3H, t).
(製造例12)
(1)
 3,6-ジクロロ-ピリジン-2-カルボン酸2.7g、及びトルエン27mLの混合物に、室温で塩化チオニル2.0mL、およびDMF1滴を順次加えた。この反応混合物を100℃に昇温し、1.5時間撹拌した後、この反応混合物を減圧濃縮した。得られた残渣に室温で、テトラヒドロフラン27mL、及び2-アミノ-4-トリフルオロメチルフェノール2.4gの混合物を加え、室温で5時間撹拌した。この反応混合物に水を加え、酢酸エチルで抽出した。有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した後、減圧下乾燥し、下記化合物Q4.7gを得た。

Figure JPOXMLDOC01-appb-I000046
化合物Q:1H-NMR (CDCl3) δ: 9.96 (1H, s), 8.82 (1H, s), 7.89 (1H, d), 7.62 (1H, d), 7.52 (1H, d), 7.44 (1H, dd), 7.14 (1H, d).
(2)
 化合物Q3.7g、トリフェニルホスフィン3.3g、テトラヒドロフラン21mLの混合物に、氷冷下、アゾジカルボン酸ビス(2-メトキシエチル)3.2gを加え、室温で5時間撹拌した。この混合物に飽和塩化アンモニウム水溶液を加え、酢酸エチルで抽出した。有機層を飽和食塩水で洗浄後、無水硫酸ナトリウムで乾燥し、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記化合物R3.0gを得た。
Figure JPOXMLDOC01-appb-I000047
化合物R:1H-NMR (CDCl3) δ: 8.22 (1H, s), 7.92 (1H, d), 7.81 (1H, d), 7.75 (1H, d), 7.49 (1H, d).
(3)
 化合物R3.0g、水素化ナトリウム(60%、油状)390mg、及びテトラヒドロフラン30mLの混合物に、氷冷下エチルメルカプタン650μLを滴下した。この混合物を室温で1時間撹拌した後、水を加え、固体が析出した。この固体を濾過後、得られた固体をメチルtert-ブチルエーテル:ヘキサン=1:3の混合溶媒で洗浄し、下記化合物S2.9gを得た。
Figure JPOXMLDOC01-appb-I000048
化合物S:1H-NMR (CDCl3) δ: 8.23 (1H, d), 7.80 (1H, d), 7.74 (1H, d), 7.71 (1H, dd), 7.44 (1H, d).
(4)
 化合物S2.9g、及びクロロホルム27mLの混合物を0℃に冷却し、ここにメタクロロ過安息香酸3.9gを加えた。この反応混合物を室温で3時間撹拌した後、氷冷下飽和亜硫酸ナトリウム水溶液と飽和炭酸水素ナトリウム水溶液を加えた。この反応混合物をクロロホルムで抽出し、得られた有機層を、無水硫酸ナトリウムで乾燥した後、減圧下乾燥し下記化合物T3.0gを得た。
Figure JPOXMLDOC01-appb-I000049
化合物T:1H-NMR (CDCl3) δ: 8.53 (1H, d), 8.15 (1H, t), 7.80-7.76 (3H, m), 4.02 (2H, q), 1.44 (3H, t).
(5)
 化合物T2.0g、及びクロロホルム 20mLの混合物に、室温で1,2,4-トリアゾール710mg、ジイソプロピルエチルアミン1.8mL、及びN,N-ジメチル-4-アミノピリジン120mgを順次加えた。この反応混合物を70℃に昇温し、15時間撹拌した後、水を加え、クロロホルムで抽出した。得られた有機層を、無水硫酸ナトリウムで乾燥した後、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記本発明化合物12を2.0g得た。
Figure JPOXMLDOC01-appb-I000050
本発明化合物12:1H-NMR (CDCl3) δ: 9.30 (1H, s), 8.75 (1H, d), 8.30 (1H, d), 8.20-8.18 (2H, m), 7.84-7.81 (2H, m), 4.00 (2H, q), 1.45 (3H, t).
(Production Example 12)
(1)
To a mixture of 2.7 g of 3,6-dichloro-pyridine-2-carboxylic acid and 27 mL of toluene, 2.0 mL of thionyl chloride and 1 drop of DMF were sequentially added at room temperature. The reaction mixture was heated to 100 ° C. and stirred for 1.5 hours, and then the reaction mixture was concentrated under reduced pressure. To the obtained residue, a mixture of 27 mL of tetrahydrofuran and 2.4 g of 2-amino-4-trifluoromethylphenol was added at room temperature, and the mixture was stirred at room temperature for 5 hours. Water was added to the reaction mixture, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and then dried under reduced pressure to obtain 4.7 g of the following compound Q.

Figure JPOXMLDOC01-appb-I000046
Compound Q: 1 H-NMR (CDCl 3 ) δ: 9.96 (1H, s), 8.82 (1H, s), 7.89 (1H, d), 7.62 (1H, d), 7.52 (1H, d), 7.44 ( 1H, dd), 7.14 (1H, d).
(2)
To a mixture of 3.7 g of compound Q, 3.3 g of triphenylphosphine, and 21 mL of tetrahydrofuran, 3.2 g of bis (2-methoxyethyl) azodicarboxylate was added under ice cooling, and the mixture was stirred at room temperature for 5 hours. To this mixture was added a saturated aqueous ammonium chloride solution, and the mixture was extracted with ethyl acetate. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 3.0 g of the following compound R.
Figure JPOXMLDOC01-appb-I000047
Compound R: 1 H-NMR (CDCl 3 ) δ: 8.22 (1H, s), 7.92 (1H, d), 7.81 (1H, d), 7.75 (1H, d), 7.49 (1H, d).
(3)
To a mixture of 3.0 g of Compound R, 390 mg of sodium hydride (60%, oily), and 30 mL of tetrahydrofuran, 650 μL of ethyl mercaptan was added dropwise under ice cooling. After this mixture was stirred at room temperature for 1 hour, water was added to precipitate a solid. After filtering this solid, the obtained solid was washed with a mixed solvent of methyl tert-butyl ether: hexane = 1: 3 to obtain 2.9 g of the following compound S.
Figure JPOXMLDOC01-appb-I000048
Compound S: 1 H-NMR (CDCl 3) δ: 8.23 (1H, d), 7.80 (1H, d), 7.74 (1H, d), 7.71 (1H, dd), 7.44 (1H, d).
(4)
A mixture of 2.9 g of compound S and 27 mL of chloroform was cooled to 0 ° C., and 3.9 g of metachloroperbenzoic acid was added thereto. The reaction mixture was stirred at room temperature for 3 hours, and then a saturated aqueous sodium sulfite solution and a saturated aqueous sodium hydrogen carbonate solution were added under ice cooling. This reaction mixture was extracted with chloroform, and the obtained organic layer was dried over anhydrous sodium sulfate and then dried under reduced pressure to obtain 3.0 g of the following compound T.
Figure JPOXMLDOC01-appb-I000049
Compound T: 1 H-NMR (CDCl 3 ) δ: 8.53 (1H, d), 8.15 (1H, t), 7.80-7.76 (3H, m), 4.02 (2H, q), 1.44 (3H, t).
(5)
To a mixture of 2.0 g of Compound T and 20 mL of chloroform, 710 mg of 1,2,4-triazole, 1.8 mL of diisopropylethylamine, and 120 mg of N, N-dimethyl-4-aminopyridine were sequentially added at room temperature. The reaction mixture was heated to 70 ° C. and stirred for 15 hours, water was added, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous sodium sulfate and then dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 2.0 g of the following present compound 12.
Figure JPOXMLDOC01-appb-I000050
Compound 12 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.30 (1H, s), 8.75 (1H, d), 8.30 (1H, d), 8.20-8.18 (2H, m), 7.84-7.81 (2H , m), 4.00 (2H, q), 1.45 (3H, t).
(製造例13)
(1)
 3,6-ジクロロ-ピリジン-2-カルボン酸12g、及びテトラヒドロフラン80mLの混合物にオキサリルクロライド6.4mL、及びN,N-ジメチルホルムアミド1滴を加え室温で1時間撹拌した。この反応混合物を濃縮し30mLのテトラヒドロフランに溶解し、これを、2-アミノ-4-(トリフルオロメチルスルファニル)フェノール13g、及びテトラヒドロフラン50mLの混合物に氷冷下で滴下した。室温で1時間撹拌した後、この反応混合物を飽和重層水溶液に加え、酢酸エチルで抽出した。得られた有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥した後に、減圧下乾燥することで下記化合物U23gを得た。
Figure JPOXMLDOC01-appb-I000051
化合物U:1H-NMR (DMSO-D6) δ: 11.14 (1H, s), 10.20 (1H, s), 8.54 (1H, d), 8.17 (1H, t), 7.77 (1H, d), 7.38 (1H, dd), 7.06 (1H, d).
(2)
 化合物U23g、p-トルエンスルホン酸一水和物2.3g、及びキシレン70mLの混合物を、加熱還流下2時間撹拌した。この混合物を室温まで放冷した後、飽和重層水溶液に加え、酢酸エチルで抽出した。得られた有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥し、減圧下乾燥した。得られた粗生成物を、ヘキサン/イソプロパノールで洗浄することで、下記化合物V17gを得た。
Figure JPOXMLDOC01-appb-I000052
化合物V:1H-NMR (CDCl3) δ: 8.25 (1H, s), 7.91 (1H, d), 7.79-7.72 (2H, m), 7.48 (1H, d).
(3)
 化合物V17g、水素化ナトリウム(60%、油状)2.1g、及びテトラヒドロフラン140mLの混合物を0℃に冷却し、エチルメルカプタン3.5mLを滴下した。この混合物を氷冷下3時間撹拌した後、この反応混合物を水に注ぎ、析出した固体を濾過した。得られた固体をヘキサン/メチル-tert-ブチルエーテルで洗浄し、乾燥することにより化合物Wを17g得た。
Figure JPOXMLDOC01-appb-I000053
化合物W:1H-NMR (CDCl3) δ: 8.26 (1H, s), 7.77-7.69 (3H, m), 7.44 (1H, d), 3.06 (2H, q), 1.47 (3H, t).
(4)
化合物W17gおよびクロロホルム130mLの混合物を0℃に冷却し、75%m-クロロ過安息香酸9.7gを加え、氷冷下2時間撹拌した。この混合物に、氷冷下75%m-クロロ過安息香酸9.7gをさらに加え、氷冷下1時間撹拌した。この混合物に、氷冷下さらに75%m-クロロ過安息香酸10gを加え、氷冷下19時間撹拌した。この反応混合物を飽和重層水溶液に加え、クロロホルムで抽出した。有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥し、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記化合物X3.0g、化合物Y14gおよび化合物Z0.6gを得た。
  化合物X
Figure JPOXMLDOC01-appb-I000054
化合物X:1H-NMR (CDCl3) δ: 8.52 (1H, d), 8.18 (1H, d), 7.80-7.72 (3H, m), 4.03 (2H, q), 1.43 (3H, t).
  化合物Y
Figure JPOXMLDOC01-appb-I000055
化合物Y:1H-NMR (CDCl3) δ: 8.53 (1H, d), 8.36 (1H, d), 7.94 (1H, dd), 7.89 (1H, d), 7.76 (1H, d), 4.01 (2H, q), 1.44 (3H, t).
  化合物Z
Figure JPOXMLDOC01-appb-I000056
化合物Z:1H-NMR (CDCl3) δ: 8.59 (1H, d), 8.54 (1H, d), 8.18 (1H, dd), 7.98 (1H, d), 7.79 (1H, d), 3.98 (2H, q), 1.45 (3H, t).
(5)
 化合物X200mg、及びクロロホルム1mLの混合物に、1,2,4-トリアゾール650mg、N,N-ジイソプロピルエチルアミン0.16mL、及びN,N-ジメチル-4-アミノピリジン5.0mgを順次加えた。この反応混合物を室温で7時間撹拌した後、この反応混合物に水を加え、クロロホルムで抽出した。得られた有機層を、無水硫酸ナトリウムで乾燥した後、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記本発明化合物13を200mg得た。
Figure JPOXMLDOC01-appb-I000057
本発明化合物13:1H-NMR (CDCl3) δ: 9.29 (1H, s), 8.74 (1H, d), 8.29 (1H, d), 8.21 (2H, t), 7.82 (1H, dd), 7.77 (1H, d), 4.00 (2H, q), 1.45 (3H, t).
(Production Example 13)
(1)
To a mixture of 12 g of 3,6-dichloro-pyridine-2-carboxylic acid and 80 mL of tetrahydrofuran, 6.4 mL of oxalyl chloride and 1 drop of N, N-dimethylformamide were added and stirred at room temperature for 1 hour. The reaction mixture was concentrated and dissolved in 30 mL of tetrahydrofuran, and this was added dropwise to a mixture of 13 g of 2-amino-4- (trifluoromethylsulfanyl) phenol and 50 mL of tetrahydrofuran under ice cooling. After stirring at room temperature for 1 hour, the reaction mixture was added to a saturated aqueous multilayer solution and extracted with ethyl acetate. The obtained organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and then dried under reduced pressure to obtain 23 g of the following compound U.
Figure JPOXMLDOC01-appb-I000051
Compound U: 1 H-NMR (DMSO-D 6 ) δ: 11.14 (1H, s), 10.20 (1H, s), 8.54 (1H, d), 8.17 (1H, t), 7.77 (1H, d), 7.38 (1H, dd), 7.06 (1H, d).
(2)
A mixture of Compound U23g, p-toluenesulfonic acid monohydrate 2.3g, and xylene 70mL was stirred with heating under reflux for 2 hours. The mixture was allowed to cool to room temperature, added to a saturated aqueous multilayer solution, and extracted with ethyl acetate. The obtained organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and dried under reduced pressure. The obtained crude product was washed with hexane / isopropanol to obtain 17 g of the following compound V.
Figure JPOXMLDOC01-appb-I000052
Compound V: 1 H-NMR (CDCl 3 ) δ: 8.25 (1H, s), 7.91 (1H, d), 7.79-7.72 (2H, m), 7.48 (1H, d).
(3)
A mixture of 17 g of Compound V, 2.1 g of sodium hydride (60%, oily), and 140 mL of tetrahydrofuran was cooled to 0 ° C., and 3.5 mL of ethyl mercaptan was added dropwise. The mixture was stirred for 3 hours under ice cooling, and then the reaction mixture was poured into water, and the precipitated solid was filtered. The obtained solid was washed with hexane / methyl-tert-butyl ether and dried to obtain 17 g of Compound W.
Figure JPOXMLDOC01-appb-I000053
Compound W: 1 H-NMR (CDCl 3 ) δ: 8.26 (1H, s), 7.77-7.69 (3H, m), 7.44 (1H, d), 3.06 (2H, q), 1.47 (3H, t).
(4)
A mixture of 17 g of Compound W and 130 mL of chloroform was cooled to 0 ° C., 9.7 g of 75% m-chloroperbenzoic acid was added, and the mixture was stirred for 2 hours under ice cooling. To this mixture, 9.7 g of 75% m-chloroperbenzoic acid was further added under ice cooling, and the mixture was stirred for 1 hour under ice cooling. To this mixture was further added 10 g of 75% m-chloroperbenzoic acid under ice cooling, and the mixture was stirred for 19 hours under ice cooling. This reaction mixture was added to a saturated multilayer aqueous solution and extracted with chloroform. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain the following compound X3.0 g, compound Y14 g and compound Z0.6 g.
Compound X
Figure JPOXMLDOC01-appb-I000054
Compound X: 1 H-NMR (CDCl 3 ) δ: 8.52 (1H, d), 8.18 (1H, d), 7.80-7.72 (3H, m), 4.03 (2H, q), 1.43 (3H, t).
Compound Y
Figure JPOXMLDOC01-appb-I000055
Compound Y: 1 H-NMR (CDCl 3 ) δ: 8.53 (1H, d), 8.36 (1H, d), 7.94 (1H, dd), 7.89 (1H, d), 7.76 (1H, d), 4.01 ( 2H, q), 1.44 (3H, t).
Compound Z
Figure JPOXMLDOC01-appb-I000056
Compound Z: 1 H-NMR (CDCl 3 ) δ: 8.59 (1H, d), 8.54 (1H, d), 8.18 (1H, dd), 7.98 (1H, d), 7.79 (1H, d), 3.98 ( 2H, q), 1.45 (3H, t).
(5)
To a mixture of 200 mg of Compound X and 1 mL of chloroform, 650 mg of 1,2,4-triazole, 0.16 mL of N, N-diisopropylethylamine, and 5.0 mg of N, N-dimethyl-4-aminopyridine were sequentially added. The reaction mixture was stirred at room temperature for 7 hours, water was added to the reaction mixture, and the mixture was extracted with chloroform. The obtained organic layer was dried over anhydrous sodium sulfate and then dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 200 mg of the following present compound 13.
Figure JPOXMLDOC01-appb-I000057
Compound 13 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.29 (1H, s), 8.74 (1H, d), 8.29 (1H, d), 8.21 (2H, t), 7.82 (1H, dd), 7.77 (1H, d), 4.00 (2H, q), 1.45 (3H, t).
(製造例14)
本発明化合物13を260mgおよびクロロホルム5mLの混合物を0℃に冷却し、75%m-クロロ過安息香酸140mgを加え、室温で16時間撹拌した。この反応混合物を飽和重層水溶液に加え、クロロホルムで抽出した。有機層を飽和食塩水で洗浄し、無水硫酸ナトリウムで乾燥し、減圧下乾燥した。得られた残渣をシリカゲルクロマトグラフィーに付し、下記本発明化合物14を180mg得た。
Figure JPOXMLDOC01-appb-I000058
本発明化合物14:1H-NMR (CDCl3) δ: 9.29 (1H, s), 8.76 (1H, d), 8.39 (1H, s), 8.32 (1H, d), 8.21 (1H, s), 7.98 (1H, d), 7.93 (1H, d), 3.99 (2H, q), 1.46 (3H, t).
(Production Example 14)
A mixture of 260 mg of the present compound 13 and 5 mL of chloroform was cooled to 0 ° C., 140 mg of 75% m-chloroperbenzoic acid was added, and the mixture was stirred at room temperature for 16 hours. This reaction mixture was added to a saturated multilayer aqueous solution and extracted with chloroform. The organic layer was washed with saturated brine, dried over anhydrous sodium sulfate, and dried under reduced pressure. The obtained residue was subjected to silica gel chromatography to obtain 180 mg of the present compound 14 shown below.
Figure JPOXMLDOC01-appb-I000058
Compound 14 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.29 (1H, s), 8.76 (1H, d), 8.39 (1H, s), 8.32 (1H, d), 8.21 (1H, s), 7.98 (1H, d), 7.93 (1H, d), 3.99 (2H, q), 1.46 (3H, t).
(製造例15)
化合物Xに代えて化合物Zを用い、製造例13(5)記載の方法に準じて、下記本発明化合物15を得た。
Figure JPOXMLDOC01-appb-I000059
本発明化合物15:1H-NMR (CDCl3) δ: 9.28 (1H, s), 8.76 (1H, d), 8.62 (1H, d), 8.34 (1H, d), 8.22 (2H, t), 8.02 (1H, dd), 3.96 (2H, q), 1.47 (3H, t).
(Production Example 15)
Using Compound Z instead of Compound X, the following Compound 15 of the present invention was obtained according to the method described in Production Example 13 (5).
Figure JPOXMLDOC01-appb-I000059
Compound 15 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.28 (1H, s), 8.76 (1H, d), 8.62 (1H, d), 8.34 (1H, d), 8.22 (2H, t), 8.02 (1H, dd), 3.96 (2H, q), 1.47 (3H, t).
(製造例16)
化合物Xに代えて化合物Yを用い、1H-1,2,4-トリアゾールに代えて3-メチル-1H-1,2,4-トリアゾールを用い、製造例13(5)に記載の方法に準じて、下記本発明化合物16を得た。
Figure JPOXMLDOC01-appb-I000060
本発明化合物16:1H-NMR (CDCl3) δ: 9.18 (1H, s), 8.71 (1H, d), 8.38 (1H, s), 8.24 (1H, d), 7.97 (1H, d), 7.93 (1H, d), 3.98 (2H, q), 2.55 (3H, s), 1.45 (3H, t).
(Production Example 16)
In accordance with the method described in Preparation Example 13 (5), using Compound Y instead of Compound X and 3-methyl-1H-1,2,4-triazole instead of 1H-1,2,4-triazole The following present compound 16 was obtained.
Figure JPOXMLDOC01-appb-I000060
Compound 16 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.18 (1H, s), 8.71 (1H, d), 8.38 (1H, s), 8.24 (1H, d), 7.97 (1H, d), 7.93 (1H, d), 3.98 (2H, q), 2.55 (3H, s), 1.45 (3H, t).
(製造例17)
化合物Xに代えて化合物Yを用い、1H-1,2,4-トリアゾールに代えて3-クロロ-1H-1,2,4-トリアゾールを用い、製造例13(5)に記載の方法に準じて、下記本発明化合物17を得た。
Figure JPOXMLDOC01-appb-I000061
本発明化合物17:1H-NMR (CDCl3) δ: 9.20 (1H, s), 8.77 (1H, d), 8.39 (1H, s), 8.25 (1H, d), 7.97 (1H, t), 7.93 (1H, d), 4.00 (2H, q), 1.46 (3H, t).
(Production Example 17)
In accordance with the method described in Preparation Example 13 (5), using Compound Y instead of Compound X and 3-chloro-1H-1,2,4-triazole instead of 1H-1,2,4-triazole Thus, the following present compound 17 was obtained.
Figure JPOXMLDOC01-appb-I000061
Compound 17 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.20 (1H, s), 8.77 (1H, d), 8.39 (1H, s), 8.25 (1H, d), 7.97 (1H, t), 7.93 (1H, d), 4.00 (2H, q), 1.46 (3H, t).
(製造例18)
化合物Xに代えて化合物Zを用い、1H-1,2,4-トリアゾールに代えて3-クロロ-1H-1,2,4-トリアゾールを用い、製造例13(5)記載の方法に準じて、下記本発明化合物18を得た。
Figure JPOXMLDOC01-appb-I000062
本発明化合物18:1H-NMR (CDCl3) δ: 9.18 (1H, s), 8.77 (1H, d), 8.61 (1H, s), 8.27 (1H, d), 8.22 (1H, d), 8.01 (1H, d), 3.97 (2H, q), 1.47 (3H, t).
(Production Example 18)
In accordance with the method described in Preparation Example 13 (5), using Compound Z instead of Compound X, and 3-chloro-1H-1,2,4-triazole instead of 1H-1,2,4-triazole The following present compound 18 was obtained.
Figure JPOXMLDOC01-appb-I000062
Compound 18 of the present invention: 1 H-NMR (CDCl 3 ) δ: 9.18 (1H, s), 8.77 (1H, d), 8.61 (1H, s), 8.27 (1H, d), 8.22 (1H, d), 8.01 (1H, d), 3.97 (2H, q), 1.47 (3H, t).
(製造例19)
化合物Xに代えて化合物Yを用い、1H-1,2,4-トリアゾールに代えて3-アミノ-1H-1,2,4-トリアゾールを用い、製造例13(5)に記載の方法に準じて、下記本発明化合物19を得た。
Figure JPOXMLDOC01-appb-I000063
本発明化合物19:1H-NMR (CDCl3) δ: 8.94 (1H, s), 8.65 (1H, d), 8.37 (1H, s), 8.03 (1H, d), 7.95 (1H, d), 7.91 (1H, d), 4.46 (2H, s), 3.95 (2H, q), 1.44 (3H, t).
(Production Example 19)
In accordance with the method described in Preparation Example 13 (5), using Compound Y instead of Compound X and 3-amino-1H-1,2,4-triazole instead of 1H-1,2,4-triazole The following present compound 19 was obtained.
Figure JPOXMLDOC01-appb-I000063
Compound 19 of the present invention: 1 H-NMR (CDCl 3 ) δ: 8.94 (1H, s), 8.65 (1H, d), 8.37 (1H, s), 8.03 (1H, d), 7.95 (1H, d), 7.91 (1H, d), 4.46 (2H, s), 3.95 (2H, q), 1.44 (3H, t).
次に本発明化合物の製剤例を示す。なお、部は重量部を表す。 Next, the formulation example of this invention compound is shown. In addition, a part represents a weight part.
製剤例1
 本発明化合物1~19のいずれか1種 10部を、キシレン35部とN,N-ジメチルホルムアミド35部との混合物に溶解し、そこにポリオキシエチレンスチリルフェニルエーテル14部及びドデシルベンゼンスルホン酸カルシウム6部を加え、混合して各々の製剤を得る。
Formulation Example 1
10 parts of any one of the compounds 1 to 19 of the present invention are dissolved in a mixture of 35 parts of xylene and 35 parts of N, N-dimethylformamide, and 14 parts of polyoxyethylene styryl phenyl ether and calcium dodecylbenzenesulfonate are dissolved therein. Add 6 parts and mix to obtain each formulation.
製剤例2
 ラウリル硫酸ナトリウム4部、リグニンスルホン酸カルシウム2部、合成含水酸化珪素微粉末20部及び珪藻土54部を混合し、更に本発明化合物1~19のいずれか1種 20部を加え、混合して各々の水和剤を得る。
Formulation Example 2
4 parts of sodium lauryl sulfate, 2 parts of calcium lignin sulfonate, 20 parts of synthetic silicon hydroxide fine powder and 54 parts of diatomaceous earth are mixed, and 20 parts of any one of the compounds 1 to 19 of the present invention are added and mixed. Get a wettable powder.
製剤例3
 本発明化合物1~19のいずれか1種 2部に、合成含水酸化珪素微粉末1部、リグニンスルホン酸カルシウム2部、ベントナイト30部及びカオリンクレー65部を加え混合する。ついで、この混合物に適当量の水を加え、さらに攪拌し、造粒機で造粒し、通風乾燥して各々の粒剤を得る。
Formulation Example 3
1 part of synthetic silicon hydrous fine powder, 2 parts of calcium lignin sulfonate, 30 parts of bentonite and 65 parts of kaolin clay are mixed with 2 parts of any one of the compounds 1 to 19 of the present invention. Next, an appropriate amount of water is added to the mixture, and the mixture is further stirred, granulated with a granulator, and dried by ventilation to obtain each granule.
製剤例4
 本発明化合物1~19のいずれか1種 1部を適当量のアセトンに溶解し、これに合成含水酸化珪素微粉末5部、酸性りん酸イソプロピル0.3部及びフバサミクレー93.7部を加え、充分攪拌混合し、アセトンを蒸発除去して各々の粉剤を得る。
Formulation Example 4
1 part of any one of the compounds 1 to 19 of the present invention is dissolved in an appropriate amount of acetone, and 5 parts of a synthetic silicon hydroxide fine powder, 0.3 part of isopropyl acid phosphate and 93.7 parts of fusami clay are added, The mixture is thoroughly mixed and acetone is removed by evaporation to obtain each powder.
製剤例5
 ポリオキシエチレンアルキルエーテルサルフェートアンモニウム塩及びホワイトカーボンの混合物(重量比19)35部と、本発明化合物1~19のいずれか1種 10部と、水55部とを混合し、湿式粉砕法で微粉砕することにより、各々のフロアブル剤を得る。
Formulation Example 5
35 parts of a mixture of polyoxyethylene alkyl ether sulfate ammonium salt and white carbon (weight ratio 19), 10 parts of any one of the compounds 1 to 19 of the present invention, and 55 parts of water are mixed and finely divided by a wet pulverization method. Each flowable agent is obtained by grinding.
製剤例6
 本発明化合物1~19のいずれか1種 0.1部をキシレン5部及びトリクロロエタン5部の混合物に溶解し、これを脱臭灯油89.9部に混合して各々の油剤を得る。
Formulation Example 6
0.1 part of any one of the compounds 1 to 19 of the present invention is dissolved in a mixture of 5 parts of xylene and 5 parts of trichloroethane, and this is mixed with 89.9 parts of deodorized kerosene to obtain each oil agent.
製剤例7
 本発明化合物1~19のいずれか1種 10mgをアセトン0.5mlに溶解し、この溶液を、動物用固形飼料粉末(飼育繁殖用固形飼料粉末CE-2、日本クレア株式会社商品)5gに滴下し、均一に混合する。ついでアセトンを蒸発乾燥させて各々の毒餌剤を得る。
Formulation Example 7
10 mg of any one of the compounds 1 to 19 of the present invention is dissolved in 0.5 ml of acetone, and this solution is added dropwise to 5 g of animal solid feed powder (solid feed powder CE-2 for breeding breeding, Nippon Claire Co., Ltd.). And mix evenly. Then acetone is evaporated to dryness to obtain each poisonous bait.
製剤例8
 本発明化合物1~19のいずれか1種 0.1部、ネオチオゾール(中央化成株式会社製)49.9部をエアゾール缶に入れ、エアゾールバルブを装着した後、ジメチルエーテル25部、LPG25部を充填し振とうを加え、アクチュエータを装着することで油剤エアゾールを得る。
Formulation Example 8
0.1 part of any one of the compounds 1 to 19 of the present invention and 49.9 parts of neothiozole (Chuo Kasei Co., Ltd.) are put in an aerosol can, and after mounting an aerosol valve, 25 parts of dimethyl ether and 25 parts of LPG are filled. Shake and attach an actuator to obtain an oil aerosol.
製剤例9
 本発明化合物1~19のいずれか1種 0.6部、BHT(2,6-ジ-tert-ブチル-4-メチルフェノール)0.01部、キシレン5部、脱臭灯油3.39部及び乳化剤{レオドールMO-60(花王株式会社製)}1部を混合したものと、蒸留水50部とをエアゾール容器に充填し、バルブを装着した後、該バルブを通じて噴射剤(LPG)40部を加圧充填して水性エアゾールを得る。
Formulation Example 9
0.6 part of any one of compounds 1 to 19 of the present invention, 0.01 part of BHT (2,6-di-tert-butyl-4-methylphenol), 5 parts of xylene, 3.39 parts of deodorized kerosene and emulsifier {Rheodor MO-60 (manufactured by Kao Corporation)} After mixing 1 part and 50 parts of distilled water into an aerosol container and attaching a valve, 40 parts of propellant (LPG) was added through the valve. Pressure filling to obtain an aqueous aerosol.
製剤例10
 本発明化合物1~19のいずれか1種 0.1gを、プロピレングリコール2mlに混合し、4.0×4.0cm、厚さ1.2cmの多孔セラミック板に含浸させて、加熱式くん煙剤を得る。
Formulation Example 10
0.1 g of any one of the compounds 1 to 19 of the present invention is mixed with 2 ml of propylene glycol, impregnated into a porous ceramic plate of 4.0 × 4.0 cm and thickness of 1.2 cm, and a heating smoke Get.
製剤例11
 本発明化合物1~19のいずれか1種 5部とエチレンーメタクリル酸メチル共重合体(共重合体中のメタクリル酸メチルの割合:10重量%、アクリフト(登録商標)WD301、住友化学製)95部を密閉式加圧ニーダー(森山製作所製)で溶融混練し、得られた混練物を押出し成型機から成型ダイスを介して押出し、長さ15cm、直径3mmの棒状成型体を得る。
Formulation Example 11
5 parts of any one of the present compounds 1 to 19 and an ethylene-methyl methacrylate copolymer (ratio of methyl methacrylate in the copolymer: 10% by weight, ACRIFT (registered trademark) WD301, manufactured by Sumitomo Chemical Co., Ltd.) 95 The part is melt-kneaded with a closed pressure kneader (manufactured by Moriyama Seisakusho), and the resulting kneaded product is extruded from an extrusion molding machine through a molding die to obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm.
製剤例12
 本発明化合物1~19のいずれか1種 5部と軟質塩化ビニル樹脂95部を密閉式加圧ニーダー(森山製作所製)で溶融混練し、得られた混練物を押出し成型機から成型ダイスを介して押出し、長さ15cm、直径3mmの棒状成型体を得る。
Formulation Example 12
5 parts of any one of the compounds 1 to 19 of the present invention and 95 parts of a soft vinyl chloride resin are melt-kneaded with a closed pressure kneader (manufactured by Moriyama Seisakusho), and the resulting kneaded product is passed from an extrusion molding machine through a molding die. To obtain a rod-shaped molded body having a length of 15 cm and a diameter of 3 mm.
製剤例13
 本発明化合物1~19のいずれか1種 100mg、ラクトース68.75mg、トウモロコシデンプン237.5mg、微結晶性セルロース43.75mg、ポリビニルピロリドン18.75mg、ナトリウムカルボキシメチルデンプン28.75mg、及びステアリン酸マグネシウム2.5mgを混合し、得られた混合物を適切な大きさに圧縮して、錠剤を得る。
Formulation Example 13
Any one of the compounds 1 to 19 of the present invention 100 mg, lactose 68.75 mg, corn starch 237.5 mg, microcrystalline cellulose 43.75 mg, polyvinylpyrrolidone 18.75 mg, sodium carboxymethyl starch 28.75 mg, and magnesium stearate Mix 2.5 mg and compress the resulting mixture to an appropriate size to obtain tablets.
製剤例14
 本発明化合物1~19のいずれか1種 25mg、ラクトース60mg、トウモロコシデンプン25mg、カルメロースカルシウム6mg、及び5%ヒドロキシプロピルメチルセルロース適量を混合し、得られた混合物をハードシェルゼラチンカプセル又はヒドロキシプロピルメチルセルロースカプセルに充填し、カプセル剤を得る。
Formulation Example 14
Any one of the compounds 1 to 19 of the present invention 25 mg, lactose 60 mg, corn starch 25 mg, carmellose calcium 6 mg, and 5% hydroxypropylmethylcellulose are mixed in an appropriate amount, and the resulting mixture is hard shell gelatin capsule or hydroxypropylmethylcellulose capsule To obtain capsules.
製剤例15
 本発明化合物1~19のいずれか1種 100mg、フマル酸500mg、塩化ナトリウム2000mg、メチルパラベン150mg、プロピルパラベン50mg、顆粒糖25000mg、ソルビトール(70%溶液)13000mg、VeegumK(VanderbiltCo.)100mg、香料35mg、及び着色料500mgに、最終容量が100mlとなるよう蒸留水を加え、混合して、経口投与用サスペンジョンを得る。
Formulation Example 15
Any one of the compounds 1 to 19 of the present invention 100 mg, fumaric acid 500 mg, sodium chloride 2000 mg, methylparaben 150 mg, propylparaben 50 mg, granule sugar 25000 mg, sorbitol (70% solution) 13000 mg, VeegumK (VanderbiltCo.) 100 mg, flavor 35 mg, And distilled water is added to 500 mg of the colorant so that the final volume becomes 100 ml, and mixed to obtain a suspension for oral administration.
製剤例16
 本発明化合物1~19のいずれか1種 5重量%を、ポリソルベート85 5重量%、ベンジルアルコール3重量%、及びプロピレングリコール30重量%に溶解し、この溶液のpHが6.0~6.5となるようにリン酸塩緩衝液を加えた後、残部として水を加えて、経口投与用液剤を得る。
Formulation Example 16
5% by weight of any one of the compounds 1 to 19 of the present invention is dissolved in 5% by weight of polysorbate 85, 3% by weight of benzyl alcohol, and 30% by weight of propylene glycol, and the pH of this solution is 6.0 to 6.5. After adding a phosphate buffer so that it becomes, the remainder is added with water to obtain a solution for oral administration.
製剤例17
 分留ヤシ油57重量%およびポリソルベート85 3重量%中にジステアリン酸アルミニウム5重量%を加え、加熱により分散させる。これを室温に冷却し、その油状ビヒクル中にサッカリン25重量%を分散させる。これに本発明化合物1~19のいずれか1種 10重量%を配分し、経口投与用ペースト状製剤を得る。
Formulation Example 17
5% by weight of aluminum distearate in 57% by weight of fractionated coconut oil and 3% by weight of polysorbate 85 is added and dispersed by heating. This is cooled to room temperature and 25% by weight of saccharin is dispersed in the oily vehicle. To this, 10% by weight of any one of the compounds 1 to 19 of the present invention is allocated to obtain a paste preparation for oral administration.
製剤例18
 本発明化合物1~19のいずれか1種 5重量%を石灰石粉95重量%と混合し、湿潤顆粒形成法を使用して経口投与用粒剤を得る。
Formulation Example 18
5% by weight of any one of the compounds 1 to 19 of the present invention is mixed with 95% by weight of limestone powder, and granules for oral administration are obtained using a wet granulation method.
製剤例19
 本発明化合物1~19のいずれか1種 5部をジエチレングリコールモノエチルエーテル80部に溶解し、これに炭酸プロピレン15部を混合して、スポットオン液剤を得る。
Formulation Example 19
5 parts of any one of the compounds 1 to 19 of the present invention are dissolved in 80 parts of diethylene glycol monoethyl ether, and 15 parts of propylene carbonate is mixed therewith to obtain a spot-on solution.
製剤例20
 本発明化合物1~19のいずれか1種 10部をジエチレングリコールモノエチルエーテル70部に溶解し、これに2-オクチルドデカノール20部を混合して、ポアオン液剤を得る。
Formulation Example 20
10 parts of any one of the compounds 1 to 19 of the present invention are dissolved in 70 parts of diethylene glycol monoethyl ether, and 20 parts of 2-octyldodecanol is mixed with this to obtain a pour-on solution.
製剤例21
 本発明化合物1~19のいずれか1種 0.5部に、ニッコール(登録商標)TEALS-42(日光ケミカルズ・ラウリル硫酸トリエタノールアミンの42%水溶液)60部、プロピレングリコール20部を添加し、均一溶液になるまで充分撹拌混合した後、水19.5部を加えてさらに充分撹拌混合し、均一溶液のシャンプー剤を得る。
Formulation Example 21
To 0.5 parts of any one of the compounds 1 to 19 of the present invention, 60 parts of Nikkor (registered trademark) TEALS-42 (42% aqueous solution of Nikko Chemicals lauryl sulfate triethanolamine) and 20 parts of propylene glycol were added, After sufficiently stirring and mixing until a uniform solution is obtained, 19.5 parts of water is added and further stirring and mixing is performed to obtain a shampoo agent of a uniform solution.
製剤例22
 本発明化合物1~19のいずれか1種 0.15重量%、動物飼料95重量%、並びに、第2リン酸カルシウム、珪藻土、Aerosil、及びカーボネート(又はチョーク)からなる混合物4.85重量%を十分攪拌混合し、動物用飼料プレミックスを得る。
Formulation Example 22
Any one of the compounds 1 to 19 of the present invention 0.15% by weight, animal feed 95% by weight, and 4.85% by weight of a mixture comprising dicalcium phosphate, diatomaceous earth, Aerosil, and carbonate (or chalk) are sufficiently stirred. Mix to obtain animal feed premix.
製剤例23
 本発明化合物1~19のいずれか1種 7.2g、及びホスコ(登録商標)S-55(丸石製薬株式会社製)92.8gを100℃で溶解混和し、坐剤形に注いで、冷却固化して、坐剤を得る。
Formulation Example 23
7.2 g of any one of the compounds 1 to 19 of the present invention and 92.8 g of Fosco (registered trademark) S-55 (manufactured by Maruishi Pharmaceutical Co., Ltd.) are dissolved and mixed at 100 ° C., poured into a suppository, and cooled. Solidify to obtain a suppository.
また、本発明化合物を含有する有害生物防除剤の製剤例を示す。なお、部は重量部を表す。 Moreover, the formulation example of the pest control agent containing this invention compound is shown. In addition, a part represents a weight part.
製剤例1A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物1を10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例2A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物2 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例3A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物3 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例4A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物4 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例5A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物5 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例6A
 下記の化合物A1~A100から選ばれるいずれか1種を0.1部、本発明化合物6を10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例7A
 下記の化合物A1~A100から選ばれるいずれか1種を0.1部、本発明化合物7を10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例8A
 下記の化合物A1~A100から選ばれるいずれか1種を0.1部、本発明化合物8を10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例9A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物9 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例10A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物10 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例11A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物11 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例12A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物12 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例13A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物13 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例14A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物14 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例15A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物15 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例16A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物16 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例17A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物17 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例18A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物18 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例19A
 下記の化合物A1~A100から選ばれるいずれか1種 0.1部、本発明化合物19 10部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
Formulation Example 1A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the compound 1 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 2A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 2 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 3A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the compound 3 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 4A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 4 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 5A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 5 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 6A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of compound 6 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 7A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 7 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 8A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 8 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 9A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the compound 9 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 10A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 10 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 11A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 11 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 12A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 12 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 13A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 13 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 14A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the compound 14 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 15A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 15 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 16A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 16 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 17A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 17 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 18A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the present compound 18 and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 19A
0.1 part of any one selected from the following compounds A1 to A100, 10 parts of the compound 19 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
製剤例20A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物1を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例21A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物2を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例22A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物3を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例23A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物4を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例24A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物5を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例25A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物6を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例26A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物7を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例27A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物8を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例28A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物9を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例29A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物10を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例30A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物11を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例31A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物12を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例32A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物13を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例33A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物14を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例34A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物15を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例35A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物16を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例36A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物17を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例37A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物18を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
製剤例38A
 下記の化合物A1~A100から選ばれるいずれか1種を10部、本発明化合物19を0.1部及びジメチルスルホキシド89.9部を混合して、各々の液剤を得る。
Formulation Example 20A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of Compound 1 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 21A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 2 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 22A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 3 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 23A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 4 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 24A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of Compound 5 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 25A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 6 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 26A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 7 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 27A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of Compound 8 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 28A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 9 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 29A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of compound 10 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 30A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 11 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 31A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 12 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 32A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 13 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 33A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 14 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 34A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 15 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 35A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 16 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 36A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 17 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 37A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 18 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 38A
10 parts of any one selected from the following compounds A1 to A100, 0.1 part of the compound 19 of the present invention and 89.9 parts of dimethyl sulfoxide are mixed to obtain each solution.
製剤例39A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物1を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例40A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物2を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例41A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物3を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例42A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物4を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例43A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物5を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例44A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物6を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例45A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物7を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例46A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物8を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例47A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物9を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例48A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物10を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例49A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物11を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例50A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物12を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例51A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物13を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例52A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物14を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例53A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物15を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例54A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物16を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例55A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物17を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例56A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物18を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
製剤例57A
 下記の化合物A1~A100から選ばれるいずれか1種を4部、本発明化合物19を4部及びジメチルスルホキシド92部を混合して、各々の液剤を得る。
Formulation Example 39A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of Compound 1 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 40A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of compound 2 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 41A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of compound 3 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 42A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 4 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 43A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of Compound 5 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 44A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of compound 6 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 45A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 7 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 46A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 8 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 47A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 9 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 48A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 10 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 49A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 11 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 50A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 12 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 51A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of compound 13 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 52A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 14 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 53A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 15 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 54A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 16 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 55A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of compound 17 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 56A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 18 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
Formulation Example 57A
4 parts of any one selected from the following compounds A1 to A100, 4 parts of the compound 19 of the present invention and 92 parts of dimethyl sulfoxide are mixed to obtain each solution.
上記の製剤例にて使用される化合物A1~A100は以下に示す化合物である。
ピレトリン(化合物A1);アレスリン(化合物A2);プラレトリン(化合物A3);イミプロトリン(化合物A4);レスメトリン(化合物A5);テトラメトリン(化合物A6);フェノトリン(化合物A7);シフェノトリン(化合物A8);フルメスリン(化合物A9);メトフルトリン(化合物A10);トランスフルトリン(化合物A11);プロフルトリン(化合物A12);ジメフルトリン(化合物A13);エンペントリン(化合物A14);フラメトリン(化合物A15);メパーフルトリン(化合物A16);2,3,5,6-テトラフルオロ-4-(メトキシメチル)ベンジル=2,2-ジメチル-3-(2-シアノ-1-プロペニル)-シクロプロパンカルボキシレート(化合物A17);2,3,5,6-テトラフルオロ-4-(メトキシメチル)ベンジル=2,2-ジメチル-3-(3,3,3-トリフルオロ-1-プロペニル)-シクロプロパンカルボキシレート(化合物A18);2,3,5,6-テトラフルオロ-4-プロパルギルベンジル=2,2,3,3-テトラメチルシクロプロパンカルボキシレート(化合物A19);アクリナトリン(化合物A20);ビフェントリン(化合物A21);シクロプロトリン(化合物A22);シフルトリン(化合物A23);ベータ-シフルトリン(化合物A24);シハロトリン(化合物A25);ラムダシハロトリン(化合物A26);ガンマシハロトリン(化合物A27);シペルメトリン(化合物A28);アルファシペルメトリン(化合物A29);ベータシペルメトリン(化合物A30);シータシペルメトリン(化合物A31);ゼータシペルメトリン(化合物A32);デルタメトリン(化合物A33);エトフェンプロックス(化合物A34);フェンプロパトリン(化合物A35);フェンバレレート(化合物A36);エスフェンバレレート(化合物A37);フルシトリネート(化合物A38);フルバリネート(化合物A39);タウフルバリネート(化合物A40);ハルフェンプロックス(化合物A41);ペルメトリン(化合物A42);シラフルオフェン(化合物A43);テフルトリン(化合物A44);トラロメトリン(化合物A45);プロトリフェンビュート(化合物A46);フェニトロチオン(化合物A47);ジクロルボス(化合物A48);プロポクスル(化合物A49);イミダクロプリド(化合物A50);クロチアニジン(化合物A51);チアメトキサム(化合物A52);ジノテフラン(化合物A53);アセタミプリド(化合物A54);チアクロプリド(化合物A55);ニテンピラム(化合物A56);エチプロール(化合物A57);フィプロニル(化合物A58);アセトプロール(化合物A59);バニリプロール(化合物A60);ピリプロール(化合物A61);ピラフルプロール(化合物A62);アバメクチン(化合物A63);エマメクチン(化合物A64);エマメクチン安息香酸塩(化合物A65);ミルベメクチン(化合物A66);ドラメクチン(化合物A67);レピメクチン(化合物A68);ビストリフルロン(化合物A69);ジフルベンズロン(化合物A70);ピリプロキシフェン(化合物A71);ヘキサフルムロン(化合物A72);ハイドロプレン(化合物A73);メトプレン(化合物A74);シロマジン(化合物A75);エトキサゾール(化合物A76);ノビフルムロン(化合物A77);アミトラズ(化合物A78);クロルフェナピル(化合物A79);メトキサジアゾン(化合物A80);アミドフルメト(化合物A81);スピロテトラマト(化合物A82);スルホキサフロル(化合物A83);ピメトロジン(化合物A84);ピリダリル(化合物A85);フルピラジフロン(化合物A86);インドキサカルブ(化合物A87);ピペロニルブトキシド(化合物A88);N-(2-エチルヘキシル)-5-ノルボルネン-2,3-ジカルボキシイミド(化合物A89);
Figure JPOXMLDOC01-appb-I000064

Figure JPOXMLDOC01-appb-I000065

クロラントラニリプロール(化合物A94);シアントラニリプロール(化合物A95);フルベンジアミド(化合物A96);トリフルメゾピリン(化合物A97);
Figure JPOXMLDOC01-appb-I000066

Figure JPOXMLDOC01-appb-I000067
Compounds A1 to A100 used in the above formulation examples are the compounds shown below.
Pyrethrin (compound A1); allethrin (compound A2); praretrin (compound A3); imiprothrin (compound A4); resmethrin (compound A5); tetramethrin (compound A6); phenothrin (compound A7); (Compound A9); Metofluthrin (Compound A10); Transfluthrin (Compound A11); Profluthrin (Compound A12); Dimefluthrin (Compound A13); Empentrin (Compound A14); Framethrin (Compound A15); Meperfluthrin (Compound A16); , 3,5,6-tetrafluoro-4- (methoxymethyl) benzyl = 2,2-dimethyl-3- (2-cyano-1-propenyl) -cyclopropanecarboxylate (Compound A17); , 6-Te Rafluoro-4- (methoxymethyl) benzyl = 2,2-dimethyl-3- (3,3,3-trifluoro-1-propenyl) -cyclopropanecarboxylate (compound A18); 2,3,5,6- Tetrafluoro-4-propargylbenzyl = 2,2,3,3-tetramethylcyclopropanecarboxylate (Compound A19); Acrinatrin (Compound A20); Bifenthrin (Compound A21); Cycloprotolin (Compound A22); Cyfluthrin (Compound) Beta-cyfluthrin (compound A24); cyhalothrin (compound A25); lambda cihalothrin (compound A26); gamma cyhalothrin (compound A27); cypermethrin (compound A28); alpha cypermethrin (compound A29); Betacypermethrin (Compound A 0); theta cypermethrin (compound A31); zeta cypermethrin (compound A32); deltamethrin (compound A33); etofenprox (compound A34); fenpropatoline (compound A35); fenvalerate (compound A36); Flucitrinate (compound A38); fulvalinate (compound A39); tau fluvalinate (compound A40); halfenprox (compound A41); permethrin (compound A42); silafluophene (compound A43); (Compound A44); Tralomethrin (Compound A45); Protrifen Bute (Compound A46); Fenitrothion (Compound A47); Dichlorvos (Compound A48); Propoxur (Compound A49); Clothipridine (compound A51); thiamethoxam (compound A52); dinotefuran (compound A53); acetamiprid (compound A54); thiacloprid (compound A55); nitenpyram (compound A56); ethiprole (compound A57); Compound A58); Acetoprole (Compound A59); Vaniliprole (Compound A60); Pyriprole (Compound A61); Pyrafluprolol (Compound A62); Abamectin (Compound A63); Emamectin (Compound A64); ); Milbemectin (Compound A66); Doramectin (Compound A67); Repimectin (Compound A68); Bistrifluron (Compound A69); Diflubenzuron (Compound A70); Hexaflumuron (Compound A72); Hydroprene (Compound A73); Metoprene (Compound A74); Ciromazine (Compound A75); Etoxazole (Compound A76); Nobiflumuron (Compound A77); Amitraz (Compound A78) ); Chlorfenapyr (Compound A79); methoxadiazone (Compound A80); amidoflumet (Compound A81); spirotetramat (Compound A82); sulfoxafurol (Compound A83); pymetrozine (Compound A84); Indoxacarb (Compound A87); Piperonyl butoxide (Compound A88); N- (2-ethylhexyl) -5-norbornene-2,3-dicarboximide (Compound A89) ;
Figure JPOXMLDOC01-appb-I000064

Figure JPOXMLDOC01-appb-I000065

Chlorantraniliprole (Compound A94); Cyantraniliprole (Compound A95); Flubendiamide (Compound A96); Triflumezopyrine (Compound A97);
Figure JPOXMLDOC01-appb-I000066

Figure JPOXMLDOC01-appb-I000067
 次に、本発明化合物の有害生物防除効力を試験例により示す。 Next, the pest control effect of the compound of the present invention is shown by test examples.
試験例1
 製剤例5により得られた本発明化合物2,3,4,5,11,12,13,14,15および16の各々の製剤を、各々有効成分濃度が200ppmとなるように水で希釈し、試験用薬液を調製した。
 一方、プラスチックカップに植えたキュウリ幼苗(第1本葉展開期)にワタアブラムシ(Aphis gossypii)(全ステージ)約30頭を接種し、1日間放置した。この幼苗に、前記試験用薬液20mlを散布した。
 散布6日後に該キュウリの葉上に寄生したワタアブラムシ生存虫数を調査し、以下の式により防除価を求めた。
    防除価(%)={1-(Cb×Tai)/(Cai×Tb)}×100
なお、式中の文字は以下の意味を表す。
   Cb:無処理区の処理前の虫数
   Cai:無処理区の観察時の寄生生存虫数
   Tb:処理区の処理前の虫数
   Tai:処理区の観察時の寄生生存虫数
 ここで無処理区とは、製剤例5において本発明化合物を含まない製剤を、処理区と同量の水で希釈した試験用薬液を散布した区を意味する。
 その結果、本発明化合物2,3,4,5,11,12,13,14,15および16の試験用薬液を用いた処理区はいずれも、防除価90%以上を示した。
Test example 1
Each formulation of the present compound 2,3,4,5,11,12,13,14,15 and 16 obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 200 ppm, A test chemical solution was prepared.
Meanwhile, about 30 Aphis gossypi (all stages) were inoculated into cucumber seedlings (first true leaf development stage) planted in plastic cups and left for 1 day. The seedlings were sprayed with 20 ml of the test chemical solution.
Six days after spraying, the number of live cotton aphids that parasitized on the leaves of the cucumber was examined, and the control value was determined by the following formula.
Control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
In addition, the character in a formula represents the following meaning.
Cb: number of insects before treatment in the untreated group Cai: number of live parasites when observed in the untreated group Tb: number of insects before treatment in the treated group Tai: number of live parasitic insects during observation of the treated group The group means a group in which a preparation containing no compound of the present invention in Preparation Example 5 was sprayed with a test chemical solution diluted with the same amount of water as the treatment group.
As a result, all of the treatment sections using the test chemical solutions of the compounds 2, 3, 4, 5, 11, 12, 13, 14, 15 and 16 of the present invention showed a control value of 90% or more.
試験例2
 製剤例5により得られた本発明化合物11、13、14および16の各々の製剤を、各々有効成分濃度が200ppmとなるように水で希釈し、試験用薬液を調製した。
 一方、プラスチックカップに植えたキュウリ幼苗(第2本葉展開期)に、前記試験用薬液5mlを株元潅注し、7日間25℃温室内に保った。ワタアブラムシ(Aphis gossypii)(全ステージ)約30頭をキュウリ葉面に接種し、更に6日該温室内に保った後に、該キュウリの葉上に寄生したワタアブラムシ生存虫数を調査し、以下の式により防除価を求めた。
    防除価(%)={1-(Cb×Tai)/(Cai×Tb)}×100
なお、式中の文字は以下の意味を表す。
   Cb:無処理区の処理前の虫数
   Cai:無処理区の観察時の寄生生存虫数
   Tb:処理区の処理前の虫数
   Tai:処理区の観察時の寄生生存虫数
 ここで無処理区とは、製剤例5において本発明化合物を含まない製剤を、処理区と同量の水で希釈した試験用薬液を散布した区を意味する。
その結果、本発明化合物11、13、14および16の試験用薬液を用いた処理区はいずれも、防除価90%以上を示した。
Test example 2
Each formulation of the present compounds 11, 13, 14 and 16 obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 200 ppm, and a test drug solution was prepared.
On the other hand, cucumber seedlings planted in plastic cups (second true leaf development stage) were irrigated with 5 ml of the test chemical solution and kept in a greenhouse at 25 ° C. for 7 days. After inoculating about 30 Aphis gossypi (all stages) on the cucumber leaf surface and keeping it in the greenhouse for another 6 days, the number of live aphids on the cucumber leaf was investigated. The control value was calculated by the following formula.
Control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
In addition, the character in a formula represents the following meaning.
Cb: number of insects before treatment in the untreated group Cai: number of live parasites when observed in the untreated group Tb: number of insects before treatment in the treated group Tai: number of live parasitic insects during observation of the treated group The group means a group in which a preparation containing no compound of the present invention in Preparation Example 5 was sprayed with a test chemical solution diluted with the same amount of water as the treatment group.
As a result, all of the treatment sections using the test chemical solutions of the compounds 11, 13, 14 and 16 of the present invention exhibited a control value of 90% or more.
試験例3
 製剤例5により得られた本発明化合物3,14および15の各々の製剤を、各々有効成分濃度が200ppmとなるように水で希釈し、試験用薬液を調製した。
 ポリエチレンカップに植えた第2葉展開期のイネ幼苗に、前記試験用薬液10mlを散布する。風乾後、トビイロウンカ(Nilaparvata lugens)の3~4齢幼虫を20頭放して、25℃の温室内に保管する。6日後イネに寄生したトビイロウンカの生存虫数を調査し、以下の式により防除価を求めた。
    防除価(%)={1-(Cb×Tai)/(Cai×Tb)}×100
なお、式中の文字は以下の意味を表す。
   Cb:無処理区の処理前の虫数
   Cai:無処理区の観察時の寄生生存虫数
   Tb:処理区の処理前の虫数
   Tai:処理区の観察時の寄生生存虫数
 ここで無処理区とは、製剤例5において本発明化合物を含まない製剤を、処理区と同量の水で希釈した試験用薬液を散布した区を意味する。
その結果、本発明化合物3,14および15の試験用薬液を用いた処理区はいずれも、防除価90%以上を示した。
Test example 3
Each formulation of the present compounds 3, 14 and 15 obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 200 ppm, respectively, to prepare a test drug solution.
10 ml of the test chemical solution is sprayed on rice seedlings in the second leaf development stage planted in a polyethylene cup. After air-drying, 20 3-4 instar larvae of Nilaparvata lugens are released and stored in a greenhouse at 25 ° C. Six days later, the number of surviving insects that were infested with rice was examined, and the control value was determined by the following formula.
Control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
In addition, the character in a formula represents the following meaning.
Cb: number of insects before treatment in the untreated group Cai: number of live parasites when observed in the untreated group Tb: number of insects before treatment in the treated group Tai: number of live parasitic insects during observation of the treated group The group means a group in which a preparation containing no compound of the present invention in Preparation Example 5 was sprayed with a test chemical solution diluted with the same amount of water as the treatment group.
As a result, all of the treatment groups using the test chemical solutions of the compounds 3, 14 and 15 of the present invention showed a control value of 90% or more.
試験例4
 製剤例5により得られた本発明化合物2,3,11および14の各々の製剤を、各々有効成分濃度が200ppmとなるように水で希釈し、試験用薬液を調製した。
 一方、プラスチックカップに植えたイネ幼苗(播種2週間後、第2葉展開期)に、前記試験用薬液5mlを株元潅注し、7日間25℃温室内に保った。トビイロウンカ(Nilaparvata lugens)の3~4齢幼虫を20頭放して、更に6日該温室内に保った後に、該イネの葉上に寄生したトビイロウンカ生存虫数を調査し、以下の式により防除価を求めた。
    防除価(%)={1-(Cb×Tai)/(Cai×Tb)}×100
なお、式中の文字は以下の意味を表す。
   Cb:無処理区の処理前の虫数
   Cai:無処理区の観察時の寄生生存虫数
   Tb:処理区の処理前の虫数
   Tai:処理区の観察時の寄生生存虫数
 ここで無処理区とは、製剤例5において本発明化合物を含まない製剤を、処理区と同量の水で希釈した試験用薬液を散布した区を意味する。
その結果、本発明化合物2,3,11および14の試験用薬液を用いた処理区はいずれも、防除価90%以上を示した。
Test example 4
Each preparation of the compounds 2, 3, 11 and 14 of the present invention obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 200 ppm, and a test drug solution was prepared.
On the other hand, 5 ml of the test drug solution was irrigated to rice seedlings planted in plastic cups (2 weeks after sowing, in the second leaf development stage) and kept in a 25 ° C. greenhouse for 7 days. After releasing 20 3-4 instar larvae of the green planthopper (Nilaparvata lugens) and keeping it in the greenhouse for another 6 days, the number of surviving insects parasitic on the rice leaves was investigated, and the control value was calculated by the following formula: Asked.
Control value (%) = {1− (Cb × Tai) / (Cai × Tb)} × 100
In addition, the character in a formula represents the following meaning.
Cb: number of insects before treatment in the untreated group Cai: number of live parasites when observed in the untreated group Tb: number of insects before treatment in the treated group Tai: number of live parasitic insects during observation of the treated group The group means a group in which a preparation containing no compound of the present invention in Preparation Example 5 was sprayed with a test chemical solution diluted with the same amount of water as the treatment group.
As a result, all of the treatment groups using the test chemical solutions of the compounds 2, 3, 11 and 14 of the present invention showed a control value of 90% or more.
試験例5
 製剤例5により得られた本発明化合物の各々の製剤を、有効成分濃度が200ppmとなるように水で希釈し、試験用薬液を調製する。
 一方、ポリエチレンカップに植えたトマト幼苗(第3本葉展開期)に、タバココナジラミ(Bemisia tabaci)成虫を放ち、約72時間産卵させる。該トマト苗を8日間温室内に保持し、産下された卵から幼虫が孵化してきたところへ前記試験用薬液を20ml/カップの割合で散布し、25℃で温室内に保持する。7日後トマト葉上の生存幼虫数の調査し死虫率を算出する。
Test Example 5
Each preparation of the compound of the present invention obtained in Formulation Example 5 is diluted with water so that the active ingredient concentration is 200 ppm to prepare a test drug solution.
On the other hand, adult tobacco whitefly (Bemisia tabaci) is released on tomato seedlings (third true leaf development stage) planted in a polyethylene cup and allowed to lay eggs for about 72 hours. The tomato seedlings are kept in a greenhouse for 8 days, and the test chemical is sprayed at a rate of 20 ml / cup to the place where the larva has hatched from the delivered eggs, and kept in the greenhouse at 25 ° C. Seven days later, the number of surviving larvae on the tomato leaves is examined to calculate the mortality rate.
試験例6
 製剤例5により得られた本発明化合物2,3,4,5,11,12,13,14,15,16,17および18の各々の製剤を、各々有効成分濃度が200ppmとなるように水で希釈し、試験用薬液を調製した。
 一方、ポリエチレンカップに植えた3葉期キャベツに、前記試験用薬液を20mL/カップの割合で散布した。薬液が乾いた後、茎葉部を切り取って50mLカップに収容し、コナガ(Plutella xylostella)2令幼虫5頭を放ち、蓋をした。25℃で保管し、5日後に死亡虫数を数え、次式より死虫率を求めた。
    死虫率(%)=(死亡虫数/供試虫数)×100 
その結果、本発明化合物2,3,4,5,11,12,13,14,15,16,17および18の試験用薬液を用いた処理区はいずれも、死虫率80%以上を示した。
Test Example 6
Each formulation of the compound of the present invention 2,3,4,5,11,12,13,14,15,16,17 and 18 obtained in Formulation Example 5 is mixed with water so that the active ingredient concentration is 200 ppm. The test drug solution was prepared.
On the other hand, the test chemical solution was sprayed at a rate of 20 mL / cup on a three-leaf cabbage planted in a polyethylene cup. After the drug solution was dried, the foliage was cut out and accommodated in a 50 mL cup, and 5 second-instar larvae (Plutella xylostella) were released and capped. After storing at 25 ° C., the number of dead insects was counted after 5 days, and the death rate was calculated from the following formula.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, all of the treatment groups using the test chemical solutions of the compounds 2, 3, 4, 5, 11, 12, 13, 14, 15, 16, 17 and 18 of the present invention showed a death rate of 80% or more. It was.
試験例7
 製剤例5により得られた本発明化合物の各々の製剤を、各々有効成分濃度が200ppmとなるように水で希釈し、試験用散布液を調製する。
一方、プラスチックカップにリンゴを植え、第7本葉ないしは第8本葉が展開するまで生育させる。そのリンゴに上記試験用薬液を20mL/カップの割合で散布する。薬液が乾いた後、リンゴコカクモンハマキ(Adoxophyes orana fasciata)初齢幼虫60頭を放ち、底面をくりぬきろ紙を貼ったプラスチックカップを逆さにして被せる。7日後に死亡虫数を調査し、死虫率を算出する。
Test Example 7
Each formulation of the compound of the present invention obtained in Formulation Example 5 is diluted with water so that the active ingredient concentration becomes 200 ppm, respectively, and a test spray solution is prepared.
On the other hand, an apple is planted in a plastic cup and grown until the seventh or eighth true leaf develops. The apple is sprayed with the test chemical at a rate of 20 mL / cup. After the chemical solution is dried, 60 first-instar larvae of Adoxophys orana fascita are released, and the bottom is covered with a plastic cup with a cut-out filter paper. After 7 days, the number of dead insects is examined and the death rate is calculated.
試験例8
 製剤例5により得られた本発明化合物4,5,14,15,17および19の各々の製剤を、各々有効成分濃度が500ppmとなるように水で希釈し、試験用薬液を調製した。
直径5.5cmのポリエチレンカップの底に同大の濾紙を敷き、上記試験用薬液0.7mlを濾紙上に滴下し、餌としてショ糖30mgを均一に入れた。該ポリエチレンカップ内にイエバエ(Musca domestica)雌成虫10頭を放ち、蓋をした。24時間後にイエバエの生死を調査し死亡虫数を数え、次式により死虫率を求めた。
    死虫率(%)=(死亡虫数/供試虫数)×100
 その結果、本発明化合物4,5,14,15,17および19の試験用薬液を用いた処理区はいずれも、死虫率100%を示した。
Test Example 8
Each preparation of the compounds 4, 5, 14, 15, 17 and 19 of the present invention obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 500 ppm, and a test drug solution was prepared.
A filter paper of the same size was laid on the bottom of a polyethylene cup having a diameter of 5.5 cm, 0.7 ml of the test chemical solution was dropped onto the filter paper, and 30 mg of sucrose was uniformly added as a bait. Ten female fly (Musca domestica) females were released into the polyethylene cup and capped. After 24 hours, the life and death of the house fly was investigated, the number of dead insects was counted, and the death rate was calculated by the following formula.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, all of the treatment groups using the test chemical solutions of the compounds 4, 5, 14, 15, 17 and 19 of the present invention showed a death rate of 100%.
試験例9
 製剤例5により得られた本発明化合物4,5および14の各々の製剤を、各々有効成分濃度が500ppmとなるように水で希釈し、試験用薬液を調製した。
 直径5.5cmのポリエチレンカップの底に同大の濾紙を敷き、上記試験用薬液0.7mlを濾紙上に滴下し、餌としてショ糖30mgを均一に入れる。該ポリエチレンカップ内にチャバネゴキブリ(Blattella germanica)雄成虫2頭を放ち、蓋をした。6日後にチャバネゴキブリの生死を調査し死亡虫数を数え、次式により死虫率を求めた。
    死虫率(%)=(死亡虫数/供試虫数)×100
 その結果、本発明化合物の試験用薬液4,5および14を用いた処理区はいずれも、死虫率100%を示した。
Test Example 9
Each formulation of the present compounds 4, 5 and 14 obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 500 ppm, respectively, to prepare a test drug solution.
A filter paper of the same size is placed on the bottom of a polyethylene cup having a diameter of 5.5 cm, 0.7 ml of the test chemical solution is dropped on the filter paper, and 30 mg of sucrose is uniformly added as food. Two adult male cockroaches (Blatella germanica) were released into the polyethylene cup and capped. Six days later, the death and death of German cockroaches were investigated, the number of dead insects was counted, and the death rate was calculated by the following formula.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, all of the treatment groups using the test chemical solutions 4, 5 and 14 of the compound of the present invention showed a death rate of 100%.
試験例10
 製剤例5により得られた本発明化合物4,5,14,15,16,17,18および19の各々の製剤を、各々有効成分濃度が500ppmとなるように水で希釈し、試験用薬液を調製した。
 上記試験用薬液0.7mlをイオン交換水100mlに加えた(有効成分濃度3.5ppm)。該液中にアカイエカ(Culex pipiens pallens)終令幼虫20頭を放ち、1日後にその生死を調査し死亡虫数を数え、死虫率を求めた。
    死虫率(%)=(死亡虫数/供試虫数)×100
その結果、本発明化合物4,5,14,15,16,17,18および19の試験用薬液を用いた処理区はいずれも、死虫率95%以上を示した。
Test Example 10
Each formulation of the present compound 4, 5, 14, 15, 16, 17, 18 and 19 obtained in Formulation Example 5 was diluted with water so that the active ingredient concentration was 500 ppm, respectively, and a test drug solution was prepared. Prepared.
0.7 ml of the test chemical solution was added to 100 ml of ion-exchanged water (active ingredient concentration: 3.5 ppm). Twenty dead larvae of Culex pipiens pallens were released into the solution, and after 1 day, the viability was investigated, the number of dead worms was counted, and the mortality rate was determined.
Death rate (%) = (Number of dead insects / number of test insects) × 100
As a result, all of the treatment groups using the test chemical solutions of the compounds 4, 5, 14, 15, 16, 17, 18 and 19 of the present invention showed a death rate of 95% or more.
試験例11
本発明化合物14の試料2mgをスクリュー管(マルエム No.5;27×55mm)に量り取りアセトン0.2mLを加えて蓋をし溶解した。スクリュー管を回転・反転させ内壁全体に均一になるよう薬液をコーティングし、蓋を取り約2時間風乾させた後、フタトゲチマダニ(Haemaphysalis longicornis)未吸血若ダニ1群5頭を放し蓋をした。2日後に死亡虫数を数え、次式により死虫率を求めた。
   死虫率(%)=100×(死亡虫数/供試虫数)
 その結果、本発明化合物14の試験用薬液を用いた処理区は、死虫率60%以上を示した。
Test Example 11
A 2 mg sample of the compound 14 of the present invention was weighed into a screw tube (Marume No. 5; 27 × 55 mm), 0.2 mL of acetone was added, and the solution was covered and dissolved. The screw tube was rotated and inverted to coat the chemical solution so that the entire inner wall was uniform, and the lid was removed and air-dried for about 2 hours. Then, 5 groups of unsucked ticks of Haemaphysalis longicornis were released and capped. Two days later, the number of dead insects was counted, and the death rate was calculated by the following formula.
Death rate (%) = 100 x (number of dead insects / number of test insects)
As a result, the treatment group using the test chemical solution of the compound 14 of the present invention showed a death rate of 60% or more.
試験例12
 本発明化合物の5mgを、炭酸プロピレン5mLに、0.1%w/vとなるように溶解し、試験用薬液を調整する。
該試験用薬液の投与前日に、マウスに供試ダニ(フタトゲチマダニ、若ダニ)30頭を接種した。滴下処理前に、非寄生ダニを除去する。
 該マウスの体表全体に、上記試験用薬液をピペットを用い200μL滴下投与する。また、対照群には炭酸プロピレンのみを200μL投与する。1群あたり3反復実施する。滴下投与2日後に供試ダニの致死数を調査し、死虫率を算出する。
Test Example 12
5 mg of the compound of the present invention is dissolved in 5 mL of propylene carbonate so as to be 0.1% w / v to prepare a test drug solution.
On the day before the administration of the test drug solution, mice were inoculated with 30 test mites (Mite mite, young mite). Remove non-parasitic ticks before dripping.
200 μL of the test drug solution is administered dropwise to the entire body surface of the mouse using a pipette. In addition, 200 μL of propylene carbonate alone is administered to the control group. Repeat 3 times per group. Two days after the instillation, the lethality of the test mite is investigated, and the mortality is calculated.
 本発明防除剤は、有害生物に対して防除効力を有し、有害生物の有効成分として有用である。 The control agent of the present invention has a control effect on pests and is useful as an active ingredient of pests.

Claims (8)

  1.  式(1)
    Figure JPOXMLDOC01-appb-I000001

    [式中、
    AはNCH又は酸素原子を表し、
    は、水素原子、1個以上のハロゲン原子を有していてもよいC1-C3アルキル基、ハロゲン原子、C1-C3アルコキシ基、C2-C4アルコキシカルボニル基、S(O)、NR、ニトロ基又はシアノ基を表し、
    は、C1-C3アルキル基を表し、
    およびRは、各々独立して水素原子又はC1-C3アルキル基を表し、
    はC1-C3パーフルオロアルキル基又はS(O)-Rを表し、
    はC1-C3パーフルオロアルキル基を表し、
    nは0,1又は2を表し、
    mは0,1又は2を表し、
    pは0,1又は2を表す。]
    で示される縮合複素環化合物。
    Formula (1)
    Figure JPOXMLDOC01-appb-I000001

    [Where:
    A represents NCH 3 or an oxygen atom,
    R 1 is a hydrogen atom, a C1-C3 alkyl group optionally having one or more halogen atoms, a halogen atom, a C1-C3 alkoxy group, a C2-C4 alkoxycarbonyl group, S (O) m R 2 , NR 3 R 4 represents a nitro group or a cyano group,
    R 2 represents a C1-C3 alkyl group,
    R 3 and R 4 each independently represents a hydrogen atom or a C1-C3 alkyl group,
    R 5 represents a C1-C3 perfluoroalkyl group or S (O) p —R 6 ,
    R 6 represents a C1-C3 perfluoroalkyl group,
    n represents 0, 1 or 2,
    m represents 0, 1 or 2;
    p represents 0, 1 or 2. ]
    A condensed heterocyclic compound represented by
  2.  AがNCHである、請求項1記載の化合物。 The compound of claim 1, wherein A is NCH 3 .
  3.  Aが酸素原子である、請求項1記載の化合物。 The compound according to claim 1, wherein A is an oxygen atom.
  4.  Rが、水素原子、1個以上のハロゲン原子を有していてもよいC1-C3アルキル基、ハロゲン原子、C1-C3アルコキシ基、又はS(O)である請求項1~請求項3いずれか一に記載の化合物。 R 1 is a hydrogen atom, a C1-C3 alkyl group optionally having one or more halogen atoms, a halogen atom, a C1-C3 alkoxy group, or S (O) m R 2. Item 4. The compound according to any one of Items 3.
  5.  Rが、水素原子、塩素原子、臭素原子、メチル基、トリフルオロメチル基、メトキシ基、メチルスルファニル基、メチルスルフィニル基、又はメチルスルホニル基である請求項1~請求項3いずれか一に記載の化合物。 Wherein R 1 is a hydrogen atom, a chlorine atom, a bromine atom, a methyl group, a trifluoromethyl group, a methoxy group, methylsulfanyl group, according to claims 1 to 3 any one is methylsulfinyl group, or methylsulfonyl group Compound.
  6. が、トリフルオロメチル基又はS(O)-CF基である請求項1~請求項5いずれか一に記載の化合物。 The compound according to any one of claims 1 to 5 , wherein R 5 is a trifluoromethyl group or an S (O) p -CF 3 group.
  7.  請求項1~請求項6いずれかに記載の化合物と、不活性担体とを含有する有害生物防除組成物。 A pest control composition comprising the compound according to any one of claims 1 to 6 and an inert carrier.
  8.  請求項1~請求項6いずれかに記載の化合物の有効量を有害生物又は有害生物の生息場所に施用する有害生物の防除方法。 A method for controlling pests, wherein an effective amount of the compound according to any one of claims 1 to 6 is applied to pests or habitats of pests.
PCT/JP2015/066673 2014-06-26 2015-06-10 Condensed heterocyclic compound WO2015198859A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014-131038 2014-06-26
JP2014131038 2014-06-26

Publications (1)

Publication Number Publication Date
WO2015198859A1 true WO2015198859A1 (en) 2015-12-30

Family

ID=54937951

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2015/066673 WO2015198859A1 (en) 2014-06-26 2015-06-10 Condensed heterocyclic compound

Country Status (1)

Country Link
WO (1) WO2015198859A1 (en)

Cited By (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017025419A3 (en) * 2015-08-07 2017-04-06 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents
WO2017072039A1 (en) 2015-10-26 2017-05-04 Bayer Cropscience Aktiengesellschaft Condensed bicyclic heterocycle derivatives as pest control agents
WO2017146221A1 (en) * 2016-02-26 2017-08-31 日本農薬株式会社 Condensed heterocyclic compound having bonded heterocycles and salts thereof, agricultural/horticultural insecticide containing said compound, and method for using said insecticide
KR20170117079A (en) 2015-02-12 2017-10-20 닛산 가가쿠 고교 가부시키 가이샤 Condensed heterocyclic compound and noxious organism control agent
WO2018065288A1 (en) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonyl-methyl)-vinyl]-imidazo-[4,5-b] pyridine derivatives and related compounds as pesticides in plant protection
WO2018065292A1 (en) 2016-10-06 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents
WO2018091389A1 (en) 2016-11-17 2018-05-24 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2018130443A1 (en) 2017-01-10 2018-07-19 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
WO2018130437A1 (en) 2017-01-10 2018-07-19 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
WO2018138050A1 (en) 2017-01-26 2018-08-02 Bayer Aktiengesellschaft Condensed bicyclic heterocyclene derivatives as pest control agents
WO2018141954A1 (en) 2017-02-06 2018-08-09 Bayer Aktiengesellschaft Aryl or heteroaryl-substituted imidazo pyridine derivatives and their use as pesticides
WO2018141955A1 (en) 2017-02-06 2018-08-09 Bayer Aktiengesellschaft Process for preparing halogenated imidazopyridine derivatives
KR20180116303A (en) 2016-03-10 2018-10-24 닛산 가가쿠 가부시키가이샤 Condensed heterocyclic compounds and pesticides
WO2019008072A1 (en) 2017-07-05 2019-01-10 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
JP2019502713A (en) * 2016-01-11 2019-01-31 バイエル・クロップサイエンス・アクチェンゲゼルシャフト Heterocyclen derivatives as pest control agents
WO2019059244A1 (en) 2017-09-21 2019-03-28 日本農薬株式会社 Benzimidazole compound having cyclopropylpyridyl group or salt thereof, agricultural and horticultural pesticide containing said compound, and method of using said pesticide
KR20190038890A (en) * 2016-08-16 2019-04-09 바이엘 크롭사이언스 악티엔게젤샤프트 (3,6-dihalopyridin-2-yl) -3H-imidazole [4,5-c] pyridine derivative by reaction of 3H-imidazo [4,5-c] pyridine derivative with an organometallic zinc- ] Pyridine derivatives and related compounds
WO2019131576A1 (en) 2017-12-26 2019-07-04 住友化学株式会社 Pest control composition and use of same
WO2019234160A1 (en) 2018-06-06 2019-12-12 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
US10745398B2 (en) 2015-09-28 2020-08-18 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted fused heterocycle derivatives as pesticides
WO2020173861A1 (en) 2019-02-26 2020-09-03 Bayer Aktiengesellschaft Condensed bicyclic heterocyclic derivatives as pest control agents
WO2020173860A1 (en) 2019-02-26 2020-09-03 Bayer Aktiengesellschaft Fused bicyclic heterocycle derivatives as pesticides
CN112824402A (en) * 2019-11-21 2021-05-21 浙江省化工研究院有限公司 Benzimidazole derivative, preparation method and application thereof
WO2021213978A1 (en) 2020-04-21 2021-10-28 Bayer Aktiengesellschaft 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents
WO2022002818A1 (en) 2020-07-02 2022-01-06 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
WO2022238391A1 (en) 2021-05-12 2022-11-17 Bayer Aktiengesellschaft 2-(het)aryl-substituted condensed heterocycle derivatives as pest control agents
US11926623B2 (en) 2018-06-26 2024-03-12 Bayer Aktiengesellschaft Heterocycle derivatives as pesticides

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006516126A (en) * 2002-12-23 2006-06-22 イサグロ リチェルカ ソシエタ ア レスポンサビリタ リミタータ New uracil-related compounds with herbicidal activity
WO2009150095A1 (en) * 2008-06-12 2009-12-17 Syngenta Participations Ag Pesticidal compositions containing a pyrandione or a thiopyrandione or a cyclohexanetrione derivative
JP2010512360A (en) * 2006-12-14 2010-04-22 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 4-Phenylpyran-3,5-dione, 4-phenylthiopyran-3,5-dione and cyclohexanetrione as novel herbicides
JP2014005263A (en) * 2011-08-04 2014-01-16 Sumitomo Chemical Co Ltd Condensed heterocyclic compound and use thereof for pest control
JP2014111558A (en) * 2013-05-15 2014-06-19 Sumitomo Chemical Co Ltd Pest controlling composition and its use
WO2014125651A1 (en) * 2013-02-13 2014-08-21 Sumitomo Chemical Company, Limited Pest controlling composition and use thereof
WO2015002211A1 (en) * 2013-07-01 2015-01-08 住友化学株式会社 Fused heterocyclic compound and pest control use thereof

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006516126A (en) * 2002-12-23 2006-06-22 イサグロ リチェルカ ソシエタ ア レスポンサビリタ リミタータ New uracil-related compounds with herbicidal activity
JP2010512360A (en) * 2006-12-14 2010-04-22 シンジェンタ パーティシペーションズ アクチェンゲゼルシャフト 4-Phenylpyran-3,5-dione, 4-phenylthiopyran-3,5-dione and cyclohexanetrione as novel herbicides
WO2009150095A1 (en) * 2008-06-12 2009-12-17 Syngenta Participations Ag Pesticidal compositions containing a pyrandione or a thiopyrandione or a cyclohexanetrione derivative
JP2014005263A (en) * 2011-08-04 2014-01-16 Sumitomo Chemical Co Ltd Condensed heterocyclic compound and use thereof for pest control
WO2014125651A1 (en) * 2013-02-13 2014-08-21 Sumitomo Chemical Company, Limited Pest controlling composition and use thereof
JP2014111558A (en) * 2013-05-15 2014-06-19 Sumitomo Chemical Co Ltd Pest controlling composition and its use
WO2015002211A1 (en) * 2013-07-01 2015-01-08 住友化学株式会社 Fused heterocyclic compound and pest control use thereof

Cited By (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20170117079A (en) 2015-02-12 2017-10-20 닛산 가가쿠 고교 가부시키 가이샤 Condensed heterocyclic compound and noxious organism control agent
US10882869B2 (en) 2015-02-12 2021-01-05 Nissan Chemical Corporation Condensed heterocyclic compounds and pesticides
US10464950B2 (en) 2015-02-12 2019-11-05 Nissan Chemical Corporation Condensed heterocyclic compounds and pesticides
EP3896065A1 (en) 2015-08-07 2021-10-20 Bayer CropScience Aktiengesellschaft 2-(het)aryl-substituted condensed heterocycle derivatives as pesticides
WO2017025419A3 (en) * 2015-08-07 2017-04-06 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents
AU2016307233B2 (en) * 2015-08-07 2020-12-24 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents
US10986840B2 (en) 2015-08-07 2021-04-27 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted fused heterocycle derivatives as pesticides
CN108137548A (en) * 2015-08-07 2018-06-08 拜耳作物科学股份公司 The condensed heterocyclic derivates that 2- (miscellaneous) aryl as pesticide replaces
US10667517B2 (en) 2015-08-07 2020-06-02 Bayer Cropscience Aktiengesellschaft 2-(Het)aryl-substituted fused heterocycle derivatives as pesticides
EP3896066A2 (en) 2015-08-07 2021-10-20 Bayer CropScience Aktiengesellschaft 2-(het)aryl-substituted condensed heterocycle derivatives as pesticides
US10745398B2 (en) 2015-09-28 2020-08-18 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted fused heterocycle derivatives as pesticides
US10550116B2 (en) 2015-10-26 2020-02-04 Bayer Cropscience Aktiengesellschaft Fused bicyclic heterocycle derivatives as pesticides
WO2017072039A1 (en) 2015-10-26 2017-05-04 Bayer Cropscience Aktiengesellschaft Condensed bicyclic heterocycle derivatives as pest control agents
US10375962B2 (en) 2016-01-11 2019-08-13 Bayer Cropscience Aktiengesellschaft Heterocycle derivatives as pesticides
JP2019502713A (en) * 2016-01-11 2019-01-31 バイエル・クロップサイエンス・アクチェンゲゼルシャフト Heterocyclen derivatives as pest control agents
WO2017146221A1 (en) * 2016-02-26 2017-08-31 日本農薬株式会社 Condensed heterocyclic compound having bonded heterocycles and salts thereof, agricultural/horticultural insecticide containing said compound, and method for using said insecticide
US11208410B2 (en) 2016-02-26 2021-12-28 Nihon Nohyaku Co., Ltd. Heterocycle-bound condensed heterocyclic compound or salt thereof, agricultural and horticultural insecticide comprising the compound, and method for using the insecticide
US10544163B2 (en) 2016-03-10 2020-01-28 Nissan Chemical Corporation Condensed heterocyclic compounds and pesticides
KR20180116303A (en) 2016-03-10 2018-10-24 닛산 가가쿠 가부시키가이샤 Condensed heterocyclic compounds and pesticides
US10640518B2 (en) 2016-03-10 2020-05-05 Nissan Chemical Corporation Condensed heterocyclic compounds and pesticides
KR102420235B1 (en) 2016-08-16 2022-07-12 바이엘 크롭사이언스 악티엔게젤샤프트 2-(3,6-dihalopyridin-2-yl)-3H-imidazole[4,5-c by reaction of 3H-imidazole[4,5-c]pyridine derivative with organometallic zinc-amine base ]Pyridine derivatives and methods for preparing related compounds
KR20190038890A (en) * 2016-08-16 2019-04-09 바이엘 크롭사이언스 악티엔게젤샤프트 (3,6-dihalopyridin-2-yl) -3H-imidazole [4,5-c] pyridine derivative by reaction of 3H-imidazo [4,5-c] pyridine derivative with an organometallic zinc- ] Pyridine derivatives and related compounds
US11339155B2 (en) 2016-10-06 2022-05-24 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted fused bicyclic heterocycle derivatives as pesticides
WO2018065292A1 (en) 2016-10-06 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted condensed bicyclic heterocycle derivatives as pest control agents
WO2018065288A1 (en) 2016-10-07 2018-04-12 Bayer Cropscience Aktiengesellschaft 2-[2-phenyl-1-(sulfonyl-methyl)-vinyl]-imidazo-[4,5-b] pyridine derivatives and related compounds as pesticides in plant protection
WO2018091389A1 (en) 2016-11-17 2018-05-24 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulphur containing substituents
WO2018130437A1 (en) 2017-01-10 2018-07-19 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
WO2018130443A1 (en) 2017-01-10 2018-07-19 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
US11083199B2 (en) 2017-01-10 2021-08-10 Bayer Aktiengesellschaft Heterocycle derivatives as pesticides
US11058115B2 (en) 2017-01-10 2021-07-13 Bayer Aktiengesellschaft Heterocycle derivatives as pesticides
WO2018138050A1 (en) 2017-01-26 2018-08-02 Bayer Aktiengesellschaft Condensed bicyclic heterocyclene derivatives as pest control agents
WO2018141954A1 (en) 2017-02-06 2018-08-09 Bayer Aktiengesellschaft Aryl or heteroaryl-substituted imidazo pyridine derivatives and their use as pesticides
US10772332B2 (en) 2017-02-06 2020-09-15 Bayer Aktiengesellschaft 2-(het)aryl-substituted fused heterocycle derivatives as pesticides
WO2018141955A1 (en) 2017-02-06 2018-08-09 Bayer Aktiengesellschaft Process for preparing halogenated imidazopyridine derivatives
US11072609B2 (en) 2017-02-06 2021-07-27 Bayer Aktiengesellschaft Method for preparing halogenated imidazopyridine derivatives
WO2019008072A1 (en) 2017-07-05 2019-01-10 Syngenta Participations Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
WO2019059244A1 (en) 2017-09-21 2019-03-28 日本農薬株式会社 Benzimidazole compound having cyclopropylpyridyl group or salt thereof, agricultural and horticultural pesticide containing said compound, and method of using said pesticide
WO2019131576A1 (en) 2017-12-26 2019-07-04 住友化学株式会社 Pest control composition and use of same
WO2019234160A1 (en) 2018-06-06 2019-12-12 Syngenta Crop Protection Ag Pesticidally active heterocyclic derivatives with sulfur containing substituents
US11926623B2 (en) 2018-06-26 2024-03-12 Bayer Aktiengesellschaft Heterocycle derivatives as pesticides
WO2020173861A1 (en) 2019-02-26 2020-09-03 Bayer Aktiengesellschaft Condensed bicyclic heterocyclic derivatives as pest control agents
WO2020173860A1 (en) 2019-02-26 2020-09-03 Bayer Aktiengesellschaft Fused bicyclic heterocycle derivatives as pesticides
CN112824402A (en) * 2019-11-21 2021-05-21 浙江省化工研究院有限公司 Benzimidazole derivative, preparation method and application thereof
CN112824402B (en) * 2019-11-21 2023-02-28 浙江省化工研究院有限公司 Benzimidazole derivative, preparation method and application thereof
WO2021213978A1 (en) 2020-04-21 2021-10-28 Bayer Aktiengesellschaft 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents
WO2022002818A1 (en) 2020-07-02 2022-01-06 Bayer Aktiengesellschaft Heterocyclene derivatives as pest control agents
WO2022238391A1 (en) 2021-05-12 2022-11-17 Bayer Aktiengesellschaft 2-(het)aryl-substituted condensed heterocycle derivatives as pest control agents

Similar Documents

Publication Publication Date Title
JP6422941B2 (en) Fused heterocyclic compounds and their use for pest control
JP6060263B2 (en) Condensed oxazole compounds and their use for pest control
WO2015198859A1 (en) Condensed heterocyclic compound
JP6350528B2 (en) Fused heterocyclic compounds and their use for pest control
JP6168055B2 (en) Fused heterocyclic compounds
JP6493394B2 (en) Diaryl-azole compounds
JP6380375B2 (en) Fused heterocyclic compounds and their use for pest control
WO2013191188A1 (en) Fused heterocyclic compound
WO2014123206A1 (en) Condensed heterocyclic compound
WO2014123205A1 (en) Condensed heterocyclic compound
WO2014002754A1 (en) Amide compound and use thereof for pest control
WO2015087458A1 (en) Fused heterocyclic compound and pest control application thereof
WO2015146870A1 (en) Pyrimidine compound
WO2013191189A1 (en) Fused heterocyclic compound
JP2015189703A (en) Pyrimidine compound and its application to pest control
JP2015189704A (en) Pyrimidine compound and its application to pest control
JP2012102088A (en) Heteroaromatic ring compound and use thereof for pest control
JP2015086177A (en) Pyrazole compound and use thereof in pest control
JP2015086179A (en) Pyrazole compound and pest control use thereof
JP2015086178A (en) Pyrazole compound and use thereof in pest control
WO2015064725A1 (en) Pyrazole compound and pest control application thereof
JP2015086176A (en) Pyrazole compound and use thereof in pest control

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15812720

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: JP

122 Ep: pct application non-entry in european phase

Ref document number: 15812720

Country of ref document: EP

Kind code of ref document: A1